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ABSTRACT 
 
In this dissertation, the development of highly effective, chiral monofunctional and 
bifunctional hydrogen bond donor catalysts based on cobalt(III) Werner complexes and 
their applications in enantioselective catalysis have been described. Furthermore, a 
protocol was developed to extend this chemistry into the fluorous media. 
Section 1 provides an overview of the hydrogen bond mediated organocatalysis 
and the scope of Werner complexes as hydrogen bond donors. 
Section 2 describes the fundamental stereochemical features of the trication 
[Co(en)3]3+ (en = ethylenediamine). Interactions between the trication, counter anions, 
and solvates are analyzed and a systematic nomenclature is developed. 
Section 3 provides highly diastereoselective syntheses of variety of diastereopure 
salts Λ- and -[Co((S,S)-NH2CHArCHArNH2)3]3+ 2X–X'– (Ar = C6H5, 4-C6H4n-Bu, 4-
C6H4Cl, 4-C6H4CF3, 4-C6H4OCH3, -naphthyl, ß-naphthyl, 2-C6H4OBn; X/X' = 
Cl/BArf (BArf = B(3,5-C6H3(CF3)2)4), PF6/BArf, BF4/BArf, PhBF3/BArf, Cl/BArf20 
(BArf20 = B(C6F5)4), BArf/BArf, BArf20/BArf20, BF4/BF4, PF6/PF6) and probes their 
properties.  
Sections 4 and 5 provide detail applications of the lipophilic salts of Λ- or -
[Co((S,S)-dpen)3]3+ ((S,S)-dpen = (S,S)-1,2-diphenylethylenediamine) in enantioselect-
ive addition reactions. Under optimized conditions, Λ-[Co((S,S)-dpen)3]3+ 3BF4– 
catalyzes the Michael addition of dialkyl malonate to nitroalkenes in the presence of 
Et3N, affording adducts in up to 98% yields and 96% ee. Interestingly, -[Co((S,S)-
dpen)3]3+ 2Cl–BArf20– is superior for the additions of cyclic ß-ketoesters to 
azodicarboylate diesters (up to 99% yields and >99% ee). 
 iii 
 
Section 6 describes efficient syntheses of tris(hydrochloric acid) salts of chiral 
triamines H2NCH((CH2)nNMe2)CH2NH2 (n = 1-4) from commercial starting materials 
in overall yields of 38-18%.  
Section 7 highlights syntheses of bifunctional catalysts and their applications in 
additions of dialkyl malonates to nitroalkenes. Racemic [Co(en)2O2CO]+ Cl– and 
enantiopure (S)-[H3NCH((CH2)nNHMe2)CH2NH3]3+ 3Cl– (n = 1-4) are combined (wat-
er/charcoal/100 °C) to give [Co(en)2((S)-H2NCH((CH2)nNMe2H)CH2NH2)]4+ 4Cl–. 
The cobalt diastereomers () are separated via chiral Sephadex columns. Reactions 
with NaOH and Na+ BArf
– give the catalysts Λ- or -[Co(en)2((S)-H2NCH-
((CH2)nNMe2)CH2NH2)]3+ 3BArf–. Under optimized condition, Λ-[Co(en)2((S)-
H2NCH((CH2)3NMe2)CH2NH2)]3+ 3BArf– gives addition products up to 98% yield and 
99% ee. 
Section 8 describes an optimized procedure for the synthesis of highly fluorous 
Na+ B(3,5-C6H3((CF2)5CF3)2)4– and its application in transporting polycations into 
fluorous media. 
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NOMENCLATURE 
 
δ  chemical shift 
  molar extinction coefficient 
ν  stretching mode (IR) 
{1H}  proton decoupled 
Å  Angstrom 
Anal.  analysis 
Ar  aryl 
aq  aqueous 
Bn  benzyl 
br  broad 
Bz  benzoyl 
Bu  butyl 
Calcd.  calculated 
CD  circular dichroism 
chxn  1,2-cyclohexanediamine 
d  doublet (NMR), days 
dec  decomposition 
DMAP  dimethylamino pyridine 
dr  diastereomer ratio 
DMSO  dimethylsulfoxide 
dnen  dinaphthyl ethylenediamine 
dpen  1,2-diphenyl ethylenediamine 
ee  enantiomeric excess 
en  ethylenediamine 
Et  ethyl 
Et3N  triethylamine 
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EtOAc  ethyl acetate 
equiv  equivalent 
fac  facial 
h  hour 
HPLC  high pressure liquid chromatography 
Hz  hertz 
i  ipso, iso 
iJjk  scalar coupling constant for coupling of nucleus j with nucleus k 
through i bonds 
IR  infrared 
kcal  kilocalorie 
lel  parallel to the C3 axis 
M  mol/Liter 
m  multiplet (NMR), medium (IR) 
m  meta 
Me  methyl 
MeOH  methanol 
mer  meridional 
mg  milligram 
min  minutes 
mol  mole 
mmol  millimole 
mp  melting point 
NMM  N-methyl morpholine 
NMR  nuclear magnetic resonance 
o  ortho 
OAc  acetate 
ob  oblique to the C3 axis 
OTf  triflate 
 x 
 
p  para 
Ph  phenyl 
ppm  parts per million 
Pr  propyl 
q  quartet 
R  organic group 
rac  racemic 
rt  room temperature 
s  singlet (NMR), strong (IR) 
t  triplet 
t  tertiary 
temp  temperature  
TLC  thin layer chromatography 
UV  ultraviolet 
v/v  volume/volume 
vis  visible 
vs  very strong 
w  weak 
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1. INTRODUCTION  
 
1.1. Hydrogen bond mediated organocatalysis 
In the last twenty years, the field of organocatalysis has exploded from a few 
isolated reactions in the literature to a thriving new field of chemical research 
encompassing a broad range of useful transformations and unprecedented reactivities.1 
Organocatalysis is the process of acceleration of a chemical reaction with an organic 
compound that does not contain a metal atom in its active center2 or its ''primary'' 
catalytic cycle ― the bond forming and breaking steps of the reaction. This type of 
catalysis is complementary with the metal-complex mediated biocatalytic 
transformations. Preparative advantages of organocatalysts are notable: they are readily 
available from simple chiral feedstocks. Furthermore, the organocatalytic reactions can 
usually be performed under an aerobic atmosphere, with wet solvents, and in many cases 
protection of functional groups is not required.1 
Hydrogen bonding acts as a ubiquitous glue to sustain the intricate architecture 
and functionality of proteins, nucleic acids, and many supramolecular assemblies, and 
thus is responsible for the structure of much of the world around us.3 The enormous 
potential of hydrogen bonding for activating an intermediate has been recognized only 
recently. For example, catalysis by urea and thiourea derivatives through hydrogen 
bonding found momentum after the pioneering work of Curran who discovered that 
substoichiometic amounts of diarylurea (Ia) accelerated the Claisen rearrangement of 6-
methoxyallyl vinyl ether compared to the uncatalyzed reaction (Scheme 1.1).4 Soon 
thereafter asymmetric variants came into play. Besides urea (I) and thiourea (II), 
additional new hydrogen bond donor motifs like guanidine (III),5 squaramide (IV),6 
TADDOL (V),7 BINOL (VI),8 silanediols (VII)9 etc were also developed (Figure 1.1). 
 2 
 
Scheme 1.1. Claisen rearrangement in the presence of diarylurea Ia. 
 
 
Figure 1.1. Representative hydrogen bond donors 
 
 
 
The scope of applications for thiourea catalysts was considerably broadened by 
the introduction of an additional basic group. Takemoto et al. developed such a 
bifunctional organocatalyst which combined the quasi-Lewis acidic thiourea and a 
Brønsted basic tertiary amine. These two functionalities operate in a single chiral 
environment to generate a highly efficient catalyst that promotes the Michael addition of 
malonates to nitroolefins to afford products with high enantioselectivities (Scheme 
1.2).10 The authors also investigated the mechanism of this reaction and proposed a 
bifunctional mode of activation (TSa) of both the substrates by the catalyst. Later, 
another group suggested the alternative TSb (Scheme 1.2).11 
 3 
 
 
Scheme 1.2. Michael reaction catalyzed by chiral bifunctional thiourea IIa and two 
possible transition states for the reaction. 
 
 
 
1.2. Werner complexes as hydrogen bond donors 
There is currently much interest in chiral hydrogen bond donors as 
enantioselective catalysts for organic reactions.12 A variety of literature data suggest that 
many Werner cations with amine ligands are exceptional hydrogen bond donors to the 
anions and small molecules such as water (see Section 2).13 This hydrogen bonding 
pattern is conceptually similar to those of catalysts having thiourea backbones. Since 
octahedral cobalt(III) Werner cations are substitution inert and do not readily exchange 
ligands, activation and asymmetric induction must take place via the second-
coordination sphere involving hydrogen bonding to the NH2 moieties of the amine 
ligands. Thus, cobalt(III) Werner complexes were considered as possible metal-
containing hydrogen bond donor catalysts. The role of central metal cobalt(III) is 
 4 
altering the electronic properties of the ligand and fixing them in a defined position 
without being involved in any bond forming and breaking steps.  
When octahedral cobalt(III) Werner cations feature at least two chelating ligands, 
they are chiral, often termed "chiral-at-metal". Accordingly, in 2008 the Gladysz group 
reported that the classical Werner complexes of the type [Co(en)3]3+ (en = 
ethylenediamine), and related species provide a novel architecture for asymmetric 
hydrogen bond mediated catalysis.14 The Michael addition of dimethyl malonate to 2-
cyclopenten-1-one with a stoichiometric amount of Et3N was performed in the presence 
of 9 mol% Δ-[Co(en)3]3+ 3BArf–.14H2O (BArf = B(3,5-C6H3(CF3)2)4) in CH2Cl2 to 
give the addition product in 78% yield and 33% ee (Scheme 1.3). 
 
 
 
Scheme 1.3. Enantioselective Michael addition catalyzed by a chiral Werner type 
complex. 
 
 
 
Despite extensive optimization of reactions and screening of substrates, reactions 
with higher enantioselectivities could not be achieved. Thus, the first generation catalytic 
moiety [Co(en)3]3+ was modified to (1) the bulkier hexa(aryl) Werner cations of the 
formula [Co((S,S)-NH2CHArCHArNH2)3]3+ (Figure 1.2) and (2) bifunctional Werner 
cations [Co(en)2((S)-H2NCH((CH2)nNMe2)CH2NH2)]3+ in which one chelating 
diamine incorporates a pendant basic moiety (CH2)nNMe2 (Figure 1.2). It was thought 
 5 
that the fixed basic functionality might lead to a higher enantioselectivity as the reaction 
may occur through a highly organized transition state.  
 
 
 
 
Figure 1.2. First and second generation Werner cation catalysts. 
 
 
 
The syntheses of these types of second generation Werner complexes and their 
applications are described in the next sections.   
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2. HYDROGEN BONDING MOTIFS IN STRUCTURALLY 
CHARACTERIZED SALTS OF THE TRIS(ETHYLENEDIAMINE) 
COBALT TRICATION, [Co(en)3]3+† 
 
2.1. Introduction 
 The title complexes, Werner salts of the trication [Co(en)3]3+ (en = ethylene-
diamine), have always been a classroom favorite.1,2 However, until recently the 
emphasis has been on illustrating well understood physical phenomena that were 
established long ago. For example, the trication is chiral, as can easily be appreciated 
when the non-superimposable mirror images are represented in a "Star of David" motif 
as shown in Figure 2.1-A.3 The descriptors  and  are used to specify the cobalt 
configuration. The former indicates a left handed helix, consistent with the 
counterclockwise direction that the chelates must take in connecting the front and rear 
triangles in the left structure (Figure 2.1-A). The latter indicates a right handed helix, 
with the chelates taking a clockwise direction when connecting the front and rear 
triangles (right structure). The hydrogen atoms on each NH2 group are diastereotopic, 
and are sometimes distinguished as NHH'. 
 Salts of the types [Co(en)3]3+ yXz–, [Co(en)2(A—A)]n+ yXz–, and [Co(en)2(A—
B)]n+ yXz– were the first inorganic compounds to be resolved into enantiomers, as 
detailed by Werner in a series of five papers in 1911-1912.3 Several recipes have been 
applied to the trication [Co(en)3]3+.3e,4 The original procedure of Werner began with an 
aqueous solution of silver (R,R)-tartrate (2Ag+ (R,R)-tart2–), as shown in Scheme 2.1.3e  
 
 
†Reproduced with permission from Ghosh, S. K.; Ehnbom, A.; Lewis, K. G.; Gladysz, J. A. Coord. Chem. 
Rev. 2017, in press, doi: 10.1016/j.ccr.2017.04.002.  
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This led to the diastereomeric mixed chloride/tartrate salts - and -[Co(en)3]3+ Cl–
(R,R)-tart2–. The former crystallized as a pentahydrate, and the latter remained in 
solution. Chloride ion exchange then provided the resolved enantiomers - and -
[Co(en)3]3+ 3Cl–. Later, Broomhead replaced silver (R,R)-tartrate with the less 
expensive and more stable barium salt (Ba2+ (R,R)-tart2–).4a He also treated the 
intermediate chloride/tartrate salts with iodide ion, leading to - and -[Co(en)3]3+ 3I–. 
Additional variants, such as with antimony tartrate, have also been described.4b These 
procedures are so simple and forgiving that they are often used as undergraduate 
laboratory experiments. 
 Despite the chirality of the trication [Co(en)3]3+, symmetry elements are present. 
For example, there is a principal C3 axis that runs perpendicular to the plane of the paper 
and through the centers of the triangles in Figure 2.1-A. This axis is also easily 
visualized in the wire-frame representations in Figure 2.1-C, or the space filling analogs 
in Figure 2.1-D. There are furthermore three C2 axes in a perpendicular plane, parallel to 
that of the paper. One C2 axis is redirected perpendicular to the plane of the paper in 
Figures 2.1-E and 2.1-F. Together, the C3 and three C2 axes code for the chiral point 
group D3. Importantly, this symmetry requires that the three chelates either (1) be planar 
(which is not the case for ethylenediamine, but would be applicable to bipy, 1,10-
phenanthroline, and related ligands), or (2) have identical non-planar conformations. 
These issues are parsed in more detail elsewhere,5 and the non-planar conformations are 
analyzed further below. 
 10 
 
Figure 2.1. Representations of the enantiomeric - and -[Co(en)3]3+ trications. 
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Scheme 2.1. Resolution of the enantiomeric  and -[Co(en)3]3+ trications.3e,4a 
 
 
 
 Several recent developments have prompted renewed interest in salts of the 
trication [Co(en)3]3+ and related complexes. One has been the realization that the NH 
bonds associated with coordinated amines are capable of functioning as hydrogen bond 
donors towards Lewis basic organic substrates.6,7 Over the last 20 years, a number of 
H2N
H2N
N
N
N
H2
H2
N
Co
3+
3Cl– or Cl–SO4–
,-[Co(en)3]3+ 
3Cl– or Cl–SO4–
NH2
NH2
N
N    
  H2
N
H2
H2
N
Co
3+
Cl–
HO
CO2–
CO2–
HO
2Ag+
HO
CO2–
CO2–
HO
H2N
H2N
N
N
N
H2
H2
N
Co
3+
Cl–
HO
CO2–
CO2–
HO
2Ag+
(R,R)-tart2–
-[Co(en)3]3+ Cl–
(R,R)-tart2–·5H2O
NH2
NH2
N
N
N
H2
H2
N
Co
3+
3Cl–
3Cl–
-[Co(en)3]3+ 3Cl–·H2O
-[Co(en)3]3+ 3Cl–·H2O
1) HBr
2) Ag+ Cl–
1) HBr
2) Ag+ Cl–
HO
CO2–
CO2–
HO
or
NH2
NH2
N
N
N
H2
H2
N
Co
3+
3I–
-[Co(en)3]3+ 3I–·H2O
Na+ I–
Na+ I–
H2N
H2N
N
N
N
H2
H2
N
Co
3+
3I–
-[Co(en)3]3+ 3I–·H2O
Ba2+
Broomhead
Werner
Werner
WernerBa2+
(R,R)-tart2–
-[Co(en)3]3+ Cl–
(R,R)-tart2–(aq)
d-tart2– = (R,R)-tart2–
H
H2
H
H2
H2
H2
H2
H2
2 2
H2N
H2N
N
N
N
H2
H2
N
Co
3+
H2
H2
H2
H2
H2
 
Broomhead
Broomhead
 12 
chiral organic hydrogen bond donors have been found to be effective catalysts for a 
multitude of enantioselective transformations.8 Due to my work, the same is proving to 
be true for Werner complexes and related species.7,9-11  
 These results were to some extent foreshadowed by the resolution of enantiomers 
in Scheme 2.1. It is thought that the relative solubilities of the diastereomeric salts are 
primarily controlled by the strengths of the trication/tartrate hydrogen bonding 
interactions (stronger interaction = lower aqueous solubility). Thus, the resolution 
reflects the thermodynamic binding preference of a given cobalt configuration for a 
specific tartrate configuration. It has been established crystallographically that for 
diastereomeric tartrate salts of the tris(trans-1,2-cyclohexanediamine) cobalt trication, 
- and -[Co(S,S-chxn)3]3+ Cl–(R,R)-tart2–·2H2O, the more soluble diastereomer 
exhibits longer NH…O contacts and an unfavorable tartrate conformation.12,13  
 These investigators also conclude, in line with earlier analyses,14 that a similar 
scenario applies with tartrate salts of the tris(ethylenediamine) trication [Co(en)3]3+, 
where there is much crystallographic data.15 However, here comparisons must be made 
between diastereomers with different hydration levels and/or counteranions that 
accompany tartrate, per the mixed chloride and iodide salts in Scheme 2.1 (as well as 
crystals that contain more than one independent trication).15e Furthermore, some of 
these analyses involve crystal structures that have never been deposited in publically 
accessible databases (apparently not an editorial requirement for early papers in Chem. 
Lett.).16 Hence, certain published conclusions are difficult to independently assess. 
 Given the increasing numbers of enantioselective reactions catalyzed by tris(1,2-
diamine) cobalt(III) species,7 I sought to better understand the nature of hydrogen 
bonding to the [Co(en)3]3+ trication. In contrast to the many organic hydrogen bond 
donors applied in catalysis, which commonly feature one or two binding sites, 
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[Co(en)3]3+ contains twelve NH groups. As can be inferred from Figure 2.1, at least 
three of these, and more likely four or five, can be simultaneously accessed in transition 
state assemblies. As one approach to systematizing the possibilities, I, together with my 
collaborator for most of this section, decided to examine hydrogen bonding in crystalline 
salts of the formula [Co(en)3]3+ yXz– (y/z = 3/1, 1/3, 1.5/2), and analogous species with 
mixed anions. We wondered whether there might be recurring or "conserved" motifs – or 
rare and presumably disfavored motifs – that could provide guidance. 
 Indeed, over one hundred fifty crystal structures of such salts have been reported 
in the literature, and everyone, including those with anions that are poor hydrogen bond 
acceptors, show extensive hydrogen bonding in the solid state. An exhaustive list of 
structures is given in Table A-1 (Appendix), and several dozen representative complexes 
are examined in detail in sections 2.4.2-2.4.8 below. Nomenclature for classifying the 
various modes of hydrogen bonding is developed. 
2.2. Ethylenediamine ligand conformations 
 In order to thoroughly analyze the hydrogen bonding motifs, certain 
stereochemical features of ethylenediamine ligands must be briefly reviewed.5 With 
respect to the CH2CH2 backbone, a gauche orientation of the two NH2 groups (torsion 
angle 60°) would be expected to be much more stable than an eclipsed orientation 
(torsion angle ca. 0°). Thus, as illustrated by I and II in Figure 2.2, nonplanar chelate 
rings would be anticipated.  
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Figure 2.2. Chelate conformations of ethylenediamine. 
 
 
 
 For each Co(en) moiety, two nonsuperimposable mirror images are possible. 
These are commonly designated with the lower case Greek letters  and  and 
correspond to left handed and right handed helices, respectively.5,17 The 
counterclockwise and clockwise senses are illustrated with purple arrows in Figure 2.2. 
Each NH2 and CH2 group features one hydrogen atom that is pseudoaxial, and one that 
is pseudoequatorial. The axial and equatorial atoms rapidly exchange via "ring flips". 
Thus, the  and  conformers will readily equilibrate. However, in the absence of 
disorder, each chelate will crystallize in one conformation or the other. 
 Importantly, the conformation of the chelate affects the relative orientations of 
the CH2–CH2 bonds and the symmetry of the [Co(en)3]3+ trication. First, consider the 
"docking" of three  ethylenediamine units to give a trication with a  configuration at 
cobalt. The initial step is shown in Figure 2.3-A, and when all three chelates are in place, 
the structure represented as  results. Next, consider the docking of three  
ethylenediamine units to give a trication with the same  configuration at cobalt (i.e., an 
identical spatial orientation of chelating cobalt-nitrogen bonds). The initial step is shown 
in Figure 2.3-B. In order for the cobalt-nitrogen bond locations to "match up", the  
ethylenediamine must first be rotated by 90°. When all three chelates have been 
similarly put in place, a  structure results. 
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Figure 2.3. Accommodation of ethylenediamine ligands with three or three  
conformations in the coordination sphere of an octahedral cobalt atom with a  
configuration. 
 
 
 
 In the first or  structure (Figure 2.3-A), the  chelates are said to adopt lel 
orientations, so named because the three CH2–CH2 bonds are parallel to the C3 
symmetry axis.5,17 These linkages are often incorporated into Newman type projections, 
as indicated by hollow circles. In the second or  structure (Figure 2.3-B), the  
chelates are said to adopt ob orientations, so named because the three CH2–CH2 bonds 
are oblique to the C3 axis. The designations  and -lel3 (Figure 2.3-A) are both 
found in the literature, and can be used interchangeably. The same holds for  and 
-ob3. However, an important caveat follows below. 
 When the [Co(en)3]3+ trication has a  configuration at cobalt, these relation-
ships are reversed. A  chelate leads to an ob orientation while a  chelate results in a lel 
orientation. Furthermore, each of the three ethylenediamine ligands can independently 
adopt either an ob or lel orientation. Therefore, for a complex with a given cobalt 
configuration, four diastereomers exist. All possibilities are depicted in Figure 2.4. In 
contrast, in Figure 2.1 only the lel3 orientations of - and -[Co(en)3]3+ were depicted. 
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One motivation was to keep the number of structural variables to a minimum in the 
introduction; another was that, as will be seen below, lel chelate orientations dominate in 
the crystal structures. Indeed, a number of studies point to the lel3 form of each 
enantiomer being more stable than the ob3 form.17,18 Figure 2.4 also illustrates a "trap" 
or potential error in identifying enantiomers. Just like the descriptors R/S always identify 
enantiomers of compounds with a single tetrahedral carbon stereocenter, so will the  
 
 
 
 
Figure 2.4. All possible stereoisomers of the [Co(en)3]3+ trication. 
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family of descriptors consisting of upper/ lower case delta/lambda identify mirror image 
components of the [Co(en)3]3+ trication. In other words,  and  
stereoisomers can automatically be regarded as enantiomers.  
However, this is not the case with lel/ob. Instead, -lel3 and -ob3 stereoisomers 
are diastereomers, as is easily seen in the upper left and lower right structures in Figure 
2.4. Rather, -lel3 and -lel3 would designate enantiomers. Another way to view this is 
as follows: if the C3 axis is perpendicular to the plane of the paper, and one enantiomer 
is reflected in the plane of the paper to give the other, a "parallel" (lel) orientation of the 
CH2–CH2 bond with respect to the C3 axis must be preserved. For these reasons, I 
generally refer to lel/ob as "orientations" or "perspectives". 
In practice, the conformations of the ethylenediamine chelate rings rapidly 
interconvert in solution, and therefore the diastereomeric trications in Figure 2.4 will 
usually not be distinguishable. However, crystal structures will normally exhibit fixed 
motifs. Importantly, since the mixed lel/ob stereoisomers in Figure 2.4 have C2 
symmetry, they lack a formal C3 axis. Nonetheless, a comparable pseudo-C3 reference 
axis is available. This runs perpendicular to the two unique Star of David triangles that 
are comprised of one NH2 group from each of the three chelate rings. 
2.3. A syntax for hydrogen bonding to the trication [Co(en)3]3+ 
 Certain views provide instructive starting points for the hydrogen bond 
classifications that follow. Some are illustrated in Figure 2.5 for [Co(en)3]3+ with a 
 configuration (lel3, D3 symmetry). In Figure 2.5-B (middle row), the C3 
symmetry axis is (as usual) perpendicular to the plane of the paper and highlighted with 
two blue spheres above and below the plane. Three synperiplanar nitrogen-hydrogen 
bonds, one from each chelate and together defining a C3 binding site, point in the 
direction of the blue spheres. These NHH' units are also readily visualized in Figures 
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2.1-C,D; the  enantiomer of the former, a wire-frame representation, is repeated in 
Figure 2.5-B (right). The three orange spheres in Figure 2.5-B "hover" above the C2 
binding sites, each comprised of two nitrogen-hydrogen bonds from different chelates. 
These NHH' units are also readily visualized in Figures 2.1-E,F. 
 In Figure 2.5-A (top row), the structures in 1.5-B are rotated 90° about a vertical 
axis to bring the C3 axis into the plane of the paper. The second blue sphere associated 
with the C3 binding sites is now better visible, but in the interest of clarity all the atoms 
and bonds have been omitted. The wire-frame structures in Figures 2.5-B and 2.5-A 
provide alternative points of reference. Figure 2.5-C (bottom row) depicts a different 90° 
rotation of 2.5-B, now involving a horizontal axis. This nicely highlights each C3 
binding site with three vertically directed synperiplanar nitrogen-hydrogen bonds. The 
hydrogen atoms associated with the C2 binding sites are color coded; the symmetry 
relationship between the two depicted in red is particularly clear. 
 Various types of hydrogen bonding motifs for individual anions (or 
cocrystallized molecules) are summarized in Table 2.1, and "named" using the general 
formula [CWX][YZ] in Figure 2.5 (bottom). The terms comprising the formula are 
defined as follows: (a) CW denotes the origin of the NH hydrogen bond donor, the C3 
site or C2 site; (b) X denotes the number of acceptor atoms of the anion that are engaged 
by the NH hydrogen bond donor (default = 1); (c) Y denotes the number of acceptor 
atoms of the anion engaged by the NH hydrogen bond donor; (d) Z denotes the type of 
atom that is accepting the hydrogen bond, which is only included in cases of potential 
ambiguity, such as with ambident anions. For a given salt, there will be a set of such 
formulae, as illustrated in the examples that follow. 
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Table 2.1. Syntax for hydrogen bonding interactions between the [Co(en)3]3+ trication and anions or solvent molecules. 
Hydrogen bond motif C2 N-H C3 N-H Interligand C2,C3 N-H Intraligand (C2/C3) N-H
a Intraligand (C2//C3) N-H
b 
one N-H unit binds to 
anion at a single atom [C2][1] [C3][1] --- --- --- 
two N-H units bind to 
anion at a single atom [C2,C2][1] [C3,C3][1] [C3,C2][1] [(C3/C2)][1] [(C3//C2)][1] 
three N-H units bind to 
anion at a single atom --- [C3,C3,C3][1] 
[C3,C3,C2][1]
c or 
[C3,C2,C2][1]
c 
[C3,(C3/C2)][1]
c or 
[(C3/C2),C2][1]
c 
[C3,(C3//C2)][1]
c or 
[(C3//C2),C2][1]
c 
one N-H unit bind to 
anion at two different 
atoms 
[C2
2][2] [C3
2][2] --- --- --- 
two N-H units bind to 
anion at two different 
atoms 
[C2,C2][2] [C3,C3][2] [C3,C2][2] [(C3/C2)][2] [(C3//C2)][2] 
three N-H units bind to 
anion at two different 
atoms 
--- [C3,C3,C3][2] 
[C3,C3,C2][2] or 
[C3,C2,C2][2] 
[C3,(C3/C2)][2] or 
[(C3/C2),C2][2] 
[C3,(C3//C2)][2] or 
[(C3//C2),C2][2] 
one N-H unit binds to 
anion at three different 
atoms 
[C2
3][3] [C3
3][3] --- --- --- 
two N-H units bind to 
anion at three different 
atoms 
[C2
2,C2][3] [C3
2,C3][3] 
[C3,C2
2][3] or 
[C3
2,C2][3] 
[(C3
2/C2)][3] or 
[(C3/C2
2)][3] 
[(C3
2//C2)][3] or 
[(C3//C2
2)][3] 
three N-H units bind to 
anion at three different 
atoms 
--- [C3,C3,C3][3] 
[C3,C3,C2][3] or 
[C3,C2,C2][3] 
[C3,(C3/C2)][3] or 
[(C3/C2),C2][3] 
[C3,(C3//C2)][3] or 
[(C3//C2),C2][3] 
Miscellaneous motifs from Section 2.4 
three N-H units bind to 
anion at two different 
atoms with each atom of 
the anion making two 
hydrogen bonds 
 [C3
2,C3,C3][2,2:2]    
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Table 2.1. Continued. Syntax for hydrogen bonding interactions between the [Co(en)3]3+ trication and anions or solvent 
molecules. 
Hydrogen bond motif C2 N-H C3 N-H Interligand C2,C3 N-H Intraligand (C2/C3) N-H
a Intraligand (C2//C3) N-H
b 
three N-H units bind 
to anion at two 
different atoms, with 
one atom making two 
hydrogen bonds and 
the other making one. 
 [C3
2,C3,C3][1,3:2]    
a The N-H bonds are geminal (NH2; see Figure 2.6). 
b The N-H bonds involve different nitrogen atoms on the same ligand (see Figure 2.6). c Considering the 
substantial distance at which the third N-H unit will be from the other two, this will be a rare motif.
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Figure 2.5. Representations of the C2 and C3 binding sites of the -[Co(en)3]3+ 
trication, and a general nomenclature system for hydrogen bonding to a given anion. 
 
 
 
 Thus, when one N-H unit of a C2 site binds to an anion X– at a single acceptor 
atom, the representation [C2][1] is employed. For a corresponding interaction at a C3 
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H units via a single atom, representations such as [C2,C2][1], [C3,C3][1], and 
[C3,C3,C3][1] are employed. When such binding involves two distinct but like atoms of 
the anion, representations such as [C2,C2][2] and [C3,C3][2] may apply. When binding 
involves three distinct but like atoms of the anion, the representation [C3,C3,C3][3] may 
apply.  
 Of course, each like atom of an anion could make more than one hydrogen bond. 
Thus, there are additional manifolds of motifs along the lines of [C22,C2][2] (three 
hydrogen bonds between two N-H units of a C2 site and two like atoms of anion) or 
[C32,C32,C3][2] (five hydrogen bonds between three N-H units of a C3 site and two like 
atoms of an anion). A reader who would like to see these relationships developed in a 
more systematic as opposed to intuitive way should consult Tables A-1 and A-2 
(Appendix). The latter includes graphical representations. 
 It should also be possible for anions to hydrogen bond to both C2 and C3 sites. 
Complementary views of the three most likely motifs are depicted in Figure 2.6. First, 
the C2 and C3 N-H units can be on the same ethylenediamine ligand. The most easily 
conceptualized possibility involves the same NH2 group, as shown in Figure 2.6-A. In 
structures with crystallographic D3 symmetry (vide infra), this H…H distance is typically 
1.46 Å.19 Alternatively, hydrogen bonding could involve a pseudoequatorial C3 N-H 
unit of one NH2 group, and a pseudoaxial C2 N-H unit of the other (Figure 2.6-B). In 
structures with crystallographic D3 symmetry, this H…H distance is typically 3.73 Å.19b 
This is much longer than in the preceding example, but the atoms can easily be bridged 
by delocalized multidentate anions.  
As shown in Figure 2.6-C, the C2 and C3 N-H units can also be on different 
ethylenediamine ligands. In structures with crystallographic D3 symmetry, this H…H 
distance is typically 2.95 Å.19b With regard to nomenclature, these motifs are designated 
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as summarized in Figure 2.6. The binding sites are separated by commas for the 
interligand case ([C3,C2]), and one or two slashes for the intraligand cases ([C3/C2] for 
the shorter contact in Figure 2.6-A; [C3//C2] for the longer contact in Figure 2.6-B).20  
 
 
 
 
Figure 2.6. Anion binding modes involving hydrogen bonding to both the C2 and C3 
sites of the -[Co(en)3]3+ trication. 
 
 
 
 Some illustrative examples are presented in Figure 2.7 using the enantiomer of a 
nitrate salt analyzed below. In Figures 2.6-A-C, the nitrate anion occupies a position 
near the blue sphere in Figure 2.5-B – i.e., in the vicinity of the C3 site, but not 
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one N-H unit of the C3 site, and is thus designated [C3][1]. In Figure 2.7-B, one oxygen 
atom binds to the same N-H unit of the C3 site, and the same oxygen atom as well as a 
second one binds to a different N-H unit of the C3 site. This motif is designated 
[C32,C3][2].  
 In Figure 2.7-C, one oxygen atom is bound to all three N-H units of the C3 site. 
A second oxygen atom binds to one. This might have been designated [C32,C3,C3][2]. 
However, this would also be consistent with an alternative motif in which the two 
oxygen atoms each make two hydrogen bonds. Therefore it is designated 
[C32,C3,C3][1,3:2], with the alternative motif then being [C32,C3,C3][2,2:2]. The first 
two integers in the second square bracket represent the numbers of hydrogen bonds to 
each oxygen atom. 
Figures 2.6-D and 2.6-E involve nitrate anion binding to the C2 site. In the first, 
one oxygen atom is bound to one N-H unit of the C2 site, and the other to both N-H 
units. This motif is designated [C22,C2][2]. In the second, both oxygen atoms bind to 
both N-H units. This is designated [C22,C22][2].  
2.4. Overview of crystallographically characterized salts of the trication [Co(en)3]3+ 
2.4.1. General procedures and comments  
Table A-1 (Appendix) summarizes the 150 unique crystal structures containing 
the trication [Co(en)3]3+ that have been deposited in the Cambridge Structural Database 
(CSD). There are furthermore nineteen duplicate crystal structures, as listed in Table A-2 
(Appendix). Of the 150, six are lacking atomic coordinates, and in two the trication is 
severely disordered. Hence, 142 [Co(en)3]3+ salts are amenable to detailed analyses, and 
a few more to partial analyses. The 21 structures in the following sections 2.4.2-2.4.8 are 
representative. They are arranged in order of increasing charge and/or complexity of the 
counter anions.  
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Figure 2.7. Representative hydrogen bonding motifs for the -[Co(en)3]3+ 
trication (lel3, D3) and the nitrate anion. 
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 All anions as well as cocrystallized water molecules that hydrogen bond to a 
given trication are considered. In many cases, these species also hydrogen bond to 
adjacent trications. However, these are not enumerated. Rather, the priority is to 
visualize all second coordination sphere interactions about a single trication. 
 For determining the presence or absence of hydrogen bonds, the default 
parameters in the program Mercury21 have been employed. These take into account the 
van der Waals radius of the acceptor atom, so different atoms have different cutoff 
distances. Since hydrogen bonding is not an "all or nothing" property, the cutoff 
distances in the structures in sections 2.4.2-2.4.8 were increased by 5%. No additional 
hydrogen bonds were revealed.  
 Some of the crystal structures in sections 2.4.2-2.4.8 were determined using 
enantiopure -[Co(en)3]3+ salts, and others using racemates. In the latter cases, only the 
 enantiomers have been depicted. Crystal structures of enantiopure -[Co(en)3]3+ salts 
have also been determined, but these are less common (reflecting the manner that the 
resolution in Scheme 2.1 is most commonly applied). Only one example is presented in 
the text (2.4.7.2), and the  ratio in Table A-1 (Appendix) is 32:12 (21%/8%). 
 For all structures, two views are given. One is always labeled as along the C3 
axis, even though the idealized C3 axes evident in Figures 2.1-A-D translate in only a 
few cases to crystallographic C3 axes (for mixed lel/ob systems, this is denoted as a 
pseudo C3 axis; vide supra). The other is a view down one of the three C2 axes (or for 
mixed lel/ob systems, the only C2 axis). Again, in only a few cases do these correspond 
to crystallographic C2 axes. 
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2.4.2. Salts with three monoanions (point charge)  
Note that for cases in which the anion can be approximated as a point charge, the 
generalized hydrogen bonding nomenclature [CWX][YZ] (Figure 2.5) will reduce to 
[CWX][1].  
2.4.2.1. -[Co(en)3]3+ 3Cl–·2.8H2O (lel3) 
 
 
 
 
 
H-bond acceptor type of H-bond number of similar interactions 
Cl– [C3][1] 3 
Cl– [C2,C2][1] 3 
Cl– [C3,C3][1] 3 
Figure 2.8. Hydrogen bonding interactions in -[Co(en)3]3+ 3Cl–·2.8H2O (lel3) 
viewed along the C3 axis (left) and a C2 axis (right). 
 
 
 
The structure and hydrogen bonding interactions of the polyhydrated trichloride 
salt -[Co(en)3]3+ 3Cl–·2.8H2O (lel3) are shown in Figure 2.8.22 This represents 
one of the two enantiomers in the crystallographically characterized racemate. There is a 
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crystallographic C3 axis corresponding to the idealized C3 axis of the trication, and three 
crystallographic C2 axes that do not pass through a trication. All twelve N-H units 
engage in hydrogen bonding to nine Cl– anions. The two N-H units of all three C2 sites 
exhibit a single hydrogen bond to a chelating Cl– anion. Each N-H unit of one C3 site 
exhibits a single hydrogen bond to a non-chelating Cl– anion, and each N-H unit of the 
other C3 site exhibits two hydrogen bonds to two chelating Cl– anions. 
2.4.2.2. -[Co(en)3]3+ 3Cl– (lel3) 
 
 
 
 
H-bond acceptor type of H-bond number of similar interactions 
Cl– [C2,C2][1] 3 
Cl– [C3,C3][1] 6 
Figure 2.9. Hydrogen bonding interactions in -[Co(en)3]3+ 3Cl– (lel3) viewed 
along the C3 axis (left) and a C2 axis (right). 
 
 
 
The structure and hydrogen bonding interactions of -[Co(en)3]3+ 3Cl– 
(lel3) are shown in Figure 2.9.23 This represents one of the two enantiomers in the 
crystallographically characterized racemate. There is a crystallographic C3 axis corresp-
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onding to the idealized C3 axis of the trication, and three crystallographic C2 axes that 
do not pass through a trication. All twelve N-H units are engaged in hydrogen bonding 
with nine Cl– anions. The pattern is quite close to that of the previous structure (a 
polyhydrate), except that now each N-H unit of both C3 sites exhibits two hydrogen 
bonds to two chelating Cl– anions. 
2.4.2.3. -[Co(en)3]3+ 3Br–·H2O (lel3) 
 
 
 
 
 
H-bond acceptor type of H-bond number of similar interactions 
Br– [C2,C2][1] 2 
Br– [C3,C3,C3][1] 2 
H2O [C2,C2][1] 1 
Figure 2.10. Hydrogen bonding interactions in -[Co(en)3]3+ 3Br–·H2O (lel3) 
viewed along the C3 axis (left) and a C2 axis (right). 
 
 
 
The structure and hydrogen bonding interactions of the enantiopure monohydra-
ted bromide salt, -[Co(en)3]3+ 3Br–·H2O (lel3), are shown in Figure 2.10.24 All 
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twelve N-H units engage in hydrogen bonding to four Br– anions and one H2O molecule. 
There is a crystallographic C2 axis corresponding to one idealized C2 axis of the 
trication (right view). The three N-H units of each C3 site form a single hydrogen bond 
to a triply bridging Br– anion. The two N-H units of two C2 sites exhibit a single 
hydrogen bond to a chelating Br– anion. Those of the third C2 site exhibit a single 
hydrogen bond to a chelating H2O molecule.  
2.4.2.4. -[Co(en)3]3+ 3I–·H2O (oblel2) 
 
 
 
 
 
H-bond acceptor type of H-bond number of similar interactions 
I– [C2][1] 2 
I– [C2,C2][1] 2 
I– [C3][1] 2 
I– [C3,C3][1] 1 
H2O [C3][1] 1 
Figure 2.11. Hydrogen bonding interactions in -[Co(en)3]3+ 3I–·H2O (oblel2) 
viewed along the pseudo C3 axis (left) and the C2 axis (right). 
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The structure and hydrogen bonding interactions of the enantiopure monohydra-
ted iodide salt, -[Co(en)3]3+ 3I–·H2O (oblel2), are shown in Figure 2.11.25 
Although one might have thought that this complex would be isostructural with the 
preceding tribromide salt, it crystallizes instead in an oblel2 orientation – i.e., with one 
chelate in an ob as opposed to a lel conformation. Despite the lower symmetry, a pseudo 
C3 reference axis remains (vide supra). 
The trication forms hydrogen bonds to seven I– anions and one H2O molecule. In 
contrast to the preceding halide salts, only eleven N-H units are engaged in hydrogen 
bonding; one C3 N-H unit remains free. Some of the I– anions are singly hydrogen 
bonded, and others doubly; no pattern is apparent. The H2O molecule is engaged by one 
C3 N-H unit. 
2.4.3. Salts with three monoanions (delocalized)  
Now possibilities for the hydrogen bonding nomenclature [CWX][YZ] (Figure 
2.5) include [CWX][1Z] and [CWX][2Z] (and potentially but also much less frequently 
higher values of Y).  
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2.4.3.1. -[Co(en)3]3+ 3ReO4– (oblel2) 
 
 
 
      
H-bond acceptor type of H-bond number of similar interactions 
ReO4– [C2][1] 2 
ReO4– [C2,C2][1] 2 
ReO4– [C3][1] 1 
ReO4– [C3,C3][2] 2 
ReO4– [C32,C3,C3][3,1:2] 1 
Figure 2.12. Hydrogen bonding interactions in the -[Co(en)3]33+ 3ReO4– (oblel2) 
viewed along the pseudo C3 axis (left) and the C2 axis (right). Non-interacting oxygen 
atoms of the ReO4– anions have been omitted for clarity. 
 
 
 
 The structure and hydrogen bonding interactions of the enantiopure perrhenate 
salt, -[Co(en)3]3+ 3ReO4– (oblel2), are shown in Figure 2.12.26 As with 2.4.2.4, 
the complex crystallizes in an oblel2 orientation. All twelve N-H units are engaged in 
hydrogen bonding to eight ReO4– anions. The six C2 N-H units are singly hydrogen 
bonded to the oxygen atoms of four ReO4– anions (two chelating, two non chelating). 
Each C3 site interacts with two ReO4– anions, one of which chelates two N-H units via a 
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O-Re-O linkage. The remaining ReO4– anion is either singly hydrogen bonded to the 
third N-H unit, or quadruply hydrogen bonded to all three N-H units via a O-Re-O 
linkage. 
2.4.4. Salts with three monoanions (two types) 
2.4.4.1. -[Co(en)3]3+ Cl–2I–·H2O (lel3) 
 
 
 
       
H-bond acceptor type of H-bond number of similar interactions 
I– [C2,C2][1] 3 
I– [C3,C3][1] 3 
Cl– [C3,C3][1] 3 
Figure 2.13. Hydrogen bonding interactions in -[Co(en)3]3+ Cl–2I–·H2O (lel3) 
viewed along the C3 axis (left) and a C2 axis (right). 
 
 
 
 The structure and hydrogen bonding interactions of the mixed chloride/diiodide 
salt, -[Co(en)3]3+ Cl–2I–·H2O (lel3) are shown in Figure 2.13.27 This represents 
one of the two enantiomers in the crystallographically characterized racemate. All 
twelve N-H units are engaged in hydrogen bonding to six I– anions and three Cl– anions. 
At one C3 site, all three N-H units are doubly hydrogen bonded to one of three Cl– 
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anions. On the opposite C3 site, all three N-H units are doubly hydrogen bonded to one 
of three I– anions. The former motif was seen in the trichloride salts in 2.4.2.1 and 
2.4.2.2, but the latter was not seen in the triiodide salt in 2.4.2.4. The two N-H units of 
each C2 site chelate to a single I– anion. 
2.4.5. Salts with two anions (one monoanion and one dianion) 
2.4.5.1. -[Co(en)3]3+ B5O6(OH)4–B8O10(OH)62–·5H2O (oblel2). The 
structure and hydrogen bonding interactions of the pentahydrated bis(borate) salt, 
-[Co(en)3]3+ B5O6(OH)4–B8O10(OH)62–·5H2O (oblel2) are shown in Figure 
2.14.28 This represents one of the two enantiomers in the crystallographically 
characterized racemate. As with 2.4.2.4, the complex crystallizes in an oblel2 orientat-
ion. All twelve N-H units are engaged in hydrogen bonding to two octaboron dianions 
and three pentaboron monoanions. 
All three C2 sites exhibit different hydrogen bonding motifs. The two N-H units 
of one make separate hydrogen bonds to a H2O molecule and a B5O6(OH)4– monoanion. 
The two N-H units of another make a total of three hydrogen bonds to a B5O6(OH)4– 
monoanion. The two N-H units of the third chelate a H2O molecule, and make a third 
hydrogen bond to a B8O10(OH)62– dianion. This initiates a very unique motif, as this 
dianion further hydrogen bonds to two N-H units of a C3 site; one involves a O-B-O 
chelate interaction with the same ethylenediamine ligand (see Figure 2.6-A), and the 
other a B-O-H interaction with a different ethylenediamine ligand (see Figure 2.6-C). 
This may provide a model for the interactions of Lewis basic substrates with an extended 
catalytic site, or the binding of a multifunctional product. Two N-H units on this site also 
chelate to an oxygen atom of a B5O6(OH)4– monoanion. The three N-H units of the 
remaining C3 site make a total of three hydrogen bonds to two oxygen atoms of another 
B8O10(OH)62– dianion. 
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H-bond acceptor type of H-bond number of similar interactions 
B5O6(OH)4– [C2][1] 1 
B5O6(OH)4– a [C22,C2][2] 1 
B5O6(OH)4– [C3,C3][1] 1 
B8O10(OH)62– a [C3,C3,C3][2] 1 
B8O10(OH)62– b [(C32/C2),C3][3] 1 
H2O [C2][1] 1 
H2O [C2,C2][1] 1 
a Two of the hydrogen bonds involve BOB linkages, and one a BOH linkage. b Two of the hydrogen 
bonds involve BOB linkages, and two BOH linkages. 
Figure 2.14. Hydrogen bonding interactions in -[Co(en)3]3+ B5O6(OH)4–
B8O10(OH)62–·5H2O (oblel2) viewed along the pseudo C3 axis (left) and the C2 axis 
(right). The larger borate dianion is colored orange and the smaller borate monoanion is 
colored light green. In both cases, some non-interacting atoms have been omitted for 
clarity. 
 
 
 
2.4.6. Salts with achiral dianions 
2.4.6.1. -[Co(en)3]3+ 1.5C4O42–·4.5H2O (oblel2). The structure and 
hydrogen bonding interactions of the polyhydrated squarate salt, -[Co(en)3]3+ 
1.5C4O42–·4.5H2O (oblel2), are shown in Figure 2.15.29 This represents one of the two 
enantiomers in the crystallographically characterized racemate. As with 2.4.2.4, 2.4.3.1, 
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and 2.4.5.1, the complex crystallizes in an oblel2 orientation. All twelve N-H units are 
engaged in hydrogen bonding to five C4O42– dianions and two H2O molecules. One C3 
site is occupied by one C4O42– dianion, two oxygen atoms of which each make two 
hydrogen bonds (two to one N-H unit, one to two N-H units). The other C3 site is 
occupied by two C4O42– dianions; two oxygen atoms of one dianion chelate two N-H 
units, and one oxygen atom of the other bonds to the remaining N-H unit. For two C2 
sites, both N-H units chelate to two oxygen atoms of a C4O42– dianion. For the third, 
each N-H unit is singly hydrogen bonded to separate H2O molecules. 
 
 
 
              
H-bond acceptor type of H-bond number of similar interactions 
C4O42– [C2,C2][2] 2 
C4O42– [C3][1] 1 
C4O42– [C3,C3][2] 1 
C4O42– [C32,C3,C3][2,2:2] 1 
H2O [C2][1] 2 
Figure 2.15. Hydrogen bonding interactions in -[Co(en)3]3+ 1.5C4O42–·4.5H2O 
(oblel2) viewed along the pseudo C3 axis (left) and the C2 axis (right). Several non-
interacting atoms of the squarate anions have been omitted for clarity. 
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2.4.6.2. -[Co(en)3]3+·1.5C5O52–·3H2O (lelob2) 
 
 
 
    
H-bond acceptor type of H-bond number of similar interactions 
C5O52– [C3,C2][1] 1 
C5O52– [C2,C2][2] 1 
C5O52– [C3,C2][2] 1 
C5O52– [C3,C3][2] 1 
C5O52– [C32,C3,C3][3,1:2] 1 
H2O [C2][1] 2 
Figure 2.16. Hydrogen bonding interactions in -[Co(en)3]3+·1.5C5O52–·3H2O 
(lelob2) viewed along the pseudo C3 axis (left) and the C2 axis (right). Several atoms of 
the C5O52– dianions have been omitted for clarity. 
 
 
 
The structure and hydrogen bonding interactions of the trihydrated croconate salt, 
-[Co(en)3]3+·1.5C5O52–·3H2O (lelob2), are shown in Figure 2.16.30 The cyclic 
croconate dianion is the next higher homolog of squarate. Figure 2.16 shows one of the 
two enantiomers in the crystallographically characterized racemate. This is the only salt 
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presented in the text in which the trication [Co(en)3]3+ crystallizes in a lelob2 
orientation.  
All twelve N-H units are engaged in hydrogen bonding to five C5O52– dianions 
and two H2O molecules. The two N-H units of one C2 site each hydrogen bond to 
separate H2O molecules. The N-H units of another C2 site chelate a O-C-C-O linkage of 
a C5O52– dianion. The N-H units of the third C2 site each hydrogen bond to a single 
oxygen atom of separate C5O52– dianions. However, in a rare motif, one of these oxygen 
atoms further hydrogen bonds to a N-H unit of a C3 site. This involves two different 
ethylenediamine ligands, per Figure 2.6-C. With the other C5O52– dianion, a second 
oxygen atom hydrogen bonds to a N-H unit of the opposite C3 site. This also involves 
two different ethylenediamine ligands, but now the N-H units are spanned by four atoms 
as opposed to one. An additional C5O52– dianion completes the hydrogen bonding at 
each C3 site (one uses two oxygen atoms to chelate two N-H units, and the other uses 
two oxygen atoms to make four hydrogen bonds involving all three N-H units). 
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2.4.7. Salts with chiral tartrate dianions  
As noted above, there is a series of papers in which the relative ability of a given 
enantiomer of the trication [Co(en)3]3+ or substituted derivatives to hydrogen bond to a 
given enantiomer of the tartrate dianion is critiqued.12-15 The analyses that follow are 
restricted to the modes of hydrogen bonding. 
2.4.7.1. -[Co(en)3]3+ Cl–(R,R)-tart2–·5H2O (lel3) 
 
 
 
      
 
H-bond acceptor type of H-bond number of similar interactions 
(R,R)-tart2– [C22,C2][2] 1 
(R,R)-tart2– [C33,C32,C32][2,2,2,1:4] 1 
Cl– [C3,C3,C3][1] 1 
H2O [C2][1] 2 
H2O [C2,C2][1] 1 
Figure 2.17. Hydrogen bonding interactions in -[Co(en)3]3+ Cl–(R,R)-tart2–
·5H2O (lel3) viewed along the C3 axis (left) and a C2 axis (right). Most non-interacting 
atoms of the tartrate dianions have been omitted for clarity. 
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The structure and hydrogen bonding interactions of the enantiopure 
pentahydrated mixed chloride/tartrate salt, -[Co(en)3]3+ Cl–(R,R)-tart2–·5H2O 
(lel3), are shown in Figure 2.17.15a All twelve N-H units are engaged in hydrogen 
bonding to two (R,R)-tart2– dianions, one Cl– anion, and two H2O molecules. At one C3 
site, all three N-H units hydrogen bond to a single chloride ion, a motif seen in 2.4.2.3 
above. At the other, the three N-H units bind to four oxygen atoms of a single (R,R)-
tart2– dianion (O=C-CHOH-CHOH-C=O) via a total of seven hydrogen bonds. At one 
C2 site, the two N-H units make three hydrogen bonds to the two oxygen atoms of a 
carboxylate group. At the other C2 sites, there is hydrogen bonding either to one (chel-
ating) or two (non-chelating) H2O molecules. 
2.4.7.2. -[Co(en)3]3+ 1.5(R,R)-tart2–·5.75H2O (lel3). The structure and 
hydrogen bonding interactions of the enantiopure polyhydrated tartrate salt, 
[Co(en)3]3+ 1.5(R,R)-tart2–·5.75H2O, are shown in Figure 2.18.15e This 
complex lacks the chloride anion found in the previous example 2.4.7.1. There are two 
independent trications in the unit cell, which are linked as shown at the top of Figure 
2.18, and separately depicted in the middle and bottom. Of the N-H units, ten and twelve 
are engaged in hydrogen bonding, respectively. 
 With the first trication (middle), all three C2 sites are different. In one, the two N-
H units chelate a H2O molecule. In another, the N-H units make three hydrogen bonds to 
two oxygen atoms of a carboxylate group. In the third, there is no hydrogen bonding, 
which is unique to all the structures surveyed. Each of the C3 sites is occupied by a 
single tartrate dianion. In one, the three N-H units make a total of six hydrogen bonds to 
three oxygen atoms (O=C-CHOH-CHOH). In the other, the three N-H units make five 
hydrogen bonds to the two oxygen atoms of a carboxylate group. 
 
 
 41 
 
  
 
H-bond acceptor type of H-bond number of similar interactions 
(R,R)-tart2– [C22,C2][2] 1 
(R,R)-tart2– [C32,C32,C3][3,2:2] 1 
(R,R)-tart2– [C32,C32,C32][2,2,2:3] 1 
H2O [C2,C2][1] 1 
Figure 2.18. Hydrogen bonding interactions in the two independent trications of -
[Co(en)3]3+ 1.5(R,R)-tart2–·5.75H2O (lel3) viewed along the C3 axis (left middle, left 
bottom) and a C2 axis (right middle, right bottom), or as linked together (top). In the 
middle and bottom representations, most non-interacting atoms of the tartrate dianions 
have been omitted for clarity.  
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H-bond acceptor type of H-bond number of similar interactions 
(R,R)-tart2– [C22,C2][2] 2 
(R,R)-tart2– [C32,C32,C3][3,2:2] 1 
(R,R)-tart2– [C33,C32,C32][2,2,2,1:4] 1 
H2O [C2][1] 1 
H2O [C2,C2][1] 1 
Figure 2.18 Continued.  
 
 
 
With the second trication (bottom), the two N-H units of two C2 sites each make 
three hydrogen bonds to two oxygen atoms of a carboxylate group.31 The N-H units of 
the remaining C2 site make three hydrogen bonds to two H2O molecules (one chelating, 
one not). Each of the C3 sites is again occupied by a single tartrate dianion. In one, the 
three N-H units make a total seven hydrogen bonds to four oxygen atoms (O=C-CHOH-
CHOH-C=O); an identical motif was observed in 2.4.7.1. In the other (as in the 
independent trication), the three N-H units make five hydrogen bonds to the two oxygen 
atoms of a carboxylate group. 
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2.4.7.3. -[Co(en)3]3+ 1.5(R,R)-tart2–·9.5H2O (lel3). The structure and 
hydrogen bonding interactions of the enantiopure polyhydrated tartrate salt, -
[Co(en)3]3+ 1.5(R,R)-tart2–·9.5H2O (lel3), are shown in Figure 2.19.15e This is simply a 
different hydrate – sometimes called a pseudopolymorph32 – of the salt in 2.4.7.2. As 
with 2.4.7.3, there are two independent trications in the unit cell, which are depicted in 
the top and bottom of Figure 2.19. The hydrogen bonding motifs do not break any new 
ground vis-à-vis the previous structure. Of the N-H units, eleven and twelve are engaged 
in hydrogen bonding, respectively. 
 
 
 
 
 
H-bond acceptor type of H-bond number of similar interactions 
H2O [C2][1] 2 
H2O [C2,C2][1] 1 
(R,R)-tart2– [C22,C2][2] 2 
(R,R)-tart2– [C3,C3][2] 1 
(R,R)-tart2– [C32,C32,C32][2,2,2:3] 1 
Figure 2.19. Hydrogen bonding interactions in the two independent trications of -
[Co(en)3]3+ 1.5(R,R)-tart2–·9.5H2O (lel3) viewed along the C3 axis (left) and a C2 axis 
(right). Most non-interacting atoms of the tartrate dianions have been omitted for clarity.  
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H-bond acceptor type of H-bond number of similar interactions 
H2O [C2][1] 2 
H2O [C2,C2][1] 1 
(R,R)-tart2– [C22,C2][2] 1 
(R,R)-tart2– [C32,C32,C3][2,2,1:3] 1 
(R,R)-tart2– [C32,C32,C32][2,2,2:3] 1 
Figure 2.19 Continued.  
 
 
 
For the first independent cation (top), two N-H units of one C3 site chelate the O-
C-O linkage of a carboxylate group; the third N-H unit exhibits no hydrogen bonding. 
The three N-H units of the other C3 site make a total of six hydrogen bonds to three 
oxygen atoms of a tartrate dianion (O=C-CHOH-CHOH). The two N-H units of two C2 
sites each make three hydrogen bonds to the two oxygen atoms of separate carboxylate 
groups. In the third C2 site, each N-H unit hydrogen bonds to an oxygen atom of a 
separate H2O molecule. 
For the second independent trication (bottom), three N-H units of one C3 site 
make (as in the other trication) a total of six hydrogen bonds to three different oxygen 
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atoms of a tartrate dianion (O=C-CHOH-CHOH). The three N-H units of the other C3 
site make five hydrogen bonds to the same three oxygen atoms of a second tartrate 
dianion. The two N-H units of one C2 site make a total three hydrogen bonds to the two 
oxygen atoms of a carboxylate. In another C2 site, the N-H units chelate an oxygen atom 
of a disordered H2O molecule. In the third C2 site, each N-H unit hydrogen bonds to an 
oxygen atom of a separate H2O molecule. 
2.4.8. Salts with one trianion 
2.4.8.1. -[Co(en)3]3+ AsO43–·3H2O (lel3) 
 
 
 
     
 
H-bond acceptor type of H-bond number of similar interactions 
AsO43– [C3,C3,C3][3] 1 
AsO43– [C2,C2][1] 3 
H2O [C3][1] 3 
Figure 2.20. Hydrogen bonding interactions in -[Co(en)3]3+ AsO43–·3H2O (lel3) 
viewed along the C3 axis (left) and a C2 axis (right). Non-interacting oxygen atoms of 
the arsenate trianion have been omitted for clarity. 
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The structure and hydrogen bonding interactions of the trihydrated arsenate salt, 
-[Co(en)3]3+ AsO43–·3H2O (lel3) are shown in Figure 2.20.33 This represents one 
of the two enantiomers in the crystallographically characterized racemate. There is a 
crystallographic C3 axis corresponding to the idealized C3 axis of the trication. All 
twelve N-H units engage in hydrogen bonding to four arsenate anions and three H2O 
molecules. The AsO43– trianions exhibit only two hydrogen bonding motifs. The two N-
H units of all three C2 sites chelate to an AsO43– oxygen atom. The three N-H units of 
one C3 site each hydrogen bond to a different oxygen atom of the AsO43– anion. In the 
other C3 site, each N-H unit hydrogen bonds to the oxygen atom of a separate H2O 
molecule. 
2.4.8.2. -[Co(en)3]3+ AsS43– (oblel2). The structure and hydrogen bonding 
interactions of the tetrathioarsenate(V) salt, -[Co(en)3]3+ AsS43– (oblel2) are 
shown in Figure 2.21.34 This represents one of the two enantiomers in the 
crystallographically characterized racemate. As with 2.4.2.4, 2.4.3.1, 2.4.5.1, and 2.4.6.1 
above, the complex crystallizes in an oblel2 orientation. There is a crystallographic C2 
axis, but it does not correspond to the idealized C2 axis of the trication. All twelve N-H 
units engage in hydrogen bonding to five AsS43– trianions. Each of the three N-H units 
of each C3 site hydrogen bond to one of two sulfur atoms of a AsS43– trianion. The two 
N-H units of each C2 site hydrogen bond either to two sulfur atoms of a AsS43– trianion, 
or the same sulfur atom. 
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H-bond acceptor type of H-bond number of similar interactions 
AsS43– [C2,C2][1] 2 
AsS43– [C2,C2][2] 1 
AsS43– [C3,C3,C3][2] 2 
Figure 2.21. Hydrogen bonding interactions in -[Co(en)3]3+ AsS43– (oblel2) 
viewed along the pseudo C3 axis (left) and the C2 axis (right). Non-interacting sulfur 
atoms of the tetrathioarsenate trianion have been omitted for clarity. 
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2.4.8.3. -[Co(en)3]3+ GaF63– (lel3) 
 
 
 
    
H-bond acceptor type of H-bond number of similar interactions 
GaF63– [C2,C2][2] 3 
GaF63– [C32,C32,C32][2,2,2:3] 2 
Figure 2.22. Hydrogen bonding interactions in -[Co(en)3]3+ GaF63– viewed along 
the C3 axis (left) and a C2 axis (right). Non-interacting fluorine atoms of the 
hexafluorogallate trianion have been omitted for clarity. 
 
 
 
The structure and hydrogen bonding interactions of the enantiopure 
hexafluorogallate salt, -[Co(en)3]3+ GaF63– (lel3), are shown in Figure 2.22.35 
There are crystallographic C3 and C2 axes corresponding to the idealized C3 and C2 axes 
of the trication. All twelve N-H units engage in hydrogen bonding to five GaF63– 
trianions. The three N-H units of each C3 site each bind to two of three fac oriented 
fluoride ions of a single GaF63– trianion. The two N-H units of each C2 site each bind to 
two (cis) fluoride ions of a single GaF63– trianion. 
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2.4.8.4. -[Co(en)3]3+ Co(CN)63–·5H2O (oblel2) 
 
 
 
    
H-bond acceptor type of H-bond number of similar interactions 
H2Oa [C2][1] 4 
H2O [C3][1] 2 
H2O [C2,C2][1] 1 
Co(CN)63– [C2][1N] 2 
Co(CN)63– [C3,C3,C3][1N] 2 
a Although this salt has a stoichiometry of five H2O molecules per trication, there are seven H2O 
molecules in the second coordination sphere, four of which are shared with neighboring trications and 
disordered over two positions (each highlighted with an "X"). 
Figure 2.23. Hydrogen bonding interactions in -[Co(en)3]3+ Co(CN)63–·5H2O 
(oblel2) viewed along the pseudo C3 axis (left) and the C2 axis (right). Except for the 
interacting CN units, the Co(CN)63– trianions have been omitted for clarity. Disordered 
H2O molecules are denoted with an X. 
 
 
 
The structure and hydrogen bonding interactions of the pentahydrated 
hexacyanocobaltate salt, -[Co(en)3]3+ Co(CN)63–·5H2O (oblel2) are shown in 
Figure 2.23.36 This represents one of the two enantiomers in the crystallographically 
characterized racemate. As with 2.4.2.4, 2.4.3.1, 2.4.5.1, 2.4.6.1, and 2.4.8.2, the 
complex crystallizes in an oblel2 orientation. Although some disorder is apparent as 
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described in the following paragraph, there is a crystallographic C2 axis corresponding 
to the idealized C2 axis of the trication (right view). 
The three N-H units of each C3 site are hydrogen bonded to the same nitrogen 
atom of a cyanide ligand. In addition, one N-H unit of each C3 site also hydrogen bonds 
to the oxygen atom of a H2O molecule. The two N-H units of two C2 sites are separately 
hydrogen bonded to a H2O molecule and the nitrogen atom of a cyanide ligand. The N-H 
units of the third C2 site bind three H2O molecules (one chelating, two not). The four 
non-chelating H2O molecules associated with the C2 sites (labeled with "X" in Figure 
2.23) are disordered over two positions, and furthermore engage in hydrogen bonding 
with the N-H units of neighboring trications.  
2.4.8.5. -[Co(en)3]3+ -Rh(C2O4)33– (lel3). The structure and hydrogen 
bonding interactions of the enantiopure -tris(oxalate)rhodate(III) salt, -
[Co(en)3]3+ -Rh(C2O4)33– (lel3), are shown in Figure 2.24.37 Note that the tris(chelate) 
trianion now also has helical (/) chirality. The crystal structure bears a number of 
similarities to that of the arsenate salt in 2.4.8.1. There is a crystallographic C3 axis 
corresponding to the idealized C3 axis of the trication (which also contains the C3 axis of 
the trianion). All twelve N-H units are engaged in hydrogen bonding to five trianions in 
one of two motifs. The two N-H units of all three C2 sites chelate to a carbonyl oxygen 
atom of an oxalate ligand. The three N-H units of each C3 site each bind to two of three 
fac oriented Rh-O linkages. 
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H-bond acceptor type of H-bond number of similar interactions 
-Rh(C2O4)33– [C2,C2][1] 3 
-Rh(C2O4)33– [C32,C32,C32][2,2,2:3] 2 
Figure 2.24. Hydrogen bonding interactions in -[Co(en)3]3+ -Rh(C2O4)33– 
(lel3) viewed along the C3 axis (left) and a C2 axis (right). Non interacting atoms of the 
trianion have been omitted for clarity. 
 
 
 
2.4.8.6. -[Co(en)3]3+-Rh(C2O4)33– (lel3). The structure and hydrogen 
bonding interactions of the enantiopure -tris(oxalate)rhodate(III) salt, -
[Co(en)3]3+ -Rh(C2O4)33– (lel3), are shown in Figure 2.25.37 This complex is 
diastereomeric with that in 2.4.8.5 (opposite Rh(C2O4)33– chirality), and has an identical 
degree of hydration. As is easily seen with a quick glance at the "type of H-bond" entries 
in Figures 2.24 and 2.25, the second coordination spheres markedly differ, with only one 
type of hydrogen bond (a single [C2,C2][1] linkage) common to each. 
All twelve N-H units are engaged in hydrogen bonding to six trianions. The three 
C2 sites exhibit different motifs. In one, the two N-H units chelate a carbonyl oxygen 
atom of an oxalate ligand. In another, the two N-H units make a total of three hydrogen  
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H-bond acceptor type of H-bonda number of similar interactions 
-Rh(C2O4)33– [C3][1] 1 
-Rh(C2O4)33– [C2,C2][1] 1 
-Rh(C2O4)33– [C2,C2][2] 1 
-Rh(C2O4)33– [C22,C2][2] 1 
-Rh(C2O4)33– [C32,C3][2] 1 
-Rh(C2O4)33– [C3,C3,C3][3] 1 
a The CIF file for this molecule did not indicate any hydrogen atoms. Hence, they were introduced in 
idealized positions using the program Olex2.38 
Figure 2.25. Hydrogen bonding interactions in -[Co(en)3]3+ -Rh(C2O4)33– (lel3) 
viewed along the C3 axis (left) and a C2 axis (right). Non interacting atoms of the 
trianion have been omitted for clarity. 
 
 
 
bonds to the two oxygen atoms of a O=C-C=O moiety. In the third, the N-H units bind a 
separate oxygen atom of a O-Rh-O linkage. At one C3 site, each N-H unit makes one 
hydrogen bond to a different oxygen atom of three facially directed Rh-O linkages. At 
the other, one N-H unit makes a single hydrogen bond to a carbonyl oxygen atom of an 
oxalate ligand. The other two N-H units make a total of three hydrogen bonds to the two 
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oxygen atoms of a O=C-C=O moiety. 
2.4.8.7. -[Co(en)3]3+ C6H3(CO2)33–·5.55H2O (oblel2). The structure and 
hydrogen bonding interactions of the polyhydrated benzene-1,3,5-tricarboxylate 
(trimesate) salt, -[Co(en)3]3+ C6H3(CO2)33–·5.55H2O (oblel2), are shown in 
Figure 2.26.34 This represents one of the two enantiomers in the crystallographically 
characterized racemate. The H2O molecules about the  enantiomer (but not the  
enantiomer) are disordered. As with 2.4.2.4, 2.4.3.1, 2.4.5.1, 2.4.6.1, 2.4.8.2, and 2.4.8.4, 
the complex crystallizes in an oblel2 orientation.  
 
 
H-bond acceptor type of H-bond number of similar interactions 
H2O [C2][1] 4 
H2O [C3][1] 1 
C6H3(CO2)33– [C2,C2][2] 1 
C6H3(CO2)33– [C3,C3,C3][2] 1 
C6H3(CO2)33– [C3,C3,C3][1] 1 
Figure 2.26. Hydrogen bonding interactions in -[Co(en)3]3+ C6H3(CO2)33–
·5.55H2O (oblel2) viewed along the pseudo C3 axis (left) and the C2 axis (right). Non-
interacting atoms of the trianion have been omitted for clarity. 
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All twelve N-H units engage in hydrogen bonding to three tris(carboxylate) 
trianions and five H2O molecules. At two C2 sites, each N-H unit hydrogen bonds to the 
oxygen atom of a separate H2O molecule. At the third, the N-H units chelate the O-C-O 
linkage of a carboxylate group. At one C3 site, the three N-H units interact with both 
oxygen atoms of a carboxylate group via three hydrogen bonds. At the other C3 site, 
each N-H unit hydrogen bonds to the same oxygen atom of a carboxylate group, and one 
N-H unit makes an additional hydrogen bond with the oxygen atom of a H2O molecule. 
2.4.8.8. -[Co(en)3]3+ P3O93–·2H2O (lel3) (from racemic salt) 
 
 
 
    
 
H-bond acceptor type of H-bond number of similar interactions 
P3O93– [C2,C2][1] 2 
H2O [C2,C2][1] 1 
P3O93– [C3,C3,C3][2] 2 
Figure 2.27. Hydrogen bonding interactions in -[Co(en)3]3+ P3O93–·2H2O (lel3) 
viewed along the C3 axis (left) and a C2 axis (right). Most non-interacting atoms of the 
trianion have been omitted for clarity. 
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The structure and hydrogen bonding interactions of the dihydrated 
cyclotriphosphate salt, -[Co(en)3]3+ P3O93–·2H2O (lel3) are shown in Figure 
2.27.39 This represents one of the two enantiomers in the crystallographically 
characterized racemate. All twelve N-H units are engaged in hydrogen bonding to four 
P3O93– trianions and one H2O molecule. The three N-H units of both C3 sites hydrogen 
bond to two different oxygen atoms of a P3O93– trianion (1,5-relationship). The two N-H 
units of two C2 sites chelate to a single oxygen atom of a P3O93– trianion. The N-H units 
of the third C2 site chelate the oxygen atom of a H2O molecule. 
2.4.8.9. -[Co(en)3]3+ P3O93–·2H2O (lel3) (from enantiopure salt) 
 
 
 
 
H-bond acceptor type of H-bond number of similar interactions 
H2O [C2,C2][1] 1 
P3O93– [C2,C2][1] 1 
P3O93– [C22,C2][2] 1 
P3O93– [C3,C3,C3][2] 2 
Figure 2.28. Hydrogen bond interactions in -[Co(en)3]3+ P3O93–·2H2O (lel3) 
viewed along the C3 axis (left) and a C2 axis (right). Most non-interacting atoms of the 
trianion have been omitted for clarity. 
 56 
The structure and hydrogen bonding interactions of the enantiopure dihydrated 
cobalt cyclotriphosphate salt, -[Co(en)3]3+ P3O93–·2H2O (lel3), are depicted in 
Figure 2.28.39 The bonding motifs are very similar to those of the racemate in 2.4.8.8, 
which is also a dihydrate. All twelve N-H units are engaged in hydrogen bonding to four 
P3O93– trianions and one H2O molecule. The C3 sites exhibit the same interactions as 
with the racemate. However, the two N-H units of one C2 site no longer chelate to a 
single oxygen atom of a P3O93– trianion. Rather, they form three hydrogen bonds to two 
oxygen atoms with a 1,3-relationship.  
2.5. Additional structural information and generalizations 
2.5.1. General and scope of hydrogen bonding  
As noted above, Table A-1 summarizes the 150 unique crystal structures 
containing the trication [Co(en)3]3+, and 142 of these are amenable to detailed analyses 
(a few more to partial analyses). The anions or other features in about one third of these 
can be regarded (at least from an organic chemist's perspective) as mondo bizzarro (e.g., 
Zn6P8O32H83–,40 V3P3BO195–H2PO4–,41 [(Co(II)O6)Mo(VI)6O18(As(III)3O3)2]4–,42 
[Ru2(C2H4O7P2)2Cl2]5–,43 trans-CdBr4Cl24–,44 Zr4F22O210–,45 SiMo8V4O40(VO)26–
,46 In3(H2PO4)6(HPO4)33–).47 Eight different small molecule clathrates of [Co(en)3]3+ 
3Cl– have been structurally characterized.48 These types of exotic species were generally 
excluded from sections 2.4.2-2.4.8, but not from further analyses below.   
 An important initial remark is that the N-H units of the [Co(en)3]3+ trications of 
all 150 structures are extensively hydrogen bonded. Indeed, in sections 2.4.2-2.4.8 it was 
rather unusual to find cases in which all twelve of the N-H units were not so engaged. 
The N-H donor strengths must be substantial, as they interact with a variety of weak 
hydrogen bond acceptors. Although the hydrogen bond accepting strengths of many 
anions have been quantified,49 relatively few of those in Table A-1 (Appendix) have 
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been ranked. Some of the extensively delocalized anions in the previous paragraph, as 
well as GaF63– (2.4.8.3) or AuCl4– and SiF62– (Table A-1 in Appendix), are likely 
among the weakest.  
 Four crystal structures with perchlorate anions – a very feeble hydrogen bond 
acceptor49 – can be found in Table A-1 (Appendix). One is of the mixed 
oxalate/perchlorate salt [Co(en)3]3+ C2O42–ClO4– (entry 70).50 Although carboxylate 
anions are good hydrogen bond acceptors,49 the perchlorate anion competes, binding in 
a [C3,C3][1] mode with N-H…O distances of 2.596 and 2.707 Å. Two others involve 
cocrystals of [Co(en)3]3+ 3ClO4– and a neutral palladium penicillimate complex.51 One 
lattice (entry 65) features two independent trications, many N-H units of which interact 
with donor atoms of the penicillin moiety. However two perchlorate anions hydrogen 
bond to one trication ([C3][1], N-H…O 2.169 Å; [C3,C2][2], N-H…O 2.197, 2.536 Å), 
and one to the other ([C2,C2][2], N-H…O 2.144, 2.340 Å). Hydrogen bonding to 
perchlorate is evident in another structure (entry 77), but severe disorder precludes 
further analyses. 
2.5.2. Types of hydrogen bonding  
In the salts in sections 2.4.2-2.4.8, a number of very common hydrogen bonding 
motifs are apparent. For example, many anions and H2O molecules interact with two N-
H units of the same C2 binding site, or multiple N-H units from the same C3 binding site. 
However, taking the opposite perspective, H2O molecules never interact with multiple 
N-H units originating from both C2 and C3 binding sites. Anions only do so in a few 
special cases involving larger species with multiple acceptor sites.  
 The most likely modes by which anions might interact with two N-H units from 
different C2 and C3 binding sites have been summarized in Figure 2.6. The first, denoted 
[C3/C2], entails anion binding to the N-H units of the same NH2 group. This motif is 
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unequivocally absent in the 27 salts in sections 2.4.2-2.4.8, and no examples have been 
found in the remaining structures (Table A-1 in Appendix). I have also examined the 
crystal structures of all 6259 primary and secondary organoammonium halides, [RNH3]+ 
X– and [RR'NH2]+ X–, in the Cambridge Structural Database. Interestingly, none 
showed hydrogen bonding of the halide anion to two geminal N-H units. Hence, this 
motif appears to be intrinsically disfavored, presumably due to stereoelectronic reasons 
and/or the larger H-X-H angle required.  
 Although rare, it is possible to bridge the geminal N-H units of 
organoammonium halides with unusual larger anions that feature multiple acceptor 
sites.52,53 Interestingly, a more complicated variant, [(C32/C2),C3][3], occurs in 2.4.5.1 
(Figure 2.14). Here a large borate dianion, B8O10(OH)62–, bridges the C3 and C2 sites. 
The C3 N-H unit is chelated by two oxygen atoms of the dianion, and the dianion makes 
an additional hydrogen bond with another C3 N-H unit. 
 The second type of hydrogen bonding in Figure 2.6, involving an anion and non-
geminal N-H units from the same ligand [C3//C2], is not found in any of the salts in 
sections 2.4.2-2.4.8 or Table A-1 (see Appendix). The distance between the N-H units is 
much too great to be bridged by a single atom. However, hydrogen bonding to a 
structurally extended anion, like the borate in the previous example, should in principle 
be feasible. The third type of hydrogen bonding in Figure 2.6, involving an anion and C3 
and C2 sites on different ligands [C3,C2], is seen in 2.4.6.2 (Figure 2.16). Here the cyclic 
croconate dianion, C5O52–, provides two variants: one in which a single oxygen atom 
binds to the two N-H units ([C3,C2][1]), and another in which two different oxygen 
atoms bind to the two N-H units ([C3,C2][2]).  
2.5.3. Possible connections to catalysis  
The ensemble of second coordination sphere binding motifs embodied in the 
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preceding [Co(en)3]3+ salts do not directly bear on the mechanisms of any catalytic 
reactions. However, they certainly point to the viability of coordinating two reactive 
substrates to a single C2 site, or to a single C3 site. They are also entirely consistent with 
the initial binding of one substrate to a C2 site and the other to a C3 site. However, this 
might lead to a transition state or product that spans C2 and C3 sites. While there do not 
seem to be any steric or electronic impediments to such as assembly, this has much less 
precedent among the crystal structures. 
 Interestingly, sixteen of the 27 structures in sections 2.4.2-2.4.8 are hydrates. The 
conspicuous lack of other molecules of crystallization simply reflects the fact that all of 
these salts are prepared under aqueous conditions. With the recent syntheses of many 
lipophilic salts,6,54 the stage is now set to attempt the cocrystallization of guest 
molecules that are also substrates for catalysis. Strong interactions with substrates are 
evident by NMR in solution.7a Their binding modes are likely to provide better starting 
points for the development of mechanistic models, including rationales for the observed 
enantioselection. 
2.5.4. Other stereochemical issues  
Consider the relative frequencies of the various lel/ob orientations outlined in 
Figure 2.4. Well over half the [Co(en)3]3+ salts crystallize in lel3 orientations, per the 
following distribution: lel3, 81; oblel2, 35; lelob2, 14; ob3, 4 (134 total). There are an 
additional seven salts that crystallize with two independent trications, one with a lel3 
orientation and the other with an oblel2 orientation. There are also an additional three 
salts that crystallize with two independent cations, one with a lel3 orientation and the 
other with a lelob2 orientation. Taking all of the independent trications in this series of 
144 compounds, the overall distribution becomes lel3, 99; oblel2, 48; lelob2, 18; ob3, 4 
(169 total). 
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 Although it is by no means a proof, this distribution suggests that lel3 
orientations have the greatest thermodynamic stabilities, and ob3 orientations the lowest 
thermodynamic stabilities. This is in agreement with available experimental and 
computational literature.17,55 Finally, I note that the salts in which larger anions span C3 
and C2 binding sites (2.4.5.1, Figure 2.14; 2.4.6.2, Figure 2.16) possess oblel2 and lelob2 
orientations. Perhaps in these lower symmetry structures, the distances between the 
hydrogen atoms of the N-H units, or other geometric features, are more conducive to this 
motif (the analysis in Figure 2.6 is for lel3 orientations). 
2.6. Conclusion 
 The [Co(en)3]3+ trication is a hydrogen bond donor extraordinaire. Adducts 
readily form with counter anions and H2O molecules in the solid state. These usually 
engage all twelve N-H units, even when the anions include very poor hydrogen bond 
acceptors. These properties presumably extend to many other cationic metal complexes 
of primary and secondary amines. There is good NMR evidence that most of these 
interactions remain extant in solution.54  
 In the preceding sections, some generalizations could be offered about relatively 
common or less common hydrogen bonding motifs. However, the main take-home 
lesson of this review is the diversity of hydrogen bonding motifs. Insight regarding the 
energetics of various binding modes is currently being sought through computational 
studies.56 Perhaps the situation is not too different from that in nuclei acid chemistry, 
where Watson-Crick, Hoogsteen, and reverse Hoogsten base pairs – as well as other 
hydrogen bonding arrangements – can all be encountered and serve as determinants of 
biological function, depending upon circumstances.57 In any case, an essential analytical 
step has been taken in the quest for insight as to how [Co(en)3]3+ and related cations 
might bind and activate organic substrates in catalysis.  
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3. SYNTHESES OF FAMILIES OF ENANTIOPURE AND 
DIASTEREOPURE COBALT CATALYSTS DERIVED FROM 
TRICATIONS OF THE FORMULA [Co(NH2CHArCHArNH2)3]3+† 
 
3.1. Introduction 
The rational development of enantioselective catalysis requires well characteri-
zed catalyst precursors, a thorough understanding of configurational and conformational 
equilibria, and in increasing numbers of cases data regarding second coordination sphere 
phenomena1 and/or special roles of anions.2 In recent papers as well as some of the 
upcoming sections, I and my collaborators have exploited salts of the enantiopure chiral 
tris(1,2-diamine) cobalt trications [Co(en)3]3+ (en = ethylenediamine),3,4 [Co(dpen)3]3+ 
(13+; dpen = 1,2-diphenylethylenediamine),5 and [Co(en)2(NH2CH2CH((CH2)nN-
(CH3)2)NH2)]3+ (n = 1-4)6 as catalysts for enantioselective organic transformations5,6 or 
polymerizations.7 All three families feature cobalt stereocenters, the configurations of 
which are traditionally designated .8 The last two also feature carbon stereocenters 
(R/S) in the chelate backbones.  
The last two families have proven to be highly successful enantioselective 
catalysts. The NH units in these systems form strong hydrogen bonds to Lewis basic 
organic functional groups, which can activate them towards addition reactions.5 The 
metal centers, like other octahedral cobalt(III) low spin complexes with nitrogen or 
oxygen donor ligands, are substitution inert under normal conditions.9 Hence, none of 
these transformations involve direct substrate coordination or activation by the metal, as  
 
 
†Reproduced in part with the permission from Ghosh, S. K.; Lewis, K. G.; Kumar, A.; Gladysz, J. A. 
Inorg. Chem. 2017, 56, 2304-2320.  
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found with so many other transition metal catalysts. Other types of metal containing 
chiral hydrogen bond donor catalysts are seeing study in other groups, in some cases 
with outstanding results.10-12  
In the course of optimizing the catalytic reactions, it became apparent that there 
were profound counter anion effects. Definitive evidence could be obtained for hydrogen 
bonding of the NH units to anions both in solution (NMR) and the solid state 
(crystallography).5a In this context, the symmetries of the trications merit note. Both 
[Co(en)3]3+ and [Co((S,S)-dpen)3]3+ ((S, S)-13+) have formal D3 symmetry, as illustrat-
ed for the latter in Figure 3.1. This entails a C3 axis, which gives rise to two "C3 faces" 
consisting of three synperiplanar NH groups (one from each chelate) on opposite sides of 
the trication. There are furthermore three C2 axes in a perpendicular plane, which in turn 
give rise to three "C2 faces" comprised of two NH groups (from different chelates). Both 
types of faces are apparent in Figure 3.1. 
 
 
 
 
Figure 3.1. Thermal ellipsoid diagram (50% probability level) of the trication of Λ-
(S,S)-13+ 3Cl–·2H2O·2CH3OH: A, view down the idealized C3 axis; B, view down one 
of the three C2 axes.5a 
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Hydrogen bonding to counter anions would be expected to be stronger at the C3 
faces, in accord with the greater number of NH groups available.5a However, both the 
C2 and C3 faces are competent for substrate binding. As detailed in the following section 
current evidence suggests that a C3 face provides the active site for at least some 
catalytic reactions.5a In the examples investigated, a hydrogen bonded anion must first 
dissociate. One of several open questions is whether anion binding is maintained at the 
opposite C3 face. 
Unlike many chiral ligands, both enantiomers of dpen are available at modest 
prices ((S,S)-dpen, $408/100 g; (R,R)-dpen, $420/100 g).13 Hence, it is an attractive 
building block for enantioselective catalysts. However, an obvious strategy for catalyst 
optimization would involve replacement of the phenyl groups by other aryl moieties. 
This would allow both electronic and steric properties of the diamine to be fine tuned. 
For example, electron withdrawing groups normally enhance Brønsted acidities, and 
should therefore render the NH groups stronger hydrogen bond donors. 
In this context, a simple and elegant route to diaryl analogs of dpen has been 
developed in industry, as outlined in Scheme 3.1.14 It begins with (R,R)-bis(o-
hydroxy)dpen ((R,R)-2), which is relatively inexpensive ($329/10 g).15 This is 
condensed with aromatic aldehydes to yield the di-Schiff bases (R,R)-3. Due to a 
combination of factors, subsequent [3.3] sigmatropic rearrangements are exothermic, 
giving (via chair transition states that formally invert configurations) new di-Schiff bases 
(S,S)-4. Workups then afford the target ligands. As shown in Scheme 3.1 (bottom), the 
1,2-diaryldiamines (S,S)-5 through (S,S)-12 were so prepared. Whereas (S,S)-6-9 have 
been previously synthesized by this protocol,14 (S,S)-5,10-12 are new compounds that 
are described in the experimental section.  
Against this backdrop, I and my collaborators have prepared a variety of salts of 
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(S,S)-13+ and analogs with the 1,2-diaryldiamine ligands shown in Scheme 3.1. These 
include "mixed salts" comprised of two different counter anions (2:1) that are of an 
exceptionally well defined nature. As an alternative to the incremental disclosure of 
these catalysts over a series of papers, we have combined them into one resource 
describing all relevant protocols and the most distinctive spectroscopic properties. This 
furthermore facilitates analysis of the unusual kinetic and thermodynamic 
diastereoselectivities often encountered in these syntheses – i.e., the dominant cobalt 
configuration () obtained from a given dpen configuration and counter anion set.  
 
 
 
 
Scheme 3.1. Syntheses of substituted dpen ligands and related species. 
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3.2. Results 
3.2.1. Lipophobic Salts of [Co((S,S)-dpen)3]3+ ((S,S)-13+).  
The first objective was to access salts of the diastereomeric trications Λ- and ∆-
(S,S)-13+ from simple cobalt precursors and (S,S)-dpen.13 One diastereomer would 
logically give more enantioselective catalysts than the other. Towards this end, earlier 
procedures of Bosnich,16 Mason,17 and others18,19 were adapted. These feature 
substitution labile cobalt(II) educts, aerobic conditions to generate cobalt(III), and 
charcoal, which promotes the isomerization of cobalt(III) stereocenters.20 Some of these 
papers contain incorrect stereochemical assignments,16,18 which are treated in the 
discussion section in the interest of aiding readers who may consult these earlier works.  
As shown in Scheme 3.2 (step I), the acetate complex Co(OAc)2·4H2O or 
chloride complex CoCl2·6H2O and (S,S)-dpen (3.4 equiv) were combined in CH3OH. 
The solution was purged with air, and excess HCl was added. This gave a 67/10/23 
mixture of the orange trichloride salt Λ-(S,S)-13+ 3Cl–,16,17 the diastereomer -(S,S)-13+ 
3Cl–, and the green bis(dpen) complex trans-[Co((S,S)-dpen)2(Cl)2]+ Cl–,21 as assayed 
from their easily distinguished CHPh 13C NMR signals ( 63.5/66.1/66.7 ppm, 
CD3OD).22 Workup afforded diastereomerically pure Λ-(S,S)-13+ 3Cl– in 65% yield.23  
An analogous procedure was carried out with the perchlorate complex 
Co(ClO4)2.6H2O (Scheme 3.2, step II). Now, NMR analysis showed predominantly the 
opposite diastereomer of the tris(perchlorate) salt, -(S,S)-13+ 3ClO4– (8:92  Λ/). 
Workup afforded a 17:83 Λ/ mixture in 60% yield.24 The minor diastereomer, -(S,S)-
13+ 3ClO4–, could be independently prepared in 64% yield by a room temperature anion 
metathesis of the trichloride salt Λ-(S,S)-13+ 3Cl– (step III).22  
When Λ-(S,S)-13+ 3ClO4– was heated at 70 °C in CH3OH in the presence of 
charcoal (150 h), equilibration to <4:>96 Λ/ mixtures gradually occurred (step IV), 
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together with a minor amount of decomposition to an unidentified but easily separable 
species (16%). Under similar conditions, the 17:83 Λ/ mixture gave a <4:>96 Λ/ 
mixture in 99-95% yields (triplicate run). This salt or the 17:83 Λ/ mixture could be 
converted to the trichloride salt -(S,S)-13+ 3Cl– or a 17:83 Λ/ mixture in 82-93%  
 
 
 
 
Scheme 3.2. Syntheses of salts of the formula [Co((S,S)-dpen)3]3+ 3X– ((S,S)-13+ 3X–; 
X = Cl, ClO4); kinetic and thermodynamic / diastereoselectivities. 
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yields by room temperature anion metatheses (step V). When these samples were heated 
at 70 °C in CH3OH in the presence of charcoal (step VI), equilibration to mixtures 
enriched in the opposite diastereomer, Λ-(S,S)-13+ 3Cl–, occurred (61:39 to 57: 43). 
Steps IV and VI show that the trichloride and tris(perchlorate) salts of (S,S)-13+ exhibit 
divergent Λ/ thermodynamic diastereoselectivities, paralleling the kinetic diastereo-
selectivities in steps I and II. This is analyzed further in the discussion section. For now, 
note that perchlorate is a very poor hydrogen bond acceptor, whereas chloride and 
acetate (the counter anion prior to anion metathesis when Co(OAc)2 is employed in step 
I) are strong hydrogen bond acceptors.25 As described elsewhere,5a the crystal structures 
of both trichloride salts Λ- and -(S,S)-13+ 3Cl– could be determined, and verified the 
configurations assigned earlier.17  
The trichloride salts were soluble in polar organic solvents such as DMSO and 
CH3OH but insoluble in less polar solvents such as CH2Cl2. Unlike the trichloride salts 
of the tris(ethylenediamine) trication [Co(en)3]3+, they were not soluble in water. As 
with other new salts described below, they were characterized by NMR (1H, 13C{1H}) 
and microanalyses, as summarized in the experimental section. The protons of each NH2 
group are diastereotopic, and separate signals were observed as listed in Table 3.1. Some 
samples underwent slow NH/ND exchange in certain deuterated solvents, so 
occasionally the integrals were less than the theoretical values.  
3.2.2. Lipophilic Salts of (S,S)-13+ 
Less polar complexes were sought to improve solubilities and facilitate catalytic 
applications in organic media. These were accessed as exemplified for the Λ 
diastereomers shown in Scheme 3.3. Thus, Λ-(S,S)-13+ 3Cl– was suspended in CH2Cl2 
and 1.0-1.2 equiv of the lipophilic tetraarylborate salt Na+ BArf– was added (BArf = 
B(3,5-C6H3(CF3)2)4). The mixture was sonicated, and the solids dissolved as the solvent 
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turned bright orange. The resulting NaCl precipitated. 
Interestingly, the new salt was sufficiently nonpolar to be chromatographed on 
silica gel (CH2Cl2/CH3OH gradient, 100:0 to 98:2 v/v). This gave the mixed salt Λ-
(S,S)-13+ 2Cl–BArf– in 93% yield as an orange solid.23 Analogous procedures afforded 
the diastereomer ∆-(S,S)-13+ 2Cl–BArf– (76%) and (using ∆-(R,R)-13+ 3Cl– or Λ-(R,R)-
13+ 3Cl–) the enantiomers ∆-(R,R)-13+ 2Cl–BArf– and Λ-(R,R)-13+ 2Cl–BArf–. Mixed 
salts sometimes have checkered reputations, as they can be confused (in this case for 
 
 
 
 
Scheme 3.3. Syntheses of lipophilic Werner salts (yields: 83-96%). The procedures for  
diastereomers are analogous. 
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example) with a 2:1 mixture of two non mixed salts. In support of my formulation, 1H 
NMR spectra always exhibited identical integral ratios for the CH protons associated 
with the trication and the single BArf– anion (6:12).  
As shown in Scheme 3.3, a similar procedure was carried out with Λ-(S,S)-13+ 
3Cl– and the slightly less lipophilic tetrakis(pentafluorophenyl)borate salt K+ B(C6F5)4– 
(K+ BArf20–). Chromatography gave the analogous mixed salt Λ-(S,S)-13+ 2Cl–BArf20– 
in 87% yield. In order to expand the range of salts with a single tetraarylborate anion, 
CH2Cl2 solutions of Λ-(S,S)-13+ 2Cl–BArf– were treated with the silver salts Ag+ BF4– 
and Ag+ PF6–. The silver chloride byproduct was removed by filtration, and workups 
gave the mixed tetrafluoroborate and hexafluorophosphate salts Λ-(S,S)-13+ 2BF4–BArf– 
and Λ-(S,S)-13+ 2PF6–BArf– in 95-83% yields. Finally, Λ-(S,S)-13+ 2Cl–BArf– was 
treated with the trifluorophenylborate salt K+ PhBF3– (2.0 equiv) in a biphasic CH2Cl2/ 
H2O mixture. Workup of the CH2Cl2 layer gave the mixed tris(organoborate) salt Λ-
(S,S)-13+ 2PhBF3–BArf– in 96% yield.  
Related non-mixed salts were also sought. Thus, as shown in Scheme 3.3, Λ-
(S,S)-13+ 3Cl– was treated with 3.0 equiv of Na+ BArf– in CH2Cl2/H2O. Workup of the 
CH2Cl2 layer gave the anion exchanged salt Λ-(S,S)-13+ 3BArf– in 94% yield. The 
pentafluorophenylborate analog Λ-(S,S)-13+ 3BArf20– was similarly prepared in 92% 
yield. Next, Λ-(S,S)-13+ 3Cl– was treated with 3.0-3.5 equiv of Ag+ BF4– or Ag+ PF6– in 
CH3OH. Workups gave Λ-(S,S)-13+ 3BF4– or Λ-(S,S)-13+ 3PF6– in 93-87% yields. 
These last two salts were less lipophilic than the others; they remained soluble in 
acetone, but were only sparingly soluble in CH2Cl2. 
The  diastereomers were similarly synthesized. All of these complexes were 
orange solids. The 1H NMR chemical shifts of the diastereotopic NHH' protons are 
summarized in Table 3.1, and the trends interpreted below. The UV-visible spectra of 
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the representative complexes Λ-(S,S)-13+ 2X–BArf– (X = Cl, BF4, PF6) and -(S,S)-13+ 
2Cl–BArf– were determined, and exhibited weak bands at 447-462 nm (max, CH2Cl2;  
157-302 M–1 cm–1; see experimental section). The data agreed well with earlier reports 
for Λ- and -(S,S)-13+ 3Cl– (460 nm, CH3OH;  120-125 M–1 cm–1 ).16  
I sought to probe whether other salts of -(S,S)-13+ with poor hydrogen bond 
accepting counter anions might, like the tris(perchlorate) salt -(S,S)-13+ 3ClO4–, be 
more stable than the corresponding Λ diastereomers. Thus, a sample of Λ-(S,S)-13+ 
2BF4–BArf– was kept in DMSO-d6 at 80 °C and periodically monitored by 13C{1H} 
NMR. As shown in Scheme 3.4, after 1 d a ca. 80:20 mixture of Λ/ diastereomers was 
apparent ( 61.4/63.2 ppm). After 30 d, epimerization to -(S,S)-13+ 2BF4–BArf– was 
88% complete. An analogous experiment conducted in the presence of charcoal gave a 
0.2:99.8 Λ/ mixture after only 10 h.  
 
 
 
 
Scheme 3.4. Thermal epimerization of Λ-(S,S)-13+ 2X–BArf– to -(S,S)-13+ 2X–BArf–. 
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Table 3.1. Selected 1H NMR and hydration data for isolated cobalt(III) salts. 
complex solvent  NH/C3 (ppm)a 
 NH'/C2 
(ppm)a 
number H2O 
moleculesb 
Λ-(S,S)-13+ 3Cl– DMSO-d6/CD3OD 6.86 5.31 3/5c 
Λ-(S,S)-13+ 3ClO4–  CD3OD -d -d  4e/12c
∆-(S,S)-13+ 3Cl– CD3OD 6.41f 5.94 2/6c 
∆-(S,S)-13+ 3ClO4–  CD3OD -d -d  g/13c
Λ-(S,S)-13+ 2Cl–BArf–h CD2Cl2 8.17 3.86 2/3.5 
Λ-(S,S)-13+ 2Cl–BArf–h CD2Cl2 7.90 4.07 2/3.5 
Λ-(S,S)-13+ 2Cl–BArf20– acetone-d6 8.27 5.21 3/3 
Λ-(S,S)-13+ 2BF4–BArf– CD2Cl2 6.04 4.17 3/4 
Λ-(S,S)-13+ 2PhBF3–BArf–  acetone-d6 6.33 5.79  2/2
Λ-(S,S)-13+ 2PF6–BArf– CD2Cl2 5.77 4.10 1/1.5 
Λ-(S,S)-13+ 3BArf– acetone-d6 6.38 6.22 8/12 
Λ-(S,S)-13+ 3BArf– CD2Cl2 5.54 4.68 8/11 
Λ-(S,S)-13+ 3BArf20– acetone-d6 6.39 6.20 11/11 
Λ-(S,S)-13+ 3BF4– acetone-d6 5.83 (11 H)i 2/3.5 
Λ-(S,S)-13+ 3PF6– DMSO-d6 5.64 5.34 6/6.5 
∆-(S,S)-13+ 2Cl–BArf– acetone-d6 7.13 6.16f 1/4 
∆-(S,S)-13+ 2Cl–BArf– CD2Cl2/CH3OH 6.58 5.35 1/j 
Δ-(S,S)-13+ 2Cl–BArf20– CD2Cl2/acetone-d6 6.92 6.01-5.82k 3/3 
Δ-(S,S)-13+ 2BF4–BArf– acetone-d6 6.41 5.90 3/3 
Δ-(S,S)-13+ 2PF6–BArf– acetone-d6 6.53 5.92 2/8.5 
∆-(S,S)-13+ 3BArf– acetone-d6 6.87-6.70k 5.93 9/10 
Λ-(S,S)-133+ 2Cl–BArf–  acetone-d6 8.16 5.10  1/3.5
Λ-(S,S)-143+ 2Cl–BArf– acetone-d6 8.25 5.53 2/3.5 
Λ-(S,S)-143+ 2BF4–BArf– acetone-d6 5.92 3.21 g/1 
Λ-(S,S)-153+ 2Cl–BArf– acetone-d6 8.38 5.94 1/3 
Λ-(S,S)-163+ 2Cl–BArf– CD2Cl2 7.67 4.16 3/5.5 
∆-(S,S)-163+ 2Cl–BArf– CD2Cl2/CD3OD 5.82 (2H)i 5.67 (2H)i 2/6.5c 
∆-(S,S)-173+ 2Cl–BArf– acetone-d6 9.27 5.70 4/4 
Λ-(S,S)-173+ 2Cl–BArf– CD2Cl2 9.72 3.65 2/1.5 
Λ-(S,S)-173+ 2BF4–BArf– CD2Cl2 6.32 4.04 3/2 
Λ-(S,S)-183+ 2Cl–BArf– acetone-d6 8.60 5.62-5.41i,l 4/4 
Λ-(S,S)-193+ 2Cl–BArf– acetone-d6 8.56 5.15 1/3.5 
Λ-(S,S)-203+ Cl–2BArf– acetone-d6 6.64-6.52k 5.86-5.74k 3/2.5 
aAll signals are broad singlets unless noted. bThe number of H2O molecules based upon fitting of the microanalysis data/
1H NMR 
integration of the OH signal ( 4.89-1.85 as given in the experimental section). cThe integration of this 1H NMR signal reflects a 
combination of CD3OH ("impurity" in the NMR solvent CD3OD) and H2O. 
dNo signal was observed due to NH/ND exchange with 
the solvent CD3OD. 
eThis value is taken from the preparation of this salt in reference 16. fApparent doublet. gNot determined. hTwo 
samples; see text and Figure 3.3 for concentration dependences of the NHH' chemical shifts. iThe signal intensity was reduced due to 
NH/ND exchange with the solvent. jThe OH integration is not meaningful in the presence of the CH3OH cosolvent. 
kApparent 
multiplet. lThis signal overlaps with the CHNHH' signal.   
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A sample of the tris(tetraarylborate) salt Λ-(S,S)-13+ 3BArf– was kept in CD3OD 
at 75 °C. This complex can be viewed as having the least coordinating set of counter 
anions among the lipophilic salts. Epimerization was somewhat faster, with a 18:82 Λ/ 
mixture after 24 h in the absence of charcoal ( 64.6/66.5 ppm). However, some 
decomposition occurred in the presence of charcoal, with a 8:88:4 Λ//byproduct 
mixture after 4 h. In any case, the diastereomer stabilities for both salts in Scheme 3.4 – 
and probably all those in Scheme 3.3 that do not involve chloride anions – parallel those 
of the tris(perchlorate) salt (S,S)-13+ 3ClO4– ( > Λ, see experimental section). 
3.2.3. Lipophilic Salts of [Co((S,S)-NH2CHArCHArNH2)3]3+ (Ar  Ph) 
As shown in Scheme 3.5, Co(OAc)2.4H2O or CoCl2.6H2O and the 1,2-
diaryldiamines (S,S)-5-11 (see Scheme 3.1) were reacted under conditions similar to 
those used for (S,S)-dpen in Scheme 3.2. The resulting crude trichloride salts, (S,S)-13-
193+ 3Cl–, were treated with 1.0-1.2 equiv of Na+ BArf–. Silica gel column 
chromatography gave the diastereomerically pure mixed salts Λ-(S,S)-13-193+ 2Cl–
BArf– in 39-23% yields.23 In all of these syntheses, the main objective was to obtain  
 
 
 
 
Scheme 3.5. Syntheses of catalysts from substituted (S,S)-dpen ligands. 
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samples that could be evaluated as enantioselective catalysts, as opposed to optimizing 
yields as done in Scheme 3.2. However, the kinetic diastereoselectivities were high 
(>90:<10 Λ/ as assayed by 13C{1H} NMR of the trichloride salts). 
Reactions of Co(ClO4)2.6H2O and (S,S)-8-9 were conducted under conditions 
analogous to those of Co(OAc)2.4H2O or CoCl2.6H2O, followed by anion exchange to 
give the crude trichloride salts (S,S)-16-173+ 3Cl– (Scheme 3.5). These were treated with 
1.0-1.2 equiv of Na+ BArf–, and silica gel chromatography gave the diastereomerically 
pure mixed salts -(S,S)-163+ 2Cl–BArf– and -(S,S)-173+ 2Cl–BArf– in 41-18% yields. 
Again, the kinetic diastereoselectivities were high (>85:<15 /Λ), as assayed by 
13C{1H} NMR of the trichloride salts.  
As shown in Scheme 3.6, the bis(3,5-trifluoromethyl)phenyl substituted diamine 
(S,S)-12 and Co(OAc)2.4H2O were similarly reacted, and the intermediate trichloride 
salt was treated with Na+ BArf– (1.0 equiv). However, a green complex was obtained 
upon silica gel chromatography, and efforts to purify the trichloride salt gave several 
products. Apparently the reduced nucleophilicity or basicity of (S,S)-12 affects the  
 
 
 
 
Scheme 3.6. Syntheses of catalysts from a tetrakis(trifluoromethyl) substituted (S,S)-
dpen ligands. 
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efficiency of the synthesis and/or the product stability. Interestingly, a non-
chromatographic workup gave the target trication, but as a different type of mixed salt, 
with one chloride and two tetraarylborate anions, Λ-(S,S)-203+ Cl–2BArf– (28%). The 
trication/BArf– ratio was assigned on the basis of the 1H NMR spectrum and micro-
analysis.  
Most of the salts in Schemes 3.5 and 3.6 were orange, but p-methoxyphenyl 
substituted Λ- and -(S,S)-163+ 2Cl–BArf– were bright yellow. In procedures analogous 
to one in Scheme 3.3, Λ-(S,S)-143+ 2Cl–BArf– and Λ-(S,S)-173+ 2Cl–BArf– were treated 
with Ag+ BF4– (2.1-2.2 equiv). Workups gave the mixed bis(tetrafluoroborate)/ 
tetraarylborate salts Λ-(S,S)-143+ 2BF4–BArf– and Λ-(S,S)-173+ 2BF4–BArf– in 92-91% 
yields. The former exhibited the usual orange color, but the latter -naphthyl substituted 
salt was red. 
3.2.4. Key Properties 
As noted above, the NHH' protons in the preceding complexes are diastereotopic, 
and with a single exception exhibited separate 1H NMR signals, indicative of slow 
exchange. As summarized in Table 3.1, the  values ranged from 0.20 to greater than 
4.00 ppm. This large variance is illustrated by the four spectra in Figure 3.2, all of which 
were recorded at ambient probe temperature in CD2Cl2 with salts of the formula Λ-
(S,S)-13+ 2X–BArf–. Due to solubility and other issues, it was necessary to use a range of 
solvents in Table 3.1.  
In Figure 3.2, the anions of the salts are varied from 2Cl–/BArf– (top spectrum) 
to 2BF4–/BArf– to 2PF6–/BArf– to 2BArf–/BArf– (3BArf–; bottom spectrum). The two 
chloride ions – which are strong hydrogen bond acceptors – are replaced by 
progressively weaker and finally extremely poor (BArf–) hydrogen bond acceptors.25 In 
all cases, the six upfield NH' protons fall into a relatively narrow chemical shift range ( 
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3.86-4.68 ppm). In Λ-(S,S)-13+ 2Cl–BArf–, the other six NH protons are far downfield ( 
8.17 ppm, or  4.31 ppm). In the other three salts, these shift monotonically upfield ( 
6.04/5.77/5.54 ppm), with the chemical shift difference vs. the other NH protons (NH') 
progressively narrowing ( 1.87/1.67/0.86 ppm).  
 
 
 
 
Figure 3.2. 1H NMR spectra (CD2Cl2) of (a) Λ-(S,S)-13+ 2Cl–BArf–, (b) Λ-(S,S)-13+ 
2BF4–BArf–, (c) Λ-(S,S)-13+ 2PF6–BArf–, and (d) Λ-(S,S)-13+ 3BArf–. 
 
 
 
These data suggest that six of the twelve NH protons are much more predisposed 
towards hydrogen bonding, and give enthalpically stronger interactions. A model is 
proposed in the discussion section. Among the other mixed 2Cl–BArf– salts in Table 3.1, 
only the -naphthyl substituted Λ-(S,S)-173+ 2Cl–BArf– showed a distinctly higher  
value (6.07 ppm), perhaps due to additional influences arising from the magnetic 
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anisotropies of the naphthyl moieties. The  diastereomers consistently gave much lower 
 values than the Λ diastereomers. Finally, all of the non-mixed salts, in which all 
anions have equal hydrogen bond acceptor strengths, gave still lower  values.  
 The discrete natures of the mixed salts were supported by comproportionation 
experiments, as exemplified in Scheme 3.7. Here two parts of the trichloride salt Λ-
(S,S)-13+ 3Cl– were mixed with one part of the tris(tetraarylborate) salt Λ-(S,S)-13+ 
3BArf– in CD2Cl2 or CH2Cl2. The diastereotopic NHH' protons exhibited chemical 
shifts in good agreement with those of the isolated mixed salt Λ-(S,S)-13+ 2Cl–BArf– in 
Table 3.1 ( 8.07-7.83/3.95-4.14 ppm vs. 8.17-7.90/ 3.86-4.07). 
 
 
 
2 [ -(S,S)-13+ 3Cl–] 3 [ -(S,S)-13+ 2Cl–BArf–]
CD2Cl2
insoluble soluble
NMR (CD2Cl2, NH/NH'):
in situ, 8.07/3.95 ppm;
workup of reaction in CH2Cl2,
7.83/4.14 ppm;
isolated, see Table 3.1
soluble
NMR: see Table 3.1
or
CH2Cl2
1 [ -(S,S)-13+ 3BArf–]
+
 
Scheme 3.7. Comproportionation of two salts to give a mixed salt. 
 
 
 
 The moderate variance of the chemical shifts for the two samples of Λ-(S,S)-13+ 
3BArf– in Scheme 3.7 and Table 3.1 prompted us to test for a concentration dependence. 
Accordingly, the 1H NMR spectra of samples that were 0.0043 M, 0.0086 M, 0.017 M, 
0.026 M, 0.034 M, 0.043 M, and 0.051 M in CD2Cl2 were recorded. The chemical shifts 
varied linearly but in opposite directions, from  8.34 to 7.72 ppm and  3.77 to 4.15 
ppm as illustrated in Figure 3.3 (see also, Table A-3 in Appendix). Thus, the chemical 
shift data in Table 3.1 – which simply reflect spectra taken to characterize reaction 
products without attention to exact concentrations – are likely subject to some variance 
(although most samples would be 0.02-0.03 M for purposes of recording 13C{1H} NMR 
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spectra on convenient time scales).26  
 
 
 
 
Figure 3.3. Dependence of the chemical shifts of the diastereotopic NHH' protons of (a) Λ-(S,S)-13+ 2Cl–BArf–, (b) Λ-(S,S)-13+ 2BF4–BArf–, and (c) Λ-(S,S)-13+ 3BArf– upon 
concentration (CD2Cl2, ambient probe temperature). 
 
 
 
 The hydration levels of the preceding complexes are also summarized in Table 
3.1.23 This represents a nuisance with regard to the precise characterization of these 
salts, but is a logical consequence of the hydrogen bond donor properties. In any case, 
reproducibility is quite good. All efforts to date to exhaustively dry any salt (elevated 
temperatures, high vacuum) have given decomposition. In general, there are fewer water 
molecules than found with salts of the more polar trication [Co(en)3]3+.3,6 Within Table 
3.1, certain tetraarylborate salts seem to give higher degrees of hydration. It is noted in 
passing that Na+ BArf– itself is isolated as a hydrate with 2.5-3.0 water molecules.27  
3.3. Discussion  
3.3.1. Hydrogen Bonding 
As noted above, a number of properties of the title complexes 
[Co(NH2CHArCHArNH2)3]3+ 2X–X'– appear to be functions of the hydrogen bond 
acceptor strengths of the counter anions. It is widely appreciated that chloride and 
acetate anions are excellent hydrogen bond acceptors, and that perchlorate and BArf– are 
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two of the poorest.25 The trend BF4– > PF6– is also well established, although both are 
considered weak acceptors.  
 The 1H NMR data in Figure 3.2 and Table 3.1 make a persuasive case for strong 
chloride ion association with six of the twelve NHH' protons in Λ-(S,S)-13+ 2Cl–BArf–. 
As noted in connection with Figure 3.1, every trication Λ-(S,S)-13+ can be viewed as 
having five general hydrogen bonding sites: two C3 sites involving three synperiplanar 
NH groups each, and three C2 sites involving two NH groups each. One would logically 
expect the enthalpy of hydrogen bonding to be greater with the three fold donor C3 sites 
than the two fold donor C2 sites. Hence, it is proposed that the two chloride ions 
preferentially hydrogen bond as shown in C in Figure 3.4. This is currently being probed 
in a detailed computational study.28  
 There are of course alternative motifs. Both chloride ions could hydrogen bond to 
C2 sites as shown in E (Figure 3.4), but this is likely much less stable. Intermediate 
would be D, with one chloride ion bound to each type of site. Both D and E would be 
less likely to give 1H NMR spectra with six downfield NH protons. This model is 
supported by the crystal structure of the trichloride salt Λ-(S,S)-13+ 3Cl–, which shows 
 
 
 
 
Figure 3.4. Proposed ion pairing equilibria for the two chloride ions of Λ-(S,S)-13+ 2Cl–
X'–; C, most stable; D, intermediate; E, least stable. 
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hydrogen bonding of the three anions to two C3 sites and one C2 site (as opposed, for 
example, to three C2 sites).5a Presumably it is the weaker association of the chloride 
anion to the C2 site that facilitates a single anion exchange to give the mixed salts Λ-
(S,S)-13+ 2Cl–BAr4– in Scheme 3.3.  
Although it is premature to extrapolate much further, there are other suggestive 
trends in Table 3.1. For example, the lower  values for the NHH' 1H NMR signals of 
the opposite diastereomers, -(S,S)-13+ 2X–BAr4–, suggest a lower differential between 
the hydrogen bonding donor strengths of the C3 and C2 sites. This is in accord with the 
crystal structure of the trichloride salt -(S,S)-13+ 3Cl–, which exhibits a less convergent 
array of NH bonds at the two C3 sites.5a  
3.3.2 Diastereoselectivities 
The data in Schemes 3.2-3.5 define a number of diastereoselectivity trends, 
which may be summarized as follows: (1) Co(ClO4)2 gives the tris(1,2-diarylethyl-
enediamine) complexes -(S,S)-13+ 3ClO4– or -[Co((S,S)-NH2CHArCHArNH2)3]3+ 
3ClO4– with high kinetic selectivities; (2) CoCl2 or Co(OAc)2 (after chloride ion 
metathesis) give the tris(1,2-diarylethylenediamine) complexes -(S,S)-13+ 3Cl– or -
[Co((S,S)-NH2CHArCHArNH2)3]3+ 3Cl– with high kinetic selectivities; (3) The 
thermodynamic / selectivities parallel the kinetic selectivities found in (1) and (2); (4) 
The thermodynamic stability order established for the tris(perchlorate) salts holds for 
other salts with three poor hydrogen bond accepting anions (Scheme 3.4). 
 Since perchlorate is such a feeble hydrogen bond acceptor, my current model is 
that the stability trend -(S,S)-13+ 3ClO4– > -(S,S)-13+ 3ClO4– reflects the intrinsic 
thermodynamic preference of the trication in the gas phase. This would presumably have 
some type of stereoelectronic basis. The reversed stability trends with the trichloride or 
dichloride salts, -(S,S)-13+ 3Cl– > -(S,S)-13+ 3Cl– or -(S,S)-13+ 2Cl–BArf– > -
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(S,S)-13+ 2Cl–BArf– (see experimental section), presumably reflect a greater enthalpy of 
hydrogen bonding in the  diastereomers. Both of these hypotheses are currently being 
probed computationally.28  
3.3.3. Earlier Work Relevant to Scheme 3.2 
Salts of the trication [Co(dpen)3]3+ were first described in 1959 with racemic 
ligands19 and then in 1965 with enantiopure ligands.18a Subsequently, the latter were 
more extensively studied by Bosnich16 and Mason.17,18b As noted above, Bosnich 
reported a synthesis of ∆-[Co((S,S)-dpen)3]3+ 3ClO4–, which he designated (–)-[Co((–)-
stien)3]3+ 3ClO4–,21b similar to that in Scheme 3.2. He also showed the  diastereomer, 
which he designated (+)-[Co((–)-stien)3]3+ 3ClO4–,21b to be less stable. In both cases, 
Bosnich correctly assigned the cobalt configurations according to well established 
circular dichroism relationships, specifying the levorotatory complex as  and the 
dextrorotatory complex as . However, the carbon configurations of the dpen ligands 
were misassigned.  
The misstep involved two structural features common to octahedral complexes of 
chelate ligands of the formula H2NCHRCHRNH2. First, as more fully analyzed in a 
recent review,8 the five membered chelate rings adopt chiral conformations, commonly 
denoted  (left handed helix) and  (right handed helix) as depicted in Figure 3.5. For a 
given CHR configuration, the conformation that maximizes the occupancy of 
pseudoequatorial vs. pseudoaxial positions will be favored (G >> F and H >> I, Figure 
3.5). From these conformations, there are only limited numbers of ways to "build up" 
octahedral complexes. If all three chelate conformations are identical, there are four 
possibilities, given by --[Co((S,S)-dpen)3]3+ (J), ∆--[Co((S,S)-dpen)3]3+ (K), ∆-
-[Co((R,R)-dpen)3]3+ (L), and --[Co((R,R)-dpen)3]3+ (M).  
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Figure 3.5. Chelate conformations of dpen and all possible trications [Co(dpen)3]3+ with 
pseudoequatorial phenyl substituents. 
 
 
 
In J and L, the three CHPh-CHPh bonds are parallel to the C3 axis, which runs 
perpendicular to the plane of the paper.  Such species are said to have "lel3" orientations. 
In K and M, the three CHPh-CHPh bonds are oblique to the C3 axis. Such species are 
said to have "ob3" orientations. For the trications [Co(en)3]3+ and [Co(trans-chxn)3]3+ 
(chxn = 1,2-cyclohexanediamine), lel3 orientations were known to be more stable than 
ob3 orientations.29,30 Citing these examples, Bosnich assumed that the (–)-dpen ligands 
of the more stable ∆ diastereomer (–)-[Co((–)-stien)3]3+ 3ClO4– should also adopt lel3 
orientations. Thus, he paired the ∆ diastereomer with an (R,R)-dpen configuration as in 
L, or ∆--[Co((R,R)-dpen)3]3+. 
This issue was put to rest when Mason determined the crystal structure and 
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absolute configuration of (+)-[Co((–)-dpen)3]3+ 3NO3–·H2O.17 His data confirmed that 
the dextrorotatory diastereomer possessed a Λ cobalt configuration (and the levorotatory 
diastereomer a ∆ configuration), and established an S,S configuration for (–)-dpen 
(opposite to Bosnich's assignment). Each chelate adopted a δ conformation and a lel 
orientation, corresponding to J. The trication in Bosnich's complex (–)-[Co((–)-
stien)3]3+ 3ClO4– would then correspond to K as opposed to L. 
3.4. Summary  
This study has established efficient and highly diastereoselective syntheses of a 
variety of enantiopure salts of the title trications, [Co(NH2CHArCHArNH2)3]3+. The 
salts are effective hydrogen bond donors, and are easily rendered lipophobic or 
lipophilic. Lipophilic salts are usually preferable for catalysis, as reactions can be 
conducted in solvents such as CH2Cl2 or acetonitrile, allowing the organic substrates to 
interact with the hydrogen bond donor sites without competition from polar, hydrogen 
bond accepting solvents such as alcohols.  
Different aromatic residues can be introduced on the 1,2-diarylethylenediamine 
ligands essentially "at will" (Scheme 3.1), although multiple electronegative substituents 
can lead to spurious synthetic results (Scheme 3.6). In future reports from the Gladysz 
group, salts with chiral anions will be disclosed,31 and driving forces associated with 
various equilibria further clarified.28 In conclusion, an especially broad family of tunable 
catalysts applicable to a variety of enantioselective organic reactions5-7 has been 
developed and stands ready for further empirical or systematic32 optimization. 
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3.5. Experimental section 
General Data. NMR spectra were recorded on a 500 MHz spectrometer at 
ambient probe temperature and referenced as follows (, ppm): 1H, residual internal 
CHCl3 (7.26), DMSO-d5 (2.49), CHD2OD (3.30), CDHCl2 (5.32), or acetone-d5 (2.05); 
13C, CDCl3, (77.0); DMSO-d6, (39.5), CD3OD (49.0), CD2Cl2 (54.0), or acetone-d6 
(29.8). IR spectra were recorded on a Shimadzu IRAffinity-1 spectrometer (Pike 
MIRacle ATR system, diamond/ZnSe crystal). UV-visible spectra were recorded on a 
Shimadzu UV-1800 UV spectrometer. Melting points were determined using an 
OptiMelt MPA 100 instrument. Microanalyses were conducted by Atlantic Microlab.  
NMR solvents (DMSO-d6, CDCl3, CD2Cl2, acetone-d6, CD3OD; Cambridge 
Isotopes) were stored over molecular sieves. DMSO (Fischer, ACS grade), CH2Cl2 
(EMD Chemicals, ACS grade), diethyl ether (Fischer, ACS grade), CH3OH (EMD, 
anhydrous, 99.8%), THF (EMD Chemicals, ACS grade), and acetone (BDH, ACS grade) 
were used as received. 
(S,S)-dpen (dpen = 1,2-diphenylethylenediamine, Combi-blocks, 95%), (R,R)-
dpen (Oakwood, 95%), (R,R)-bis(o-hydroxy)dpen ((R,R)-2); Aldrich, 95%), Co(O-
Ac)2·4H2O (Alfa Aesar, 98%) CoCl2·6H2O (Alfa Aesar, 99.9%), Co(ClO4)2·6H2O 
(Alfa Aesar, reagent grade), HCl (Macron, ACS grade), HClO4 (35%, Macron, ACS 
grade), NaOH (Macron, ACS grade), Et3N (Alfa Aesar, 98%), Na+ BArf– (BArf– = 
B(3,5-C6H3(CF3)2)4–, Ark Pharm, Inc., 95%), K+ BArf20– (BArf20– = B(C6F5)4–, Boul-
der Scientific Company, 97%), Ag+ BF4– (Aldrich, 98%), Ag+ PF6– (Strem, 99%), K+ 
PhBF3– (Aldrich, 95%), 4-butylbenzaldehyde (Aldrich, 90%), -naphthaldehyde (Aldr-
ich, 98%), 2-benzyloxybenzaldehyde (Aldrich, 98%), 3,5-bis(trifluoromethyl)benzaldeh-
yde (TCI, 95%), activated charcoal (Acros, Norit SX 4), DOWEX 50WX2 (200-400 
mesh, Aldrich), silica gel (Silicycle SiliaFlash® F60), and Celite 545 (Aldrich) were 
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used as received.  
(S,S)-H2NCH(4-C6H4n-Bu)CH(4-C6H4n-Bu)NH2 ((S,S)-5). A round bottom 
flask was charged with (R,R)-2 (2.42 g, 10.0 mmol) and DMSO (50 mL). Then 4-n-
butylbenzaldehyde (4.20 mL; 4.05 g, 25.0 mmol) was added with stirring. After 24 h, the 
mixture was poured into H2O (100 mL), which was extracted with diethyl ether (3 × 100 
mL). The combined extracts were washed with H2O and dried (Na2SO4). The solvent 
was removed by rotary evaporation and then oil pump vacuum (6 h). The yellow solid 
was dissolved in CH3OH (50 mL), and aqueous HCl (3.0 mL, 12.0 M) was added with 
stirring. After 14 h, the solvent was removed by rotary evaporation, and H2O (70 mL) 
was added. Then aqueous NaOH (3.0 M) was added with stirring until the pH reached 
11-12. The mixture was extracted with diethyl ether (3 × 80 mL) and the combined 
extracts were dried (Na2SO4). The solvent was removed by rotary evaporation and the 
residue chromatographed on a silica gel column (4  17 cm, 100:0 to 90:10 v/v CH2Cl2/ 
CH3OH). The solvent was removed from the product containing fractions by rotary 
evaporation and then oil pump vacuum (12 h) to give (S,S)-5 as an off white solid (2.22 
g, 6.84 mmol, 68%), mp 46-49 °C (open capillary).  
NMR (CDCl3, δ in ppm):33 1H (500 MHz) 7.19 (d, 3JHH = 8.5 Hz, 4H, Ar), 7.09 
(d, 3JHH = 8.5 Hz, 4H, Ar), 4.08 (s, 2H, CHNH2), 2.57 (t, 3JHH = 8.5 Hz, 4H, ArCH2), 
1.73 (br s, 4H, NH2), 1.61-1.53 and 1.38-1.29 (2 × m, 4H each, ArCH2CH2CH2), 0.92 
(t, 3JHH = 7.4 Hz, 6H, ArCH2CH2CH2CH3); 13C{1H} (125 MHz) 141.6, 140.5, 128.2, 
126.7 (4 × s, Ar), 61.4 (s, CHNH2), 35.2, 33.6, 22.3, 13.9 (4 × s, ArCH2CH2CH2CH3). 
(S,S)-H2NCH(-naphthyl)CH(-naphthyl)NH2 ((S,S)-10). A round bottom 
flask was charged with (R,R)-2 (0.749 g, 3.07 mmol) and DMSO (17 mL). Then -
naphthaldehyde (1.29 g, 8.28 mmol) was added with stirring. After 18 h, the mixture was 
poured into H2O (100 mL), which was extracted with diethyl ether (2 × 100 mL). The 
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combined extracts were washed with H2O and dried (Na2SO4). The solvent was 
removed by rotary evaporation and then oil pump vacuum (6 h). The yellow solid was 
dissolved in THF (30 mL), and aqueous HCl (3.0 mL, 12.0 M) was added with stirring. 
After 1 h, a white precipitate had formed, which was isolated by filtration and washed 
with diethyl ether. Then H2O (50 mL) was added, and the sample was washed with 
CH2Cl2. Then aqueous NaOH (3.0 M) was added with stirring until the pH reached 11-
12. The mixture was extracted with CH2Cl2 (3 × 100 mL) and the combined extracts 
were dried (Na2SO4). The solvent was removed by rotary evaporation and then oil pump 
vacuum (12 h) to give (S,S)-10 as a yellow solid (0.566 g, 1.78 mmol, 58%), mp 139-
145 °C (open capillary).  
NMR (CDCl3, δ in ppm): 1H (500 MHz) 7.85 (br s, 2H), 7.84-7.79 (m, 5H), 7.78 
(s, 1H), 7.50-7.42 (m, 6H), 4.43 (s, 2H, CHNH2), 1.64 (br s, 4H, NH2); 13C{1H} (125 
MHz) 140.7, 133.3, 132.7, 127.93, 127.87, 127.6, 126.0, 125.6, 125.4, 125.3 (10 × s, 
C10H7), 61.5 (s, CHNH2). 
(S,S)-H2NCH(2-C6H4OBn)CH(2-C6H4OBn)NH2 ((S,S)-11). A round bottom 
flask was charged with (R,R)-2 (1.73 g, 7.09 mmol) and DMSO (50 mL). Then 2-
benzyloxybenzaldehyde (2.69 mL; 3.61 g, 17.02 mmol) was added with stirring. After 
18 h, the mixture was poured into H2O (100 mL), which was extracted with diethyl ether 
(3 × 70 mL). The combined extracts were washed with H2O and dried (Na2SO4). The 
solvent was removed by rotary evaporation and then oil pump vacuum (6 h). The yellow 
solid was dissolved in THF (80 mL) and aqueous HCl (3.0 mL, 12.0 M) was added with 
stirring. After 12 h, the solvent was removed by rotary evaporation, and H2O (70 mL) 
was added. Then aqueous NaOH (3.0 M) was added with stirring until the pH reached 
11-12. The mixture was extracted with diethyl ether (2 × 80 mL) and CH2Cl2 (80 mL). 
The combined extracts were dried (Na2SO4). The solvent was removed by rotary 
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evaporation and then oil pump vacuum (12 h) to give (S,S)-11 as a sticky yellow solid 
(1.69 g, 3.99 mmol, 56%).  
NMR (CDCl3, δ in ppm): 1H (500 MHz) 7.37-7.27 (m, 10 H), 7.23 (d, 3JHH = 
7.5 Hz, 2H), 7.11-7.05 (m, 2H), 6.81 (t, 3JHH = 7.5 Hz, 2H), 6.75 (d, 3JHH = 7.5 Hz, 
2H), 4.88 (d, 2JHH = 7.0 Hz, 2H, 2 × OCHH'Ph), 4.80 (d, 2JHH = 7.0 Hz, 2H, 2 × 
OCHH'Ph), 4.57 (s, 2H, CHNH2), 1.83 (br s, 4H, NH2); 13C{1H} (125 MHz) 155.9, 
137.2, 132.2, 128.5, 128.3, 127.7, 127.5, 127.2, 120.5, 111.5 (10 × s, Ar), 69.7 (s, 
OCH2), 55.7 (s, CHNH2). 
(S,S)-H2NCH(3,5-C6H3(CF3)2)CH(3,5-C6H3(CF3)2)NH2 ((S,S)-12). A round 
bottom flask was charged with (R,R)-2 (2.44 g, 10.0 mmol) and DMSO (50 mL). Then 
3,5-bis(trifluoromethyl)benzaldehyde (3.95 mL; 5.81 g, 24.0 mmol) was added with 
stirring. After 48 h, the mixture was poured into H2O (100 mL), which was extracted 
with diethyl ether (3 × 100 mL). The combined extracts were washed with H2O and 
dried (Na2SO4). The solvent was removed by rotary evaporation and then oil pump 
vacuum (8 h). The yellow solid was dissolved in THF (80 mL) and aqueous HCl (5.0 
mL, 12.0 M) was added with stirring. After 24 h, the solvent was removed by rotary 
evaporation, and H2O (100 mL) was added. Then aqueous NaOH (3.0 M) was added 
with stirring until the pH reached 11-12. The mixture was extracted with diethyl ether (3 
× 100 mL). The combined extracts were dried (Na2SO4). The solvent was removed by 
rotary evaporation and the residue chromatographed on a silica gel column (4  17 cm, 
100:0 to 96:4 v/v CH2Cl2/CH3OH). The solvent was removed from the product 
containing fractions by rotary evaporation and then oil pump vacuum (12 h) to give 
(S,S)-12 as a brown oil (3.41 g, 7.04 mmol, 70%).  
NMR (DMSO-d6, δ in ppm):33 1H (500 MHz) 7.80 (s, 2H, p-Ar), 7.76 (s, 4H, o-
Ar), 4.19 (s, 2H, CHNH2), 2.25 (br s, 4H, NH2); 13C{1H} (125 MHz) 147.3 (s, i-Ar), 
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129.2 (q, 2JCF = 32.3 Hz, m-Ar), 128.2 (s, o-Ar), 123.4 (q, 1JCF = 271.1 Hz, CF3), 119.9 
(s, p), 61.0 (s, CHNH2). 
 Λ-[Co((S,S)-H2NCH(C6H5)CH(C6H5)NH2)3] 3Cl– (Λ-(S,S)-13+ 3Cl–). A gas 
circulating flask34 was charged with a solution of Co(OAc)2.4H2O (0.296 g, 1.19 mmol) 
in CH3OH (50 mL). Activated charcoal (0.1 g) and (S,S)-dpen (0.849 g, 4.00 mmol, 3.4 
equiv) were added with vigorous stirring. After 17 h, the mixture was filtered through 
Celite and aqueous HCl (1.5 mL, 12.0 M) was added. The solvent was removed by 
rotary evaporation to give an orange solid. A portion was dissolved in CD3OD (13C{1H} 
NMR: CHPh at δ 63.5/66.1/66.7 ppm (67/10/23); Λ-(S,S)-13+ 3Cl–, -(S,S)-13+ 3Cl–, 
and trans-[Co((S,S)-dpen)2(Cl)2]+ Cl–).21,35 Then H2O (100 mL) was added. The 
suspension was filtered. The filter cake was washed with H2O (100 mL) and dissolved in 
CH3OH. The solvent was removed by rotary evaporation and oil pump vacuum (14 h) to 
give Λ-(S,S)-13+ 3Cl–·3H2O as an orange solid (0.662 g, 0.773 mmol, 65%), mp 220-
230 °C dec (green liquid; open capillary). The 13C{1H} spectrum showed only one 
CHPh signal, indicative of the Λ diastereomer, as confirmed crystallographically.3a 
Anal. Calcd. for C42H48Cl3CoN6·3H2O (856.21): C 58.92, H 6.36, N 9.82; found C 
58.95, H 6.46, N 9.68.  
NMR (10:1 v/v DMSO-d6/CD3OD, δ in ppm):33 1H (500 MHz) 7.65-7.42 (m, 
12H, Ph), 7.41-7.15 (m, 18H, Ph), 6.86 (br s, 6H, NHH'), 5.31 (br s, 6H, NHH'), 4.97 (s, 
6H, CHNH2), 4.06 (br s, 10H, CD3OH/H2O); 13C{1H} (125 MHz) 137.3 (s, i-Ph), 
128.9 and 128.8 (2 s, o/m-Ph), 128.6 (s, p-Ph), 61.8 (s, CHNH2). 
 ∆-(S,S)-13+ 3ClO4–. This and the following procedure involve perchlorate salts 
that are potentially explosive.36 Although they have been carried out repeatedly without 
mishap, special care and protection are always required when working with perchlorate 
salts or HClO4 solutions. A gas circulating flask34 was charged with a solution of 
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Co(ClO4)2·6H2O (0.261 g, 0.711 mmol) in CH3OH (50 mL). Activated charcoal (0.1 g) 
and (S,S)-dpen (0.505 g, 2.38 mmol, 3.3 equiv) were added with vigorous stirring. After 
17 h, the mixture was filtered through Celite, and HClO4 (2.0 mL, 35% in H2O) was 
added. The solvent was removed by rotary evaporation to give an orange solid. A 
portion was dissolved in DMSO-d6 (13C{1H} NMR: CHPh at δ 63.0/61.2 ppm (92/8); 
- and Λ-(S,S)-13+ 3ClO4–). The solid was washed with water and dissolved in CH3OH. 
The solvent was removed by rotary evaporation to give crude (S,S)-13+ 3ClO4– as an 
orange powder (0.422 g, 0.425 mmol, 60%) and an 83:17 ∆/Λ mixture, as assayed by 
13C{1H} NMR (δ, DMSO-d6, 63.2/61.4 ppm).23b,24  
 NMR (CD3OD, δ in ppm; after equilibration to a >96:<4 ∆/Λ mixture as 
described below): 1H (500 MHz) 7.41-7.37 (m, 12H, Ph), 7.34-7.30 (m, 18H, Ph), 4.89 
(br s, 26H, CD3OH/H2O), 4.52 (s, 6H, CHNH2);37 13C{1H} (125 MHz): 136.5 (s, i-Ph), 
130.4 (s, p-Ph), 130.0 and 129.0 (2 s, o/m-Ph), 66.5 (s, CHNH2). 
Λ-(S,S)-13+ 3ClO4–. A beaker was charged with Λ-(S,S)-13+ 3Cl–·3H2O (0.502 
g, 0.0.586 mmol) and boiling CH3OH (200 mL). Then NaClO4 (ca. 0.765 g, 6.25 mmol) 
was added with stirring, followed by warm water (400 mL). The solution was kept at 0 
°C. After 7 h, the yellow precipitate was collected, washed with water, dried by oil pump 
vacuum, and dissolved in a minimum of hot acetone. Ten volumes of ethanol were 
added. Ether was slowly added, initiating precipitation. More ether was added, and the 
mixture was kept at 0 °C. After 14 h, the orange solid was collected by filtration and 
dried by oil pump vacuum to give Λ-(S,S)-13+ 3ClO4–·4H2O (0.401 g, 0.376 mmol, 
64%).39   
NMR (CD3OD, δ in ppm):33 1H (500 MHz) 7.41 (br s, 12H, Ph), 7.35 (br s, 18H, 
Ph), 4.88 (br s, 24H, CD3OH/H2O), 4.81 (s, 6H, CHNH2);37 13C{1H} (125 MHz) 136.4 
(s, i-Ph), 130.5 (s, p-Ph), 130.3 and 129.7 (2 s, o/m-Ph), 63.7 (s, CHNH2).  
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∆-(S,S)-13+ 3Cl–. A (Scheme 3.2, step V with diastereomer mixture). A beaker 
was charged with the 83:17 mixture of ∆- and Λ-(S,S)-13+ 3ClO4– obtained above (0.302 
g, 0.304 mmol) and CH3OH (50 mL). The solution was sorbed onto a Dowex cation 
exchange column (3.0  12 cm), which was washed with H2O/CH3OH (1:1 v/v, 100 
mL) and eluted with increasing concentrations of 12.0 M aqueous HCl in CH3OH 
(CH3OH/HCl 9:1 v/v (100 mL), 8:2 v/v (100 mL), 7:3 v/v (100 mL), 6:4 v/v until 
product elution). An orange band was collected and the solvents were removed by rotary 
evaporation (45 °C bath; base trap to scavenge HCl). This gave (S,S)-13+ 3Cl– (0.227 g, 
0.283 mmol, 93%) as a bright orange solid and a 83:17 ∆/Λ mixture, as assayed by 
13C{1H} NMR (δ, 63.7/62.0 ppm).23b B (Scheme 3.2, step V with ∆ diastereomer). A 
beaker was charged with ∆-(S,S)-13+ 3ClO4– (0.200 g, 0.202 mmol; see below) and 
CH3OH (50 mL). The solution was sorbed onto a Dowex cation exchange column. A 
workup identical to that in A gave ∆-(S,S)-13+ 3Cl–·2H2O (0.0.139 g, 0.0.166 mmol, 
82%) as a bright orange solid, mp 193-197 °C dec (green liquid; open capillary). Anal. 
Calcd. for C42H48Cl3CoN6·2H2O (838.19): C 60.18, H 6.25, N 10.03; found C 60.23, H 
6.24, N 9.90.   
∆-(S,S)-13+ 3Cl–. NMR (3:1 v/v DMSO-d6/CD3OD, δ in ppm, from route A): 1H 
(500 MHz) 7.54-7.49 (m, 0.17·12H, Ph), 7.48-7.43 (m, 0.83·12H, Ph), 7.34-7.22 (m, 
0.17·18H and 0.83·18H, Ph), 6.77 (br s, 0.17·6H, NHH'), 6.53 (d, 3JHH = 11 Hz, 
0.83·6H, NHH'), 5.43 (br s, 0.83·6H, NHH'), 5.32 (br s, 0.17·6H, NHH'), 4.96 (s, 
0.17·6H, CHNH2), 4.77-4.62 (m, 0.83·6H, CHNH2), 4.06 (br s, 20H, CD3OH/H2O); 
13C{1H} (125 MHz) 137.6 (s, i-Ph), 129.2 (s, Ph),s3 129.0 (s, Ph), 128.9 (s, Ph), 128.6 
(s, Ph), 63.7 (s, CHNH2, 83%), 62.0 (s, CHNH2, 17%).  
NMR (CD3OD, δ in ppm, from B):33 1H (500 MHz) 7.46-7.44 (m, 12H, Ph), 
7.30 (br s, 18H, Ph), 6.41 (d, 6H, 3JHH = 10 Hz, NHH'), 5.94 (bs s, 6H, NHH'), 4.88 (br 
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s, 13H, CD3OH/H2O), 4.58 (d, 6H, 3JHH = 10 Hz, CHNH2); 13C{1H} (125 MHz) 137.3 
(s, i-Ph), 130.2 (s, p-Ph), 130.0 and 129.1 (2 s, o/m-Ph), 66.7 (s, CHNH2).  
Epimerization of (S,S)-13+ 3X– (Scheme 3.2). A (Scheme 3.2, step IV with Λ 
diastereomer).40 A 5 mm NMR tube was charged with Λ-(S,S)-13+ 3ClO4–·4H2O (0.027 
g, 0.025 mmol), activated charcoal (0.005 g), CD3OD (0.5 mL), and a stir bar, and kept 
at 70 °C with stirring. The sample was monitored by 13C{1H} NMR (stir bar removed 
prior to each spectrum), which showed the isomerization to ∆-(S,S)-13+ 3ClO4– (δ 63.6 
ppm to 66.6 ppm), with a minor byproduct (δ 71.9 ppm) becoming increasingly visible 
after 24 h. Data (time, ratios): 4 h, 25/75/-, 22 h, 14/86/-, 68 h, 10/76/14, 150 h, 3/81/16). 
No other signals were evident. B (Scheme 3.2, step IV with ∆ diastereomer dominant). A 
round bottom flask was charged with (S,S)-13+ 3ClO4– (0.118 g, 0.119 mmol; 83:17 
∆/Λ, see above), CH3OH (10 mL), and activated charcoal (0.051 g), and fitted with a 
condenser. The mixture was kept at 70 °C for 48 h, and then filtered through Celite. The 
solvent was removed by rotary evaporation and dried by oil pump vacuum to give ∆-
(S,S)-13+ 3ClO4– (0.114 g, 0.115 mmol, 97% (95-99%, triplicate runs); <4% Λ)24b as an 
orange solid, NMR data for which are given above. C (Scheme 3.2, step VI with 
diastereomer mixture). A 5 mm NMR tube was charged with (S,S)-13+ 3Cl– (0.030 g, 
0.0373 mmol; 17:83 Λ/∆), activated charcoal (0.0063 g), CD3OD (0.5 mL), and a stir 
bar, and kept at 70 °C with stirring. The sample was monitored by 13C{1H} NMR as in 
A. This showed gradual isomerization (δ 66.6 ppm to 63.5 ppm). Data (time, Λ/∆ ratios): 
18 h, 58/42, 37 h, 61/39). No other signals were evident. D (Scheme 3.2, step VI with ∆ 
diastereomer). A 5 mm NMR tube was charged with ∆-(S,S)-13+ 3Cl– (0.025 g, 0.0311 
mmol), activated charcoal (0.0010 g), CD3OD (0.5 mL), and a stir bar, and kept at 70 °C 
with stirring. The sample was monitored by 13C{1H} NMR as in A. This showed gradu-
al isomerization (δ 66.6 ppm to 63.5 ppm). Data (time, Λ/∆ ratios: 24 h, 54/46; 50 h, 
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57/43). No other signals were evident.  
Λ-(S,S)-13+ 2Cl–BArf–. A round bottom flask was charged with Λ-(S,S)-13+ 
3Cl–·3H2O (0.320 g, 0.374 mmol), CH2Cl2 (15 mL) and Na+ BArf– (0.382 g, 0.431 
mmol, 1.2 equiv). The mixture was sonicated (5 min)41 and filtered. The filtrate was 
loaded onto a silica gel column (1.9  15 cm), which was eluted with CH2Cl2/CH3OH 
(100:0 to 98:2 v/v). The solvent was removed from the main orange band by rotary 
evaporation and then oil pump vacuum (14 h) to give Λ-(S,S)-13+ 2Cl–BArf–.2H2O as an 
orange solid (0.5802 g, 0.3478 mmol, 93%), mp 116-119 °C dec (open capillary). Anal. 
Calcd. for C74H60BCl2CoF24N6·2H2O (1665.95): C 53.35, H 3.87, N 5.04, Cl 4.26; 
found C 53.50, H 3.82, N 4.84, Cl 3.94. IR (powder film, cm–1): 3039 (m, νNH), 1609 
(m, δNH), 1354 (s, νAr-CF3), 1275 (vs, νCF), 1119 (vs, δCCN). UV-visible (nm, 1.66 × 10–
3 M in CH2Cl2 (, M–1 cm–1)): 455 (157). 
NMR (CD2Cl2, δ in ppm):33 1H (500 MHz) BArf– at 7.73 (s, 8H, o), 7.54 (s, 4H, 
p); (S,S)-dpen ligand at 8.17 (br s, 6H, NHH'), 7.40-7.37 (m, 6H, p-Ph), 7.34-7.30 (m, 
24H, o/m-Ph), 4.48 (s, 6H, CHNH2), 3.86 (br s, 6H, NHH'), 2.14 (br s, 7H, H2O); 
13C{1H} (125 MHz) BArf– at 162.3 (q, 1JBC = 49.4 Hz, i), 135.4 (s, o), 129.4 (q, 2JCF = 
31.3 Hz, m), 125.2 (q, 1JCF = 271.0 Hz, CF3), 118.1 (s, p); (S,S)-dpen ligand at 134.8 (s, 
i-Ph), 131.1 (s, p-Ph), 130.6 (s, o-Ph), 128.0 (s, m-Ph),38 63.6 (s, CHNH2). See Figure 
3.3 for the concentration dependence of the NHH' signals. 
Λ-(S,S)-13+ 2Cl–BArf20–. A round bottom flask was charged with Λ-(S,S)-13+ 
3Cl–·3H2O (0.602 g, 0.703 mmol), CH2Cl2, (25 mL), and K+ BArf20– (0.606 g, 0.843 
mmol, 1.2 equiv). The mixture was sonicated (10 min)41 and filtered. The filtrate was 
loaded onto a silica gel column (3  14 cm), which was eluted with CH2Cl2/CH3OH 
(100:0 to 97:3 v/v). The solvent was removed from the main orange band by rotary 
evaporation and then oil pump vacuum (14 h) to give Λ-(S,S)-13+ 2Cl–BArf20–.3H2O as 
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an orange solid (0.918 g, 0.611 mmol, 87%), mp 138-141 °C dec (open capillary). Anal. 
Calcd. for C66H48BCl2CoF20N6·3H2O (1499.79): C 52.85, H 3.63, N 5.60; found C 
52.87, H 3.58, N 5.35. 
NMR (acetone-d6, δ in ppm):33 1H (500 MHz) 8.27 (br s, 6H, NHH'), 7.54-7.44 
(m, 12H, Ph), 7.38-7.25 (m, 18H, Ph), 5.21 (br s, 6H, NHH'), 5.14-5.05 (m, 6H, 
CHNH2), 2.87 (br s, 6H, H2O); 13C{1H,19F} (125 MHz) BArf20– at 149.0 (s), 139.0 (s), 
137.1 (s), 125.0 (q, 1JBC = 50.0 Hz, i); (S,S)-dpen ligand at 137.3 (s, i-Ph), 130.01 (s, p-
Ph), 129.95 and 129.5 (2 s, o/m-Ph), 63.5 (s, CHNH2).  
Λ-(S,S)-13+ 2BF4–BArf–. A round bottom flask was charged with a solution of 
Λ-(S,S)-13+ 2Cl–BArf–·2H2O (0.9985 g, 0.599 mmol) in CH2Cl2 (4 mL), and Ag+ BF4– 
(0.2412 g, 1.24 mmol, 2.1 equiv) was added with stirring. The mixture was sonicated (10 
min) and filtered through Celite. The solvent was removed from the filtrate by rotary 
evaporation and then oil pump vacuum (14 h) to give Λ-(S,S)-13+ 2BF4–BArf–·3H2O as 
a bright orange solid (1.019 g, 0.570 mmol, 95%), mp 140-147 °C dec (open capillary). 
Anal. Calcd. for C74H60B3CoF32N6 .3H2O (1786.67): C 49.75, H 3.72, N 4.70; found C 
49.94, H 3.69, N 4.52. IR (powder film, cm–1): 3254 (m, νNH), 1608 (m, δNH), 1354 (s, 
νAr-CF3), 1277 (vs, νCF), 1121 (vs, δCCN). UV-visible (nm, 1.67 × 10–3 M in CH2Cl2 (, 
M–1 cm–1)): 451 (sh, 231). 
NMR (CD2Cl2, δ in ppm):33 1H (500 MHz) BArf– at 7.73 (s, 8H, o), 7.56 (s, 4H, 
p); (S,S)-dpen ligand at 7.45 (t, 3JHH = 7.0 Hz, 6H, p-Ph), 7.40 (t, 3JHH = 7.0 Hz, 12H, 
m-Ph), 7.32 (d, 3JHH = 7.0 Hz, 12H, o-Ph), 6.04 (br s, 6H, NHH'), 4.52 (s, 6H, CHNH2), 
4.17 (br s, 6H, NHH'), 2.01 (s, 8H, H2O); 13C{1H} (125 MHz) BArf– at 162.2 (q, 1JBC 
= 48.8 Hz, i), 135.3 (s, o), 129.4 (q, 2JCF = 27.5 Hz, m), 125.1 (q, 1JCF = 271.3 Hz, 
CF3), 118.1 (s, p); (S,S)-dpen ligand at 133.6 and 131.4 (2 s, i/p-Ph), 130.7, (s, o-Ph), 
127.8 (s, m-Ph),38 64.5 (s, CHNH2).  
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Λ-(S,S)-13+ 2PF6–BArf–. A round bottom flask was charged with a solution of 
Λ-(S,S)-13+ 2Cl–BArf–·2H2O (0.1200 g, 0.072 mmol) in CH2Cl2 (2 mL). A solution of 
Ag+ PF6– (0.0373 g, 0.148 mmol, 2.1 equiv) in CH2Cl2 (2 mL) was added with stirring. 
A white precipitate immediately formed. The sample was sonicated (1 min) and filtered 
through Celite. The filtrate was washed with H2O (2 × 1 mL) and the solvent was 
removed by rotary evaporation and then oil pump vacuum (5 h) to give Λ-(S,S)-13+ 
2PF6–BArf–·H2O as a bright orange solid (0.1121 g, 0.060 mmol, 83%), which when 
warmed (open capillary) continually darkened and then liquefied at 160 °C. Anal. Calcd. 
for C74H60BCoF36N6P2.H2O (1866.96): C 47.61, H 3.35, N 4.50; found C 47.86, 3.49, 
4.62. IR (powder film, cm–1): 3287 (m, νNH), 1609 (m, δNH), 1354 (s, νAr-CF3), 1276 
(vs, νCF), 1122 (vs, δCCN). UV-visible (nm, 1.67 × 10–3 M in CH2Cl2 (, M–1 cm–1)): 
449 (302).  
NMR (CD2Cl2, δ in ppm):33 1H (500 MHz) BArf– at 7.73 (s, 8H, o), 7.55 (s, 4H, 
p); (S,S)-dpen ligand at 7.47 (t, 3JHH = 7.0 Hz, 6H, p-Ph), 7.42 (t, 3JHH = 7.5 Hz, 12H, 
m-Ph), 7.29 (d, 3JHH = 7.0 Hz, 12H, o-Ph), 5.77 (br s, 6H, NHH'), 4.49 (s, 6H, CHNH2), 
4.10 (br s, 6H, NHH'), 2.16 (br s, 3H, H2O); 13C{1H} (125 MHz) BArf– at 162.2 (q, 
1JBC = 48.8 Hz, i), 135.3 (s, o), 129.4 (q, 2JCF = 33.8 Hz, m), 125.1 (q, 1JCF = 271.2 Hz, 
CF3), 118.1 (s, p); (S,S)-dpen ligand at 133.0 (s, i-Ph), 131.9 (s, p-Ph), 131.0 (s, o-Ph), 
127.8 (s, m-Ph),38 64.0 (s, CHNH2).  
Λ-(S,S)-13+ 2PhBF3–BArf–. A beaker was charged with -(S,S)-13+ 2Cl–BArf–
·2H2O (0.166 g, 0.0996 mmol), K+ PhBF3– (0.0367 g, 0.199 mmol, 2.0 equiv), CH2Cl2 
(15 mL), and H2O (15 mL). The biphasic mixture was vigorously stirred (10 min) and 
then allowed to stand. The lower orange CH2Cl2 phase was separated. The solvent was 
removed by rotary evaporation to give Λ-(S,S)-13+ 2PhBF3–BArf–·2H2O as a bright 
orange solid (0.181 g, 0.0960 mmol, 96%), mp 120-134 °C dec (open capillary). Anal. 
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Calcd. for C86H70B3CoF30N6·2H2O (1884.86): C 54.80, H 3.96, N 4.46; found C 55.00, 
H 4.02, N 4.12.  
NMR (acetone-d6, δ in ppm):33 1H (500 MHz) BArf– at 7.80 (s, 24H, o), 7.68 (s, 
12H, p); PhBF3– at 7.49-7.44 (m, 4H, Ph), 7.24-7.15 (s, 6H, Ph); (S,S)-dpen ligand at 
7.61-7.51 (m, 12H, Ph), 7.37-7.28 (m, 18H, Ph), 6.33 (br s, 6H, NHH'), 5.79 (br s, 6H, 
NHH'), 5.25 (br s, 6H, CHNH2), 2.87 (br s, 4H, H2O); 13C{1H} (125 MHz) BArf– at 
162.5 (q, 1JBC = 49.6 Hz, i), 135.5 (s, o), 130.1 (m, m), 125.3 (q, 1JCF = 270.0 Hz, CF3), 
118.4 (m, p); PhBF3– and (S,S)-dpen ligand at 136.3 (br s), 134.9 (s), 132.1 (s), 130.2 
(s), 129.9 (s), 129.7 (s), 127.6 (s), 127.2 (s), 63.9 (s, CHNH2). 
Λ-(S,S)-13+ 3BArf–. A. A beaker was charged with Λ-(S,S)-13+ 2Cl–BArf–
·2H2O (0.170 g, 0.102 mmol), CH2Cl2 (15 mL), Na+ BArf– (0.188 g, 0.204 mmol, 2.0 
equiv), and H2O (15 mL). The biphasic mixture was vigorously stirred (10 min) and then 
allowed to stand. The lower orange CH2Cl2 phase was separated and the solvent allowed 
to evaporate in a hood to give Λ-(S,S)-13+ 3BArf–.8H2O as an orange solid (0.336 g, 
0.0979 mmol, 96%). B. The salt Λ-(S,S)-13+ 3Cl–·3H2O (0.170 g, 0.199 mmol), CH2Cl2 
(15 mL), Na+ BArf– (0.532 g, 0.60 mmol, 3.0 equiv), and H2O (15 mL) were combined 
in a procedure analogous to that in A. An identical workup gave Λ-(S,S)-13+ 3BArf–
·8H2O as an orange solid (0.644 g, 0.188 mmol, 94%), dec pt 68-98 °C (no melting), 
which liquefied at 106 °C (open capillary). Anal. Calcd. for C138H84B3CoF72N6. 8H2O 
(3429.55): C 48.33, H 2.94, N 2.45; found C 48.16, H 2.90, N 2.40.   
NMR (acetone-d6, δ in ppm):33 1H (500 MHz) BArf– at 7.79 (s, 24H, o), 7.67 (s, 
12H, p); (S,S)-dpen ligand at 7.40-7.37 (m, 6H, p-Ph), 7.34-7.30 (m, 24H, o/m-Ph), 6.38 
(br s, 6H, NHH'), 6.22 (br s, 6H, NHH'), 5.30 (s, 6H, CHNH2), 2.95 (br s, 24H, H2O); 
13C{1H} (125 MHz) BArf– at 162.6 (q, 1JBC = 50.0 Hz, i), 135.5 (s, o), 130.0 (q, 2JCF = 
32.5 Hz, m), 125.3 (q, 1JCF = 270.0 Hz, CF3), 118.4 (m, p); (S,S)-dpen ligand at 135.5 
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(s, i-Ph), 130.8 (s, p-Ph), 130.3 and 129.4 (2 s, o/m-Ph), 64.1 (s, CHNH2). 
1H NMR (500 MHz, CD2Cl2, δ in ppm):33 BArf– at 7.72 (s, 24H, o), 7.54 (s, 
12H, p); (S,S)-dpen ligand at 7.44 (t, 3JHH = 7.5 Hz, 6H, p-Ph), 7.37 and 7.17 (t and d, 
3JHH = 7.5 and 7.5 Hz, 12H and 12H, o/m-Ph), 5.54 (br s, 6H, NHH'), 4.68 (br s, 6H, 
NHH'), 4.44 (s, 6H, CHNH2), 2.82 (br s, 22H, H2O).  
Λ-(S,S)-13+ 3BArf20–. The salt Λ-(S,S)-13+ 3Cl–·3H2O (0.171 g, 0.199 mmol), 
CH2Cl2 (15 mL), K+ BArf20– (0.431 g, 0.60 mmol, 3.0 equiv), and H2O (15 mL) were 
combined in a procedure analogous to those given for Λ-(S,S)-13+ 3BArf–. An identical 
workup gave Λ-(S,S)-13+ 3BArf20–·11H2O as an orange solid (0.549 g, 0.184 mmol, 
92%), mp 84-130 °C (open capillary). Anal. Calcd. for C114H48B3CoF60N6.11H2O 
(2732.91): C 46.71.1, H 2.41, N 2.87; found C 46.80, H 2.35, N 2.72.   
NMR (acetone-d6, δ in ppm):33 1H (500 MHz) 7.57-7.44 (m, 12H, Ph), 7.42-7.28 
(m, 18H, Ph), 6.39 (br s, 6H, NHH'), 6.20 (br s, 6H, NHH'), 5.29 (s, 6H, CHNH2), 3.08 
(br s, 22H, H2O); 13C{1H,19F} (125 MHz) BArf20– at 149.0 (s), 140.0 (m), 138.0 (m), 
136.2 (s), 125.0 (q, 1JBC = 50.0 Hz, i);42 (S,S)-dpen ligand at 135.8 (s, i-Ph), 130.8 (s, p-
Ph), 130.3 (s, o-Ph), 129.3 (s, m-Ph),38 64.2 (s, CHNH2). 
Λ-(S,S)-13+ 3BF4–. A round bottom flask was charged with a solution of Λ-
(S,S)-13+ 3Cl–·3H2O (0.173 g, 0.202 mmol) in CH3OH (15 mL) and Ag+ BF4– (0.118 g, 
0.606 mmol, 3.0 equiv). The mixture was sonicated (10 min) and filtered through Celite. 
The solvent was removed from the filtrate by rotary evaporation and then oil pump 
vacuum (14 h) to give Λ-(S,S)-13+ 3BF4–·2H2O as a bright orange solid (0.185 g, 0.187 
mmol, 93%), mp 198-202 °C dec (open capillary). Anal. Calcd. for 
C42H48B3CoF12N6.2H2O (992.24): C 50.84, H 5.28, N 8.47; found C 51.16, H 5.42, N 
8.47.  
NMR (δ in ppm):33 1H (500 MHz, acetone-d6) 7.57-7.43 (m, 12H, Ph), 7.42-7.23 
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(m, 18H, Ph), 5.83 (br s, 11H, NHH'),37 5.18 (s, 6H, CHNH2), 2.87 (s, 7H, H2O); 
13C{1H} (125 MHz, CD3OD): 136.1 (s, i-Ph), 130.5 (s, p-Ph), 130.2 and 129.6 (2 s, 
o/m-Ph), 63.7 (s, CHNH2). 
Λ-(S,S)-13+ 3PF6–. A solution of Λ-(S,S)-13+ 3Cl–·3H2O (0.255 g, 0.298 mmol) 
in CH3OH (15 mL) and Ag+ PF6– (0.237 g, 0.939 mmol, 3.2 equiv) were combined in a 
procedure analogous to that for Λ-(S,S)-13+ 3BF4–. An identical workup gave Λ-(S,S)-
13+ 3PF6–·6H2O as a bright orange solid (0.321 g, 0.259 mmol, 87%), mp 219-226 °C 
dec (open capillary). Anal. Calcd. for C42H48P3CoF18N6.6H2O (1238.77): C 40.72, H 
4.88, N 6.78; found C 40.51, H 4.51, N 6.56.  
NMR (δ in ppm):33 1H (500 MHz, DMSO-d6) 7.46 (d, 3JCH = 7.5 Hz, 12H, o-
Ph), 7.38 (t, 3JCH = 7.5 Hz, 12H, m-Ph), 7.32 (t, 3JCH = 7.5 Hz, 6H, p-Ph), 5.64 (br s, 
6H, NHH'), 5.34 (br s, 6H, NHH'), 4.82 (s, 6H, CHNH2), 3.33 (s, 13H, H2O); 13C{1H} 
(125 MHz, 10:1 v/v DMSO-d6/CH3OH): 136.7 (s, i-Ph), 128.9, 128.8, and 128.6 (3 s, 
o/m/p-Ph), 61.4 (s, CHNH2). 
∆-(S,S)-13+ 2Cl–BArf–. A round bottom flask was charged with (S,S)-13+ 3Cl– 
(0.188 g, 0.234 mmol; 83:17 ∆/Λ), CH2Cl2 (10 mL), Na+ BArf– (0.240 g, 0.270 mmol), 
and CH3OH (0.10 mL). The mixture was sonicated (5 min)41 and filtered. The filtrate 
was loaded onto a silica gel column (1.9  14 cm), which was eluted with 
CH2Cl2/CH3OH (100:0 to 97:3 v/v). Aliquots of the main orange band were collected. 
These were analyzed by TLC, and combined accordingly. The solvents were removed by 
rotary evaporation and then oil pump vacuum to give Λ-(S,S)-13+ 2Cl–BArf–.2H2O 
(0.0586 g, 0.0352 mmol, 15% (higher Rf); see data above) and ∆-(S,S)-13+ 2Cl–BArf–
.H2O as an orange solid (0.2932 g, 0.1779 mmol, 76% (lower Rf)), which when warmed 
continually darkened and liquefied at 110 °C. Anal. Calcd. for C74H60BCl2Co-
F24N6.H2O (1647.94): C 53.93, H 3.79, N 5.10, Cl 4.30; found C 53.96, H 4.02, N 4.98, 
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Cl 4.20. IR (powder film, cm–1): 3068 (m, νNH), 1608 (m, δNH), 1574 (m, δNH), 1354 (s, 
νAr-CF3), 1275 (vs, νCF), 1119 (vs, δCCN). UV-visible (nm, 1.66 × 10–3 M in CH2Cl2 (, 
M–1 cm–1)): 462 (191). 
NMR (0.40:0.001 mL v/v CD2Cl2/CH3OH, δ in ppm):33 1H (500 MHz) BArf– at 
7.73 (s, 8H, o), 7.55 (s, 4H, p); (S,S)-dpen ligand at 7.30-7.27 (m, 18H, Ph), 7.22-7.19 (t, 
3JHH = 7.5 Hz, 12H, Ph), 6.58 (br s, 6H, NHH'), 5.35 (br s, 6H, NHH'), 4.25 (s, 6H, 
CHNH2), 2.53 (br s, 14H, CH3OH/H2O); 13C{1H} (125 MHz) BArf– at 162.3 (q, 1JBC 
= 49.6 Hz, i), 135.4 (s, o), 129.4 (q, 2JCF = 31.4 Hz, m), 125.2 (q, 1JCF = 271.0 Hz, 
CF3), 118.0 (s, p); (S,S)-dpen ligand at 134.3 (s, i-Ph), 130.6 (s, p-Ph), 129.9 (s, o-Ph), 
128.0 (s, m-Ph),38 66.7 (s, CHNH2).  
Δ-(S,S)-13+ 2Cl–BArf20–. The salt (S,S)-13+ 3Cl– (0.510 g, 0.635 mmol; 83:17 
∆/Λ), CH2Cl2 (20 mL), K+ BArf20– (0.548 g, 0.762 mmol, 1.2 equiv), and CH3OH (0.20 
mL) were combined in a procedure analogous to that for Λ-(S,S)-13+ 2Cl–BArf–. An 
identical workup gave Δ-(S,S)-13+ 2Cl–BArf20–·3H2O (0.664 g, 0.443 mmol, 58% or 
84% of theory) as an orange solid, mp 120-123 °C dec (open capillary). Anal. Calcd. for 
C66H48BCl2CoF20N6·3H2O (1499.79): C 52.85, H 3.63, N 5.60; found C 53.02, H 3.63, 
N 5.60.  
NMR (δ in ppm):33 1H (500 MHz, 9:1 v/v CD2Cl2/acetone-d6) 7.35-7.24 (m, 
18H, Ph), 7.23-7.13 (m, 12H, Ph), 6.92 (br s, 6H, NHH'), 6.01-5.82 (m, 6H, NHH'), 
4.84-4.68 (m, 6H, CHNH2), 2.34 (br s, 6H, H2O); 13C{1H,19F} (125 MHz, 9:1 v/v 
CD2Cl2/CD3OD) BArf20– at 149.1 (d, 1JCF = 133.0 Hz),42 137.7 (s), 135.1 (s), 124.4 (q, 
1JBC = 50.0 Hz, i); (S,S)-dpen ligand at 135.7 (s, i-Ph), 130.1 (s, p-Ph), 129.6 (s, o-Ph), 
127.7 (s, m-Ph),38 66.5 (s, CHNH2).  
Δ-(S,S)-13+ 2BF4–BArf–. A round bottom flask was charged with a solution of 
∆-(S,S)-13+ 2Cl–BArf–·2H2O (0.2400 g, 0.144 mmol) in CH2Cl2 (6 mL), and Ag+ BF4– 
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(0.0589 g, 0.3024 mmol, 2.1 equiv) was added with stirring. The mixture was sonicated 
(10 min) and filtered through Celite. The solvent was removed from the filtrate by rotary 
evaporation and then oil pump vacuum (12 h) to give ∆-(S,S)-13+ 2BF4–BArf–·3H2O as 
an orange solid (0.2344 g, 0.133 mmol, 94%), mp 121-124 °C dec (open capillary). 
Anal. Calcd. for C74H60B3CoF32N6·3H2O (1786.66): C 49.75, H 3.72, N 4.70; found C 
49.99, H 3.71, N 4.39.  
NMR (acetone-d6, δ in ppm):33 1H (500 MHz) BArf– at 7.81 (m, 8H, o), 7.68 (s, 
4H, p); (S,S)-dpen ligand at 7.42 (m, 12H, Ph), 7.32 (m, 18H, Ph), 6.41 (br s, 6H, 
NHH'), 5.90 (br s, 6H, NHH'), 5.21 (s, 6H, CHNH2), 3.14 (s, 6H, H2O); 13C{1H} (125 
MHz) BArf– at 162.6 (q, 1JBC = 49.6 Hz, i), 135.5 (s, o), 130.1 (m, m), 125.3 (q, 1JCF = 
271 Hz, CF3), 118.4 (s, p); (S,S)-dpen ligand at 136.6 (s, i-Ph), 130.2 (s, p-Ph), 129.9 (s, 
o-Ph), 128.8 (s, m-Ph),38 65.8 (s, CHNH2).  
Δ-(S,S)-13+ 2PF6–BArf–. A solution of ∆-(S,S)-13+ 2Cl–BArf–·2H2O (0.120 g, 
0.072 mmol) in CH2Cl2 (4 mL) and a solution of Ag+ PF6– (0.0373 g, 0.148 mmol, 2.1 
equiv) in CH2Cl2 (2 mL) were combined in a procedure analogous to that for ∆-(S,S)-
13+ 2BF4–BArf–. An identical workup gave ∆-(S,S)-13+ 2PF6–BArf–·2H2O as a bright 
orange solid (0.1084 g, 0.5356 mmol, 81%), mp 58 °C dec (open capillary). Anal. Calcd. 
for C74H60BCoF36N6P2·2H2O (1884.97): C 47.15, H 3.42, N 4.46; found C 47.43, H 
3.20, N 4.05.  
NMR (acetone-d6, δ in ppm):33 1H (500 MHz) BArf– at 7.79 (m, 8H, o), 7.67 (s, 
4H, p); (S,S)-dpen ligand at 7.44 (m, 12H, Ph), 7.33 (m, 18H, Ph), 6.53 (br s, 6H, 
NHH'), 5.92 (br s, 6H, NHH'), 5.19 (s, 6H, CHNH2), 2.93 (17H, H2O); 13C{1H} (125 
MHz) BArf– at 162.6 (q, 1JBC = 49.8 Hz, i), 135.6 (s, o), 128.9 (m, m), 125.4 (q, 1JCF = 
271.2 Hz, CF3), 117.5 (m, p); (S,S)-dpen ligand at 136.4 (s, i-Ph), 130.4, 130.2, and 
130.1 (3s, o/m/p-Ph), 66.0 (s, CHNH2).  
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∆-(S,S)-13+ 3BArf–. A beaker was charged with -(S,S)-13+ 2Cl–BArf–·H2O 
(0.0824 g, 0.050 mmol), Na+ BArf– (0.0923 g, 0.100 mmol, 2.0 equiv), CH2Cl2 (10 
mL), and H2O (10 mL). The biphasic mixture was vigorously stirred (10 min) and then 
allowed to stand. The lower orange CH2Cl2 phase was separated. The solvent allowed to 
evaporate in a hood to give -(S,S)-13+ 3BArf–·9H2O as an orange solid (0.158 g, 
0.0458 mmol, 92%), which when warmed (open capillary) continually darkened and 
then liquefied at 90 °C. Anal. Calcd. for C138H84B3CoF72N6 .9H2O (3447.57): C 48.08, 
H 2.98, N 2.44; found C 48.04, H 2.78, N 2.46.  
NMR (acetone-d6, δ in ppm):33 1H (500 MHz) BArf– at 7.80 (s, 24H, o), 7.67 (s, 
12H, p); (S,S)-dpen ligand at 7.51-7.45 (m, 12H, Ph), 7.43-7.31 (m, 18H, Ph), 6.87-6.70 
(m, 6H, NHH'), 5.93 (br s, 6H, NHH'), 5.31-5.21 (m, 6H, CHNH2), 3.01 (br s, 20H, 
H2O); 13C{1H} (125 MHz) BArf– at 162.6 (q, 1JBC = 50.0 Hz, i), 135.5 (s, o), 130.0 (m, 
m), 125.3 (q, 1JCF = 270.0 Hz, CF3), 118.4 (m, p); (S,S)-dpen ligand at 135.8 (s, i-Ph), 
130.9 (s, p-Ph), 130.3 (s, o-Ph), 128.6 (s, m-Ph),38 65.9 (s, CHNH2). 
Comproportionation, Λ-[Co((S,S)-13+ 3BArf– and Λ-[Co((S,S)-13+ 3Cl– 
(Scheme 3.7). A. A round bottom flask was charged with a solution of Λ-(S,S)-13+ 
3BArf–·8H2O (0.035 g, 0.0102 mmol) in CD2Cl2 (1.0 mL), and Λ-(S,S)-13+ 3Cl–·3H2O 
(0.0175 g, 0.0204 mmol, 2.0 equiv) was added. The heterogeneous mixture was 
sonicated (2 h). A 1H NMR spectrum of the homogeneous solution showed only Λ-
(S,S)-13+ 2Cl–BArf– (CD2Cl2, δ in ppm, 500 MHz, key data): 7.83 (d, 3JHH = 5.0 Hz, 
6H, NHH'), 4.50 (s, 6H, CHNH2), 4.14 (br s, 6H, NHH'). B. An analogous experiment 
was conducted with Λ-(S,S)-13+ 3BArf–·8H2O (0.035 g, 0.0102 mmol), CH2Cl2 (8 mL), 
and Λ-(S,S)-13+ 3Cl–·3H2O (0.0175 g, 0.0204 mmol, 2.0 equiv). The solvent was 
removed by rotary evaporation and oil pump vacuum (8 h) to give Λ-(S,S)-13+ 2Cl–
BArf–·2H2O as an orange solid (0.048 g, 0.029 mmol, 95%). 1H NMR (CD2Cl2, δ in 
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ppm, 500 MHz, key data): 8.07 (br s, 6H, NHH'), 4.46 (s, 6H, CHNH2), 3.95 (br s, 6H, 
NHH'); 13C{1H} (CD2Cl2, δ in ppm, 125 MHz, key data): 63.3 (s, CHNH2). 
Epimerizations (Scheme 3.4). A. A 5 mm NMR tube was charged with Λ-(S,S)-
13+ 2BF4–BArf– (0.025 g, 0.014 mmol) and DMSO-d6 (0.5 mL) and kept at 80 °C. The 
isomerization to ∆-(S,S)-13+ 2BF4–BArf– was monitored by 13C{1H} NMR (Λ/∆  
61.4/63.2 ppm). Data (time, ratios): 1 d, 80/20, 30 d, 12/88. No other signals were 
evident. B. A mixture of Λ-(S,S)-13+ 2BF4–BArf– (0.030 g, 0.017 mmol), activated 
charcoal (0.020 g), and DMSO-d6 (0.5 mL) was similarly kept at 80 °C. After 10 h, 
conversion to ∆-(S,S)-13+ 2BF4–BArf– was 99.8% complete. No other signals were 
evident. C. A mixture of Λ-(S,S)-13+ 3BArf24– (0.034 g, 0.0099 mmol) and CD3OD (0.5 
mL) was similarly kept at 75 °C. After 24 h, a 18:82 Λ/∆ mixture was present (13C{1H} 
NMR,  64.4/66.5 ppm). No other signals were evident. D. A mixture of Λ-(S,S)-13+ 
3BArf– (0.034 g, 0.0099 mmol), activated charcoal (0.018 g), and CD3OD (0.5 mL) was 
similarly kept at 75 °C. After 4 h, a 8:88:4 Λ/∆/byproduct mixture was present (13C{1H} 
NMR,  64.6/66.5/71.6 ppm). No other signals were evident. E. A 5 mm NMR tube was 
charged with ∆-(S,S)-13+ 2Cl–BArf– (0.031 g, 0.018 mmol), activated charcoal (0.015 
g), and acetone-d6 (0.7 mL), and kept at 60 °C. The isomerization to Λ-(S,S)-13+ 2Cl–
BArf– was monitored by 13C{1H} NMR (∆/Λ  66.0/63.1 ppm). After 12 h, a 24:76 ∆/Λ 
mixture was present. No other signals were evident. F. A mixture of ∆-(S,S)-13+ 2Cl–
BArf– (0.030 g, 0.018 mmol) and acetone-d6 (0.7 mL) was similarly kept at 60 °C. After 
40 h, no detectable isomerization had occurred. G. A mixture of ∆-(S,S)-13+ 2Cl–BArf– 
(0.030 g, 0.018 mmol), activated charcoal (0.014 g), and CD3OD (0.7 mL) was similarly 
kept at 70 °C. After 12 h, a 34:66 ∆/Λ mixture was present (13C{1H} NMR,  66.6/63.4 
ppm). No other signals were evident. H. A mixture of ∆-(S,S)-13+ 2Cl–BArf– (0.022 g, 
0.013 mmol) and DMSO-d6 (0.5 mL) was similarly kept at 80 °C. No reaction was 
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observed over 24 h. The mixture was then kept at 110 °C. After 7 h, a 88:9:3 Λ/∆/by-
product mixture was present (13C{1H} NMR,  63.2/61.5/60.2 ppm). After 19 h, several 
additional byproduct peaks appeared ( 60-65 ppm), and the solution had turned green. 
I. A mixture of ∆-(S,S)-13+ 2Cl–BArf– (0.030 g, 0.018 mmol), activated charcoal (0.015 
g), and DMSO-d6 (0.5 mL) was similarly kept at 85 °C. No reaction was observed over 
4 h. The mixture was then kept at 100 °C. After 12 h, several byproduct peaks appeared 
( 61-80 ppm), and the solution had turned green. 
Λ-[Co((S,S)-H2NCH(4-C6H4n-Bu)CH(4-C6H4n-Bu)NH2)3]3+ 2Cl–BArf– (Λ-
(S,S)-133+ 2Cl–BArf–). A gas circulating flask34 was charged with a solution of 
Co(OAc)2·4H2O (0.179 g, 0.721 mmol) in CH3OH (50 mL). Activated charcoal (0.11 g) 
and (S,S)-5 (0.748 g, 2.31 mmol, 3.2 equiv) were added with vigorous stirring. After 16 
h, the mixture was filtered through Celite, and aqueous HCl (2.0 mL, 12.0 M) was 
added. The solvent was removed by rotary evaporation and H2O/CH3OH (100 mL, 9:1 
v/v) was added. The suspension was filtered. The filter cake was washed with H2O (100 
mL) and dissolved in CH3OH. The solvent was removed by rotary evaporation and oil 
pump vacuum (6 h) to give crude Λ-(S,S)-133+ 3Cl– as an orange solid (0.665 g, 0.585 
mmol assuming a pure sample). Then CH2Cl2 (15 mL) and Na+ BArf– (0.622 g, 0.702 
mmol, 1.2 equiv) were added. The mixture was sonicated (10 min)41 and filtered. The 
filtrate was loaded onto a silica gel column (3.0  12 cm), which was eluted with 
CH2Cl2/CH3OH (100:0 to 98:2 v/v). The solvent was removed from the main orange 
band by rotary evaporation and oil pump vacuum (14 h) to give Λ-(S,S)-133+ 2Cl–BArf–
·H2O as an orange solid (0.488 g, 0.246 mmol, 34%), mp 125-131 °C dec (open 
capillary). Anal. Calcd. for C98H108BCl2CoF24N6·H2O (1984.57): C 59.31, H 5.59, N 
4.23; found C 59.36, H 5.60, N 4.13.  
NMR (acetone-d6, δ in ppm):33 1H (500 MHz) BArf– at 7.79 (s, 8H, o), 7.68 (s, 
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4H, p); (S,S)-5 ligand at 8.16 (br s, 6H, NHH'), 7.38 (d, 3JCH = 8.0 Hz, 12H, Ar), 7.15 
(d, 3JCH = 8.5 Hz, 12H, Ar), 5.10 (br s, 6H, NHH'), 5.03 (s, 6H, CHNH2), 2.54 (t, 3JHH 
= 7.5 Hz, 12H, ArCH2), 1.58-1.48 and 1.35-1.27 (2  m, 12H each, ArCH2CH2CH2), 
0.89 (t, 3JHH = 7.5 Hz, 18H, ArCH2CH2CH2CH3), 2.88 (br s, 7H, H2O); 13C{1H} (125 
MHz) BArf– at 162.5 (q, 1JBC = 50 Hz, i), 135.5 (s, o), 129.9 (m, m), 125.3 (q, 1JCF = 
270.0 Hz, CF3), 118.4 (m, p); (S,S)-5 ligand at 144.7 (s, i-Ar), 134.8 (s, Ar), 129.8 (s, 
Ar), 129.4 (s, Ar), 63.2 (s, CHNH2), 35.8, 34.2, 23.0 (3 × s, ArCH2CH2CH2CH3), 14.1 
(s, ArCH2CH2CH2CH3). 
Λ-[Co((S,S)-H2NCH(4-C6H4Cl)CH(4-C6H4Cl)NH2)3]3+ 2Cl–BArf– (Λ-(S,S)-
143+ 2Cl–BArf–). A gas circulating flask34 was charged with a solution of 
Co(OAc)2.4H2O (0.273 g, 1.09 mmol) in CH3OH (50 mL). Activated charcoal (0.10 g) 
and (S,S)-H2NCH(4-C6H4Cl)CH(4-C6H4Cl)NH2 ((S,S)-6;14 1.015 g, 3.612 mmol, 3.3 
equiv) were added with vigorous stirring. After 16 h, the mixture was filtered through 
Celite and aqueous HCl (3.0 mL, 12.0 M) was added. The solvent was removed by 
rotary evaporation, and H2O (100 mL) was added. The suspension was filtered. The 
filter cake was washed with H2O (100 mL) and dissolved in CH3OH. The solvent was 
removed by rotary evaporation and oil pump vacuum (12 h) to give crude Λ-(S,S)-143+ 
3Cl– as an orange solid (0.805 g, 0.799 mmol assuming a pure sample). Then CH2Cl2 
(15 mL) and Na+ BArf– (0.958 g, 1.04 mmol, 1.3 equiv) were added. The mixture was 
sonicated (5 min)41 and filtered. The filtrate was loaded onto a silica gel column (3.0  
15 cm), which was eluted with CH2Cl2/CH3OH (100:0 to 98:2 v/v). The solvent was 
removed from the main orange band by rotary evaporation and oil pump vacuum (12 h) 
to give Λ-(S,S)-143+ 2Cl–BArf–·4H2O as an orange solid (0.795 g, 0.425 mmol, 39%), 
mp 119-124 °C dec (open capillary). Anal. Calcd. for C74H54BCl8CoF24N6· 2H2O 
(1872.62): C 47.46, H 3.12, N 4.49; found C 47.43, H 3.36, N 5.04.  
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NMR (acetone-d6, δ in ppm):33 1H (500 MHz) BArf– at 7.80 (s, 8H, o), 7.68 (s, 
4H, p); (S,S)-6 ligand at 8.25 (br s, 6H, NHH'), 7.50 (d, 3JCH = 8 Hz, 12H, Ar), 7.38 (d, 
3JCH = 8 Hz, 12H, Ar), 5.53 (br s, 6H, NHH'), 5.11 (s, 6H, CHNH2), 3.00 (br s, 7H, 
H2O); 13C{1H} (125 MHz) BArf– at 162.5 (q, 1JBC = 50 Hz, i), 135.5 (s, o), 129.8 (q, 
2JCF = 25.0 Hz, m), 125.3 (q, 1JCF = 270.0 Hz, CF3), 118.4 (m, p); (S,S)-6 ligand at 
135.5 (s, i-Ar), 131.3 (s, Ar), 130.2 (s, Ar), 130.02 (s, Ar), 62.7 (s, CHNH2).  
Λ-[Co((S,S)-H2NCH(4-C6H4Cl)CH(4-C6H4Cl)NH2)3]3+ 2BF4–BArf– (Λ-
(S,S)-143+ 2BF4–BArf–). A round bottom flask was charged with a solution of Λ-(S,S)-
143+ 2Cl–BArf–·2H2O (0.086 g, 0.046 mmol) in CH2Cl2 (8 mL), and Ag+ BF4– (0.0194 
g, 0.0997 mmol, 2.2 equiv) was added with stirring. The mixture was sonicated (10 min) 
and filtered through Celite. The solvent was removed by rotary evaporation and oil 
pump vacuum (12 h) to give Λ-(S,S)-143+ 2BF4–BArf–·H2O as a bright orange solid 
(0.0835 g, 0.0426 mmol, 92%), dec. at 96-128 °C (no melting), liquefies at 132 °C.  
NMR (acetone-d6, δ in ppm):33 1H (500 MHz) BArf– at 7.79 (s, 8H, o), 7.67 (s, 
4H, p); (S,S)-6 ligand at 7.50 (d, 3JCH = 8 Hz, 12H, Ar), 7.39 (d, 3JCH = 8 Hz, 12H, Ar), 
5.92 (br s, 6H, NHH'); 5.18 (s, 6H, CHNH2), 3.21 (br s, 8H, NHH', H2O); 13C{1H} 
(125 MHz) BArf– at 162.6 (q, 1JBC = 50 Hz, i), 135.2 (s, o), 130.1 (s, m), 125.4 (q, 1JCF 
= 270.0 Hz, CF3), 118.4 (m, p); (S,S)-6 ligand at 135.7 (s, i-Ar), 135.5 (s, Ar), 131.4 (s, 
Ar), 130.1 (s, Ar), 62.8 (s, CHNH2). 
Λ-[Co((S,S)-H2NCH(4-C6H4CF3)CH(4-C6H4CF3)NH2)3]3+ 2Cl–BArf– (Λ-
(S,S)-153+ 2Cl–BArf–). A gas circulating flask34 was charged with a solution of 
Co(OAc)2.4H2O (0.933 g, 3.75 mmol) in CH3OH (50 mL). Activated charcoal (0.150 g) 
and (S,S)-H2NCH(4-C6H4CF3)CH(4-C6H4CF3)NH2 ((S,S)-7;14 4.308 g, 12.38 mmol, 
3.3 equiv) were added with vigorous stirring. After 24 h, the mixture was filtered 
through Celite, and aqueous HCl (5.0 mL, 12.0 M) was added. The solvent was removed 
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by rotary evaporation, and H2O/CH3OH (100 mL, 85:15 v/v) was added. The suspension 
was filtered. The filter cake was washed with H2O/CH3OH (100 mL, 80:20 v/v) and 
dissolved in CH3OH. The solvent was removed by rotary evaporation and oil pump 
vacuum (12 h) to give crude Λ-(S,S)-153+ 3Cl– (2.158 g, 1.78 mmol assuming a pure 
sample) as a dark brown solid (NMR data: see SI). A portion (0.638 g, 0.527 mmol) was 
suspended in CH2Cl2 (20 mL) and Na+ BArf– (0.518 g, 0.582 mmol, 1.1 equiv) was 
added. The mixture was sonicated (10 min)41 and filtered. The filtrate was loaded onto a 
silica gel column (1.9  15 cm), which was eluted with CH2Cl2/CH3OH (100:0 to 98:2 
v/v). The solvent was removed from the main orange band by rotary evaporation and oil 
pump vacuum (14 h) to give Λ-(S,S)-153+ 2Cl–BArf–.H2O as an orange solid (0.953 g, 
0.464 mmol, 42%), mp 100-104 °C dec (open capillary). Anal. Calcd. for 
C80H54BCl2CoF42N6·H2O (2055.92): C 46.74, H 2.75, N 4.09; found C 46.93, H 2.87, 
N 4.30.  
NMR (acetone-d6, δ in ppm):33 1H (500 MHz) 8.38 (br s, 6H, NHH'), 7.82-7.65 
(m, 12H BArf– and 24H C6H4), 5.94 (br s, 6H, NHH'), 5.36 (s, 6H, CHNH2), 3.07 (br s, 
6H, H2O); 13C{1H} (125 MHz) BArf– at 162.5 (q, 1JBC = 50 Hz, i), 135.5 (s, o), 130.0 
(m, m), 125.3 (q, 1JCF = 270.0 Hz, CF3), 118.4 (m, p); (S,S)-7 ligand at 140.8 (s, i-Ar), 
131.6 (q, 2JCF = 32.5 Hz, Ar), 130.5 (s, Ar), 127.0 (s, Ar), 124.8 (q, 1JCF = 270.9 Hz, 
CF3), 62.7 (s, CHNH2). 
Λ-[Co((S,S)-H2NCH(4-C6H4OCH3)CH(4-C6H4OCH3)NH2)3]3+ 2Cl–BArf– 
(Λ-(S,S)-163+ 2Cl–BArf–). A gas circulating flask34 was charged with a solution of 
Co(OAc)2·4H2O (0.166 g, 0.666 mmol) in CH3OH (50 mL). Activated charcoal (0.10 g) 
and (S,S)-H2NCH(4-C6H4OCH3)CH(4-C6H4OCH3)NH2 ((S,S)-8;14 0.570 g, 2.09 
mmol, 3.1 equiv) were added with vigorous stirring. After 16 h, the mixture was filtered 
through Celite and aqueous HCl (2.0 mL, 12.0 M) was added. The solvent was removed 
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by rotary evaporation and H2O/CH3OH (10 mL, 7:3 v/v) was added. The suspension 
was filtered. The filter cake was washed with acetone (2 × 10 mL) and dried by oil pump 
vacuum (12 h) to give crude Λ-(S,S)-163+ 3Cl– (0.226 g, 0.231 mmol assuming a pure 
product). This was suspended in CH2Cl2 (5 mL), and Na+ BArf– (0.209 g, 0.236 mmol, 
1.0 equiv) was added. The mixture was sonicated (1 min)41 and filtered. The filtrate was 
loaded onto a silica gel column (1.9  12 cm), which was eluted with CH2Cl2/CH3OH 
(100:0 to 97.5:2.5 v/v). The solvent was removed from the main orange band by rotary 
evaporation and oil pump vacuum (12 h) to give Λ-(S,S)-163+ 2Cl–BArf–.3H2O as a 
bright yellow solid (0.289 g, 0.155 mmol, 23%), mp 128-132 °C dec (open capillary). 
Anal. Calcd. for C80H72BCl2CoF24N6O6.3H2O (1862.42): C 51.54, H 4.22, N 4.51, Cl 
3.80; found C 51.58, H 4.12, N 4.57, Cl 3.73. IR (powder film, cm–1): 3065 (m, νNH), 
1611 (m, δNH), 1354 (s, νAr-CF3), 1275 (vs, νCF), 1121 (vs, δCCN). 
NMR (CD2Cl2, δ in ppm):33 1H (500 MHz) BArf– at 7.71 (s, 8H, o), 7.54 (s, 4H, 
p); (S,S)-8 ligand at 7.67 (br s, 6H, NHH'), 7.17 (d, 3JHH = 9.0 Hz, 12H, Ar), 6.73 (d, 
3JHH = 8.5 Hz, 12H, Ar), 4.34 (s, 6H, CHNH2), 4.16 (br s, 6H, NHH'), 3.66 (s, 18H, 
OCH3), 2.15 (br s, 11H, H2O); 13C{1H} (125 MHz) BArf– at 162.3 (q, 1JBC = 49.5 Hz, 
i), 135.3 (s, o), 129.4 (q, 2JCF = 34.5 Hz, m), 125.1 (q, 1JCF = 271.1 Hz, CF3), 118.0 (s, 
p); (S,S)-8 ligand at 161.2 (s, i-Ar), 129.8 (s, Ar), 126.8 (s, Ar), 115.6 (s, Ar), 62.9 (s, 
CHNH2), 56.1 (s, OCH3). 
∆-[Co((S,S)-H2NCH(4-C6H4OCH3)CH(4-C6H4OCH3)NH2)3]3+ 2Cl–BArf– 
(∆-(S,S)-163+ 2Cl–BArf–). The procedure involves perchlorate salts that are potentially 
explosive.36 A gas circulating flask34 was charged with a solution of Co(ClO4)2·6H2O 
(0.136 g, 0.372 mmol) in CH3OH (50 mL). Activated charcoal (0.10 g) and (S,S)-814 
(0.335 g, 1.22 mmol, 3.3 equiv) were added with vigorous stirring. After 16 h, the 
mixture was filtered through Celite, and HClO4 (2.0 mL, 35% in H2O) was added. The 
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solution was sorbed onto a Dowex cation exchange column (3.0  12 cm), which was 
washed with H2O/CH3OH (1:1 v/v, 100 mL) and eluted with increasing proportions of 
12.0 M aqueous HCl in CH3OH (CH3OH/HCl 9:1 v/v (100 mL), 8:2 v/v (100 mL), 7:3 
v/v (100 mL), 6:4 v/v until product elution). An orange band was collected and the 
solvents were removed by rotary evaporation (60 °C bath; base trap to scavenge HCl) to 
give crude ∆-(S,S)-163+ 3Cl– (0.103 g; 0.105 mmol assuming a pure product). This was 
suspended in CH2Cl2 (5.0 mL), and Na+ BArf– (0.0935 g, 0.105 mmol, 1.0 equiv) was 
added. The mixture was sonicated (5 min)41 and filtered. The filtrate was loaded onto a 
silica gel column (1.9  10 cm), which was eluted with CH2Cl2/CH3OH (100:0 to 
97.5:2.5 v/v). The solvent was removed from the main orange band by rotary 
evaporation and oil pump vacuum (12 h) to give ∆-(S,S)-163+ 2Cl–BArf–.2H2O as a 
bright yellow solid (0.125 g, 0.0678 mmol, 18%), mp 130-135 °C dec (open capillary). 
Anal. Calcd. for C80H72BCl2CoF24N6O6. 2H2O (1846.11): C 52.05, H 4.15, N 4.55, Cl 
3.84; found C 52.43, H 4.49, N 4.59, Cl 3.44. IR (powder film, cm–1): 1572 (m, νAr-CC), 
1510 (m, νAr-CC), 1354 (s, νAr-CF3), 1275 (vs, νCF), 1119 (vs, δCCN).  
NMR (40:0.1 v/v CD2Cl2/CD3OD, δ in ppm):33 1H (500 MHz) BArf– at 7.73 (s, 
8H, o), 7.57 (s, 4H, p); (S,S)-8 ligand at 7.25 (d, 3JHH = 8.5 Hz, 12H, Ar), 6.81 (d, 3JHH 
= 8.5 Hz, 12H, Ar), 5.82 (br s, 2H, NHH'),37 5.67 (br s, 2H, NHH'),37 4.27 (s, 6H, 
CHNH2), 3.74 (s, 18H, OCH3), 1.85 (br s, 13H, CD3OH/H2O); 13C{1H} (125 MHz) 
BArf– at 162.3 (q, 1JBC = 49.6 Hz, i), 135.3 (s, o), 129.4 (q, 2JCF = 34.3 Hz, m), 125.1 
(q, 1JCF = 270.6 Hz, CF3), 118.0 (s, p); (S,S)-8 ligand at 160.8 (s, i-Ar), 129.3 (s, Ar), 
127.6 (s, Ar), 114.9 (s, Ar), 64.9 (s, CHNH2), 55.8 (s, OCH3). 
Λ-[Co((S,S)-H2NCH(-naphthyl)CH(-naphthyl)NH2)3]3+ 2Cl–BArf– (Λ-
(S,S)-173+ 2Cl–BArf–). A gas circulating flask34 was charged with a solution of 
Co(OAc)2·4H2O (0.4002 g, 1.61 mmol) in CH3OH (50 mL). Activated charcoal (0.10 g) 
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and (S,S)-H2NCH(-naphthyl)CH(-naphthyl)NH2 ((S,S)-9;14 1.64 g, 5.24 mmol, 3.3 
equiv) were added with vigorous stirring. After 16 h, the mixture was filtered through 
Celite, and aqueous HCl (3.0 mL, 12.0 M) was added. The yellow precipitate was 
collected by filtration. The filtrate was concentrated to ca. 20 mL by rotary evaporation, 
and H2O was added (100 mL). The yellow precipitate was collected by filtration. The 
combined precipitates were washed with H2O/CH3OH (100 mL, 9:1 v/v). The filter cake 
was dissolved in CH3OH. The solvent was removed by rotary evaporation and oil pump 
vacuum (1 h) to give crude Λ-(S,S)-173+ 3Cl– (1.36 g, 1.23 mmol assuming pure 
product). This was suspended in CH2Cl2 (25 mL), and Na+ BArf– (1.09 g, 1.23 mmol, 
1.0 equiv) was added. The mixture was sonicated (10 min)41 and filtered. The filtrate 
was loaded onto a silica gel column (3.0  12 cm), which was eluted with 
CH2Cl2/CH3OH (100:0 to 98:2 v/v). The solvent was removed from the main orange 
band by rotary evaporation and oil pump vacuum (12 h) to give Λ-(S,S)-173+ 2Cl– BArf–
·2H2O as an orange solid (1.415 g, 0.720 mmol, 45%), mp 131-135 °C dec. (open 
capillary). Anal. Calcd. for C98H72BCl2CoF24N6·2H2O (1966.30): C 59.86, H 3.90, N 
4.27, Cl 3.61; found C 59.90, H 4.07, N 4.31, Cl 3.40. IR (powder film, cm–1): 3053 (m, 
νNH), 1604 (m, δNH), 1354 (s, νAr-CF3), 1275 (vs, νCF), 1121 (vs, δCCN). 
NMR (CD2Cl2, δ in ppm):33 1H (500 MHz) BArf– at 7.73 (s, 8H, o), 7.55 (s, 4H, 
p); (S,S)-9 ligand at 9.72 (br s, 6H, NHH'), 8.51 (s, 6H, C10H7), 8.02-7.95 (m, 24H, 
C10H7), 7.18 (s, 12H, C10H7), 5.61 (s, 6H, CHNH2), 3.65 (br s, 6H, NHH'), 2.16 (br s, 
3H, H2O); 13C{1H} (125 MHz) BArf– at 162.3 (q, 1JBC = 48.9 Hz, i), 135.4 (s, o), 129.4 
(q, 2JCF = 31.6 Hz, m), 125.2 (q, 1JCF = 271.0 Hz, CF3), 118.0 (s, p); (S,S)-9 ligand at 
134.8, 131.9, 131.1 130.3, 128.8, 127.8, 125.52, 125.48, 124.5, 122.8 (10 × s, C10H7), 
59.7 (s, CHNH2). 
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Λ-[Co((S,S)-H2NCH((-naphthyl)CH((-naphthyl)NH2)3]3+ 2BF4–BArf– 
(Λ-(S,S)-173+ 2BF4–BArf–). A round bottom flask was charged with a solution of Λ-
(S,S)-173+ 2Cl–BArf–·2H2O (0.405 g, 0.206 mmol) in CH2Cl2 (10 mL), and Ag+ BF4– 
(0.0851 g, 0.44 mmol, 2.1 equiv) was added with stirring. The mixture was sonicated (10 
min) and filtered through Celite. The solvent was removed by rotary evaporation and oil 
pump vacuum (1 h) to give Λ-(S,S)-173+ 2BF4–BArf–·(3.5±0.5)H2O as a red solid 
(0.393 g, 0.188 mmol, 91%), mp 161-167 °C dec. (open capillary). Anal. Calcd. For 
C98H72B3CoF32N6·3H2O/C98H72B3CoF32N6·4H2O (2087.05/ 2104.53): C 
56.40/55.90, H 3.77/3.83, N 4.03/3.99; found C 55.97, H 3.41, N 3.85. IR (powder film, 
cm–1): 3251 (m, νNH), 1602 (m, δNH), 1354 (s, νAr-CF3), 1275 (vs, νCF), 1119 (vs, 
δCCN). 
NMR (CD2Cl2, δ in ppm):33 1H (500 MHz) BArf– at 7.74 (s, 8H, o), 7.56 (s, 4H, 
p); (S,S)-9 ligand at 8.07 (d, 3JHH = 8.0 Hz, 6H, C10H7), 7.92 (d, 3JHH = 8.0 Hz, 6H, 
C10H7), 7.71-7.64 (m, 18H, C10H7), 7.04 (t, 3JHH = 7.5 Hz, 6H, C10H7), 6.92 (s, 6H, 
C10H7), 6.32 (s, 6H, NHH'), 5.40 (s, 6H, CHNH2), 4.04 (s, 6H, NHH'), 1.96 (s, 4H, 
H2O); 13C{1H} (125 MHz) BArf– at 162.2 (q, 1JBC = 62.5 Hz, i), 135.3 (s, o), 129.4 (q, 
2JCF = 32.4 Hz, m), 125.2 (q, 1JCF = 271.3 Hz, CF3), 118.2 (s, p); (S,S)-9 ligand at 
134.9, 132.5, 130.8, 130.0, 129.4, 128.6, 128.2, 125.7, 124.1, 121.3 (10 × s, C10H7), 
59.4 (s, CHNH2). 
-[Co((S,S)-H2NCH(-naphthyl)CH(-naphthyl)NH2)3]3+ 2Cl–BArf– (-
(S,S)-173+ 2Cl–BArf–). The procedure involves perchlorate salts that are potentially 
explosive.36 A gas circulating flask34 was charged with a solution of Co(ClO4)2·6H2O 
(0.352 g, 0.961 mmol) in CH3OH (50 mL). Activated charcoal (0.13 g) and (S,S)-914 
(0.989 g, 3.17 mmol, 3.3 equiv) were added with vigorous stirring. After 18 h, the 
mixture was filtered through Celite, and HClO4 (4.0 mL, 35% in H2O) was added. The 
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solution was sorbed onto a Dowex cation exchange column (3.0  12 cm), which was 
washed with H2O/CH3OH (1:1 v/v, 100 mL) and eluted with increasing concentrations 
of 12.0 M aqueous HCl in CH3OH (CH3OH/HCl 9:1 v/v (100 mL), 8:2 v/v (100 mL), 
7:3 v/v (100 mL), 6:4 v/v until product elution). An orange band was collected. The 
solvents were removed by rotary evaporation (60 °C bath; base trap to scavenge HCl) to 
give crude ∆-(S,S)-173+ 3Cl– (0.518 g; 0.471 mmol assuming a pure product). This was 
suspended in CH2Cl2 (15 mL), and Na+ BArf– (0.461 g, 0.518 mmol, 1.1 equiv) was 
added. The mixture was sonicated (10 min)41 and filtered. The filtrate was loaded onto a 
silica gel column (2.4  12 cm), which was eluted with CH2Cl2/CH3OH (100:0 to 98:2 
v/v). The solvent was removed from the main orange band by rotary evaporation and oil 
pump vacuum (12 h) to give ∆-(S,S)-173+ 2Cl–BArf–·4H2O as an orange solid (0.781 g, 
0.390 mmol, 41%), mp 124-128 °C dec. (open capillary). Anal. Calcd. for 
C98H72BCl2CoF24N6· 4H2O (2002.33): C 58.78, H 4.03, N 4.20; found C 58.96, H 
3.73, N 4.11. 
 NMR (acetone-d6, δ in ppm):33 1H (500 MHz) BArf– at 7.80 (s, 8H, o), 7.68 (s, 
4H, p); (S,S)-9 ligand at 9.27 (br s, 6H, NHH'), 8.67 (d, 3JCH = 7.5 Hz, 6H, C10H7), 7.97 
(d, 3JCH = 8.0 Hz, 6H, C10H7), 7.87 (d, 3JCH = 8.5 Hz, 6H, C10H7), 7.65-7.39 (m, 18H, 
C10H7), 7.16 (t, 3JCH = 7.5.0 Hz, 6H, C10H7), 6.30 (s, 6H, CHNH2), 5.70 (br s, 6H, 
NHH'), 2.86 (br s, 8H, H2O); 13C{1H} (125 MHz) BArf– at 162.5 (q, 1JBC = 50 Hz, i), 
135.5 (s, o), 129.9 (m, m), 125.3 (q, 1JCF = 271.0 Hz, CF3), 118.4 (s, p); (S,S)-9 ligand at 
135.0, 133.1, 132.1 130.6, 129.5, 128.1, 127.4, 126.0, 125.9, 125.1 (10 × s, C10H7), 59.0 
(s, CHNH2). 
Λ-[Co((S,S)-H2NCH((-naphthyl)CH((-naphthyl)NH2)3]3+ 2Cl–BArf– (Λ-
(S,S)-183+ 2Cl–BArf–). A gas circulating flask34 was charged with a solution of 
CoCl2.6H2O (0.033 g, 0.138 mmol) in CH3OH (50 mL). Activated charcoal (0.10 g) and 
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(S,S)-10 (0.139 g, 0.445 mmol, 3.2 equiv) were added with vigorous stirring. After 16 h, 
the mixture was filtered through Celite, and aqueous HCl (2.0 mL, 12.0 M) was added. 
The filtrate was concentrated to a moist paste by rotary evaporation, and H2O (100 mL) 
was added. The suspension was filtered. The filter cake was washed with H2O (50 mL) 
and dissolved in CH3OH. The solvent was removed by rotary evaporation and oil pump 
vacuum (1 h) to give crude Λ-(S,S)-183+ 3Cl– (0.127 g, 0.115 mmol, assuming a pure 
product). A portion (0.115 g, 0.105 mmol) was suspended in CH2Cl2 (25 mL), and Na+ 
BArf– (0.094 g, 0.106 mmol, 1.0 equiv) was added. The mixture was sonicated (5 min)41 
and filtered. The filtrate was loaded onto a silica gel column (1.9  15 cm), which was 
eluted with CH2Cl2/CH3OH (100:0 to 99:1 v/v). The solvent was removed from the 
main orange band by rotary evaporation and oil pump vacuum (12 h) to give Λ-(S,S)-
183+ 2Cl– BArf– (0.085 g, 0.042 mmol, 34%), mp 126-130 °C dec. (open capillary). 
Anal. Calcd. for C98H72BCl2CoF24N6·4H2O (2002.33): C 58.78, H 4.03, N 4.20; found 
C 58.55, H 3.98, N 3.99. 
NMR (acetone-d6, δ in ppm):33 1H (500 MHz) BArf– at 7.79 (m, 8H, o), 7.68 (s, 
4H, p); (S,S)-10 ligand at 8.60 (br s, 6H, NHH'), 8.08 (s, 6H, C10H7), 7.89 (d, 3JHH = 
10.0 Hz, 6H, C10H7), 7.85 (d, 3JHH = 10.0 Hz, 6H, C10H7), 7.77-7.69 (m, 12H, C10H7), 
7.53-7.43 (m, 12H, C10H7), 5.62-5.41 (br m, 12H, CHNH2, NHH'), 2.85 (s, 8H, H2O); 
13C{1H} (125 MHz) BArf– at 162.5 (q, 1JBC = 50 Hz, i), 135.5 (s, o), 129.7 (m, m), 
125.3 (q, 1JCF = 270 Hz, CF3), 118.4 (m, p); (S,S)-10 ligand at 134.7, 134.2, 134.0, 
129.8 128.9, 128.8, 128.5, 127.8, 127.6, 126.7 (10 × s, C10H7), 63.7 (s, CHNH2). 
Λ-[Co((S,S)-H2NCH(2-C6H4OBn)CH(2-C6H4OBn)NH2)3]3+ 2Cl–BArf–.(Λ-
(S,S)-193+ 2Cl–BArf–). A gas circulating flask34 was charged with a solution of 
Co(OAc)2·4H2O (0.23 g, 0.93 mmol) in CH3OH (50 mL). Activated charcoal (0.10 g) 
and (S,S)-11 (1.31 g, 3.08 mmol, 3.3 equiv) were added with vigorous stirring. After 16 
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h, the mixture was filtered through Celite, and aqueous HCl (3.0 mL, 12.0 M) was 
added. The solvent was removed by rotary evaporation, and H2O (100 mL) was added. 
The suspension was filtered. The filter cake was washed with H2O (100 mL) and 
dissolved in CH3OH. The solvent was removed by rotary evaporation and oil pump 
vacuum (12 h) to give crude Λ-(S,S)-193+ 3Cl– (1.288 g, 0.888 mmol assuming a pure 
product). This was suspended in CH2Cl2 (20 mL), and Na+ BArf– (0.993 g, 1.08 mmol, 
1.2 equiv) was added. The mixture was sonicated (5 min)41 and filtered. The filtrate was 
loaded onto a silica gel column (3.0  16 cm), which was eluted with CH2Cl2/CH3OH 
(100:0 to 98:2 v/v). The solvent was removed from the main orange band by rotary 
evaporation and oil pump vacuum (12 h) to give Λ-(S,S)-193+ 2Cl– BArf–·H2O as a deep 
yellow solid (0.834 g, 0.365 mmol, 39%), mp 122-132 °C dec (open capillary). Anal. 
Calcd. for C116H96BCl2CoF24N6O6·H2O (2284.66): C 60.98, H 4.32, N 3.68; found C 
60.95, H 4.27, N 3.56. 
NMR (acetone-d6, δ in ppm):33 1H (500 MHz) BArf– at 7.80 (s, 8H, o), 7.62 (s, 
4H, p); (S,S)-11 ligand at 8.56 (br s, 6 H, NHH'), 7.62 (br s, 12H), 7.27 (t, 3JHH = 7.5 
Hz, 6H), 7.20-7.08 (m, 30H), 6.73 (t, 3JHH = 7.5 Hz, 6H), 5.53 (d, 2JHH = 13 Hz, 6H, 
OCHH'Ph), 5.37 (s, 6H, CHNH2), 5.28 (d, 2JHH = 13 Hz, 6H, OCHH'Ph), 5.15 (br s, 
6H, NHH'), 2.89 (br s, 7H, H2O); 13C{1H} (125 MHz) BArf– at 162.6 (q, 1JBC = 50 Hz, 
i), 135.5 (s, o), 130.0 (q, 2JCF = 31.25 Hz, m), 125.3 (q, 1JCF = 270.0 Hz, CF3), 118.4 
(m, p); (S,S)-11 ligand at 157.5, 138.3, 131.2, 129.3, 128.7, 128.4, 128.2, 125.5, 122.1, 
114.1 (10  s), 71.0 (s, OCH2), 57.0 (s, CHNH2). 
Λ-[Co((S,S)-H2NCH(3,5-C6H3(CF3)2)CH(3,5-C6H3(CF3)2)NH2)3]3+ Cl–
2BArf– (Λ-(S,S)-203+ Cl–2BArf–). A gas circulating flask34 was charged with a 
solution of Co(OAc)2.4H2O (0.714 g, 2.87 mmol) in CH3OH (50 mL). Activated 
charcoal (0.20 g) and (S,S)-12 (4.60 g, 9.50 mmol, 3.3 equiv) were added with vigorous 
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stirring. After 72 h, the mixture was filtered through Celite, and aqueous HCl (3.0 mL, 
12.0 M) was added. The solvent was removed by rotary evaporation, and H2O/CH3OH 
(100 mL, 70:30 v/v) was added. The suspension was filtered. The filter cake was washed 
with H2O/CH3OH (100 mL, 70:30 v/v) and dissolved in CH3OH. The solvent was 
removed by rotary evaporation and oil pump vacuum (12 h) to give crude Λ-(S,S)-203+ 
3Cl– (2.54 g, 2.52 mmol assuming a pure product). A portion (1.52 g, 0.939 mmol) was 
suspended in CH2Cl2 (30 mL), and Na+ BArf– (0.917 g, 1.03 mmol, 1.1 equiv) was 
added. The mixture was sonicated (15 min)41 and filtered. The solvent was removed by 
rotary evaporation and oil pump vacuum (12 h) to give Λ-(S,S)-203+ Cl–2BArf– as an 
deep brown solid (1.594 g, 0.479 mmol, 28%), mp 55-69 °C dec (open capillary).43 
Anal. Calcd. for C118H60B2ClCoF84N6·3H2O (3327.70): C 42.59, H 2.00, N 2.53; 
found C 42.36, H 2.12, N 2.90.  
NMR (acetone-d6, δ in ppm): 33 1H (500 MHz) BArf– at 7.80 (s, 16H, o), 7.67 (s, 
8H, p); (S,S)-12 ligand at 8.31 (s, 12H, Ar), 8.05 (s, 6H, Ar), 6.64-6.52 (br m, 6H, 
NHH'), 5.86-5.74 (br m, 6H, NHH'), 5.54-5.43 (m, 6H, CHNH2), 3.31 (br s, 5H, 
H2O);43 13C{1H} (125 MHz) BArf– at 162.6 (q, 1JBC = 50 Hz, i), 135.6 (s, o), 130.0 (m, 
m), 125.4 (q, 1JCF = 270.0 Hz, CF3), 118.4 (m, p); (S,S)-12 ligand at 140.3 (s, i-Ar), 
132.9 (q, 2JCF = 33.5 Hz, Ar), 130.1 (s, Ar), 124.02 (q, 1JCF = 270.9 Hz, CF3), 124.00 
(s, Ar), 65.0 (s, CHNH2). 
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Figure 3.6. (a) Components of the gas circulating flask; (b) The assembled flask. 
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4. COBALT(III) WERNER COMPLEXES WITH 1,2-
DIPHENYLETHYLENEDIAMINE LIGANDS: READILY 
AVAILABLE, INEXPENSIVE, AND MODULAR CHIRAL 
HYDROGEN BOND DONOR CATALYSTS FOR 
ENANTIOSELECTIVE MICHAEL REACTIONS† 
 
4.1. Introduction 
 The pervasive role of hydrogen bonding in enzymatic catalysis has been 
recognized for more than a half century,1 and recently numerous small molecule 
hydrogen bond donor catalysts have been developed,2 in parallel with the growth of 
"organocatalysis".3 Due to the desirability of single enantiomer pharmaceuticals and 
agrichemicals, enantiopure chiral donors have received particular focus.2 However, from 
the standpoint of innovative new paradigms, much of the "chiral pool"4 applicable to 
catalysis has been quite thoroughly picked over, especially with regard to inexpensive, 
readily available building blocks.  
 In this context, my attention was drawn to Werner complexes featuring the chiral 
tris(ethylenediamine) substituted trication [Co(en)3]3+, and related octahedral systems.  
 
 
 
 
 
 
 
†Reproduced in part with the permission from Lewis, K. G.; Ghosh, S. K.; Bhuvanesh, N.; Gladysz, J. A. 
ACS Cent. Sci. 2015, 1, 50-56.  
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These were the first inorganic compounds resolved into enantiomers some 103 years 
ago,5 with the configurations of the helically chiral mirror images later denoted as  and 
. Cobalt is an earth abundant metal, but none of these salts has ever been applied in any 
type of enantioselective organic reaction, despite facile resolution procedures. Given the 
mechanisms of most transition metal catalysts, many would presume the necessity of a 
metal based vacant coordination site to bind and activate a substrate. However, such d6 
cobalt(III) systems are "substitution inert",6,7 especially at temperatures lower than 100 
°C.  
I and my collaborator wondered about the possibility of an alternative 
binding/activation mode, in which the ligating NH2 groups would function as hydrogen 
bond donors, leading to what could be termed "second coordination sphere promoted 
catalysis". Thus, nearly 150 crystal structures of salts of the formula [Co(en)3]3+ yXz– 
(y/z = 3/1, 1.5/2, 1/3) were surveyed as detailed in section 2.8 Every one showed 
significant NH…X hydrogen bonding, even when the anions were poor acceptors. 
Furthermore, data for related cobalt(III) complexes suggested pKa values of 13-14,9 or 
acidities greater than other hydrogen bond donors that are effective organocatalysts.2  
 Cobalt(III) has an extensive aqueous chemistry, but water would be expected to 
compete with substrates for hydrogen bond donor sites, suppressing rates. Accordingly, 
past researchers in the Gladysz group have shown that salts of the lipophilic BArf– anion 
(BArf = B(3,5-C6H3(CF3)2)4), such as -[Co(en)3]3+ 3BArf– and trans-1,2-
cyclohexanediamine analogs, are soluble in a variety of organic solvents.10,11 However, 
enantioselectivities in screening reactions were disappointing. I now report that similar 
adducts of (S,S)-1,2-diphenylethylenediamine ((S,S)-dpen),12,13 which is commercially 
available as either enantiomer,14 afford high enantioselectivities in a benchmark carbon-
carbon bond forming reaction, the addition of malonate esters to nitroalkenes,15 as well 
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as others. Together with recent studies involving metal catalysts with hydrogen bond 
donors remote from coordinating atoms,16-19 this work firmly establishes the viability of 
highly enantioselective second coordination sphere promoted catalysis, and presages a 
"gold rush" on widely available NH-containing coordination compounds that have 
heretofore unrecognized potential as catalysts. Some of these reactions were carried out 
by Dr. Kyle G. Lewis. 
4.2. Results 
 First, (S,S)-dpen was elaborated into a series of diastereomeric complexes Λ- and 
∆-[Co((S,S)-dpen)3]3+ 3X– (Λ- and ∆-(S,S)-13+ 3X–, X = Cl–, ClO4– differing in the 
cobalt chirality, by adapting earlier procedures of Bosnich,12 Mason,13 and others as 
shown in Scheme 4.1. These efforts were detailed in section 3.21  
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Scheme 4.1. Syntheses of salts of the formula [Co((S,S)-dpen)3]3+ 3X– ((S,S)-13+ 3X–; 
X = Cl, ClO4); kinetic and thermodynamic / diastereoselectivities. 
 
 
 
Next, lipophilic salts were prepared as exemplified for the Λ diastereomers in 
Scheme 4.2 (see also section 3).21 It has not yet been possible to obtain a crystal 
structure of one of the lipophilic salts. However, crystal structures of Λ-, -(S,S)-13+ 
3Cl–, and -(R,R)-13+ 3Cl– could be determined, as described in the experimental 
section. Views of the structures are presented in Figures 4.1-4.3.  
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Scheme 4.2. Syntheses of lipophilic Werner salts (yields: 83-96%).The procedures for ∆ 
diastereomers are analogous. 
 
 
 
As expected, the trication in -(S,S)-13+ 3Cl– (Figure 4.1), exhibits a nearly 
idealized D3 geometry, with a principal C3 symmetry axis and three C2 symmetry axes 
that define a plane perpendicular to the principal axis. The three NH protons on each of 
the two "C3 faces" are oriented in a convergent manner that should afford particularly 
strong hydrogen bonds. The two protons on each of three "C2 faces" are also effectively 
aligned for hydrogen bonding, but the enthaplic interactions should be lower, consistent 
with the more facile exchange of the first chloride ion by BArf– (Scheme 4.2).  
A similar motif is found with the opposite diastereomer -(S,S)-13+ 3Cl– (Figure 
4.2), but the protons on the C3 faces are oriented in a divergent manner, and the C2 faces 
are much more congested, precluding simultaneous bonding of chloride to both NH 
protons (Figure 4.2). In any event, for both diastereomers of the mixed salts (S,S)-13+ 
2X–BArf–, the dominant hydrogen bonding interactions should involve X– and the C3 
faces. 
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Figure 4.1. Thermal ellipsoid diagram (50% probability level) of Λ-(S,S)-13+ 3Cl–
·2H2O·2CH3OH with solvent molecules removed for clarity. Upper left and right, views 
down the idealized C3 and C2 axes with chloride ions omitted; lower left and right, 
analogous views with chloride ions. 
                              
Figure 4.2. Thermal ellipsoid diagram (50% probability level) of -(S,S)-13+ 3Cl–
·12.5H2O with solvent molecules removed for clarity. Upper left and right, views down 
the idealized C3 and C2 axes with chloride ions omitted; lower left and right, analogous 
views with chloride ions. 
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Figure 4.3. Thermal ellipsoid diagram (50% probability level) of -(R,R)-13+ 3Cl–
·H2O·3CH3OH with solvent molecules removed for clarity. Upper left and right, views 
down the idealized C3 and C2 axes with chloride ions omitted; lower left and right, 
analogous views with chloride ions. 
 
 
The crystal structure of -(R,R)-13+ 3Cl– is shown in Figure 4.3. Though, this 
complex is the enantiomer of -(S,S)-13+ 3Cl–, a different solvate was obtained because 
of different crystallization conditions. There were one H2O and three MeOH molecules 
within the asymmetric unit. Both of the enantiomers -(S,S)-13+ 3Cl– and -(R,R)-13+ 
3Cl– have very similar trication geometries (Table A-6). The difference is that in -
(S,S)-13+ 3Cl–, the chelating ligand (S,S-dpen) adopts a δ conformation, whereas in -
(R,R)-13+ 3Cl–, the chelating ligand (R,R-dpen) adopts a λ conformation. Overall, both 
of the enantiomers have lel3 conformations. 
 The complexes in Scheme 4.2 were screened as catalysts for additions of 
malonate esters to trans-ß-nitrostyrene (21a),15 as summarized in Scheme 4.3. As shown 
in entries 1 and 2, di(isopropyl) malonate (22a) and 21a were combined in the presence 
of Et3N (1.0 equiv) and Λ- or ∆-(S,S)-13+ 2Cl–BArf– (10 mol%) under an ambient air 
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atmosphere in CD2Cl2 at room temperature. Conversions were monitored by 1H NMR in 
the presence of an internal standard. Over the course of 2 h, the enantiomeric addition 
products (R)- or (S)-23aa formed in 88 and >99% yields and 80% ee and 76% ee, 
respectively, as assayed by chiral HPLC. These impressive lead results also established  
 
 
 
 
Scheme 4.3. Initial screening reactions: Data for additions of dialkyl malonates (22) to 
trans--nitrostyrene (21a) catalyzed by - and -(S,S)-13+ 2Cl–BArf– in CD2Cl2 at 
room temperature (entries 1-6), and additions catalyzed by other salts of -(S,S)-13+ in 
acetone-d6 at 0 °C (entries 7-11). 
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that the cobalt configurations control the product configuration. However, when diethyl 
and dimethyl malonate (22b,c) were investigated, it became clear that Λ-(S,S)-13+ 2Cl–
BArf– was a more enantioselective catalyst (23ab, 79% (R) or 59% (S) ee; 23ac, 82% 
(R) or 40% (S) ee). In optimization experiments, acetone was found to be a somewhat 
better solvent, especially at lower temperatures, and CH3CN gave in many cases 
comparable data. Other bases were examined, but none gave better results than Et3N. 
Other salts were investigated, now at 0 °C in acetone-d6 with 22c, as summarized 
in entries 7-12 of Scheme 4.3. With Λ-(S,S)-13+ 2Cl–BArf–, the ee value of the resulting 
23ac increased to 87%. The other mixed salts Λ-(S,S)-13+ 2BF4–BArf– and Λ-(S,S)-13+ 
2PF6–BArf– were comparably effective (90%, 85% ee). The slightly higher enantiosele-
ctivity with the former was reproducible, prompting Λ-(S,S)-13+ 3BF4– to be synthesized 
(above) and tested. Interestingly, this catalyst gave the highest ee value of all (93%). In 
contrast, the tris(BArf) salt Λ-(S,S)-13+ 3BArf– was the least enantioselective catalyst, 
with an ee value of 80%.  
The catalysts exhibited significant reactivity differences, as signaled by the 
reaction times in Scheme 4.3. Hence, rate profiles were measured in CD2Cl2, but using a 
lower catalyst loading (2 mol%), a less reactive Michael acceptor (trans-4-methoxy-β-
nitrostyrene, 21d), and a lower Et3N charge (0.35 equiv) to enhance differentiation. As 
shown in Figure 4.4, the less enantioselective diastereomer, -(S,S)-13+ 2Cl–BArf– (■), 
was significantly more reactive than the more enantioselective diastereomer Λ-(S,S)-13+ 
2Cl–BArf– (◆). Among the Λ diastereomers, rates increased as the chloride anions in Λ-
(S,S)-13+ 2Cl–BArf– were replaced by progressively more weakly hydrogen bonding 
anions (2Cl– < 2BF4– < 2PF6– < 2BArf–). 
These data are interpreted as indicative of substrate activation at the more 
strongly hydrogen bonding C3 trication sites, subsequent to initial anion dissociation. In 
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the mixed salts, the C2 sites should be unencumbered, or very weakly interacting with 
BArf–; if these were responsible for catalysis, comparable rates would be expected as the 
other anions are varied.  
 
 
 
 
Figure 4.4. Rate profiles for additions of dimethyl malonate (22c) to trans-4-methoxy-ß-
nitrostyrene (21d) catalyzed by lipophilic Werner salts. Conditions: 2 mol% catalyst, 
0.35 equiv Et3N, CD2Cl2, rt. 
 
 
 
In this context, a CD2Cl2 solution of Λ-(S,S)-13+ 2Cl–BArf– has been titrated 
with substrates such as trans-ß-nitrostyrene (21a) and dimethyl malonate (22c). 
Progressive downfield shifts of the upfield (non-hydrogen bonded) NH protons are 
observed, whereas the downfield (hydrogen bonded) NH protons are essentially 
unchanged. A series of spectra for a representative titration with 21a is provided in 
Figure 4.5.  
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These experiments show that the C2 sites are capable of binding substrates, but of 
course do not establish a reaction pathway. Faster catalysis with the diastereomer -
(S,S)-13+ 2Cl–BArf– logically follows from the enthalpically weaker interactions of the 
 trication with chloride ion. The lower enantioselectivities would then be ascribed to 
less favorable architectural factors. With Λ-(S,S)-13+ 2X–BArf–, the moderate 
dependence of enantioselectivities upon the anion X– might reflect the continued 
association of X– with one of the two C3 sites. 
 
 
 
 
Figure 4.5. 1H NMR spectra: titration of a 0.017 M CD2Cl2 solution of Λ-(S,S)-13+ 
2Cl–BArf– with trans-ß-nitrostyrene (21a). Data (equiv of 21a/NH signals, δ in ppm): 
0.250/4.010 and 8.127; 0.500/4.053 and 8.134; 0.750/4.094 and 8.141; 1.00/4.129 and 
8.131; 1.25/4.165 and 8.155; 1.50/4.195 and 8.158; 1.75/4.204 and 8.162; 2.00/4.241 
and 8.169; 2.50/4.28 and 8.179; 2.75/4.296 and 8.183; 3.00/4.31 and 8.178; 4.00/4.342 
and 8.184; 5.00/4.368 and 8.196; 6.00/4.387 and 8.227; 7.00/4.405 and 8.236; 
8.00/4.418 and 8.234; 9.00/4.432 and 8.249. 
 
 
 
 Despite any oversimplifications in the preceding models, the enantioselectivity 
trends in Scheme 4.3 generally hold for a variety of nitroalkene substrates, as 
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summarized in Scheme 4.4. Reactions were conducted in acetone at 0 °C, with the rates 
and yields determined by 1H NMR (Λ-(S,S)-13+ 2Cl–BArf–) or isolation following 
chromatography (Λ-(S,S)-13+ 2BF4–BArf–, Λ-(S,S)-13+ 3BF4–). In eight out of ten cases, 
the second catalyst afforded higher enantioselectivities than the first; the third 
tris(tetrafluoroborate) catalyst was superior in all cases, delivering an average of 94% ee 
for the aryl-substituted nitroalkenes. A good ee value was also obtained with an alkyl-
substituted nitroalkene (21l, 86% ee).20 Although these enantioselectivities have been 
matched or slightly exceeded by organic hydrogen bond donor catalysts,15,20 these were 
in all cases bifunctional, incorporating the amine base. Thus, Scheme 4.4 represents an 
impressive debut for a new catalyst family at an early stage of development. 
Furthermore, Λ-(S,S)-13+ 2Cl–BArf– is easily recovered in near quantitative yields 
chromatographically (experimental section). 
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Scheme 4.4. Substrate scope. Data for additions of dimethyl malonate (22c) to 
nitroalkenes catalyzed by -(S,S)-13+ 2Cl–BArf–, -(S,S)-13+ 2BF4–BArf–, and -(S,S)-
13+ 3BF4–. 
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4.3. Discussion 
 Several additional themes merit emphasis. First, as established by chemists at 
Diaminopharm Inc. analogs of dpen with substituted aryl groups are readily available.21 
New families of catalysts in which the phenyl group has been replaced by other aromatic 
groups have been discussed in section 3. Chiral counter anions are easily introduced by 
extending Scheme 4.2. Thus, it should be possible to further optimize catalysis by 
exploiting these diversity elements, and by synthesizing bifunctional tertiary amine 
containing analogs.22 Some of the systems described in section 7 may give improved 
results. 
Second, many chiral ligands with a C3 symmetry axis are known, but metal 
containing catalysts in which the active sites have C3 symmetry (i.e., devoid of 
symmetry lowering ancillary ligands) are much less common, especially with transition 
metals.23 Some transition metal based catalytic systems considered to have C3 
symmetric active sites are shown in Figure 4.6.23b The catalytic system in Figure 4.6-A 
was highly effective in asymmetric allylic oxidations. The Cu2+ is proposed to complex 
with the C3 symmetric ligand N(CH2-ox) in situ to give a highly enantioselective 
catalyst (up to 84% ee).  
 
 
 
 
Figure 4.6. Catalytic systems with active sites having C3 symmetry. 
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Similarly, in the catalytic system Figure 4.6-B rhodium(III) reacts with C3 
symmetric ligand tris(oxazoline) to give tris(oxazoline)rhodium complex, which 
catalyzes the asymmetric cyclopropanation of styrene with tert-butyl and ethyl 
diazoacetate with high stereoselectivity (up to 56% de and 67% ee). The rigid, C3-
symmetric titanium complex in Figure 4.6-C was formed in situ and catalyzed the 
ethylation of benzaldehyde with enantioselectivities of up to 98%. 
Third, note that most other hydrogen bond donor catalysts feature two donor 
groups (e.g., thioureas). Since, per the crystallographic data8 and other evidence, the title 
complexes are capable of 3-5 or more simultaneous NH interactions, they can potentially 
give rise to new chemistries, i.e. transformations that cannot be realized with established 
catalysts. Efforts involving all of these themes are in progress and will be reported in due 
course.  
 
 
 
 
Figure 4.7. Metal catalysts with hydrogen bond donors remote from coordinating atoms. 
 
 
 
Finally, there are other recently published metal catalysts with hydrogen bond 
donors remote from coordinating atoms, some of them are shown in Figure 4.7.16-18 
This study underscores the rich possibilities associated with enantioselective second coo-
rdination sphere promoted catalysis. This may presage a revival of interest in classical 
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NH coordination compounds, many of which feature inexpensive metals and ligands, 
can be utilized under an air atmosphere as in the above reactions, and can (when chiral) 
easily be obtained in enantiopure form. Such systems promise, in both conceptual and 
practical senses, to be transformational new additions to the chiral pool. 
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4.4. Experimental section 
General Data. NMR spectra were recorded on a Varian NMRS 500 MHz 
spectrometer at ambient probe temperatures. Chemical shifts (δ in ppm) were referenced 
to residual solvent signals (1H: CHCl3, 7.26; 2.50; CDHCl2, 5.32; acetone-d5, 2.05; 13C: 
CDCl3, 77.2; CD2Cl2, 54.0; acetone-d6, 29.8). IR spectra were recorded on a Shimadzu 
IRAffinity-1 spectrometer (Pike MIRacle ATR system, diamond/ZnSe crystal). Melting 
points were determined using an OptiMelt MPA 100 instrument. Microanalyses were 
conducted by Atlantic Microlab. HPLC analyses were carried out with a Shimadzu 
instrument package (pump/autosampler/detector LC-20AD/SIL-20A/SPD-M20A). 
NMR solvents (Cambridge Isotopes) were treated as follows: CDCl3, CD2Cl2, 
and acetone-d6, stored over molecular sieves. HPLC solvents (hexanes, Fischer; 
isopropanol, JT Baker; both HPLC Grade) were degassed before use. CH2Cl2 (EMD 
Chemicals, ACS grade), CH3OH (EMD, anhydrous, 99.8%), hexanes (Macron, ACS 
grade), EtOAc (Macron, ACS grade), and acetone (BDH, ACS grade), used as received 
unless noted. 
 Reactions were conducted under air unless noted. The syntheses and the 
equilibrium studies of the salts of (S,S)-13+ are described in the section 3. Chemicals 
were treated as follows. The trans-β-nitrostyrene (21a, Alfa Aesar, 98%) was column 
chromatographed (silica gel, 9:1 v/v hexanes/EtOAc). The trans-4-methoxy-β-
nitrostyrene (21d), 3,4-dichloro-β-nitrostyrene (21e), and 1-(2-furyl)-2-nitroethylene 
(21k) were used as received from Alfa Aesar (NMR showed 21e,k to be >98% trans). 
Other previously reported nitroolefins (21b-c, 21f-g, 21j, 21l; see Scheme 4.4) were pre-
pared by Henry reactions of nitromethane and the corresponding aldehydes.24 Dimethyl 
malonate (22c, Alfa Aesar, 98%), diethyl malonate (22b, Alfa Aesar, 99%), diisopropyl 
malonate (22a, TCI, 99%), trans-2-(2-nitrovinyl)phenol (Aldrich, 97%), acetyl chloride 
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(Aldrich, 98%), benzoyl chloride (Aldrich, 99%), Et3N (Alfa Aesar, 98%), silica gel 
(Silicycle SiliaFlash® F60), and Na2SO4 (EMD) were used as received. 
Representative 1H NMR titration. A 5 mm NMR tube was charged with Λ-
(S,S)-13+ 2Cl–BArf–·2H2O (0.0141 g, 0.00848 mmol) and CD2Cl2 (0.5 mL). A solution 
of 21a (2.1 M in CD2Cl2) was added in increments of 0.001 mL (0.25 equiv) and 1H 
NMR spectra were recorded. Selected peaks shifted, as shown by the spectra in Figure 
4.5 (see text). 
 Syntheses of previously unreported nitroolefins. A (trans-2-acetoxy-β-
nitrostyrene; 21h). A Schlenk flask was charged with trans-2-(2-nitrovinyl)phenol 
(0.5871 g, 3.54 mmol),24a Et3N (0.500 mL, 3.58 mmol, 1.01 equiv), and CH2Cl2 (10 
mL, dried and degassed using a Glass Contour solvent purification system) under N2. 
The solution was cooled to 0 °C and acetyl chloride (0.375 mL, 5.28 mmol, 1.49 equiv) 
was added dropwise by syringe with stirring. The cold bath was removed. After 12 h, 
CH2Cl2 (50 mL) was added. The mixture was washed with H2O (50 mL), 1.0 M HCl, 
(50 mL), and brine (50 mL). The organic layer was dried (Na2SO4) and the solvent was 
removed by rotary evaporation. The residue was chromatographed on a silica gel column 
(80:20 v/v hexanes/EtOAc). The solvent was removed from the combined product frac-
tions by rotary evaporation. The residue was dried by oil pump vacuum at room 
temperature to give 21h as a pale yellow solid (0.473 g, 2.28 mmol, 65%), which 
became a wax at 69-71 °C and liquefied at 74-76 °C (open capillary). Anal. Calcd. for 
C10H9NO4 (207.18): C 57.97, H 4.38, N 6.76; found C 58.13, H 4.40, N 6.73. B. (trans-
2-benzoyloxy-β-nitrostyrene; 21i). trans-2-(2-nitrovinyl)phenol (0.5943 g, 3.60 
mmol),24a Et3N (0.630 mL, 4.52 mmol, 1.26 equiv), CH2Cl2 (10 mL, dried and 
degassed using a Glass Contour solvent purification system), and benzoyl chloride 
(0.790 mL, 6.81 mmol, 1.89 equiv) were combined in a procedure analogous to A. An 
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identical workup gave 21i as a pale yellow solid (0.6629 g, 2.46 mmol, 69%), which 
became a wax at 78-82 °C and liquefied at 87-89 °C (open capillary). Anal. Calcd. for 
C15H11NO4 (269.25): C 66.91, H 4.12, N 5.20; found C 67.04, H 4.20, N 5.01. 
 Data for 21h. NMR (CDCl3, δ in ppm): 1H (500 MHz) 8.06 (d, 3JHH = 13.5 Hz, 
1H, CHNO2), 7.61-7.58 (m, 2H, CH=CHNO2 and 1H of C6H4), 7.52 (t, 3JHH = 8.5 Hz, 
1H of C6H4), 7.32 (t, 3JHH = 7.5 Hz, 1H of C6H4), 7.23 (d, 3JHH = 8.5 Hz, 1H of C6H4), 
2.43 (s, 3H, CH3); 13C{1H} (125 MHz): 168.8 (s, C(O)Me), 150.2, 138.7, 133.2, 133.1, 
129.1, 126.8, 123.8, 123.0 (8 × s, C6H4, CH=CHNO2), 21.2 (s, CH3). IR (powder film, 
cm–1): 3115 (w), 1753 (s), 1638 (m), 1510 (s), 1339 (vs), 1194 (vs), 963 (s), 758 (s). 
Data for 21i. NMR (CDCl3, δ in ppm): 1H (500 MHz) 8.24 (m, 2H, CHNO2 and 
1 H of C6H5/C6H4), 8.13 (d, 3JHH = 13.5 Hz, 1H, CH=CHNO2), 7.70 (t, 3JHH = 7.5 Hz, 
1H of C6H5/ C6H4), 7.66-7.56 (m, 5H of C6H5/C6H4), 7.38-7.33 (m, 2H of 
C6H5/C6H4); 13C{1H} (125 MHz) 164.7 (s, C(O)Ph), 150.6 138.7, 134.5, 133.2, 133.2, 
130.5, 129.2, 129.1, 128.5, 126.9, 124.0, 123.4 (12  s, CH=CHNO2, C6H4, C6H5). IR 
(powder film, cm–1): 3105 (w), 1742 (s), 1340 (s), 1209 (vs), 1057 (vs), 700 (vs).  
Rate profiles, Figure 4.4. A 5 mm NMR tube was charged with a solution of 
21d (0.0180 g, 0.101 mmol), dimethyl malonate (22c, 0.0127 mL, 0.111 mmol, 1.10 
equiv), catalyst (0.0020 mmol, 0.020 equiv), and Ph2SiMe2 (0.0020 mL, internal 
standard) in CD2Cl2 (1.0 mL). A 1H NMR spectrum was recorded to measure the initial 
ratio of 21d to the standard. Then Et3N (0.0050 mL, 0.036 mmol, 0.36 equiv) was added 
and the conversion to 23ac was periodically measured by 1H NMR. After 2 h, the 
mixture was loaded directly onto a plug of silica gel. The 23ac was eluted with 
hexanes/EtOAc (1:1 v/v, 50 mL). The solvent was removed by rotary evaporation. The 
ee was assayed by chiral HPLC.26  
Reactions, Scheme 4.3. A (entries 1-6). A 5 mm NMR tube was charged with a 
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solution of 21a (0.0054 g, 0.036 mmol, 1.0 equiv), dialkyl malonate (22, 0.039 mmol, 
1.1 equiv), catalyst (0.0036 mmol, 0.10 equiv), and Ph2SiMe2 (0.0020 mL, internal 
standard) in CD2Cl2 (0.40 mL). A 1H NMR spectrum was recorded to measure the 
initial ratio of the nitroolefin to the standard. Then Et3N (0.0050 mL, 0.0036 g, 0.036 
mmol, 1.0 equiv) was added. The conversion was monitored by 1H NMR. After the 
specified time (Scheme 4.3), the mixture was loaded onto a plug of silica gel. The 
organic product (23aa-ac) was eluted with hexanes/EtOAc (1:1 v/v, 50 mL). The solvent 
was removed by rotary evaporation. The product ee was assayed by chiral HPLC.26 B 
(entries 7-11). A 5 mm NMR tube was charged with a solution of 21a (0.0149 g, 0.10 
mmol, 1.0 equiv), 22c, (0.0138 mL, 0.0158 g, 0.120 mmol, 1.2 equiv), catalyst (0.010 
mmol, 0.10 equiv), and Ph2SiMe2 (0.0020 mL, internal standard) in acetone-d6 (0.7 
mL). A 1H NMR spectrum was recorded to measure the initial ratio of the nitroolefin to 
the standard. The sample was cooled to 0 °C, and Et3N (0.0140 mL, 0.0101 g, 0.10 
mmol, 1.0 equiv) was added. The conversion to 23ac was monitored by 1H NMR. After 
the specified time (Scheme 4.3), the mixture was loaded directly onto a plug of silica 
gel. The 23ac was eluted with hexanes/EtOAc (7:3 v/v, 50 mL). The solvent was 
removed by rotary evaporation. The ee was assayed by chiral HPLC.26  
Reactions, Scheme 4.4. A (with Λ-(S,S)-13+ 2Cl–BArf–). A 5 mm NMR tube 
was charged with a solution of nitroolefin (0.036 mmol, 1.0 equiv), Λ-(S,S)-13+ 2Cl–
BArf–·2H2O (0.0059 g, 0.0036 mmol, 0.10 equiv), 22c (0.0045 mL, 0.0052 g, 0.039 
mmol, 1.1 equiv), and Ph2SiMe2 (0.0020 mL, internal standard) in acetone-d6 (0.40 
mL). A 1H NMR spectrum was recorded to measure the initial ratio of the nitroolefin to 
the standard. The sample was cooled to 0 °C, and Et3N (0.0050 mL, 0.0036 g, 0.036 
mmol, 1.0 equiv) was added. The conversion was monitored by 1H NMR. After the 
specified time (Scheme 4.4), the mixture loaded onto a plug of silica gel. The organic 
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product (23ac-jc) was eluted with hexanes/EtOAc (1:1 v/v). The solvent was removed 
by rotary evaporation. The product was dried by oil pump vacuum at room temperature 
and the ee assayed by chiral HPLC (Figures A-2 to A-15).26 B (with Λ-(S,S)-13+ 2BF4–
BArf–). A round bottom flask was charged with a solution of nitroolefin (0.355 mmol, 
1.0 equiv), Λ-(S,S)-13+ 2BF4–BArf–·3H2O (0.0634 g, 0.0355 mmol, 0.10 equiv), and 
22c (0.0458 mL, 0.0529 g, 1.13 equiv) in acetone (3.3 mL), and cooled to 0 °C. Then 
Et3N (0.0495 mL, 0.0359 g, 0.355 mmol, 1.0 equiv) was added. The reaction was 
monitored by TLC. After the specified time (Scheme 4.4), the solvent was removed by 
rotary evaporation and the residue was dissolved in CH2Cl2 (2 mL). The orange solution 
was chromatographed on a silica gel column (1.9  14 cm, 9:1 v/v hexanes/ EtOAc). The 
solvent was removed from the product containing fractions by rotary evaporation. The 
product was dried by oil pump vacuum at room temperature (yields: Scheme 4.4) and the 
ee assayed by chiral HPLC (Figures A-2 to A-15 in appendix).26 C (with Λ-(S,S)-13+ 
3BF4–). A 5 mL vial was charged with a solution of nitroolefin (0.10 mmol, 1.0 equiv), 
Λ-(S,S)-13+ 3BF4–·2H2O (0.0099 g, 0.010 mmol, 0.1 equiv), 22c (0.0138 mL, 0.0158 g, 
0.120 mmol, 1.2 equiv), and Ph2SiMe2 (0.0020 mL, internal standard) in acetone-d6 
(0.70 mL). A 1H NMR spectrum was recorded to measure the initial ratio of the 
nitroolefin to the standard. The sample was cooled to 0 °C, and Et3N (0.0140 mL, 
0.0101 g, 0.10 mmol, 1.0 equiv) was added. The reaction was monitored by 1H NMR 
and TLC. After the specified time (Scheme 4.4), the mixture was worked up as described 
in B. 
Catalyst recycling, Λ-(S,S)-13+ 2Cl–BArf–. A round bottom flask was charged 
with a solution of 21a (0.0529 g, 0.355 mmol, 1.0 equiv), Λ-(S,S)-13+ 2Cl–BArf–·2H2O 
(0.0543 g, 0.0326 mmol, 0.0918 equiv), and 22c (0.0460 mL, 0.401 mmol, 1.13 equiv) 
in acetone (3.3 mL), and cooled to 0 °C. Then Et3N (0.0460 mL, 0.0333 g, 0.330 mmol, 
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0.93 equiv) was added. The reaction was monitored by TLC. After 15 h, the solvent was 
removed by rotary evaporation and the residue was dissolved in CH2Cl2 (2 mL). The 
orange solution was washed with 3.0 M HCl (1 mL) and H2O (2 × 1 mL) and 
chromatographed on a silica gel column (1.9  14 cm, 9:1 v/v hexanes/EtOAc). The 
solvent was removed from the organic product containing fractions by rotary 
evaporation and oil pump vacuum to give 23ac as a white solid (0.0940 g, 0.334 mmol, 
94%), which was analyzed by HPLC and 1H and 13C{1H} NMR as described below. 
The column was then washed with CH2Cl2 and the orange catalyst band was eluted with 
CH2Cl2/CH3OH (98:2 v/v). The solvent was removed by rotary evaporation and oil 
pump vacuum at room temperature to recover Λ-(S,S)-13+ 2Cl–BArf–·H2O (0.0526 g, 
0.0319 mmol, 98%). Anal. Calcd. for C74H60BCl2CoF24N6H2O (1647.94): C 53.91, H 
3.79, N 5.10; found C 53.84, H 4.08, N 4.96.  
Diisopropyl 2-(2-nitro-1-phenylethyl)malonate (23aa).27 This known 
compound was obtained as a spectroscopically pure colorless oil per the general 
procedures for Scheme 4.3. NMR (CDCl3, δ in ppm):28 1H (500 MHz) 7.32-7.22 (m, 
5H, C6H5), 5.08 (sept, 3JHH = 6.0 Hz, 1H, CH(CH3)2), 4.92 (dd, 2JHH = 13.0 Hz, 3JHH 
= 4.5 Hz, 1H, CHH'NO2), 4.86-4.60 (m, 2H, C'H(C'H3)2 and CHH'NO2), 4.20 (td, 3JHH 
= 8.5 Hz, 3JHH = 5.0 Hz, 1H, CH=CH2NO2), 3.75 (d, 3JHH = 9.5 Hz, 1H, 
CH(CO2iPr)2), 1.24 (d, 3JHH = 6.5 Hz, 6H, CH(CH3)2), 1.07 (d, 3JHH = 6.0 Hz, 3H, 
C'H((CH3)(C'H3))), 1.01 (d, 3JHH = 6.5 Hz, 3H, C'H((CH3)(C'H3))); 13C{1H} (125 
MHz): 167.2 (s, CO2iPr), 166.5 (s, C'O2iPr), 136.4 (s, i), 129.0 (s, o), 128.4 (s, p), 128.3 
(s, m),25 78.1 (s, CH2NO2), 70.1 (s, CH(CH3)2), 69.7 (s, C'H(C'H3)2), 55.3 (s, 
CH(CO2iPr)2), 43.1 (s, CH=CH2NO2), 21.7, 21.6, 21.41, 21.39 (4 × s, 4 × CH3). 
Enantiomeric excesses were determined by HPLC (see Figure A-2) with a 
Chiralcel OD column (95:05 v/v hexane/isopropanol, 0.75 mL/min, λ = 220 nm); for Λ-
 147 
(S,S)-13+ 2Cl–BArf–, tR = 10.8 min (major), 13.3 min (minor); for Δ-(S,S)-13+ 2Cl–
BArf–, similar but with major/minor reversed.26  
 Diethyl 2-(2-nitro-1-phenylethyl)malonate (23ab).27 This known compound 
was obtained as a spectroscopically pure colorless oil per the general procedures for 
Scheme 4.3. NMR (CDCl3, δ in ppm):28 1H (500 MHz) 7.33-7.22 (m, 5H, C6H5), 4.92 
(dd, 2JHH = 13.5 Hz, 3JHH = 5.0 Hz, 1H, CHH'NO2), 4.86 (dd, 2JHH = 13.0 Hz, 3JHH = 
9.0 Hz, 1H, CHH'NO2), 4.26-4.19 (m, 3H, CH2CH3 and CH=CH2NO2), 4.00 (q, 3JHH = 
7.5 Hz, 2H, C'H2C'H3), 3.81 (d, 3JHH = 9.5 Hz, 1H, CH(CO2Et)2), 1.26 (t, 3JHH = 7.0 
Hz, 3H, CH2CH3), 1.04 (t, 3JHH = 7.0 Hz, 3H, C'H2C'H3); 13C{1H} (125 MHz): 167.6 
(s, CO2Et), 166.9 (s, C'O2Et), 136.3 (s, i), 129.1 (s, o), 128.5 (s, p) 128.1 (s, m),25 77.8 
(s, CH2NO2), 62.3 (s, CH2CH3), 62.0 (s, C'H2C'H3), 55.1 (s, CH(CO2Et)2), 43.1 (s, 
CH=CH2NO2), 14.1 (s, CH3), 13.9 (s, C'H3). 
 Enantiomeric excesses were determined by HPLC (see Figure A-3) with a 
Chiralpak AS-H column (90:10 v/v hexane/isopropanol, 1.0 mL/min, λ = 220 nm); for 
Λ-(S,S)-13+ 2Cl–BArf–, tR = 12.7 min (minor), 14.3 min (major); for Δ-(S,S)-13+ 2Cl–
BArf–, similar but with major/minor reversed.26  
 Dimethyl 2-(2-nitro-1-phenylethyl)malonate (23ac).27 This known compound 
was isolated as a white solid per the general procedures for Scheme 4.4. NMR (CDCl3, δ 
in ppm):28 1H (500 MHz) 7.33-7.21 (m, 5H, C6H5), 4.93 (dd, 2JHH = 13.0 Hz, 3JHH = 
5.0 Hz, 1H, CHH'NO2), 4.87 (dd, 2JHH = 13.0 Hz, 3JHH = 9.0 Hz, 1H, CHH'NO2), 4.24 
(td, 3JHH = 9.0 Hz, 3JHH = 5.0 Hz, 1H, CH=CH2NO2), 3.86 (d, 3JHH = 9.0 Hz, 1H, 
CH(CO2Me)2), 3.75 (s, 3H, CH3), 3.54 (s, 3H, C'H3); 13C{1H} (125 MHz) 167.9 (s, 
CO2Me), 167.3 (s, C'O2Me), 136.2 (s, i), 129.1 (s, o) 128.4 (s, p), 128.0 (s, m), 77.5 (s, 
CH2NO2), 54.8 (s, CH(CO2Me)2), 53.1 (s, CH3), 52.9 (s, C'H3), 43.0 (s, 
CH=CH2NO2).  
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 Enantiomeric excesses were determined by HPLC (see Figure A-4) with a 
Chiralpak AD column (98:02 v/v hexane/isopropanol, 1.0 mL/min, λ = 220 nm); for Λ-
(S,S)-13+ 2BF4–BArf– (Λ-(S,S)-13+ 2Cl–BArf– similar), tR = 32.4 min (major), 42.3 min 
(minor); for Λ-(S,S)-13+ 3BF4–, tR = 33.3 min (major), 43.4 min (minor); for Δ-(S,S)-13+ 
2Cl–BArf–, similar but with major/minor reversed.26  
 Dimethyl 2-(2-nitro-1-α-naphthylethyl)malonate (23bc).15a,b This known 
compound was isolated as a colorless oil per the general procedures for Scheme 4. NMR 
(CDCl3, δ in ppm):28 1H (500 MHz) 8.18 (d, 3JHH = 8.5 Hz, 1H of C10H7), 7.87 (d, 
3JHH = 8.0 Hz, 1H of C10H7), 7.80 (d, 3JHH = 8.0 Hz, 1H of C10H7), 7.62 (t, 3JHH = 8.5 
Hz, 1H of C10H7), 7.53 (t, 3JHH = 8.0 Hz, 1H of C10H7), 7.44-7.38 (m, 2H of C10H7), 
5.25-5.16 (m, 2H, CHH′NO2 and CH=CH2NO2), 5.07 (dd, 2JHH = 13.5 Hz, 3JHH = 4.5 
Hz, 1H, CHH'NO2), 4.12 (d, 3JHH = 7.5 Hz, 1H, CH(CO2Me)2), 3.72 (s, CH3), 3.54 (s, 
C'H3); 13C{1H} (125 MHz) 168.1 (s, CO2Me), 167.6 (s, C'O2Me), 134.3, 132.3, 131.1, 
129.4, 129.2, 127.2, 126.2, 125.2, 124.1, 122.3 (10 × s, C10H7), 76.7 (s, CH2NO2), 54.6 
(s, CH(CO2Me)2), 53.1 (s, CH3), 53.0 (s, C'H3), 36.9 (s, CH=CH2NO2). 
 Enantiomeric excesses were determined by HPLC (see Figure A-5) with a 
Chiralpak AD column (90:10 v/v hexane/isopropanol, 1.0 mL/min, λ = 254 nm); for all 
catalysts tR = 13.5-14.1 min (major), 18.9-19.6 min (minor).26  
 Dimethyl 2-(2-nitro-1-β-naphthylethyl)malonate (23cc).15b,c This known 
compound was isolated as a yellow solid per the general procedures for Scheme 4.4. 
NMR (CDCl3, δ in ppm):28 1H (500 MHz) 7.83-7.79 (m, 3H of C10H7), 7.70 (s, 1H of 
C10H7), 7.50-7.48 (m, 2H of C10H7), 7.34 (d, 3JHH = 8.5 Hz, 1H of C10H7), 5.01 (d, 
3JHH = 8.0 Hz, 2H, CH2NO2), 4.43 (q, 3JHH = 7.0 Hz, 1H, CH=CH2NO2), 3.98 (d, 3JHH 
= 9.0 Hz, 1H, CH(CO2Me)2), 3.77 (s, 3H, CH3), 3.54 (s, 3H, C'H3); 13C{1H} (125 
MHz) 166.0 (s, CO2Me), 167.4 (s, C'O2Me), 133.7, 133.4, 133.2, 129.1, 128.1, 127.8, 
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127.5, 126.7, 126.6, 125.3 (10 × s, C10H7), 77.5 (s, CH2NO2), 54.9 (s, CH(CO2Me)2), 
53.2 (s, CH3), 53.0 (s, C'H3), 43.2 (CH=CH2NO2). 
Enantiomeric excesses were determined by HPLC (see Figure A-6) with a 
Chiralcel OD column (70:30 v/v hexane/isopropanol, 1.0 mL/min, λ = 254 nm); for Λ-
(S,S)-13+ 2BF4–BArf–, tR = 14.4 min (major), 39.2 min (minor); for Λ-(S,S)-13+ 3BF4– 
(older column), tR = 12.5 min (major), 37.0 min (minor).26  
 Dimethyl 2-(2-nitro-1-(4-methoxyphenyl)ethyl)malonate (23dc).15b,c This 
known compound was isolated as a colorless oil per the general procedures for Scheme 
4.4. NMR (CDCl3, δ in ppm):28 1H (500 MHz) 7.14 (d, 3JHH = 8.5 Hz, 2H, m to CH), 
6.83 (d, 3JHH = 8.5 Hz, 2H, o to CH), 4.89 (dd, 2JHH = 13.0 Hz, 3JHH = 5.0 Hz, 1H, 
CHH'NO2), 4.82 (dd, 2JHH = 13.5 Hz, 3JHH = 9.5 Hz, 1H, CHH'NO2), 4.19 (td, 3JHH = 
9.0 Hz, 3JHH = 5.0 Hz, 1H, CH=CH2NO2), 3.82 (d, 3JHH = 9.5 Hz, 1H, CH(CO2Me)2), 
3.77 (s, 3H, CO2CH3), 3.76 (s, 3H, C'O2C'H3), 3.57 (s, 3H, ArOCH3); 13C{1H}29 (125 
MHz) 168.0 (s, CO2Me), 167.4 (s, C'O2Me), 159.6 (s, p to CH), 129.1 (s, o to CH), 
128.0 (s, i to CH), 114.5 (s, m to CH), 77.8 (s, CH2NO2), 55.3 (s, ArOCH3), 55.0 
(CH(CO2Me)2), 53.1 (s, CO2CH3), 53.0 (s, C'O2C'H3), 42.4 (s, CH=CH2NO2).  
Enantiomeric excesses were determined by HPLC (see Figure A-7) with a 
Chiralpak AD column (80:20 v/v hexane/isopropanol, 1.0 mL/min, λ = 220 nm); for all 
catalysts tR = 11.5-11.7 min (major), 17.5-18.2 min (minor).26  
Dimethyl 2-(2-nitro-1-(3,4-dichlorophenyl)ethyl)malonate (23ec). This new 
compound was isolated as a white solid per the general procedures for Scheme 4.4. 
NMR (CDCl3, δ in ppm):28 1H (500 MHz) 7.40 (d, 3JHH = 9.0 Hz, 1H of C6H3), 7.35 (s, 
1H of C6H3), 7.10 (d, 3JHH = 8.5 Hz, 1H of C6H3), 4.90 (dd, 2JHH = 13.5 Hz, 3JHH = 
5.0 Hz, 1H, CHH'NO2), 4.85 (dd, 2JHH = 13.5 Hz, 3JHH = 9.5 Hz, 1H, CHH'NO2), 4.20 
(td, 3JHH = 9.0 Hz, 3JHH = 5.0 Hz, 1H, CH=CH2NO2), 3.82 (d, 3JHH = 9.5 Hz, 1H, 
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CH(CO2Me)2), 3.77 (s, 3H, CH3), 3.62 (s, 3H, C'H3); 13C{1H} (125 MHz) 167.5 (s, 
CO2Me), 167.0 (s, C'O2Me), 136.5, 133.3, 132.9, 131.1, 130.2, 127.4 (6 × s, C6H3), 
76.9 (s, CH2NO2), 54.4 (s, CH(CO2Me)2) , 53.3 (CH3), 53.2 (C'H3), 42.1 
(CH=CH2NO2). IR (powder film, cm–1): 1744 (s), 1715 (s), 1549 (vs), 1265 (s), 1611 
(s). mp 78-81 °C (open capillary). Anal. Calcd. for C13H13Cl2NO6 (350.15): C 44.59, H 
3.74, N 4.00; found C 44.82, H 3.82, N 4.02. 
Enantiomeric excesses were determined by HPLC (see Figure A-8) with a 
Chiralpak AS-H column (90:10 v/v hexane/isopropanol, 1.0 mL/min, λ = 220 nm); for 
all catalysts tR = 20.4-21.3 min (minor), 22.7-23.5 min (major).26  
Dimethyl 2-(2-nitro-1-(pyridine-3-yl)ethyl)malonate (23fc).15a This known 
compound was isolated as an off white solid per the general procedures for Scheme 4.4. 
NMR (CDCl3, δ in ppm):28 1H (500 MHz) 8.55-8.52 (m, 2H of C5H4N), 7.59 (dt, 3JHH 
= 8.0 Hz, JHH = 2.0 Hz, 1H of C5H4N), 7.27-7.25 (m, 1H of C5H4N), 4.94 (dd, 2JHH = 
13.5 Hz, 3JHH = 8.5 Hz, CHH'NO2), 4.89 (dd, 2JHH = 13.5 Hz, 3JHH = 9.5 Hz, 1H, 
CHH'NO2), 4.26 (td, 3JHH = 8.5 Hz, 3JHH = 5.0 Hz, CH=CH2NO2), 3.86 (d, 3JHH = 8.5 
Hz, 1H, CH(CO2Me)2), 3.76 (s, CH3), 3.58 (s, C'H3); 13C{1H} (125 MHz) 167.6 (s, 
CO2Me), 167.0 (s, C'O2Me), 149.9, 149.7, 135.5, 132.1, 123.8 (5 × s, C5H4N), 76.9 (s, 
CH2NO2), 54.3 (s, CH(CO2Me)2), 53.3 (s, CH3), 53.2 (s, C'H3), 40.7 (s, 
CH=CH2NO2). 
Enantiomeric excesses were determined by HPLC (see Figure A-9) with a 
Chiralpak AD column (60:40 v/v hexane/isopropanol, 1.0 mL/min, λ = 220 nm); for Λ-
(S,S)-13+ 2BF4–BArf– (Λ-(S,S)-13+ 2Cl–BArf– similar), tR = 6.8 min (major), 9.2 min 
(minor).26  
Dimethyl 2-(2-nitro-1-(2-trifluoromethylphenyl)ethyl)malonate (23gc). This 
new compound was isolated as a white solid per the general procedures for Scheme 4.4. 
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NMR (CDCl3, δ in ppm):28 1H (500 MHz) 7.72 (d, 3JHH = 7.5 Hz, 1H of C6H4), 7.53 (t, 
3JHH = 7.5 Hz, 1H of C6H4), 7.43 (t, 3JHH = 8.0 Hz, 1H of C6H4), 7.37 (d, 3JHH = 8.0 
Hz, 1H of C6H4), 5.16 (dd, 2JHH = 13.5 Hz, 3JHH = 7.5 Hz, 1H, CHH'NO2), 4.94 (dd, 
2JHH = 13.5 Hz, 3JHH = 4.5 Hz, 1H, CHH'NO2), 4.65 (td, 3JHH = 7.5 Hz, 3JHH = 4.5 Hz, 
1H, CH=CH2NO2), 4.11 (d, 3JHH = 7.5 Hz, 1H, CH(CO2Me)2), 3.75 (s, 3H, CH3), 3.64 
(s, 3H, C'H3); 13C (125 MHz) 168.0 (s, CO2Me), 167.3 (s, C'O2Me), 135.1, 132.5 (2  
s, C6H4), 129.0 (q, 2JCF = 29.8 Hz, CCF3), 128.6, 128.0 (2  s, C6H4), 127.3 (q, 3JCF = 
5.9 Hz, CHCCF3), 124.2 (q, 1JCF = 272.6 Hz, CF3), 76.6 (s, CH2NO2), 54.0 (s, 
CH(CO2Me)2), 53.2 (CH3), 53.1 (C'H3), 38.1 (s, CH=CH2NO2). IR (powder film, cm–
1): 2957 (w), 1751 (s), 1734 (s), 1549 (s), 1126 (vs), 777 (s). mp 76-79 °C (open 
capillary). Anal. Calcd. for C14H14F3NO6 (349.26): C 48.14, H 4.04, N 4.01; found C 
47.91, H 3.93, N 3.91. 
Enantiomeric excesses were determined by HPLC (see Figure A-10) with a 
Chiralcel OD column (95:05 v/v hexane/isopropanol, 1.0 mL/min, λ = 220 nm); for all 
catalysts tR = 12.7 min (minor), 26.6-28.6 min (major).26  
Dimethyl 2-(2-nitro-1-(2-acetoxyphenyl)ethyl)malonate (23hc). This new 
compound was isolated as a colorless oil per the general procedures for Scheme 4.4. 
NMR (CDCl3, δ in ppm):28 1H (500 MHz) 7.32 (t, 3JHH = 7.0 Hz, 1H of C6H4), 7.27-
7.25 (m, 1H of C6H4), 7.20 (t, 3JHH = 7.5 Hz, 1H of C6H4), 7.15 (d, 3JHH = 8.0 Hz, 1H 
of C6H4), 4.94-4.86 (m, 2H, CH2NO2), 4.50 (q, 3JHH = 7.0 Hz, 1H, CH=CH2NO2), 
3.92 (d, 3JHH = 8.5 Hz, 1H, CH(CO2Me)2), 3.74 (s, 3H, OCH3), 3.59 (s, 3H, OC'H3), 
2.39 (s, 3H, CH3); 13C{1H} (125 MHz) 169.2, 168.0, 167.4 (3 × s, CO2Me, C'O2Me, 
C(O)Me), 148.7, 129.4, 128.5, 128.2, 126.5, 123.5 (6 × s, C6H4), 76.7 (s, CH2NO2), 
53.8 (s, CH(CO2Me)2), 53.1 (s, OCH3, OC'H3), 36.7 (s, CH=CH2NO2), 21.2 (s, CH3), 
IR (neat oil, cm–1): 2957 (w), 1734 (vs), 1555 (s), 1192 (s), 1171 (s). Anal. Calcd. for 
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C15H17NO8 (339.30): C 53.10, H 5.05, N 4.13; found C 53.39, H 5.11, N 4.11. 
Enantiomeric excesses were determined by HPLC (see Figure A-11) with a 
Chiralcel OD column (90:10 v/v hexane/isopropanol, 1.0 mL/min, λ = 220 nm); for Λ-
(S,S)-13+ 2BF4–BArf– (Λ-(S,S)-13+ 2Cl–BArf– similar), tR = 18.9 min (minor), 28.5 min 
(major)); for Λ-(S,S)-13+ 3BF4– (older column), tR = 19.7 min (minor), 31.3 min 
(major).26  
Dimethyl 2-(2-nitro-1-(2-benzoyloxyphenyl)ethyl)malonate (23ic). This new 
compound was isolated as a pale yellow oil per the general procedures for Scheme 4.4. 
NMR (CDCl3, δ in ppm):28 1H (500 MHz) 8.27 (d, 3JHH = 7.0 Hz, 2H of C6H5/C6H4), 
7.69 (t, 3JHH = 7.0 Hz, 1H of C6H5/C6H4), 7.57 (t. 3JHH = 8.0 Hz, 2H of C6H5/C6H4), 
7.39-7.33 (m, 2H of C6H5/C6H4), 7.28-7.25 (m, 2H of C6H5/C6H4), 4.98 (dd, 2JHH = 
13.5 Hz, 3JHH = 8.5 Hz, 1H, CHH'NO2), 4.91 (dd, 2JHH = 13.5 Hz, 3JHH = 5.0 Hz, 1H, 
CHH'NO2), 4.60 (td, 3JHH = 8.5 Hz, 3JHH = 5.0 Hz, 1H, CH=CH2NO2), 3.96 (d, 2JHH = 
8.5 Hz, 1H, CH(CO2Me)2), 3.72 (s, 3H, CH3), 3.53 (s, 3H, C'H3); 13C{1H} (125 MHz) 
167.9 (s, CO2Me), 167.4 (s, C'O2Me), 164.9 (s, C(O)Ph), 149.0, 134.1, 130.5, 129.6, 
129.1, 129.0, 128.7, 128.3, 126.6, 123.6 (10 × s, C6H5/C6H4), 76.6 (s, CH2NO2), 53.8 
(s, CH(CO2Me)2), 53.1 (s, CO2Me), 53.1 (s, C'O2Me), 36.7 (s, CH=CH2NO2). IR (neat 
oil, cm–1): 2955 (w), 1732 (vs), 1555 (s), 1213 (s), 708 (vs). Anal. Calcd. for 
C20H19NO8 (401.37): C 59.85, H 4.77, N 3.49; found C 59.59, H 4.80, N 3.40. 
Enantiomeric excesses were determined by HPLC (see Figure A-12) with a 
Chiralpak AD column (90:10 v/v hexane/isopropanol, 1.0 mL/min, λ = 220 nm); for all 
catalysts tR = 15.5-15.7 min (major), 26.0-26.3 min (minor).26  
Dimethyl 2-(2-nitro-1-(2-benzyloxyphenyl)ethyl)malonate (23jc). This new 
compound was isolated as a colorless oil per the general procedures for Scheme 4.4. 
NMR (CDCl3, δ in ppm):28 1H (500 MHz) 7.47 (d, J = 7.5 Hz, 2H of C6H5/C6H4), 7.42 
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(t, 7.5 Hz, 2H of C6H5/ C6H4), 7.36 (t, J = 7.5 Hz, 1H of C6H5/C6H4), 7.24 (t, J = 7.5 
Hz, 1H of C6H5/C6H4), 7.17 (d, J = 7.5 Hz, 1H of C6H5/ C6H4), 6.93 (d, J = 8.5 Hz, 1H 
of C6H5/C6H4), 6.89 (t, J = 7.5 Hz, 1H of C6H5/C6H4); 5.13 (d, 3JHH = 2.5 Hz, 2H, 
CH2Ph), 5.05 (dd, J = 13.0 Hz, J = 4.5 Hz, 1H, CHH'NO2), 4.84 (dd, J = 13.0 Hz, J = 
4.5 Hz, 1H, CHH'NO2), 4.44 (td, 3JHH = 9.5 Hz, 3JHH = 4.5 Hz, 1H, CH=CH2NO2), 
4.17 (d, 3JHH = 9.5 Hz, 1H, CH(CO2Me)2), 3.72 (s, 3H, CH3), 3.50 (s, 3H, C'H3); 13C 
(125 MHz) 168.3, (s, CO2Me), 167.7 (s, C'O2Me), 156.7, 136.5, 130.9, 129.8, 128.9, 
128.3, 127.7, 123.9, 121.2, 112.4 (10 × s, C6H4/C6H5), 76.0 (s, CH2NO2), 70.6 
(CH2Ph), 53.0 (s, CH(CO2Me)2), 52.7 (s, CH3), 52.6 (s, C'H3), 40.5 (s, CH=CH2NO2). 
IR (neat oil, cm–1): 3034 (w), 2955 (w), 2886 (w), 1732 (vs), 1553 (vs), 1238 (vs), 752 
(s), 696 (m). Anal. Calcd. for C20H21NO7 (387.38): C 62.01, H 5.46, N 3.62; found C 
62.25, H 5.46, N 3.57.  
Enantiomeric excesses were determined by HPLC (see Figure A-13) with a 
Chiralcel OD column (90:10 v/v hexane/isopropanol, 1.0 mL/min, λ = 220 nm); for all 
catalysts tR = 12.2-12.4 min (minor), 23.7-24.0 min (major).26  
 Dimethyl 2-(2-nitro-1-furylethyl)malonate (23kc).15b,c This known compound 
was isolated as a yellowish oil per the general procedures for Scheme 4.4. NMR (CDCl3, 
δ in ppm):28 1H (500 MHz) 7.33 (m, 1H of C4H3O), 6.28 (m, 1H of C4H3O), 6.21 (d, 
3JHH = 3.5 Hz, 1H of C4H3O), 4.89 (m, 2H, CH2NO2), 4.39 (td, 3JHH = 17.5 Hz, 3JHH = 
12.5 Hz, 1H, CH=CH2NO2), 3.93 (d, 3JHH = 8.0 Hz, 1H, CH(CO2Me)2), 3.75 (s, 3H, 
CH3), 3.68 (s, 3H, C'H3); 13C{1H} (125 MHz) 167.6 (s, CO2Me), 167.3 (s, C'O2Me), 
149.5, 143.0, 110.7, 106.5 (4 × s, C4H3O), 75.4 (s, CH2NO2), 53.2 (s, CH3), 53.1 (s, 
C'H3), 52.8 (s, CH(CO2Me)2), 36.9 (s, CH=CH2NO2). 
Enantiomeric excesses were determined by HPLC (see Figure A-14) with a 
Chiralcel OD column (90:10 v/v hexane/isopropanol, 1.0 mL/min, λ = 220 nm); for all 
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catalysts tR = 11.8-12.0 min (minor), 28.7-29.0 min (major).26  
 Dimethyl 2-(2-nitro-1-propylethyl)malonate (23lc).20a This known compound 
was isolated as a colorless oil per the general procedures for Scheme 4.4. NMR (CDCl3, 
δ in ppm):28 1H (500 MHz) 4.69 (dd, 2JHH = 13.5 Hz, 3JHH = 8.5 Hz, 1H, CHH'NO2), 
4.52 (dd, 2JHH = 13.5 Hz, 3JHH = 6.5 Hz, 1H, CHH'NO2), 3.762 (s, 3H, OCH3), 3.756 
(s, 3H, OC'H3), 3.66 (d, 3JHH = 6.0 Hz, 1H, CH(CO2Me)2), 2.90 (sext, 3JHH = 6.5 Hz, 
1H, CH=CH2NO2), 1.46-1.34 (m, 4H, CH2CH2), 0.92 (t, 3JHH = 7.5 Hz, 3H, CH3); 
13C{1H} (125 MHz) 168.5 (s, CO2Me), 168.3 (s, C'O2Me), 76.7 (s, CH2NO2), 53.0 (s, 
OCH3), 52.9 (s, OC'H3), 52.4 (s, CH(CO2Me)2), 36.9 (s, CH=CH2NO2), 32.3 (s, 
CH2CH2CH3), 20.0 (s, CH2CH2CH3), 13.9 (s, CH3). 
Enantiomeric excesses were determined by HPLC (see Figure A-15) with a 
Chiralcel OD column (97.5:2.5 v/v hexane/isopropanol, 1.0 mL/min, λ = 220 nm); for 
(S,S)-13+ 2BF4–BArf– (newer column), tR = 12.4 min (minor), 20.3 min (major); for Λ-
(S,S)-13+ 3BF4– (older column), tR = 9.7 min (minor), 18.8 min (major).26  
4.5. Crystallography.  
A (Λ-(S,S)-13+ 3Cl–·2H2O·2CH3OH). A solution of Λ-(S,S)-13+ 3Cl– in 
CH3OH/H2O (2:1 v/v) was allowed to slowly concentrate at room temperature. After 3 
d, orange rods were collected. Data were obtained as noted in Table A-5. Cell 
parameters were determined from 60 data frames taken at 0.5° widths. Integrated 
intensity information for each reflection was obtained by reduction of the data frames 
with the program APEX2.30 Data were corrected for Lorentz, polarization, and crystal 
decay effects. The program SADABS31 was used to correct for absorption effects. The 
structure was solved by direct methods using SHELXTL (XS).32 For each cobalt atom, 
two molecules of both H2O and CH3OH were located. Hydrogen atoms were placed in 
idealized positions and refined using a riding model. Non-hydrogen atoms were refined 
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with anisotropic thermal parameters. The thermal ellipsoids of the carbon atoms of two 
phenyl rings showed significant elongation, indicating disorder. This was successfully 
modeled (C2B/C, C3B/C, C4B/C, C5B/C, C6B/C, C7B/C, 61:39 occupancy ratio; 
C9A/E, C10A/E, C11A/E, C12A/E, C13A/E, and C14A/E, 53:47 occupancy ratio). The 
parameters were refined by weighted least squares refinement on F2 to 
convergence.32,33 The absolute stereochemistry was confirmed (absolute structure 
parameter = 0.000(12); Table A-5).34 B (-(R,R)-13+ 3Cl·H2O·3CH3OH). A solution 
of ∆-(R,R)-13+ 3Cl– in CH3OH was allowed to slowly concentrate at room temperature. 
After 5 d, orange rods were collected. Data were obtained as noted in Table A-5. Cell 
parameters were determined from 180 data frames taken at 0.5° widths. Integrated 
intensity information for each reflection was obtained by reduction of the data frames 
with the program APEX2.30 Data were corrected for Lorentz, polarization, and crystal 
decay effects. The program SADABS31 was used to correct for absorption effects. The 
structure was solved by direct methods using SHELXTL (XS).32 For each cobalt atom, 
one molecule of water and ca. three molecules of CH3OH were located. The thermal 
ellipsoids associated with one CH3OH molecule indicated partial occupancy, which 
refined to 0.88; this value was fixed for the final refinement. Hydrogen atoms were 
placed in idealized positions and refined using a riding model. Non-hydrogen atoms 
were refined with anisotropic thermal parameters. The thermal ellipsoids of the carbon 
atoms of one phenyl ring indicated disorder. This refined to a 76:24 occupancy ratio 
(C30/30A, C31/31A, C32/32A, C33/33A, C34/34A, C35/35A). The ellipsoids of the 
disordered atoms were constrained. The parameters were refined by weighted least 
squares refinement on F2 to convergence.32,33 The absolute stereochemistry was 
confirmed (absolute structure parameter = 0.012 (4); Table A-5).34 C (-(S,S)-13+ 3Cl–
·12.5H2O). A solution of crude ∆-(S,S)-13+ 3Cl– (obtained from the Dowex column and 
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containing some Λ diastereomer) in hot H2O was allowed to slowly concentrate at room 
temperature. After 7 d, orange blocks were collected. Data were obtained as noted in 
Table A-5. Cell parameters were determined from 180 data frames taken at 0.5° widths. 
Integrated intensity information for each reflection was obtained by reduction of the data 
frames with the program APEX2.30 Data were corrected for Lorentz, polarization, and 
crystal decay effects. The program SADABS31 was used to correct for absorption 
effects, and the structure was solved using SHELXTL (XS).32 The asymmetric unit 
contained two unique -(S,S)-13+ moieties (Z = 4; Z′ = 2) and 25 molecules of water. 
Hydrogen atoms were placed in idealized positions and refined using a riding model. All 
non-hydrogen atoms were refined with anisotropic thermal parameters. Several atoms 
yielded non-positive definite matrices and some exhibited elongated thermal ellipsoids. 
Strong constraints (listed in the Validation Response Form of the CHECKCIF file) were 
placed to keep the thermal ellipsoids meaningful. The parameters were refined by 
weighted least squares refinement on F2 to convergence.32,33 Platon35 was used to 
verify the absence of additional symmetry and voids. The absolute stereochemistry was 
confirmed (absolute structure parameter = 0.069(4); Table A-5).34  
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5. TRIS(1,2-DIPHENYLETHYLENEDIAMINE) COBALT(III) 
COMPLEXES: CHIRAL HYDROGEN BOND DONOR CATALYSTS 
FOR ENANTIOSELECTIVE -AMINATIONS OF 1,3-
DICARBONYL COMPOUNDS† 
 
5.1. Introduction 
 The last 15 years have witnessed an extensive development of small molecule 
hydrogen bond donor catalysts for enantioselective organic synthesis.1 During this 
period, many types of catalyst based stereogenic elements have been evaluated. I and my 
collaborators have sought to (1) expand the chiral pool to include inorganic or 
organometallic molecules that exhibit chirality motifs not commonly encountered in 
organic systems,2 and (2) explore the utility of NH hydrogen bond donor groups that are 
either ligated to the metal3 or positioned at remote sites.4,5 Related themes have been of 
interest in the Meggers group.5,6   
 In particular, our attention has been attracted to helically chiral Werner 
complexes, for which the D3 symmetric trication [Co(en)3)]3+ (en = 1,2-
ethylenediamine) is the prototype.3 As noted in previous sections in this dissertation, the 
mirror images of [Co(en)3)]3+, depicted in Scheme 5.1 (top), have commonly been 
designated Λ and ∆. Salts of these trications were among the first inorganic compounds 
separated into enantiomers.7 However, the solubilities of such species are generally 
restricted to water or other protic media, which can inhibit the binding of substrates to 
NH donor sites.  
 
 
†Reproduced with permission from Kumar, A.; Ghosh, S. K.; Gladysz, J. A. Org. Lett. 2016, 18, 760-763. 
Copyright 2016 American Chemical Society. 
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In earlier work, I synthesized a series of salts of a related trication with (S,S)-1,2-
diphenylethylenediamine ligands ((S,S)-dpen) as shown in Scheme 5.1 (middle).3b The 
starting trichloride [Co((S,S)-dpen)3]3+ 3Cl– ((S,S)-13+ 3Cl–) was easily obtained as the 
Λ or ∆ diastereomer, and the exchange of one chloride for the lipophilic anion BArf– 
(B(3,5-C6H3(CF3)2)4–) gave salts with high solubilities in aprotic media. This in turn 
facilitated the formation of a number of mixed salts of the formula Λ- or ∆-(S,S)-13+ 2X–
X'– as well as analogs with three lipophilic anions (Λ- or ∆-(S,S)-13+ 3X"–, see section 
3). Many of these gave high levels of enantioselection as catalysts for Michael additions 
of malonate esters to nitroalkenes (see section 4).3b  
 
 
 
 
Scheme 5.1. A chiral cobalt(III) trication originally separated into enantiomers by 
Werner (top); general catalyst family (middle); reaction to be investigated (bottom). 
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In order to demonstrate the applicability of such catalysts to a broader palette of 
transformations, we began to investigate additions of 1,3-dicarbonyl and related comp-
ounds to azo linkages, a reaction type shown in Scheme 5.1 (bottom). Such additions, 
often termed aminations, have been demonstrated with other hydrogen bond donor 
catalysts,8 and yield nitrogen functionalized systems that can be elaborated to -amino 
acids.9 In this section, I report that salts derived from the trication (S,S)-13+ also effect 
additions of activated methylene compounds to azo species in very high 
enantioselectivities. Some of these reactions were carried out by Dr. Anil Kumar. 
5.2. Results 
As shown in Scheme 5.2, catalysts were screened at 5 mol % loadings using the 
ß-keto ester 24a and di-t-butyl azodicarboxylate (25). The first experiments used the 
base N-methylmorpholine and were carried out in CD2Cl2 in NMR tubes at room 
temperature. Entries 1 and 2, which involve the previously reported diastereomeric 
mixed bis(chloride) salts Λ- and Δ-(S,S)-13+ 2Cl–BArf–, gave opposite enantiomers of 
the addition product 26a in 76% and 79% ee, respectively, roughly on same time scale. 
Hence, the cobalt configuration is the main determinant of the product configuration. 
The corresponding bis(tetrafluoroborate) and bis(hexafluorophosphate) salts gave 
diminished enantioselectivities (entries 3-6, 70-56% ee). However, the perfluorotetra-
phenylborate salts Δ- and Λ-(S,S)-13+ 2Cl– BArf20– gave equal or better results (entries 
7, 8), with the improvement more pronounced in the Δ series (84% ee). Hence, this 
catalyst was selected for solvent, temperature, and base optimization. 
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Entrya catalyst solvent base  (1 equiv) 
temp 
(°C)
conversion
(%) (time)b
ee (%)
(config)c
1 Λ-(S,S)-13+ 2Cl–BArf– (5) CD2Cl2 NMM rt 99 (20 min) 76 (S) 
2 ∆-(S,S)-13+ 2Cl–BArf– (5) CD2Cl2 NMM rt 99 (20 min) 79 (R) 
3 Λ-(S,S)-13+ 2BF4–BArf– (5) CD2Cl2 NMM rt 99 (20 min) 70 (S) 
4 ∆-(S,S)-13+ 2BF4–BArf– (5) CD2Cl2 NMM rt 99 (20 min) 56 (R) 
5 Λ-(S,S)-13+ 2PF6–BArf– (5) CD2Cl2 NMM rt 99 (20 min) 60 (S) 
6 ∆-(S,S)-13+ 2 PF6–BArf– (5) CD2Cl2 NMM rt 99 (20 min) 68 (R) 
7 Λ-(S,S)-13+ 2Cl–BArf20– (5) CD2Cl2 NMM rt 99 (20 min) 77 (S) 
8 ∆-(S,S)-13+ 2Cl–BArf20– (5) CD2Cl2 NMM rt 99 (20 min) 84 (R) 
9 ∆-(S,S)-13+ 2Cl–BArf20– (5) acetone-d6 NMM rt 99 (20 min) 87 (R) 
10 ∆-(S,S)-13+ 2Cl–BArf20– (5) CD3CN NMM rt 99 (20 min) 89 (R) 
11 ∆-(S,S)-13+ 2Cl–BArf20– (5) CD3CN NMM 0  99 (20 min) 91 (R) 
12 ∆-(S,S)-13+ 2Cl–BArf20– (5) CD3CN NMM –35  99 (20 min) 84 (R) 
13 ∆-(S,S)-13+ 2Cl–BArf20– (5) CD3CN Et3N 0  99 (20 min) 81 (R) 
14 ∆-(S,S)-13+ 2Cl–BArf20– (5) CD3CN DABCO 0  99 (20 min) 77 (R) 
15 ∆-(S,S)-13+ 2Cl–BArf20– (5) CD3CN DBU 0  99 (20 min) 80 (R) 
16 ∆-(S,S)-13+ 2Cl–BArf20– (5) CD3CN DMAP 0  99 (20 min) 80 (R) 
17 ∆-(S,S)-13+ 2Cl–BArf20– (1) CD3CN NMM 0  99 (8 h) 70 (R) 
18 ∆-(S,S)-13+ 2Cl–BArf20– (2) CD3CN NMM 0  99 (4 h) 84 (R) 
19 ∆-(S,S)-13+ 2Cl–BArf20– (10) CD3CN NMM 0  99 (20 min) 91 (R) 
20 ∆-(S,S)-13+ 2Cl–BArf20– (5) CD3CN NMMd 0  99 (35 min) 91 (R) 
21 ∆-(S,S)-13+ 2Cl–BArf20– (5) CD3CN NMMe 0  99 (6 h) 91 (R) 
aReactions were carried out with 0.050 mmol of 24a and 0.050 mmol of 25 in 0.50 mL of solvent. bThe conversion was  
determined by 1H NMR integration of the CHCO2Me proton of 24a versus the internal standard Ph2SiMe2. 
cEnantiosel- 
ectivities were determined by chiral HPLC analyses. d0.50 equiv base . e0.10 equiv base. 
Scheme 5.2. Optimization of catalysts and conditions
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For Δ-(S,S)-13+ 2Cl–BArf20–, enantioselectivities increased slightly in acetone-d6 
(87% ee, entry 9) and still more in CD3CN (89% ee, entry 10). Next, reactions were 
conducted in CD3CN at lower temperatures (entries 11-12). Interestingly, the ee values 
first increased (91% ee, 0 °C), but diminished with further cooling (84%, –35 °C). Thus, 
four additional bases were evaluated at 0 °C (Et3N, DABCO, DBU, DMAP), but the ee 
values decreased to 81-77% ee (entries 13-16). Next, the catalyst charge was varied. At 1 
and 2 mol% loadings (entries 17-18), enantioselectivities decreased (70% and 84% ee), 
presumably due to increased competition from background reaction or catalysis. 
However, 10% loadings gave no improvement (entry 19). Finally the amount of base 
was decreased from 1.0 equiv to 0.50-0.10 equiv (entry 20-21). Reactions times 
increased, but enantioselectivities were maintained.  
Next, the optimal conditions from Scheme 5.2 were applied to additional 
substrates, giving the results summarized in Scheme 5.3. Five different cyclic ß- 
ketoesters were examined, providing products 26a-d,h in 88-97% yields. The 
carboethyoxy cyclohexanone 26c formed somewhat more slowly than the others, 
whereas the carbomethoxy cyclopentanone 26a formed somewhat faster. Within this 
group, the ee values were excellent for the five and six membered ring keto esters (26a-
d; >99-91% ee). However, the seven membered ring keto ester formed with lower 
enantioselectivity (5 h; 72% ee, Scheme 5.3). 
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 aAll reactions were carried out with 0.1 mmol of 24 and 0.1 mmol of 25 in 1.0 mL of CH3CN. bYields are 
for isolated products. cEnantioselectivities were determined by chiral HPLC analyses. 
Scheme 5.3. Substrate scope under optimized conditions.a-c  
 
 
 
An acyclic ß-keto ester also underwent amination in high yield (98%) and 
enantioselectivity (>99% ee) to give 26e. A cyclic 1,3 diketone was also efficiently 
derivatized to give 26g in 99% yield and 93% ee. Finally, when -cyanocyclopentanone 
was employed, 26f was obtained in 92% yield, but the ee value dropped to 45%. 
Importantly, the dominant product configurations were, in a relative sense, the same in 
each case. 
Naturally, it is by no means assured that the screening results in Scheme 5.2 
reflect the optimum conditions for all of the substrates in Scheme 5.3. Thus, for the 
reactions yielding 26e and 26g, additional catalysts were investigated, as summarized in 
Table 5.1.  
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Table 5.1. Variation of the catalyst used for 26e and 26g under optimized conditions.a 
entry product catalyst 
time 
(h) 
yield  
(%)  
ee (%) 
(config) 
1 26e ∆-(S,S)-13+ 2Cl–BArf20– 12 94 >99 (R) 
2 26e Λ-(S,S)-13+ 2Cl–BArf20– 15 97 84 (S) 
3 26e ∆-(S,S)-13+ 2Cl–BArf– 13 93 84 (R) 
4 26g ∆-(S,S)-13+ 2Cl–BArf20– 30 98 93 (R) 
5 26g Λ-(S,S)-13+ 2Cl–BArf20– 28 97 92 (S) 
6 26g ∆-(S,S)-13+ 2Cl–BArf– 32 94 70 (R) 
aAll reactions were carried out with 0.10 mmol each of 24 and 25 in 1.0 mL of CH3CN at 0 °C in the 
presence of N-methylmorpholine (0.10 equiv.). 
 
 
 
These data confirm that the best overall catalyst is ∆-(S,S)-13+ 2Cl–BArf20–. For 
the acyclic substrate yielding 26e, the ∆ diastereomer gives significantly higher 
enantioselectivity than the Λ diastereomer (entries 1 vs. 2, >99% vs. 84% ee). However, 
for the diketone 26g, these two catalysts give comparable enantioselectivities (entries 4 
vs. 5, 93-92% ee). It is noted in passing that these would be excellent test systems for 
multivariate reaction parameter analyses.10   
5.3. Discussion.  
As summarized in Scheme 5.2, this study shows that all of the cobalt(III) salts 
prepared catalyze the title reaction with appreciable enantioselectivities. Curiously, the Δ 
diastereomers always afford slightly greater enantioselectivities. This is in stark contrast 
to the malonate/nitroalkene additions,3b for which the Λ diastereomers are distinctly 
superior; current evidence suggests that these proceed via a C3 face of the trication, 
where three NH bonds are directed in a roughly synperiplanar fashion. As shown in 
Scheme 5.4 (top), the three NH protons on each C3 face of the trichloride salt Δ-(S,S)-
13+ 3Cl– are directed in a more divergent fashion than those of Λ-(S,S)-13+ 3Cl–, and the 
C2 face is much more congested.3b While it borders on pure speculation to propose 
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transition state assemblies for the reactions in Schemes 5.2 and 5.3, the model I (Scheme 
5.4, middle) can be offered as a starting point. Note the possibility that the educts may 
also simultaneously bind to one or more NH units associated with a C2 face.  
 
 
 
 
Scheme 5.4. Views of the C3 and C2 faces of the trication of Λ-(S,S)-13+ 3Cl– (top),3b A 
possible transition state Assembly (middle), Other chiral hydrogen bond donor catalysts 
employed for the title reaction (bottom). 
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Although it is difficult to quantitatively compare the effectiveness of different 
families of enantioselective catalysts, the ee values in Scheme 5.3 usually rank with the 
best in the literature. For products 26a,b,d, the current "records" are 96% ee (vs. 91%),8g  
98% ee (vs. 92%),8e and 97% ee (vs. 92%),8e respectively. For 26c,e,g, our data are sup-
erior (>99% ee vs. 98%;8e >99% ee vs. 85%;8e 93% vs. no previous reports). With the 
products 26f,h, our data are inferior (45% ee vs. 90%;8g 72% ee vs. 94%8g). The 
catalysts that feature in these comparisons are depicted in Scheme 5.4 (A, B; bottom), 
together with other representative examples (C, D). Importantly, A and B were effective 
at somewhat lower loadings than (S,S)-13+ 2Cl–BArf20– (2-0.5 vs. 5 mol %). This may 
be due, at least in part, to their bifunctional nature, obviating the need for an external 
base. 
In summary, this study has expanded the applicability of chiral Werner 
complexes based upon ethylenediamine chelates as hydrogen bond donor catalysts for 
enantioselective organic reactions. The anion effects evident in Scheme 5.2 furthermore 
raise the possibility of additional types of controlling interactions. These will be probed 
in future efforts, together with bifunctional catalysts that incorporate tertiary amines 
(section 7)11 and transformations that cannot be effected with existing hydrogen bond 
donor catalysts. 
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5.4. Experimental section 
General Data. Reactions were conducted under air. NMR spectra were recorded 
on a Varian NMRS 500 MHz spectrometer at ambient probe temperatures. Chemical 
shifts (δ in ppm) were referenced to residual solvent signals (1H: CDCl3, 7.26; CD2Cl2, 
5.32; acetone-d6, 2.05; CD3CN, 1.94; 13C: CDCl3, 77.2; CD2Cl2, 54.0; acetone-d6, 
29.9). Melting points were determined using an OptiMelt MPA 100 instrument. 
Microanalyses were conducted by Atlantic Microlab. HPLC analyses were carried out 
with a Shimadzu instrument package (pump/autosampler/detector LC-20AD/SIL-
20A/SPD-M20A). 
NMR solvents (Cambridge Isotopes; CDCl3, CD2Cl2, acetone-d6, CD3CN) were 
stored over molecular sieves. HPLC solvents (hexanes, Fischer; isopropanol, JT Baker; 
both HPLC Grade) were degassed before use. Other solvents (CH2Cl2 (EMD, ACS 
grade), hexanes (Macron, ACS grade), EtOAc (Macron, ACS grade), acetone (BDH, 
ACS grade), CH3CN (BDH, ACS grade)) were used as received. 
The following chemicals were used as received: di-t-butyl azodicarboxylate (25, 
Aldrich, 98%), methylcyclopentanone-2-carboxylate (24a, TCI, >97%), ethyl 2-
oxocyclopentanecarboxylate and ethyl 2-oxocyclohexanecarboxylate (24b,c, Aldrich, 
95%), ethyl-1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate, (24d, Oxchem, 95%), 
ethyl-2-methylacetoacetate (24e, Alfa Aesar, 95%), cyclopentanone-2-carbonitrile (24f, 
Oxchem, 95%), 2-acetylcyclopentanone (24g, Alfa Aesar, 98%), methyl 2-oxo-1-
cycloheptanecarboxylate (24h, Aldrich, >99%), Et3N (Alfa Aesar, 98%), N-methyl 
morpholine (Alfa Aesar, 99%), DBU (Acros Organics), DMAP (Aldrich, > 99%), 
DABCO (Aldrich, >99%), silica gel (Silicycle SiliaFlash® F60). 
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 Reactions, Scheme 5.3. A 5 mm NMR tube was charged with a solution of β-
ketoester or related compound (24; 0.10 mmol, 1.0 equiv), azodicarboxylate 25 (0.023 g, 
0.10 mmol, 1.0 equiv) and catalyst (0.0050 mmol, 0.05 equiv) in CH3CN (1.0 mL), and 
cooled to 0 °C. Then N-methylmorpholine (0.0011 mL, 0.010 mmol, 0.10 equiv) was 
added. The reaction was monitored by TLC. After the specified time (Scheme 5.3), the 
mixture was loaded onto a plug of silica gel. The organic product (26) was eluted with 
hexane/EtOAc (80:20 to 70:30 v/v). The solvent was removed by rotary evaporation. 
The product was dried by oil pump vacuum at room temperature and the ee assayed by 
chiral HPLC (Figure A-16 to Figure A-23 in appendix). 
N,N'-Bis(t-butoxycarbonyl)-1-hydrazino-2-oxocyclopentanecarboxylic acid 
methyl ester (26a).8a This known compound was obtained as a colorless oil (0.036 g, 
0.097 mmol) per the procedure for Scheme 5.3. NMR (CDCl3, δ in ppm): 1H (300 MHz) 
6.51 (br s, 1H, NH), 3.74 (s, 3H, COOCH3), 2.82-1.86 (m, 6H, ring CH2), 1.66-1.06 (m, 
18H, C(CH3)3 and C'(C'H3)3); 13C{1H} (125 MHz), 205.6 (s, (C=O)CH2), 168.6 (s, 
(C=O)OMe), 155.4 and 154.5 (2s, (C=O)O-tBu and (C'=O')O'-tBu'), 83.0 and 81.7 (2s, 
C(CH3)3 and C'(C'H3)3), 53.20, (s, OCH3), 36.7 (s), 31.7 (s), 29.7 (s), 28.3 and 28.2 (2s, 
C(CH3)3 and C'(C'H3)3), 18.7 (s). 
Enantiomeric excesses were determined by HPLC (see Figure A-16) with a 
Chiralpak AD column (96:4 v/v hexane/isopropanol, 1.0 mL/min, λ = 210 nm); for Δ-
(S,S)-13+ 2Cl–BArf20–, tR = 13.2 min (major), 19.5 min (minor).8a,12  
N,N'-Bis(t-butoxycarbonyl)-1-hydrazino-2-oxocyclopentanecarboxylic acid 
ethyl ester (26b).8e This known compound was obtained as a colorless oil (0.036 g, 
0.092 mmol) per the procedure for Scheme 5.3. NMR (CDCl3, δ in ppm): 1H (500 MHz) 
6.51 (br s, 1H, NH), 4.16 (br s, 2H, CH2CH3), 2.79-1.80 (m, 6H, 3  ring CH2), 1.60-
1.28 (m, 18H, C(CH3)3 and C'(C'H3)3), 1.25-1.12 (m, 3H, CH2CH3); 13C{1H} (125 
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MHz), 205.6 (s, (C=O)CH2), 167.8 (s, (C=O)OEt), 155.2 and 154.4 (2s, (C=O)O-tBu 
and (C'=O')O'-tBu'), 82.8 and 81.5 (2s, C(CH3)3 and C'(C'H3)3), 62.2 (s, CH2CH3), 35.9 
(s), 32.0 (s), 29.7 (s), 28.2 and 28.1 (2s, C(CH3)3 and C'(C'H3)3), 18.6 (s), 14.1 (s, 
CH2CH3).  
Enantiomeric excesses were determined by HPLC (see Figure A-17) with a 
Chiralpak AD column (96:4 v/v hexane/isopropanol, 1.0 mL/min, λ = 210 nm); for Δ-
(S,S)-13+ 2Cl–BArf20–, tR = 10.4 min (major), 15.5 min (minor).8e,12 
N,N'-Bis(t-butoxycarbonyl)-1-hydrazino-2-oxocyclohexanecarboxylic acid 
ethyl ester (26c).8e This known compound was obtained as a colorless oil (0.035 g, 
0.088 mmol) per the procedure for Scheme 5.3. NMR (CDCl3, δ in ppm): 1H (500 MHz) 
6.50 (br s, 1H, NH), 4.33-4.12 (m, 2H, CH2CH3), 2.92-1.81 (m, 8H, 4  ring CH2), 
1.52-1.37 (m, 18H, C(CH3)3 and C'(C'H3)3), 1.28-1.22 (m, 3H, CH2CH3); 13C{1H} 
(CD2Cl2, 125 MHz) 202.2 (s, (C=O)CH2), 169.1 (s, (C=O)OEt), 157.2 and 155.7 (2s, 
(C=O)O-tBu and (C'=O')O'-tBu'), 83.3, 81.5, and 78.6 (3s, C(CH3)3 and C'(C'H3)3),13 
62.3 (s, CH2CH3), 40.3 (s), 35.3 (s), 30.1 (s), 29.4 (s), 28.2 and 28.1 (2s, C(CH3)3 and 
C'(C'H3)3), 21.0 (s), 20.4 (s), 14.3 (s, CH2CH3). 
Enantiomeric excesses were determined by HPLC (see Figure A-18) with a 
Chiralpak AS-H column (99:1 v/v hexane/isopropanol, 1.0 mL/min, λ = 210 nm); for Δ-
(S,S)-13+ 2Cl–BArf20–, tR = 9.5 min (minor), 13.1 min (major).8e,12 
N,N'-Bis(t-butoxycarbonyl)-1-hydrazino-1,2,3,4-tetrahydro-1-oxonaphthal-
ene-2-carboxylic acid ester (26d).8e This known compound was obtained as a colorless 
oil (0.042 g, 0.095 mmol) per the procedure for Scheme 5.3. NMR (CDCl3, δ in ppm): 
1H (500 MHz) 8.10-7.75 (m, 1H, arom), 7.54-7.37 (m, 1H, arom), 7.35-7.10 (m, 2H, 
arom), 6.49-5.98 (m, 1H, NH), 4.46-4.10 (m, 2H, CH2CH3), 3.45-2.50 (m, 4H), 1.56-
1.05 (m, 21H, C(CH3)3, C'(C'H3)3 and CH2CH3 ); 13C{1H} (125 MHz), 190.8 (s, 
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(C=O)CCOOEt), 169.7 (s, (C=O)OEt), 155.6 and 154.5 (2s, (C=O)O-tBu and 
(C'=O')O'-tBu'), 144.4 (s, arom), 133.6 (s, arom), 131.8 (s, arom), 128.7 (s, arom), 127.9 
(s, arom), 126.6 (s, arom), 82.8, 81.3, 81.0, and 75.6 (4s, C(CH3)3 and C'(C'H3)3),13 
62.4, 62.1 (2s, CH2CH3), 36.8, 34.6, 31.3 and 29.8 (4s), 28.3, 28.2, 28.0 and 27.7 (4s, 
C(CH3)3 and C'(C'H3)3),s7 25.7 (s), 24.8 (s), 24.2 (s), 14.3 and 14.1 (2s, CH2CH3).13 
Enantiomeric excesses were determined by HPLC (see Figure A-19) with a 
Chiralpak AD-H column (80:20 v/v hexane/isopropanol, 1.0 mL/min, λ = 220 nm); for 
Δ-(S,S)-13+ 2Cl–BArf20–, tR = 7.5 min (minor), 10.1 min (major).8e,12 
N,N'-Bis(t-butoxycarbonyl)-2-hydrazino-2-methyl-3-oxobutyric acid ethyl 
ester (26e).8e This known compound was obtained as a colorless oil (0.037 g, 0.098 
mmol) per the procedure for Scheme 5.3. NMR (CDCl3, δ in ppm): 1H (500 MHz) 6.29-
5.99 (br m, 1H, NH), 4.32-4.13 (m, 2H, CH2CH3), 2.43-2.18 (3H, br m), 1.86-1.17 (m, 
24H, C(CH3)3, C'(C'H3)3, CCH3 and CH2CH3); 13C{1H} (125 MHz) 199.7 (s, 
(C=O)CH3), 169.6 (s, (C=O)OEt), 156.5 and 155.7 (2s, (C=O)O-tBu and (C'=O')O'-
tBu'), 85.0, 83.1, and 81.2 (3s, C(CH3)3 and C'(C'H3)3),13 62.2 (s, CH2CH3), 29.8 (s), 
28.3 and 28.1 (2s, C(CH3)3 and C'(C'H3)3), 24.5, 20.0, and 19.2 (3s),13 14.2 (s, 
CH2CH3). 
Enantiomeric excesses were determined by HPLC (see Figure A-20) with a 
Chiralpak AD-H column (95:5 v/v hexane/isopropanol, 1.0 mL/min, λ = 210 nm); for Δ-
(S,S)-13+ 2Cl–BArf20–, tR = 11.6 min (minor), 17.5 min (major); for Λ-(S,S)-13+ 2Cl–
Barf20–, tR = 13.0 min (major), 18.4 min (minor); for Δ-(S,S)-13+ 2Cl–BArf–, tR = 13.1 
min (minor), 17.7 min (major).8e,12 
Di-t-butyl-1-(1-cyano-2-oxocyclopentyl)hydrazine-1,2-dicarboxylate (26f).8a 
This known compound was obtained as a white flakes (0.031 g, 0.092 mmol) per the 
procedure for Scheme 5.3. NMR (CDCl3, δ in ppm): 1H (500 MHz) 6.84-6.24 (br s, 1H, 
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NH), 2.92-1.81 (m, 6H, 3  ring CH2), 1.59-1.27 (m, 18H, C(CH3)3 and C'(C'H3)3); 
13C{1H} (125 MHz) 202.5 (s, (C=O)CH2), 155.3 and 153.1 (2s, (C=O)O-tBu and 
(C'=O')O'-tBu'), 115.2 (s, CN), 84.1 and 82.6 (2s, C(CH3)3 and C'(C'H3)3), 69.4 (s, 
CCN), 35.0 and 34.1 (2s, ring CH2), 28.3 and 28.1 (2s, C(CH3)3 and C'(C'H3)3), 18.8 
(s, ring CH2). 
Enantiomeric excesses were determined by HPLC (see Figure A-21) with a 
Chiralpak AD-H column (99:1 v/v, hexane/isopropanol, 1.0 mL/min, λ = 220 nm); for 
Δ-(S,S)-13+ 2Cl–BArf20–, tR = 7.9 min (major), 10.8 min (minor).8e,12  
N,N'-Bis(t-butoxycarbonyl)-2-hydrazino-2-acetylcyclopentanone (26g). This 
new compound was obtained as a white flakes (0.037 g, 0.099 mmol) per the procedure 
for Scheme 5.3. NMR (CDCl3, δ in ppm): 1H (500 MHz) 6.30-5.79 (br m, 1H, NH), 
3.25-1.58 (m, 11H), 1.52-1.24 (m, 18H, C(CH3)3, and C'(C'H3)3); 13C{1H} (125 MHz) 
206.0 (s, (C=O)CH2), 202.7 (s, (C=O)CH3), 156.6 and 155.9 (2s, (C=O)O-tBu and 
(C'=O')O'-tBu'), 84.8, 83.1, 81.9, 81.5 (4s, C(CH3)3 and C'(C'H3)3),s7 41.8, 33.0 and 
29.4 (3s), 28.3 and 28.1 (2s, C(CH3)3 and C'(C'H3)3), 27.3, 25.0, 20.7, and 20.2 (4s), 
mp 39-41 °C dec (open capillary). Anal. Calcd. for C16H32O5N2 (370.43): C 58.36, H 
8.16, N 7.56; found C 58.47, H 8.03, N 7.41. 
Enantiomeric excesses were determined by HPLC (see Figure A-22) with a 
Chiralpak AD-H column (95:5 v/v hexane/isopropanol, 1.0 mL/min, λ = 210 nm); for Δ-
(S,S)-13+ 2Cl–BArf20–, tR = 14.0 min (minor), 38.9 min (major); for Λ-(S,S)-13+ 2Cl–
BArf20–, tR = 14.1 min (major), 42.8 min (minor); for Δ-(S,S)-13+ 2Cl–BArf–, tR = 14.2 
min (minor), 39.3 min (major). 
N,N'-Bis(t-butoxycarbonyl)-1-hydrazino-2-oxocycloheptanecarboxylic acid 
methyl ester (26h).8a This known compound was obtained as a white flakes (0.038 g, 
0.094 mmol) per the procedure for Scheme 5.3. NMR (CDCl3, δ in ppm): 1H (500 MHz) 
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6.40-5.95 (br m, 1H, NH), 3.95-3.42 (s, 3H, COOCH3), 3.25-0.66 (m, 28H, 5  ring 
CH2, C(CH3)3,and C'(C'H3)3); 13C{1H} (125 MHz) 204.5 and 201.9 (2s, (C=O)CH2), 
171.4 (s, (C=O)OMe), 156.0 and 155.6 (2s, (C=O)O-tBu and (C'=O')O'-tBu'), 83.2, 
81.5, 80.1, and 78.9 (4s, C(CH3)3 and (C'C'H3)3),13 53.0 and 52.7 (2s, OCH3),13 40.8, 
39.7, 34.6, 33.1, 30.5, and 29.8 (6s),13 28.2 and 28.1 (2s, C(CH3)3 and C'(C'H3)3), 25.9 
and 23.9 (2s).13  
Enantiomeric excesses were determined by HPLC (see Figure A-23) with a 
Chiralpak OD-H column (97:7 v/v hexane/isopropanol, 1.0 mL/min, λ = 210 nm); for Δ-
(S,S)-13+ 2Cl–BArf20– tR = 6.4 (minor), 8.7 min (major).8a,12 
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(13) In accord with previous reports,8e,g some 13C NMR signals are doubled 
(unequal intensities) due to geometric isomerism about the carbamate carbon-nitrogen 
bonds (Z/E N–+N(R)=C(O–)O-tBu).  
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6. SYNTHESIS OF A SERIES OF -DIMETHYLAMINOALKYL 
SUBSTITUTED ETHYLENEDIAMINE LIGANDS FOR USE IN 
ENANTIOSELECTIVE CATALYSIS† 
 
6.1. Introduction 
Over the last fifteen years, a variety of small molecule hydrogen bond donor 
catalysts have been developed and found diverse applications in enantioselective 
syntheses.1 Some of the most useful catalysts have been based upon urea and thiourea 
moieties.2 These readily bind to a number of Lewis basic organic functional groups, as 
demonstrated by a series of crystal structures.3 Importantly, some of the most effective 
urea and thiourea catalysts are bifunctional, incorporating an auxiliary tertiary amine 
group.2b,4 This can serve as either a Lewis or Brønsted base during the catalytic cycle. 
We have begun to study Werner complexes as possible NH hydrogen bond donor 
catalysts for enantioselective organic syntheses.5,6 This includes the historically 
important chiral-at-metal tris(ethylenediamine) cobalt trication [Co(en)3]3+, which was 
among the first few inorganic species to be resolved into enantiomers,7 as well as 
analogs with substituted diamines, such as 1,2-diphenylethylenediamine (dpen).6 We 
have also developed cationic ruthenium complexes in which NH bonds remote from the 
metal effect catalysis.8,9 Dramatic improvements in the performance of this catalyst 
family were realized when dimethylamino substituents were incorporated into the NH 
containing ligand.8b Closely related themes have also received attention in the Meggers 
group.10  
 
 
†Reproduced from Ghosh, S. K.; Ganzmann, C.; Gladysz, J. A. Tetrahedron: Asymmetry. 2015, 26, 1273-
1280, with permission from Elsevier. 
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In the first communication, which focused on additions of malonates to enones in 
organic media, we were only able to realize modest enantioselectivities using lipophilic 
salts of [Co(en)3]3+.5 I speculated that adducts of ethylenediamine ligands containing an 
-dimethylaminoalkyl substituent might give improved results. Hence, I sought to 
synthesize a series of ligands H2NCH((CH2)nNMe2)CH2NH2 in enantiopure form, so 
that they could be incorporated into cobalt complexes such as I3+ (Figure 6.1) without 
increasing the numbers of diastereomers.  
 
 
 
 
Figure 6.1. Target ligands and complexes. 
 
 
 
Curiously, I could only locate one such triamine in the literature, that with n = 
2.11 The overall yield was modest, and only the 1H NMR spectrum and optical rotation 
were reported. Hence, I set out to prepare the ligands with n = 1-4, termed L1-L4 
(Figure 6.1), and/or the functionally equivalent tris(hydrochloric acid) salts. In this 
section, I describe practical six to nine step syntheses for all of these species from 
inexpensive, commercially available enantiopure starting materials in 38-13% overall 
yields (average: 26%), and their detailed characterization. Some of the reactions 
involving L1 were carried out by Dr. Carola Ganzmann. Applications of these ligands 
will be described separately in section 7.12  
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6.2. Results 
6.2.1. L1 
As shown in Scheme 6.1, commercial (S)-asparagine ((L)-asparagine or (S)-1L1, 
$0.09/g for 100g)13a was elaborated in a series of five known steps.14,15 The first 
involved treatment with CbzCl to give the Cbz protected amine (S)-2L1 (our yield/lit: 
80/84%).14a A Hofmann type rearrangement was then effected with PhI(OAc)2 to give  
 
 
 
 
Scheme 6.1. Synthesis of the tris(hydrochloric acid) salt of (S)-L1. 
 
 
 
the ß-amino acid (S)-3L1 (my yield/lit: 89/89%),14b which was protected with Boc to 
afford (S)-4L1 (my yield/lit: 68/91%).14a,16 Following a patent procedure, the carboxylic 
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acid was activated with isobutyl chloroformate, and reaction with NaBH4 gave the 
primary alcohol (S)-5L1 (my yield/lit: 72/55%).15,16 Mesylation was effected to give 
(S)-6L1,15 the last known compound in this sequence, which was employed in the 
following step assuming a quantitative yield. 
In order to introduce the dimethylamino group, (S)-6L1 and a THF solution of 
HNMe2 were refluxed (Scheme 6.1). Workup gave the protected triamine (S)-7L1 (81%, 
two steps). Addition of CF3CO2H removed the Boc protecting group, affording the 
diamine (S)-8L1 (71%). Hydrogenolysis then detached the Cbz group, giving the target 
triamine (S)-L1 (90%) in 18% overall yield from (S)-1L1. For long term storage, this 
was converted to the tris(hydrochloric acid) salt (S)-[H3NCH((CH2)NHMe2)CH2NH3]3+ 
3Cl– ((S)-L1·(HCl)3) in 99% yield. This sequence has been repeated by several 
coworkers, sometimes with even higher yields than those indicated above and in the 
experimental section (maximum values for the first five yields in Scheme 6.1: 85%, 
90%, 80%, 80%, 86%). 
6.2.2. L2  
 As shown in Scheme 6.2, commercial (S)-5-hydroxymethyl-2-pyrrolidinone ((S)-
1L2, $2.8/g for 100 g)13b was elaborated in a series of five known steps.17 The first 
involved treatment with tosyl chloride to give the tosylate (S)-2L2 (my yield/lit: 
84/93%).17a Subsequent reaction with NaN3 afforded (S)-3L2 (my yield/lit: 90/99%).17a 
The azide was reduced to the primary amine (S)-4L2 with Pd/C and H2 (my yield/lit: 
91/99%).17a Hydrolysis (6 M HCl) then provided (S)-5L2 (my yield/lit: 97/83%).17b 
Both primary amine groups were protected using isobutyl chloroformate to give (S)-6L2 
(my yield/lit: 88/88%).17b  
 It was next sought to remove a methylene group from the carboxylic acid chain. 
Thus, (S)-6L2 was first converted to the corresponding amide (S)-7L2 (85%), a new 
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compound. A modified Hofmann rearrangement was then carried out using PhI(OAc)2. 
The resulting primary amine (S)-8L2 (57%) was a known compound.17b A reductive 
dimethylation (aqueous HCHO, Pd/C, H2) yielded the new tertiary amine (S)-9L2 (50%). 
Refluxing aqueous HCl afforded the tris(hydrochloric acid) salt (S)-[H3NCH-
((CH2)2NHMe2)CH2NH3]3+ 3Cl– ((S)-L2·(HCl)3) as a colorless sticky compound in 
13% overall yield from (S)-1L2. As noted above, this compound has been previously 
synthesized, but in only 7% overall yield, although the sequence involved one fewer 
step.11 
 
 
 
Scheme 6.2. Synthesis of the tris(hydrochloric acid) salt of (S)-L2. 
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6.2.3. L3 
 As shown in Scheme 6.3, L3 can be accessed using (S)-6L2 from Scheme 6.2. 
The carboxylic acid was first activated with isobutyl chloroformate, and NaBH4 
reduction gave the new primary alcohol (S)-1L3 (82%). Mesylation was effected to give 
(S)-2L3. The crude mesylate was refluxed in a THF solution of HNMe2, affording the 
corresponding dimethylamine (S)-3L3 (86%, two steps). The protecting groups were 
removed in refluxing aqueous HCl to give the new tris(hydrochloric acid) salt (S)-
[H3NCH((CH2)3NHMe2)CH2NH3]3+ 3Cl– ((S)-L3·(HCl)3) as a colorless sticky 
compound in 86% yield or 36% overall yield from the ultimate starting material in 
Scheme 6.2, (S)-1L2. 
 
 
 
 
Scheme 6.3. Synthesis of the tris(hydrochloric acid) salt of (S)-L3. 
 
 
 
6.2.4. L4 
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series of three known steps.18 The carboxylic acid was first activated with isobutyl 
chloroformate, and NaBH4 reduction yielded the primary alcohol (S)-2L4 (my yield/lit: 
92/94%).18a Mesylation was effected to give (S)-3L4, which was treated with NaN3 to 
give (S)-4L4 (my yield/lit: 80/86%).18b The azide was reduced to the primary amine 
using NaBH4 in the presence of Pd/C. This was protected in situ with Boc to give (S)-
5L4 (71%). During the preparation of the paper corresponding to this section,19 an 
independent synthesis of (S)-5L4 was reported by Carell.20 His route, which involves a 
starting material of similar cost, is slightly more efficient (five steps, 55% overall yield 
vs. four steps, 52% overall yield). 
 
 
 
 
Scheme 6.4. Synthesis of the tris(hydrochloric acid) salt of (S)-L4. 
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 Next, (S)-5L4 was treated with aqueous HCHO in presence of Pd/C and H2. This 
removed the Cbz protecting group and delivered the new tertiary amine (S)-6L4 (88%). 
Finally, the Boc groups were removed using HCl in aqueous dioxane to give the new 
tris(hydrochloric acid) salt (S)-[H3NCH((CH2)4NHMe2)CH2NH3]3+ 3Cl– ((S)-L4 
(HCl)3) as a colorless sticky compound in 80% yield or 38% overall yield from (S)-1L4. 
All of the new compounds described above gave correct microanalyses. They 
were furthermore characterized by 1H and 13C NMR spectroscopy, as summarized in the 
experimental section.  
6.3. Discussion 
The syntheses in Schemes 6.1-6.4 represent highly optimized protocols leading 
to a novel family of enantiopure triamine ligands (L1-L4). One common feature is that 
the dimethylamino groups are introduced at late stages, either via reductive 
dimethylations or nucleophilic displacements involving mesylates and HNMe2. A 
Hofmann type rearrangement allows L2 and L3 to be accessed from the same precursor, 
and L1 to be prepared from a less costly precursor ((S)-1L1 vs. (S)-3L1).  
To my knowledge, only one of the ligands and two late stage intermediates, (S)-
L2·(HCl)3),11 (S)-8L2,17b and (S)-5L4,20 have been independently synthesized. My route 
to (S)-L2·(HCl)3 constitutes a distinct improvement. However, the literature preparation 
of (S)-5L4, which was only reported in 2015, is competitive with my methodology. 
Importantly, the enantiomers of the three starting materials used in Schemes 6.1-6.4 are 
commercially available, but at prices that are 3-4 times greater per mole.  
In the planned applications with cobalt(III) complexes (e.g., I3+), the two 
primary amino groups of L1-L4 are intended to serve as chelates. The tertiary 
dimethylamino groups are designed, by analogy to their roles in thiourea and urea 
catalysts,2b,4 to aid the activation of substrates. However, other coordination modes and 
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roles can be envisioned, suggesting a class of compounds that may have a 
mechanistically diverse spectrum of applications in enantioselective synthesis. Also, 
although L4 has not previously been synthesized, it has served as a linking unit in a 
series of cisplatin-N-mustard conjugates.20  
In summary, a series of four homologous -dimethylaminoalkyl substituted 
ethylenediamine ligands (L1-L4) are now readily available in enantiopure form. In the 
following section 7, the cobalt(III) complexes that contain such ligands will be 
described.12 Some of these will be highly enantioselective hydrogen bond donor 
catalysts, superior to those detailed previously.6  
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6.4. Experimental section 
 General Data: 1H and 13C{1H} NMR spectra were recorded on standard 300-
500 MHz spectrometers at ambient probe temperatures. Chemical shifts (δ in ppm) were 
referenced to residual solvent signals (1H: CHCl3, 7.26; DMSO-d5, 2.49, HOD, 4.79 
ppm; 13C: CDCl3, 77.2; DMSO-d6, 39.5),21 except for 13C{1H} spectra recorded in 
D2O, which were referenced to internal dioxane (67.2).21 IR spectra were recorded on 
ASI React IR®-1000 or Shimadzu IRAffinity-1 spectrometers. Microanalyses were 
conducted by Atlantic Microlab or in house using a Carlo Erba EA 1110 CHN 
instrument. Optical rotations were measured with a Perkin-Elmer model 431 polarimeter 
as described previously.22  
Reactions were conducted under air unless noted. Chemicals were treated as 
follows: DMSO-d6 and CDCl3 (Cambridge Isotopes), stored over molecular sieves; 
CH2Cl2 (EMD Chemicals, ACS grade), CH3OH (EMD, anhydrous, 99.8%), hexanes 
(Macron, ACS grade), Et2O (Macron, ACS grade), EtOAc (Macron, ACS grade), THF 
(Macron, ACS grade), DMF (Mallinckrodt, ACS grade), EtOH (BDH, ACS grade), 
dioxane (Macron, ACS grade), 1,2-dimethoxyethane (Acros, 99+%), acetone (BDH, 
ACS grade), (L)-Asparagine (Aroz Technologies, LLC, 98%), (S)-5-Hydroxymethyl-2-
pyrrolidinone (AK Scientific, Inc, 98%), (S)-6-(((Benzyloxy)carbonyl)amino)-2-((tert-
butoxycarbonyl)amino)hexanoic acid (Aroz Technologies, LLC, 98%), citric acid 
(EMD, ACS grade), tosyl chloride (TsCl, Alfa Aesar, 98%), N-methyl morpholine 
(NMM, Acros, 99%), isobutyl chloroformate (ClCOOi-Bu, Alfa Aesar, 98%), 
iodosobenzenediacetate (PhI(OAc)2, Alfa Aesar, 98+%), CbzCl (TCI, 30-35 weight% in 
toluene), Boc2O (Chem-Impex International, Inc., 98%), Conc. NH4OH (30%, EMD, 
ACS grade), aqueous HCHO (EMD, ACS grade), NaBH4 (Aldrich, 98%), 
methanesulfonyl chloride (CH3SO2Cl, Acros, 99.5%), HNMe2 (2.0 M in THF, Alfa 
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Aesar), Pd/C (10%, Aldrich), Pd/C (10%, "nominally 50% water wet", Alfa Aesar), 
NaOH (Macron, ACS grade), Et3N (Alfa Aesar, 98%), NaN3 (Alfa Aesar, 99%), 
NaHCO3 (Alfa Aesar, 98%), CF3COOH (99%, Acros), HCl (2.0 M in Et2O, Acros), 
KHSO4 (Alfa Aesar, 98%), Celite 545 (Aldrich), and Na2SO4 (EMD), used as received.  
 (S)-N2-Benzyloxycarbonyl-N3-tert-butyloxycarbonyl-2,3-diaminopropan-1-ol 
or (S)-((t-BuOC(O))NHCH2CH(CH2OH)NH(C(O)OCH2Ph) ((S)-5L1).15,16 A round 
bottom flask was charged with (S)-4L1 (15.90 g, 47.0 mmol)14a and 1,2-dimethox-
yethane (65 mL), and N-methyl morpholine (5.4 mL; 5.0 g, 49 mmol) was added with 
stirring. The solution was cooled to –25 °C, and isobutyl chloroformate (6.50 mL; 6.8 g, 
50 mmol) was slowly added. The cold bath was removed. After 30 min, the precipitate 
was collected by filtration and washed with 1,2-dimethoxyethane (2 × 30 mL). The 
combined filtrate and washings were sparged with nitrogen and cooled to 0 °C. A 
solution of NaBH4 (2.52 g, 66.5 mmol) in EtOH (150 mL) was added dropwise with 
stirring. After 1 h, H2O (10 mL) was cautiously added. The cold bath was removed. 
After 12 h, the solvent was removed by rotary evaporation. The solid was dissolved in 
EtOAc (200 mL), and H2O (200 mL) was added. The aqueous phase was extracted with 
EtOAc (2 × 50 mL) and the combined organic phases were dried (MgSO4). The solvent 
was removed by rotary evaporation and the solid was chromatographed on a silica gel 
column (4  17 cm, 20:80 to 50:50 v/v EtOAc/hexane). The solvent was removed from 
the product containing fraction by rotary evaporation. The residue was dried by oil pump 
vacuum to give (S)-5L1 (11.0 g, 33.8 mmol, 72%) as a white solid.  
NMR (DMSO-d6, δ in ppm): 1H (400 MHz)16 7.37-7.28 (m, 5H, Ph), 6.86 (d, 
3JHH = 8.4 Hz, 1H, CHNH), 6.72 (t, 3JHH = 5.2 Hz, 1H, CH2NH), 4.99 (m, 2H, 
OCH2Ph), 4.61 (t, 3JHH = 5.6 Hz, 1H, OH), 3.52-3.48 (m, 1H, CHNHCbz), ca. 3.4 
(CH2OH, signal obscured by solvent impurity), 3.10-3.03 (m, 1H, CHH'NHBoc), 2.98-
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2.93 (m, 1H, CHH'NHBoc), 1.35 (s, 9H, C(CH3)3); 13C{1H} (CDCl3, 75.5 MHz) 157.6 
and 156.3 (2 × s, (C=O)O from Boc and Cbz); Ph at 136.1 (s, i), 128.4 (s, m),23 128.0 (s, 
p), 127.9 (s, o); 80.1 (s, C(CH3)3), 66.7 (s, OCH2Ph), 61.3 (s, CH2OH), 52.8 (s, 
CHNHCbz), 40.1 (s, CH2NHBoc), 28.2 (s, C(CH3)3). 
(S)-N2-Benzyloxycarbonyl-N3-tert-butyloxycarbonyl-2,3-diaminopropyl met-
hanesulfonate or (S)-((t-BuOC(O))NHCH2CH(CH2OSO2Me)NH(C(O)OCH2Ph) 
((S)-6L1).15 A Schlenk flask was charged with (S)-5L1 (10.4 g, 32.1 mmol), CH2Cl2 
(150 mL), and Et3N (10.7 mL, 7.77 g, 76.9 mmol), and cooled to –78 °C. Methane-
sulfonyl chloride (4.7 mL, 7.0 g, 61 mmol) was added dropwise with stirring. The cold 
bath was allowed to warm to 0 °C over the course of 3 h. Aqueous citric acid (20% w/v, 
200 mL) and CH2Cl2 (100 mL) were added. The organic phase was separated, washed 
with saturated NaHCO3 (200 mL) and brine (200 mL), and dried (MgSO4). The solvent 
was removed by oil pump vacuum to give (S)-6L1 as a white solid. This material was 
used without further purification. 
NMR (DMSO-d6, δ in ppm): 1H (500 MHz): 7.36-7.28 (m, 5H, Ph), 5.73 (br d, 
3JHH = 5.2 Hz, 1H, CHNH), 5.07 (s, CH2OPh), 4.94 (br t, 3JHH = 6 Hz, 1H, CH2NH), 
4.27-4.21 (m, 2H, CH2OS), 3.98-3.93 (m, 1H, CHNHCbz), 3.36-3.30 (m, 2H, 
CH2NHBoc), 2.98 (s, 3H, SCH3), 1.40 (s, 9H, C(CH3)3). 
(S)-N1,N1-dimethyl-N2-Benzyloxycarbonyl-N3-tert-butyloxycarbonyl-N1,N1-
dimethylpropane-1,2,3-triamine or (S)-((t-BuOC(O))NHCH2CH(CH2NMe2)NH(C-
(O)OCH2Ph) ((S)-7L1). A round bottom flask was charged with the crude (S)-6L1 from 
the preceding synthesis and HNMe2 (2.0 M in THF; 80 mL, 160 mmol), and fitted with 
a condenser cooled to –55 °C (using a cold fluid recirculating bath) to return the HNMe2 
to the flask. The flask was placed in a 80 °C oil bath. After 9 h, the bath was allowed to 
cool to rt and the solvent was removed by rotary evaporation. The residue was dissolved 
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in CH2Cl2 (200 mL), washed with saturated NaHCO3 (200 mL) and brine (200 mL), and 
dried (MgSO4). The solvent was removed by rotary evaporation and the oily yellow 
residue was chromatographed on a silica gel column (3 × 30 cm, 10:1 v/v 
CH2Cl2/CH3OH). The solvent was removed from the product containing fractions by 
rotary evaporation to give (S)-7L1 as a white solid (9.08 g, 25.8 mmol, 81% for two 
steps), mp 88 °C (open capillary). Anal. Calcd. for C18H29N3O4 (351.44): C 61.52, H 
8.32, N 11.96; found C 61.50, H 8.29, N 11.74. [α]24589 = –2.6 ± 0.2° (1.25 mg mL–1, 
CH3OH). 
 NMR (CDCl3, δ in ppm): 1H (400 MHz) 7.34-7.28 (m, 5H, Ph), 5.43 (br s, 1H, 
CHNHBoc), 5.16 (br s, 1H, CH2NHBoc), 5.07 (m, 2H, OCH2Ph), 3.68-3.66 (m, 1H, 
CHNHCbz), 3.41-3.35 (m, 1H, CHH'NHBoc), 3.22-3.17 (m, 1H, CHH'NHBoc), 2.35 
(dd, 2JHH = 12.2 Hz, 3JHH = 8.0 Hz, 1H, CHH'N(CH3)2), 2.24 (dd, 2JHH = 12.6 Hz, 
3JHH = 7.0 Hz, 1H, CHH'N(CH3)2), 2.19 (s, 6H, N(CH3)2), 1.41 (s, 9H, C(CH3)3); 
13C{1H} (100.6 MHz) 156.7 and 156.6 (2 × s, (C=O)O from Boc and Cbz); Ph at 136.4 
(s, i), 128.4 (s, m),23 128.03 (s, p), 127.97 (s, o); 79.4 (s, C(CH3)3), 66.7 (s, OCH2Ph), 
60.6 (s, CH2N(CH3)2), 50.7 (s, CHNHCbz), 45.6 (s, N(CH3)2), 43.2 (s, CH2NHBoc), 
28.3 (s, C(CH3)3). IR (powder film, cm–1): 3358 (m, νNH), 1677 (vs, νC=O), 1522 (vs, 
δNH); MS:24 352 (100) [7L1+H]+, 296 (100) [7L1+2H-C(CH3)3]+. 
(S)-N2-Benzyloxycarbonyl-N1,N1-dimethylpropane-1,2,3-triamine or (S)-
NH2CH2CH(CH2NMe2)NH(C(O)OCH2Ph) ((S)-8L1). A round bottom flask was 
charged with (S)-7L1 (9.08 g, 25.8 mmol) and CH2Cl2 (150 mL). Then CF3COOH (40.0 
mL, 61.9 g, 540 mmol) was added in one portion with stirring. After 14 h, aqueous 
NaOH (10%, 200 mL) was added and the phases were separated. The aqueous phase was 
extracted with CH2Cl2 (2 × 150 mL) and the combined organic phases were dried 
(Na2SO4). The solvent was removed by rotary evaporation and the clear oil was 
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chromatographed on a silica gel column (3 × 15 cm, 1:1 v/v CH2Cl2/CH3OH). The 
solvent was removed from the product containing fractions (Rf = 0.09, TLC) by rotary 
evaporation to give (S)-8L1 as a waxy solid (5.08 g, 18.18 mmol, 71%). Anal. Calcd. for 
C13H21N3O2·0.33CH2Cl2 (279.35): C 57.31, H 7.82, N 15.04; found C 57.00, H 7.44, N 
14.97. [α]24589 = –5.3 ± 0.2° (11.5 mg mL–1, CH3OH). 
 NMR (CDCl3, δ in ppm): 1H (400 MHz): 7.32-7.25 (m, 5H, Ph), 5.34 (br s, 1H, 
NH), 5.06 (m, 2H, OCH2Ph), 3.65-3.64 (m, 1H, CHNHCbz), 2.83 (dd, 2JHH = 13.2 Hz, 
3JHH = 4.4 Hz, 1H, CHH'NH2), 2.73 (dd, 2JHH = 13.2 Hz, 3JHH = 4.4 Hz, 1H, 
CHH'NH2), 2.33 (dd, 2JHH = 11.8 Hz, 3JHH = 8.2 Hz, 1H, CHH'N(CH3)2), 2.22 (dd, 
2JHH = 12.2 Hz, 3JHH = 6.6 Hz, 1H, CHH'N(CH3)2), 2.18 (s, 6H, N(CH3)2), 1.37 (br s, 
2H, NH2); 13C{1H} (100.6 MHz) 156.2 (s, (C=O)O), Ph at 136.2 (s, i), 128.0 (s, m),23 
127.6 (s, p), 127.5 (s, o); 66.1 (s, OCH2Ph), 60.3 (s, CH2N(CH3)2), 53.1 (s, CH2Cl2), 
50.8 (s, CHNHCbz), 45.3 (s, N(CH3)2), 43.8 (s, CH2NH2). IR ((powder film, cm–1): 
3358 (m, νNH), 2995, 2822, and 2771 (3 × m, νCH), 1693 (vs, νC=O), 1531 (s, δNH), 
1247 (vs, ν(C=O)OC); MS:24 252 (95) [8L1+H]+, 180 (100) [8L1+H–C3H8N2]+. 
(S)-N1,N1-dimethylpropane-1,2,3-triamine or (S)-NH2CH2CH(CH2NMe2)-
NH2 ((S)-L1) A Schlenk flask was charged with (S)-8L1 (5.08 g, 18.18 mmol), CH3OH 
(60 mL), and Pd/C (10%, 0.795 g). The solution was sparged with H2 and stirred under a 
H2 atmosphere (balloon). After 14 h, the mixture was filtered through a plug of Celite 
and the solvent was removed under reduced pressure (17 mbar) at 0 °C to give (S)-L1 as 
a colorless oil (1.90 g, 16.3 mmol, 90%).  [α]24589 = –9.3 ± 0.1° (1.08 mg mL–1, 
CH3OH). 
 NMR (CDCl3, δ in ppm): 1H (400 MHz): 2.90-2.85 (m, 1H, CHNH2), 2.72 (dd, 
2JHH = 12.4 Hz, 3JHH = 4.0 Hz, 1H, CHH'NH2), 2.52 (dd, 2JHH = 12.6 Hz, 3JHH = 7.0 
Hz, 1H, CHH'N(CH3)2), 2.21 (s, 6H, N(CH3)2, partly overlapped by CHH'N(CH3)2), 
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2.16 (m, 1H, CHH'N(CH3)2, partly overlapped by N(CH3)2), 2.10 (dd, 2JHH = 12.0 Hz, 
3JHH = 4.4 Hz, 1H, CHH'NH2); 13C{1H} (75.5 MHz) 64.1 (s, CH2N(CH3)2), 50.1 (s, 
CHNH2), 46.1 (s, CH2NH2), 45.5 (s, N(CH3)2). IR (powder film, cm–1): 3280 (m, νNH), 
2949 and 2831 (2 × m, νCH), 1571 (s, δNH), 1461 (s, δCH2); MS:25 118 (100) [L1+H]+. 
Tris(hydrochloric acid) salt of (S)-N1,N1-dimethylpropane-1,2,3-triamine or 
(S)-H3NCH2CH(CH2NMe2H)NH3]3+ 3Cl– ((S)-L1·(HCl)3). A Schlenk flask was 
charged with (S)-L1 (1.90 g, 16.3 mmol) and CH3OH (10 mL). A solution of HCl in 
Et2O (2.0 M, 12 mL) was added dropwise. A precipitate formed. The supernatant was 
decanted and the precipitate was washed with Et2O (2 × 10 mL) and dried by oil pump 
vacuum to give (S)-L1·(HCl)3·H2O as a white powder (3.95 g, 16.1 mmol, 99%), dec pt 
213 °C (capillary). Anal. Calcd. for C5H18Cl3N3·H2O (244.59): C 24.55, H 8.24, N 
17.18; found C 24.58, H 8.00, N 16.96. [α]24589 = –8.7 ± 0.4° (1.16 mg mL–1, H2O). 
NMR (D2O, δ in ppm): 1H (400 MHz): 4.20-4.13 (m, 1H, CHNH3), 
CH2N(CH3)2H and CH2NH3 at 3.68-3.57 (m, 2H) and 3.54-3.42 (m, 2H), 3.06 (s, 6H, 
N(CH3)2H+); 13C{1H} (100.6 MHz) 59.4 (s, CH2N(CH3)2H), 47.7 (s, N(CH3)2H), 46.6 
(s, CHNH3), 42.4 (s, CH2NH3). IR (powder film, cm–1): 3479 and 3424 (2 × m, νOH), 
2902 and 2816 (2 × s, νCH), 2708 and 2627 (2 × s, νNH3+), 1625 (w, δNH), 1481 (vs, 
δCH2). 
(S)-N4,N5-Di-i-butoxycarbonyl-4,5-diaminopentamide or (S)-(i-BuOC(O))-
NHCH(CH2CH2CONH2)CH2NH(C(O)Oi-Bu) ((S)-7L2). A round bottom flask was 
charged with ((S)-6L2 (4.010 g, 12.078 mmol)17b and THF (130 mL). Then N-methyl 
morpholine (1.70 mL, 1.565 g, 15.49 mmol) was added with stirring and the solution 
was cooled to –20 °C. Isobutyl chloroformate (2.0 mL, 2.091 g, 15.30 mmol) was slowly 
added. After 0.5 h, aqueous NH4OH (30%, 8.8 mL) was added. The cold bath was 
allowed to warm to 0 °C over the course of 6 h. The solvent was removed by rotary 
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evaporation and the residue was chromatographed on a silica gel column (3  14 cm, 
93:7 v/v CH2Cl2/(85:15 v/v CH3OH/30% aqueous NH4OH)). The solvent was removed 
from the product containing fractions by rotary evaporation. The residue was dried by oil 
pump vacuum to give (S)-7L2 (3.42 g, 10.2 mmol, 85%) as a white solid, mp 126-129 °C 
(open capillary). Anal. Calcd. for C15H29N3O5 (331.41): C 54.36, H 8.82, N 12.68; 
found C 54.33, H 8.71, N 12.54. 
 NMR (DMSO-d6, δ in ppm): 1H (500 MHz) 7.21 (br s, 1H, CHNH), 7.04 (t, 
3JHH = 5.5 Hz, 1H, CONHH'), 6.83 (m, 1H, CONHH'), 6.68 (br s, 1H, CH2NH), 3.70 
(d, 3JHH = 7.0 Hz, 4H, 2 × OCH2CH(CH3)2), 3.44 (br s, 1H, CHNH), 2.98 (t, 3JHH = 
6.0 Hz, 2H, CH2NH), 2.09-1.93 (m, 2H, CH2CONH2), 1.87-1.73 (m, 2H, 2 × 
CH(CH3)2), 1.69-1.57 (m, 1H, CHCHH'CH2), 1.50-1.37 (m, 1H, CHCHH'CH2), 0.94-
0.77 (m, 12H, 2 × CH(CH3)2); 13C{1H} (125 MHz) 174.0 (s, CONH2), 157.6 and 156.2 
(2 × s, 2 × (C=O)O), 69.7 and 69.6 (2 × s, 2 × OCH2CH(CH3)2), 50.6 (s, CHNH), 44.2 
(s, CH2NH), 31.7 (s, CH2CONH2), 27.68 and 27.65 (2 × s, 2 × CH(CH3)2), 27.5 (s, 
CHCHH'CH2),  19.0 and 18.9 (2 × s, 2 × CH(CH3)2). IR (powder film, cm–1): 3414 (m, 
νNH), 3352 and 3312 (m, νNH), 2959 and 2876 (2 × m, νCH), 1690, 1678, and 1663 (3 × 
vs, 3 × νC=O), 1539 (s, δNH). 
(S)-N1,N2-Di-i-butoxycarbonyl-1,2,4,-triaminobutane or (S)-(i-BuOC(O))-
NHCH(CH2CH2NH2)CH2NH(C(O)Oi-Bu) ((S)-8L2). A round bottom flask was 
charged with (S)-7L2 (3.0 g, 8.96 mmol), CH3CN (25 mL), EtOAc (25 mL), H2O (12 
mL), and PhI(OAc)2 (4.2 g, 13 mmol) with stirring. After 15 h, the solvents were 
removed by rotary evaporation. The residue was chromatographed on a silica gel column 
(3  8 cm, 100:0 to 80:20 v/v CH2Cl2/CH3OH). The solvent was removed from the 
product containing fractions to give (S)-8L2 (1.55 g, 5.05 mmol, 57%)17b as a colorless 
sticky liquid. 
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 NMR (CDCl3, δ in ppm): 1H (500 MHz) 5.57 (br s, 1H, CHNH), 5.43 (br s, 1H, 
CH2NH), 3.89-3.70 (m, 5H, 2 × OCH2CH(CH3)2 and CHNH), 3.26 (br s, 2H, CH2NH), 
2.81 (t, 3JHH = 5 Hz,  2H, CH2NH2), 2.36 (br s, 2H, NH2), 1.94-1.79 (m, 2H, 2 × 
CH(CH3)2), 1.73-1.63 (m, 1H, CHCHH'CH2), 1.60-1.47 (m, 1H, CHCHH'CH2), 0.89 
(d, 3JHH = 5 Hz, 12H, 2 × CH(CH3)2); 13C{1H} (125 MHz) 157.6 and 157.4 (2 × s, 2 × 
(C=O)O), 71.1 and 71.0 (2 × s, 2 × OCH2CH(CH3)2), 49.9 (s, CHNH), 45.1 (s, 
CH2NH), 38.2 (s, CH2NH2), 35.1 (s, CHCHH'CH2), 28.0 (s, 2 × CH(CH3)2), 19.0 (s, 2 
× CH(CH3)2). 
(S)-N1,N2-Di-i-butoxycarbonyl-N4,N4-dimethyl-1,2,4-triaminobutane or (S)-
(i-BuOC(O))NHCH(CH2CH2NMe2)CH2NH(C(O)Oi-Bu) ((S)-9L2). A Fisher Porter 
bottle was charged with (S)-8L2 (1.80 g, 5.863 mmol), CH3OH (50 mL), distilled H2O 
(15 mL), and 37% aqueous HCHO (1.6 mL). The mixture was stirred for 1 h. Then 10% 
Pd/C (1.2 g, "nominally 50% water wet") was added, and 50 psig of H2 was introduced. 
After 24 h, the mixture was filtered through a plug of Celite and washed with 
CH3OH/distilled H2O (1:1 v/v). The solvent was removed by rotary evaporation and the 
residue was chromatographed on a silica gel column (3  8 cm, 100:0 to 80:20 v/v 
CH2Cl2/CH3OH). The solvent was removed from the product containing fractions by 
rotary evaporation and oil pump vacuum to give (S)-9L2 (1.02 g, 2.87 mmol, 50%) as 
colorless oil that often solidified upon storage, mp 47-50 °C (open capillary). Anal. 
Calcd. for C16H33N3O4·0.75CH3OH, (355.48): C 56.59, H 10.21, N 11.82; Calcd. for 
C16H33N3O4·0.33CH3OH, (342.02, corresponding to 1H NMR integration): C 57.35, H 
10.11, N 12.29; found C 56.26, H 9.95, N 12.22.  
 NMR (CDCl3, δ in ppm): 1H (500 MHz) 5.98 (br s, 1H, CHNH), 5.53 (br s, 1H, 
CH2NH), 3.87-3.78 (m, 4H, 2 × OCH2CH(CH3)2), 3.77-3.70 (m, 1H, CHNH), 3.47 (s, 
1H, CH3OH), 3.37-3.30 (m, 1H, CHH'NH), 3.29-3.19 (m, 1H, CHH'NH), 2.57-2.39 (m, 
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2H, CH2N(CH3)2), 2.30 (s, 6H, N(CH3)2), 1.96-1.82 (m, 2H, 2 × CH(CH3)2), 1.82-1.72 
(m, 1H, CHCHH'CH2), 1.71-1.57 (m, 1H, CHCHH'CH2), 1.02-0.83 (m, 12H, 2 × 
CH(CH3)2); 13C{1H} (125 MHz) 157.5 and 157.2 (2 × s, 2 × (C=O)O), 71.1 and 71.0 (2 
× s, 2 × OCH2CH(CH3)2), 56.0 (s, CH2N(CH3)2), 51.0 (s, CHNH), 45.1 and 45.0 (2 × s, 
CH2NH and N(CH3)2), 29.2 (s, 2 × CHCHH'CH2), 28.0 (s, 2 × CH(CH3)2), 19.0 (s, 2 × 
CH(CH3)2). IR (powder film, cm–1): 3325 (m, νNH), 2959, 2874, and 2762 (m and 2 × 
w, νCH), 1684 (vs, νC=O), 1533 (s, δNH). 
Tris(hydrochloric acid) salt of (S)-N4, N4-dimethylbutane-1,2,4-triamine or 
(S)-H3NCH(CH2CH2NMe2H)CH2NH3]3+ 3Cl– ((S)-L2·(HCl)3). A round bottom 
flask was charged with (S)-9L2 (0.9 g, 2.7 mmol) and aqueous HCl (6.0 M, 50 mL) with 
stirring and fitted with a condenser. The solution was refluxed. After 50 h, the solvent 
was removed by rotary evaporation (using a base trap to protect the pump). The residue 
was dissolved in H2O and the solution was washed with CH2Cl2. The solvent was 
removed from the aqueous phase by rotary evaporation and the residue was dried by oil 
pump vacuum to give the ((S)-L2·(HCl)3 (0.607 g, 2.53 mmol, 94%)11 as sticky solid.  
 NMR (D2O, δ in ppm): 1H (500 MHz) 3.88-3.72 (m, 1H, CHNH3), 3.51-3.32 
(m, 4H, CH2NH(CH3)2 and CH2NH3), 2.96 (s, 6H, NH(CH3)2), 2.40-2.19 (m, 2H, 
CHCHH'CH2); 13C{1H} (125 MHz) 53.9 (s, CH2NH(CH3)2), 47.9 (s, CHNH3), 43.7 (s, 
NH(CH3)2), 41.3 (s, CH2NH3), 26.4 (s, CHCHH'CH2). 
 (S)-N4,N5-Di-i-butoxycarbonyl-4,5-diaminopentane-1-ol or (S)-((i-BuOC-
(O))NHCH(CH2CH2CH2OH)CH2NH(C(O)Oi-Bu) ((S)-1L3). A round bottom flask 
was charged with (S)-6L2 (14.220 g, 42.831 mmol)17b and 1,2-dimethoxyethane (70 
mL), and N-methyl morpholine (5.24 mL; 4.821 g, 47.73 mmol) was added with stirring. 
The solution was cooled to –25 °C, and isobutyl chloroformate (6.80 mL; 7.11 g, 52.03 
mmol) was slowly added. The cold bath was removed. After 30 min, the precipitate was 
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collected by filtration and washed with 1,2-dimethoxyethane (2 × 30 mL). The combined 
filtrate/washings were sparged with nitrogen and cooled to 0 °C. A solution of NaBH4 
(2.43 g, 64.3 mmol) in EtOH (150 mL) was added dropwise with stiring. After 2 h, H2O 
(10 mL) was cautiously added. The cold bath was removed. After 12 h, the solvent was 
removed by rotary evaporation. The solid was dissolved in EtOAc (300 mL), and H2O 
(200 mL) was added. The aqueous phase was extracted with EtOAc (2 × 100 mL) and 
the combined extracts were dried (Na2SO4). The solvent was removed by rotary 
evaporation. The solid was chromatographed on a silica gel column (4  17 cm, 20:80 to 
50:50 v/v EtOAc/hexane). The solvent was removed from the product containing 
fractions by rotary evaporation. The residue was dried by oil pump vacuum to give (S)-
1L3 (11.137 g, 35.022 mmol, 82%) as a white solid, mp 87-90 °C (open capillary). Anal. 
Calcd. for C15H30N2O5 (318.41): C 56.58, H 9.50, N 8.80; found C 56.30, H 9.67, N 
8.73. 
NMR (CDCl3, δ in ppm): 1H (500 MHz) 5.17 (br s, 1H, CHNH), 5.08 (d, 3JHH = 
10 Hz, 1H, CH2NH), 3.90-3.76 (m, 4H, 2 × OCH2CH(CH3)2), 3.72 (br s, 1H, CHNH), 
3.68-3.60 (m, 2H, CH2OH), 3.26 (d, 3JHH = 5 Hz, 2H, CH2NH), 1.97-1.81 (m, 2H, 2 × 
CH(CH3)2), 1.69-1.56 (m, 3H, CHCHH'CH2), 1.55-1.44 (m, 1H, CHCHH'CH2), 0.97-
0.86 (m, 12H, 2 × CH(CH3)2); 13C{1H} (125 MHz) 157.6 and 157.3 (2 × s, (C=O)O), 
71.2 and 71.1 (2 × OCH2CH(CH3)2), 62.2 (s, CH2OH), 51.7 (s, CHNH), 45.1 (s, 
CH2NH), 29.2 and 28.6 (2 × s, CHCHH'CH2), 28.0 (s, 2 × CH(CH3)2), 19.0 (s, 2 × 
CH(CH3)2). IR (powder film, cm–1): 3323 (m, νOH), 2957 and 2860 (2 × w, νCH), 1684 
(vs, νC=O), 1541 (s, δNH). 
 (S)-N4,N5-Di-i-butoxycarbonyl-4,5-diaminopentyl methanesulfonate or (S)-
(i-BuOC(O))NHCH(CH2CH2CH2OSO2CH3)CH2NH(C(O)Oi-Bu) ((S)-2L3). A 
round bottom flask was charged with (S)-1L3 (5.032 g, 15.82 mmol), CH2Cl2 (80 mL), 
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and Et3N (5.30 mL; 3.843 g, 38.04 mmol), and cooled to –78 °C. Methanesulfonyl 
chloride (2.30 mL; 3.404 g, 29.71 mmol) was added dropwise with stirring. The cold 
bath was allowed to warm to 0 °C over the course of 5 h. Aqueous citric acid (20% w/v, 
140 mL) and CH2Cl2 (150 mL) were added and the phases were separated. The organic 
phase was washed with saturated aqueous NaHCO3 and dried (Na2SO4). The solvent 
was removed by rotary evaporation. The residue was dried by oil pump vacuum to give 
crude (S)-2L3 (6.227 g, 15.72 mmol) as a yellowish white solid. This material was used 
without further purification. 
 NMR (CDCl3, δ in ppm): 1H (500 MHz) 5.11 (br s, 1H, CHNH), 5.01 (br s, 1H, 
CH2NH), 4.23 (t, 3JHH = 6 Hz, 2H, CH2OS), 3.80 (br s, 4H, 2 × OCH2CH(CH3)2), 3.71 
(br s, 1H, CHNH), 3.25 (br s, 2H, CH2NH), 3.00 (s, 3H, SCH3), 1.96-1.73 (m, 4H, 2 × 
CH(CH3)2 and CHCHH'CH2), 1.69-1.58 (m, 1H, CHCHH'CH2), 1.55-1.43 (m, 1H, 
CHCHH'CH2), 0.89 (d, 3JHH = 7 Hz, 12H, 2 × CH(CH3)2); 13C{1H} (125 MHz) 157.4 
and 157.0 (2 × s, (C=O)O), 71.2 and 71.1 (2 × OCH2CH(CH3)2), 69.5 (s, CH2OS), 51.3 
(s, CHNH), 44.9 (s, CH2NH), 37.3 (s, SCH3) 28.7 and 25.6 (2 × s, CHCHH'CH2), 27.9 
(s, 2 × CH(CH3)2), 19.0 (s, 2 × CH(CH3)2). 
 (S)-N1,N2-Di-i-butoxycarbonyl-N5,N5-dimethyl-1,2,5-triaminopentane or 
(S)-(i-BuOC(O))NHCH(CH2CH2CH2NMe2)CH2NH(C(O)Oi-Bu) ((S)-3L3). A 
sealable tube (180 mL, threaded cap) was charged with crude (S)-2L3 (6.227 g, 15.72 
mmol) and HNMe2 (2.0 M in THF; 80 mL, 160 mmol). The cap was tightened, and the 
bottom half of the tube was placed in an 80 °C oil bath. After 15 h, the bath was 
removed. After 2 h, the tube was vented and the solvent was removed by rotary 
evaporation. The residue was dissolved in CH2Cl2 (200 mL), washed with saturated 
aqueous NaHCO3 (150 mL) and brine (100 mL), and dried (Na2SO4). The solvent was 
removed by rotary evaporation. The residue was chromatographed on a silica gel column 
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(3  16 cm, 100:0 to 85:15 v/v CH2Cl2/CH3OH). The solvent was removed from the 
product containing fractions to give (S)-3L3 (4.664 g, 13.52 mmol, 86% from (S)-1L3) as 
a yellow oil that often solidified upon storage, mp 68-71 °C (open capillary). Anal. 
Calcd. for C17H35N3O4 (345.48): C 59.10, H 10.21, N 12.16; found C 58.41, H 10.09, N 
11.92. 
 NMR (CDCl3, δ in ppm): 1H (500 MHz) 5.73 (d, 3JHH = 7 Hz, 1H, CHNH), 5.25 
(br s, 1H, CH2NH), 3.80 (d, 3JHH = 6 Hz, 4H, 2 × OCH2CH(CH3)2), 3.69-3.60 (m, 1H, 
CHNH), 3.39-3.14 (m, 2H, CH2NH), 2.26 (br s, 2H, CH2N(CH3)2), 2.20 (s, 6H, 
N(CH3)2), 1.98-1.78 (m, 2H, 2 × CH(CH3)2), 1.62-1.36 (m, 4H, CHCHH'CH2), 0.98-
0.82 (m, 12H, 2 × CH(CH3)2); 13C{1H} (125 MHz) 157.4 and 157.3 (2 × s, (C=O)O), 
71.1 and 70.9 (2 × OCH2CH(CH3)2), 59.1 (s, CH2N(CH3)2), 51.5 (s, CHNH), 45.4 (s, 
CH2NH), 45.1 (s, N(CH3)2), 30.4 and 23.6 (2 × s, CHCHH'CH2), 28.0 (s, 2 × 
CH(CH3)2), 19.0 (s, 2 × CH(CH3)2). IR (powder film, cm–1): 3329 (m, νNH), 2961 and 
2943 (2 × m, νCH), 1697 and 1683 (s and vs, νC=O), 1537 (s, δNH). 
Tris(hydrochloric acid) salt of (S)-N5,N5-dimethylpentane-1,2,5-triamine or 
(S)-H3NCH(CH2CH2CH2NMe2H)CH2NH3]3+ 3Cl– ((S)-L3•(HCl)3). A round bottom 
flask was charged with (S)-3L3 (4.212 g, 12.21 mmol) and aqueous HCl (6.0 M, 250 
mL) and fitted with a condenser. The solution was refluxed. After 36 h, the solvent was 
removed by rotary evaporation (using a base trap to protect the pump). The residue was 
dissolved in H2O and the solution was washed with CH2Cl2. The solvent was removed 
from the aqueous phase by rotary evaporation. The residue was washed with Et2O and 
CH3OH, and dried by oil pump vacuum. This gave the solvate ((S)-L3·(HCl)3·CH3OH 
(2.994 g, 10.44 mmol, 86%) as a colorless sticky hygroscopic solid. Anal. Calcd. for 
C7H22Cl3N3·CH3OH (286.67):26 C 33.52, H 9.14, N 14.66; Calcd. for C7H22Cl3-
N3·0.33CH3OH (265.2, corresponding to 1H NMR integration): C 33.20, H 8.86, N 
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15.84; found C 33.31, H 8.81, N 14.85.  
 NMR (D2O, δ in ppm): 1H (500 MHz) 3.77-3.66 (m, 1H, CHNH3), 3.42-3.37 
(m, 2H, CH2NH3), 3.34 (s, 1H, CH3OH), 3.26-3.18 (m, 2H, CH2NH(CH3)2), 2.91 (s, 
6H, NH(CH3)2), 2.01-1.74 (m, 4H, CHCHH'CH2); 13C{1H} (125 MHz) 57.2 (s, 
CHNH3), 49.6 (s, CH2N(CH3)2), 43.4 (s, CH2NH3), 41.2 (s, NH(CH3)2), 27.7 and 20.7 
(2 × s, CHCHH'CH2). 
(2S)-N6-benzyloxycarbonyl-N1,N2-di-tert-butoxycarbonyl-1,2,6-triaminohex-
ane or (S)-(t-BuOC(O))NHCH(CH2CH2CH2CH2NH(C(O)OCH2Ph))CH2NH(C-
(O)Ot-Bu) ((S)-5L4). A round bottom flask was charged with 10% Pd/C (0.16 g, 
"nominally 50% water wet") and H2O (8 mL) and flushed with N2. After 10 min, a 
solution of NaBH4 (0.284g, 7.50 mmol) in H2O (8 mL) was added with stirring, 
followed by solid Boc2O (0.82 g, 3.75 mmol) and then a solution of (S)-4L4 (0.98 g, 2.5 
mmol)18b in CH3OH (22 mL). After 1 h, the mixture was filtered through celite. The 
filtrate was neutralized with KHSO4, and the solvent was removed by rotary 
evaporation. Then H2O (50 mL) was added and the mixture was extracted with EtOAc 
(2  70 mL). The combined extracts were dried (Na2SO4). The solvent was removed by 
rotary evaporation and the solid was chromatographed on a silica gel column (3  8 cm, 
20:80 to 50:50 v/v EtOAc/hexane). The solvent was removed from the product 
containing fractions by rotary evaporation. The residue was dried by oil pump vacuum to 
give (S)-5L4 (0.823 g, 1.77 mmol, 71%)20 as a white solid. 
 NMR (CDCl3, δ in ppm):20 1H (500 MHz) 7.39-7.27 (m, 4H, Ph),27 5.07 (br s, 
2H, OCH2Ph), 4.96 (br s, 1H, NH(C=O)O), 4.85-4.61 (br m, 2H, 2 × NH(C=O)O), 3.57 
(br s, 1H, CHNH(Boc)), 3.22-3.03 (m, 4H, CH2NH(Boc) and CH2NH(Cbz)), 1.52-1.32 
(m, 24H, 3 × CH2, 2 × OC(CH3)3); 13C{1H} (125 MHz) 156.6, 156.5, and 156.2 (3 × s, 
3 × (C=O)O); Ph at 136.6 (s, i), 128.4 (s, o), 128.0 (s, p), 127.9 (s, m);23 79.3 (s, 2 × 
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OC(CH3)3), 66.5 (s, OCH2Ph), 51.1 (s, CHNH(Boc)), 44.5 (s, CH2NH(Boc)), 40.4 (s, 
CH2NH(Cbz)), 32.2 (s, CH2), 29.5 (s, CH2), 28.4 (s, 2 × C(CH3)3), 22.7 (s, CH2). IR 
(powder film, cm–1): 3352 (m, νNH), 2982 and 2932 (2 × w, νCH), 1682 (vs, νC=O), 1530 
(s, δNH). 
(S)-N1,N2-di-tert-butoxycarbonyl-N6,N6-dimethyl-1,2,6-triaminohexane or 
(S)-(t-BuOC(O))NHCH(CH2CH2CH2CH2NMe2)CH2NH(C(O)Ot-Bu) ((S)-6L4). A 
Fisher Porter bottle was charged with (S)-5L4 (5.72 g, 12.3 mmol), CH3OH (100 mL), 
distilled H2O (30 mL), and 37% aqueous HCHO (2.6 mL). The mixture was stirred for 1 
h. Then 10% Pd/C (3.0 g, "nominally 50% water wet") was added, and H2 was 
introduced (50 psig). After 24 h, the mixture was filtered through a plug of Celite and 
washed with CH3OH/distilled H2O (1:1 v/v). The solvent was removed by rotary 
evaporation. The residue was chromatographed on a silica gel column (3  14 cm, 100:0 
to 85:15 v/v CH2Cl2/CH3OH). The solvent was removed from the product containing 
fractions by rotary evaporation and oil pump vacuum to give (S)-6L4 (4.07 g, 10.8 mmol, 
88%) as a colorless sticky solid. Anal. Calcd. for C18H37N3O4·H2O (377.51): C 57.27, 
H 10.41, N 11.13; found C 57.22, H 10.03, N 10.58.28  
NMR (CDCl3, δ in ppm): 1H (500 MHz) 4.96 (br s, 1H, NH(C=O)O), 4.74 (br s, 
1H, NH(C=O)O), 3.57 (br s, 1H, CHNH(Boc)), 3.22-3.03 (br s, 2H, CH2NH(Boc)), 2.26 
(t, 3JHH = 7.5 Hz, 2H, CH2N(CH3)2), 2.21 (s, 6H, N(CH3)2), 1.52-1.31 (m, 26H, 3 × 
CH2, 2 × C(CH3)3, and H2O); 13C{1H} (125 MHz) 156.5, and 156.2 (2 × s, 2 × 
(C=O)O), 79.2 (s, 2 × OC(CH3)3), 59.3 (s, CH2N(CH3)2), 51.2 (s, CHNH(Boc)), 45.2 
(s, CH2N(CH3)2), 44.8 (s, CH2NH(Boc)), 32.5 (s, CH2), 28.3 (s, CH2), 27.1 (s, 2 × 
C(CH3)3), 23.5 (s, CH2). IR (powder film, cm–1): 3346 (m, νNH), 2976 and 2932 (2 × 
m, νCH), 1682 (vs, νC=O), 1526 (s, δNH). 
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Tris(hydrochloric acid) salt of (S)-N6,N6-dimethylhexane-1,2,6-triamine or 
(S)-H3NCH(CH2CH2CH2CH2NMe2H)CH2NH3]3+ 3Cl– ((S)-L4·(HCl)3). A round 
bottom flask was charged with (S)-6L4 (3.61 g, 10.0 mmol) and 12.0 M HCl/dioxane 
(25:75 v/v; 150 mL) with stirring. After 12 h, the solvent was removed by rotary 
evaporation (using a base trap to protect the pump). The residue was dissolved in H2O 
and the solution was washed with CH2Cl2. The solvent was removed from the aqueous 
phase by rotary evaporation. The residue was washed with Et2O and CH3OH, and dried 
by oil pump vacuum to give (S)-L4·(HCl)3·CH3OH (2.40 g, 7.98 mmol, 80%) as a 
colorless sticky hygroscopic solid. Anal. Calcd. for C8H24Cl3N3·CH3OH (300.67):26 C 
35.95, H 9.39, N 13.97; Calcd. for C8H24Cl3N3·0.33CH3OH (279.23, corresponding to 
1H NMR integration): C 35.83, H 9.14, N 15.05; found C 35.97, H 9.16, N 13.81.  
NMR (D2O, δ in ppm): 1H (500 MHz) 3.75-3.69 (m, 1H, CHNH3), 3.42-3.37 
(m, 2H, CH2NH3), 3.36 (s, 1H, CH3OH), 3.26-3.17 (m, 2H, CH2NH(CH3)2), 2.91 (s, 
6H, NH(CH3)2), 1.94-1.78 (m, 4H, CHCHH'CH2CH2), 1.62-1.50 (m, 2H, 
CHCHH'CH2CH2); 13C{1H} (125 MHz) 57.8 (s, CH2NH(CH3)2), 49.9 (s, CHNH3), 
49.8 (s, CH3OH), 43.4 (s, NH(CH3)2), 41.4 (s, CH2NH3), 30.2, 24.3, and 22.0 (3 × s, 
CHCHH'CH2CH2). 
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7. WERNER COMPLEXES WITH -DIMETHYLAMINOALKYL 
SUBSTITUTED ETHYLENEDIAMINE LIGANDS: BIFUNCTIONAL 
HYDROGEN BOND DONOR CATALYSTS FOR HIGHLY 
ENANTIOSELECTIVE MICHAEL ADDITIONS† 
 
7.1. Introduction 
During the past two decades, numerous types of small molecule hydrogen bond 
donor catalysts have been developed, almost always under the umbrella of 
"organocatalysis".1,2 These have included many chiral, enantiopure species, and 
applications to a variety of enantioselective organic reactions.2 I, together with others in 
the Gladysz group, have sought to broaden this field to include inorganic and 
organometallic hydrogen bond donors that feature earth abundant metals and chirality 
motifs not normally achievable in organic architectures.3-5 Allied themes have been 
studied by Meggers and others.6-8  
Importantly, the performances of hydrogen bond donor catalysts are often 
markedly improved when they are rendered bifunctional.5b,9-11 For example, thioureas 
constitute a widely applied class of two fold NH bond donors,2,10,12 and the 
incorporation of tertiary amines can give catalysts that afford superior rates, yields, and 
enantioselectivities in addition reactions.10 Figure 7.1 shows the examples of mono-
functional and bifunctional thiourea catalysts which were used in the Michael reaction of 
diethyl malonate (22b) to trans-ß-nitrostyrene (21a). The monofunctional catalyst gave 
the addition product with 57% yield (24 h) in presence of an external base (Et3N),  
 
 
†Reproduced in part with permission from Ghosh, S. K.; Ganzmann, C.; Gladysz, J. A. Angew. Chem. Int. 
Ed. 2016, 55, 4356-4360. Coyright 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. 
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whereas the bifunctional catalyst gave an 86% yield with 93% enantioselectivity within 
same time.10a The external base was not required in case of bifunctional catalyst as the 
base is incorporated within the catalyst (see Figure 7.1) 
 
 
 
 
Figure 7.1. Monofunctional and bifunctional thiourea catalysts and their possible 
activation modes. 
 
 
 
From past research in Gladysz group, attention has been drawn to Werner 
complexes of cobalt(III) and 1,2-diamines.3 These represent textbook examples of 
substitution inert low spin d6 complexes, and are therefore incapable of traditional metal 
based substrate activation. However, the coordinated NH groups are superb hydrogen 
bond donors.3 Furthermore, salts of the helically chiral ethylenediamine substituted 
cations [Co(en)2(A)(A')]n+ and [Co(en)3]3+ represent the first inorganic molecules to be 
separated into enantiomers.13 The mirror images of the trication [Co(en)3]3+ are 
 208 
depicted in Scheme 7.1, together with the / descriptors employed to distinguish the 
cobalt configurations. By using lipophilic anions such as BArf– (B(3,5-C6H3(CF3)2)4–), 
this species could be solubilized in nonpolar solvents that do not compete with substrates 
for the hydrogen bonding sites.3a However, while Λ- or -[Co(en)3]3+ 3BArf– proved to 
be competent catalysts, enantioselectivities have been modest in all reactions assayed to 
date (<33% ee).  
 
 
 
 
Scheme 7.1. Design of families of cobalt(III) hydrogen bond donor catalysts. 
 
 
 
Hence, two related families of catalysts were targeted. As shown in Scheme 7.1, 
one involved analogs with 1,2-disubstituted diamines. As described in section 4, those 
with aryl substituents have afforded greatly improved enantioselectivities.3b The other 
involved the exchange of one or more of the 1,2-ethylenediamine ligands by analogs 
with -dimethylaminoalkyl substituents, H2NCH((CH2)nNMe2)CH2NH2 (n = a, 1; b, 2; 
c, 3; d, 4; L1-L4, respectively).14 In this section, it is shown that when a single 
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ethylenediamine ligand in [Co(en)3]3+ is replaced by Ln with a suitable methylene 
spacer length (n), exceptional catalysts are obtained that match or exceed the highest 
enantioselectivities realized with hydrogen bond donors to date. Some of the reactions 
involving the poor catalyst 27a3+ 3BArf– were done by Dr. Carola Ganzmann.   
7.2. Results 
7.2.1. Syntheses of the catalysts 
As depicted in Scheme 7.2, the triply protonated triamine ligands (S)-Ln·(HCl)3 (n = 
1-4, 0.92-0.83 equiv)14 and the racemic carbonate  
 
 
 
 
Scheme 7.2. Syntheses of bifunctional catalysts 27a-d3+ 3BArf– from (S)-Ln·(HCl)3 (n 
= 1-4). 
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complex [Co(en)2O2CO]+ Cl–15 were combined in water in the presence of activated 
charcoal and heated to 100 °C. In this process, the charcoal labilizes the normally 
substitution inert cobalt(III) educt,16 and the carbonate ligand that is displaced acts as a 
dibase, deprotonating the two -NH3+ moieties of (S)-Ln·(HCl)3. The resulting tetra-
cation salts [Co(en)2((S)-H2NCH((CH2)nNMe2H)CH2NH2)]4+ 4Cl– (27a-d·H4+ 4Cl–) 
were separated from redistribution products using a DOWEX 50WX2 ion exchange  
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Figure 7.2. Separation of the tetracation 27c·H4+ 4Cl– from redistribution products. 
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resin column as illustrated for n = 3 in Figure 7.2. This gave hydrates of 27a-d·H4+ 4Cl– 
as orange powders in 59-33% yields (based upon the limiting triamine) as mixtures of 
 diastereomers (a, 30:70; b-d, 70-72:30-28), consistent with the use of a racemic 
cobalt carbonate precursor. 
The reusable chiral support Sephadex has often been employed to separate 
enantiomeric and diastereomeric cobalt(III) diamine complexes.17 When 27a-d·H4+ 
4Cl– were eluted from SP-Sephadex columns with tartrate gradients, 2Na+ d-tart2–, two 
well resolved bands were obtained. A representative separation for the diastereomers of 
27c·H4+ 4Cl– is shown in Figure 7.3, together with the structure of SP-Sephadex.17c  
 
 
 
 
Figure 7.3. Separation of the diastereomers of 27c·H4+ 4Cl– and structure of SP-
Sephadex. 
 
 
 
Each band was collected, concentrated, and eluted through DOWEX columns to 
exchange the tartrate anions back to chloride anions. The resulting Λ- and -27a-d·H4+ 
4Cl– were characterized by NMR (1H/13C{1H}, D2O) and elemental analyses as 
summarized in the experimental section. The cobalt configurations of Λ- and -27a-
d·H4+ 4Cl– were assigned by CD spectroscopy and by comparison with the known CD 
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spectra of Λ- and -[Co(en)3]3+ 3I– as illustrated in Figure 7.4. In addition, that of -
27a·H4+ 4Cl– was confirmed by the crystal structure shown in Figure 7.5. 
In the crystal, the octahedral cobalt(III) tetracation of -27a·H4+ 4Cl– is 
surrounded by four chloride ions and three water molecules. The chloride anions and 
water molecules form hydrogen bonds with the amino groups of the ligands (NH···O 
and NH···Cl–) and between each other (O-H···Cl– and O-H···O). Thus, the tetracation 
units are linked together in a network. The cobalt configuration was confirmed to be Δ. 
Among the three chelate rings, one is parallel to the C3 axis, occupying the Δ(lel) or Δ(λ) 
conformation, and other two are perpendicular to the C3 axis, occupying Δ(ob) or Δ(δ) 
conformations. The overall designation for -27a·H4+ 4Cl–·3H2O is Δ-lelob2. 
It was next sought to solubilize deprotonated analogs of the diastereomerically 
pure cations in organic media. Thus, Λ- and -27a-d·H4+ 4Cl– were treated with 
aqueous NaOH (1.0 equiv) and then CH2Cl2 solutions of Na
+ BArf
– (Scheme 7.3). 
Workups gave Λ- and -[Co(en)2((S)-H2NCH((CH2)nNMe2)CH2NH2)]3+ 3BArf–·xH2O 
(27a-d3+ 3BArf
–·xH2O; x = 9-12) as orange solids in 92-87% and 95-84% yields, 
respectively (51-25% overall from Ln). Attempts to more rigorously dry cobalt(III) 
BArf
– salts can be problematic. For example, when the solvent is removed from CH2Cl2 
solutions of the bifunctional catalyst Λ-27d3+ 3BArf– at 40 °C by rotary evaporation 
and/or oil pump vacuum, a violet residue results and considerable decomposition is 
evident by 13C NMR. However, Λ-[Co(en)3]3+ 3BArf– persists under these conditions, 
although about half the water molecules are removed. When Λ-[Co(en)3]3+ 3BArf– is
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Figure 7.4. Circular dichroism spectra of (a) Δ- and Λ-[Co(en)3]3+ 3I–, (b) Δ- and Λ-27a·H4+ 4Cl–, and (c) Δ- and Λ-27b-
d·H4+ 4Cl–. 
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Figure 7.5. The crystal structure of the tetracation of -27a·H4+ 4Cl–·3H2O with 
thermal ellipsoids at the 50% probability level (the anions and water molecules are not 
shown). Key bond lengths (Å) and angles (°): Co-N1 1.9692(18), Co-N2 1.9703(19), 
Co-N3 1.9634(18), Co-N4 1.9627(18), Co-N5 1.9685(19), Co-N6 1.9710(18), C1-N1 
1.489(3), C2-N2 1.488(3), C3-N3 1.489(3), C4-N4 1.494(3), C5-N5 1.495(3), C6-N6 
1.483(3), C7-N7 1.488(3), C8-N7 1.490(3), C9-N7 1.492(3), C1-C2 1.504(3), C3-C4 
1.510(3), C5-C6 1.517(3), C6-C7 1.532(3), N1-Co-N2 85.06(8), N1-Co-N3 91.57(8), 
N4-Co-N1 175.52(8), N1-Co-N5 90.82(8), N1-Co-N6 92.60(8), N3-Co-N6 175.39(8), 
N5-Co-N2 173.98(7), N4-Co-N3 84.58(8), N4-Co-N6 91.33(8), N4-Co-N5 91.70(8), 
N4-Co-N2 92.71(8). 
 
 
 
kept under oil pump vacuum at 80 °C, all of the water molecules are removed but 
appreciable decomposition occurs, as assayed by 1H NMR (some decomposition of the 
anion is also evident by 19F NMR). One can speculate that, as is often seen with certain 
fluoride salts, the anion becomes activated in the absence of a minimum level of 
hydration. 
7.2.2. Enantioselective catalysis 
The diastereomerically pure BArf
– salts were screened as catalysts (10 mol%) for 
additions of dimethyl malonate (22c, 1.2 equiv) to trans-ß-nitrostyrene (21a) at room 
temperature. This transformation has been effected by other hydrogen bond donor 
catalysts, always in conjunction with an external or internal base,3b,5,18 as well as 
transition metal catalysts.19 In accord with the oxidative and hydrolytic stabilities of 
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cobalt(III) diamine complexes, reactions were carried out in air. Conversions to the 
addition product 23ac were assayed by 1H NMR in the presence of an internal standard. 
Key data are summarized in Scheme 7.3.  
 
 
 
 
Scheme 7.3. Optimization of conditions for catalysis. 
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 When either diastereomer of 27a3+ 3BArf
– was employed in CD2Cl2, reactions 
were sluggish at room temperature and 23ac was obtained in only 21-11% ee (entries 
1,2). However, Λ-27b3+ 3BArf– was a much more effective catalyst (entry 3), affording 
85% conversion to 23ac of 75% ee (R major) after 24 h. In contrast, the diastereomer -
27b3+ 3BArf
– was a sluggish catalyst (entry 4), and gave 23ac of only 9% ee (R major). 
When the methylene tether was further lengthened to give Λ- and -27c3+ 3BArf–, both 
diastereomers exhibited much faster rates (>99% conversions, 2-4 h; entries 5-6).  
However, the Λ diastereomer again afforded a much more enantioselective 
reaction (86% vs. 5% ee). Finally, Λ- and -27d3+ 3BArf– gave somewhat slower rates, 
with more comparable enantioselectivities (48% vs. 33% ee; entries 7-8). In efforts to 
date, the analog of Λ-27c3+ 3BArf– in which the dimethylamino group is replaced by a 
pyrrolidinyl group has given comparable enantioselectivities. The preparation of this 
molecule is provided in a separate research report. Interestingly, in every case the 
dominant product configuration was controlled by the ligand based carbon stereocenter.  
The most enantioselective catalysts, Λ-27b-d3+ 3BArf–, were further studied. 
With Λ-27c3+ 3BArf–, the ee values decreased when reactions were conducted in 
CD3CN or acetone (entries 9, 10 vs. 5). However, Λ-27c,d3+ 3BArf– afforded much 
higher enantioselectivities when reactions were conducted at –35 °C (entries 13,14), with 
the former giving 97% conversion to 23ac of 97% ee after 15 h. Accordingly, these 
conditions were applied to a variety of other substrates per Scheme 7.4. The yield data 
are for isolated products.  
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Scheme 7.4. Scope of additions under optimum conditions. 
 
 
 
As shown in Scheme 7.4, enantioselectivities decreased only slightly when 
dimethyl malonate was replaced by the diethyl or dibenzyl esters (from 97% to 95% ee). 
When electron donating or withdrawing substituents were introduced on the phenyl ring 
of 21a, the ee values remained high (99-93% ee). Similar values were obtained with 
other aryl moieties such as 1-naphthyl and 2-furyl (97-96% ee). However, particularly 
noteworthy were analogous additions to ß-alkylnitroethenes. These afforded adducts of 
94-90% ee, a rarely seen level of asymmetric induction, as further analyzed in the 
discussion section. 
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Figure 7.6. Rates of reaction of trans-ß-nitrostyrene (21a) and dimethyl malonate (22c, 
1.2 equiv) in CD2Cl2 in the presence of an internal standard and catalyst (2 mol%; see 
experimental section): (■) Λ-[Co(en)3]3+ 3BArf–/Et3N, (♦) Λ-27c3+ 3BArf–, (▲) -
27c3+ 3BArf–, Λ-[Co(en)3]3+ 3BArf–. 
 
 
 
In view of these excellent results in Scheme 7.4, the rates of several catalytic 
systems were monitored by 1H NMR using 2% loadings in CD2Cl2 at ambient 
temperature. As shown in Figure 7.6, when the monofunctional complex Λ-[Co(en)3]3+ 
3BArf
– (Scheme 7.1), augmented by an equimolar quantity of Et3N, was compared to 
bifunctional Λ-27c3+ 3BArf–, nearly equal rates were found. However, the former 
system gave only a 9% ee, as opposed to 81% for the latter. The less enantioselective 
diastereomeric catalyst -27c3+ 3BArf– gave a slower rate. Importantly, when Λ-
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[Co(en)3]3+ 3BArf– was employed in the absence of an external base, there was no 
detectable conversion after 2 h (<3%).  
7.3. Discussion 
The trends in Scheme 7.3 raise a number of issues. Efficacies in enantioselective 
catalysis are normally analyzed in the context of a G‡ value for two competing 
diastereomeric transition states. Given the lower symmetries of Λ-27b-d3+ 3BArf– (C1) 
compared to the trication [Co(en)3]3+ or substituted analogs 13+ (Scheme 7.1; both D3), 
a much wider range of ternary assemblies are possible.  
Since the carbon configurations of the catalysts set the dominant product 
configurations, it might be suggested that the malonate esters simultaneously interact 
with the dimethylamino groups and the proximal NH donor sites, and that this somehow 
fixes the nitroethene C=C enantioface that is predominantly attacked.10a,20 For the 
system in Figure 7.5 (protonated form of a poor catalyst), this would correspond to N7 
(after rotation about C6-C7) and the nearest hydrogen atoms on N1, N5, or N6. In any 
event, Scheme 7.3 establishes a "sweet spot" with respect to both rate and 
enantioselectivity with three methylene groups and /S cobalt/carbon configurations.21  
The data from Figure 7.6 show that the internal trialkylamine base in Λ-27c3+ 
3BArf
– does not lead to a rate acceleration versus an external triethylamine base. This is 
in contrast to the results in Figure 7.1, for which an internal base improves the rate of a 
thiourea catalyst versus one used with external base. However, the enantioselectivity is 
much higher with the bifunctional catalyst Λ-27c3+ 3BArf– (81% versus 9%; Figure 
7.6). Both the rate and enantioselectivity of -27c3+ 3BArf– are poorer than other two 
catalysts in Figure 7.6.  
It is difficult to compare enantioselective catalysts in an even handed manner. 
However, while some of the ee values in Scheme 7.4 have been matched by other 
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hydrogen bond donor catalysts (Figure 7.7), I am unaware of a system with comparable 
overall effectiveness. For example, 23ac has been accessed in 93-96% ee via recipes that 
use 2-3 equiv of 22c and require 36-24 h (10 mol% catalyst),18a-c and in 99% ee via a 
protocol that uses 5 equiv of 22c and requires 144 h.18d Similarly, 23ab has been 
accessed in 92-95% ee over 44-48 h,18b,c,e 23dc in 92-97% ee over 30-72 h,18a-c 23bc in 
98% ee over 36 h,18a and 23kc in 98-93% ee over 30-36 h (all 10 mol% catalyst).18a,b,d 
Enantioselectivities of >85% with ß-alkylnitroethenes are especially rare; I am aware of  
 
 
 
 
Figure 7.7. Hydrogen bond donor catalysts that have been reported to give high ee 
values for some of the products in Scheme 7.4. 
 
 
 
only a single example with 23lc (90% ee over 36 h; 10 mol%18d) and 23nc (94% ee over 
108 h, 20 mol%18a). For 23ac, two transition metal catalysts have been reported that are 
effective at 2 mol% loadings (94-95% ee, 48-4 h).19a,b All data in Scheme 7.4 are 
superior to those reported for the monofunctional cobalt(III) catalysts Λ-13+ 3X– 
(Scheme 7.1, R = Ph).3b in section 4. 
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In conclusion, I have shown that the performance of hydrogen bond donor 
catalysts based upon the "second coordination sphere" of Werner cobalt(III) diamine 
complexes can be dramatically enhanced by incorporating additional functionality. Such 
cobalt systems represent exciting new additions to the pool of chiral building blocks for 
enantioselective catalysts. Since many more NH bonds are available to simultaneously 
participate in transition state assemblies than with thioureas or related NH bond donors, 
these species should also give rise to new chemistries not realizable with established 
catalysts. Finally, it is worth noting that little of the organocatalysis review literature1,2 
attempts to treat related systems with "spectator" metal fragments that do not directly 
participate in bond breaking or making. This unfortunate emphasis on pedigree over 
functionality only serves to obscure logical mechanism based connections and impede 
the discovery of new classes of catalysts. Indeed, given the countless numbers of 
classical coordination compounds featuring NH donor ligands, it is highly probable that 
many additional families of metal containing hydrogen bond donor catalysts have been 
in existence for some time. 
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7.4. Experimental section 
 General Data: NMR spectra were recorded on standard 400-500 MHz 
spectrometers at ambient probe temperatures. 1H chemical shifts (δ in ppm) were 
referenced to residual solvent signals (CHCl3, 7.26; CDHCl2, 5.32; acetone-d5, 2.05; 
CD2HCN, 1.95; HDO, 4.79). 
13C chemical shifts (δ in ppm) were referenced to internal 
dioxane (67.2; spectra in D2O) or solvent signals (CDCl3, 77.2; CD3CN, 1.3).
21 Melting 
points were determined in open capillaries using an OptiMelt MPA 100 instrument. 
Circular dichroism spectra were obtained with a Chirascan CD Spectrometer (Applied 
Photophysics). C/H/N analyses were carried out by Atlantic Microlab or in house; 
sodium was assayed by instrumental neutron activation analysis (INAA). HPLC analyses 
were carried out with a Shimadzu instrument package (pump/autosampler/detector LC-
20AD/SIL-20A/SPD-M20A). 
CDCl3, CD2Cl2, acetone-d6, and acetonitrile-d3 (Cambridge Isotopes) were 
stored over molecular sieves. HPLC grade solvents (hexanes, Fischer; isopropanol, JT 
Baker) were degassed before use. Hexanes (Macron, ACS grade), CH2Cl2 (EMD, ACS 
grade), EtOAc (Macron, ACS grade), and dioxane (Macron, ACS grade) were used as 
received. The Na+ BArf– was prepared by a literature procedure.22  
The trans-β-nitrostyrene (21a, Alfa Aesar, 98%) was column chromatographed 
(silica gel, 9:1 v/v hexanes/EtOAc) prior to use. The trans-4-methoxy-β-nitrostyrene 
(21d), 3,4-dichloro-β-nitrostyrene (21e), 3,4-methylenedioxy-β-nitrostyrene (21m), and 
1-(2-furyl)-2-nitroethylene (21k) were used as received from Alfa Aesar (NMR spectra 
verified that 21e,k,m were >98% trans). The trans-1-(naphth-1-yl)-2-nitroethylene 
(21b), trans-1-nitro-1-pentene (21l), and trans-1-cyclohexyl-2-nitroethylene (21n) were 
prepared by literature procedures.23  
Dimethyl malonate (22c, Alfa Aesar, 98%), diethyl malonate (22b, Alfa Aesar, 
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99%), dibenzyl malonate (22d, TCI, 99%), 2Na+ d-tart2–·2H2O (Alfa Aesar, 99%), 
Ph2SiMe2 (Aldrich, 97%), Et3N (Alfa Aesar, 98%), NaOH (Macron, ACS grade), HCl 
(Macron, ACS grade), Na2SO4 (EMD), SP-Sephadex C25 (Aldrich), activated charcoal 
(Acros, Norit SX 4), DOWEX 50WX2 (200-400 mesh, Aldrich), and silica gel (Silicycle 
SiliaFlash® F60) were used as received.  
 Λ-[Co(en)3]3+ 3BArf–. This synthesis mirrors that reported previously for the 
enantiomer.3a A round bottom flask was charged with a solution of Na+ BArf– (0.498 g, 
0.561 mmol) in CH2Cl2 (20 mL). A solution of Λ-[Co(en)3]3+ 3I–·H2O (0.120 g, 0.187 
mmol)24 in water (20 mL) was added with stirring. After 15 min, the biphasic mixture 
was allowed to stand. The lower orange CH2Cl2 phase was separated. This solution was 
allowed to evaporate to give Λ-[Co(en)3]3+ 3BArf–·14H2O as an orange solid (0.505 g, 
0.164 mmol, 88%),26 which continuously darkened with heating and liquefied at 136-
141 °C. Anal. Calcd. for C102H60B3CoF72N6·14H2O (3081.07): C 39.76, H 2.88, N 
2.73; found: C 39.95, H 2.89, N 2.69.  
NMR (CD2Cl2, δ in ppm): 1H (500 MHz) BArf– at 7.72 (t, 3JHH = 2.5 Hz, 24H, 
o), 7.58 (s, 12H, p); NH2 at 4.81-4.60 (br m, 12H); 2.98 (br s, 6H, 3CHH'CHH'), 2.73 (s, 
29H, H2O), 2.65 (s, 6H, 3CHH'CHH'); 13C{1H} NMR (125 MHz) BArf– at 162.1 (q, 
1JBC = 49.6 Hz, i), 135.2 (m, o), 129.5 (qm, 2JCF = 31.5 Hz, m), 125.0 (q, 1JCF = 271.0 
Hz, CF3), 117.9 (m, p); 45.8 (s, 3CH2CH2). 
Λ- and Δ-[Co(en)2((S)-H2NCH(CH2NMe2H)CH2NH2)]4+ 4Cl– (Λ- and Δ-
27a·H4+ 4Cl–). A. A round bottom flask was charged with [Co(en)2O2CO]+ Cl– (0.606 
g, 2.21 mmol),15 activated charcoal (0.440 g), and H2O (20 mL), and fitted with a 
condenser. The mixture was heated to 40 °C and a solution of the tris(hydrochloric acid) 
salt of (S)-H2NCH(CH2NMe2H)CH2NH2 ((S)-L1·(HCl)3; 0.500 g, 2.04 mmol; 0.92 
equiv)14a in H2O (5 mL) was added in one portion with stirring. The temperature was 
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raised to 100 °C. After 0.75 h, the mixture was filtered. The solvent was removed from 
the red filtrate by rotary evaporation. The deep red solid was dissolved in HCl (0.50 M, 
50 mL). The solution was added to a Dowex column (50WX2, hydrogen form; 3 × 20 
cm; packed in water), which was eluted with HCl (1.0 M, 250 mL; 2.0 M, until the 
second orange band began to elute; then 3.0 M). The solvent was removed from the 
second orange band by rotary evaporation to give crude 27a·H4+ 4Cl– as an orange solid 
(0.410 g. 0.934 mmol, 45%) and a 30:70 mixture of Λ/∆ isomers, as assayed by 
13C{1H} NMR (δ, D2O, 58.1/ 57.8 ppm).25 NMR (D2O, δ in ppm): 1H (400 MHz) NH2 
at 5.62-4.84 (br m, 11H), 4.73-4.65 (br m, 1H); 2CH2CH2, CH2CHCH2NMe2H+ at 
3.84-3.59 (m, 3H), 3.31-3.15 (m, 1H), 3.13-2.73 (m, 15H); 13C{1H} (125 MHz) 
58.1/57.8 (s, CH2NHMe2+), 53.5/52.5 (s, CHNH2), 48.2/47.3 (s, CHCH2NH2), 45.82, 
45.77, 45.6, 45.41, 45.36, 45.3, 45.2, 45.0, 44.7, 44.6 (10 × s, 2CH2CH2, NHMe2+). 
B. A solution of 27a·H4+ 4Cl– from A (0.201 g, 0.455 mmol) in H2O (20 mL) 
was added to a SP Sephadex column (C-25; 6.0 × 50 cm). Elution with 0.10 M (250 
mL), 0.15 M (250 mL), 0.20 M (500 mL) and 0.25 M aqueous 2Na+ d-tart2–·2H2O gave 
two bands. The first was concentrated to 150 mL. This was added to a Dowex column 
(3.3 × 25 cm), which was eluted with aqueous HCl (gradient, 1.0 M to 3.0 M). The 
orange band was collected (yellow eluent) and the solvent was removed by rotary 
evaporation and oil pump vacuum. This gave Δ-27a·H4+ 4Cl–·3H2O as an orange solid 
(0.129 g, 0.262 mmol, 58% or 82% of theory from the 30:70 mixture),26 which turned 
green at ca. 220 °C and liquefied at 239 °C. Anal. Calcd. for C9H32Cl4CoN7·3H2O 
(493.19): C 21.92, H 7.77, N 19.88; found: C 22.14, H 7.40, N 19.46.  
 NMR (D2O, δ in ppm): 1H (400 MHz) NH2 at 5.51 (br s, 1H), 5.38 (br s, 1H), 
5.27-5.12 (br m, 5H), 5.11-4.8 (br m, 5H); 2CH2CH2, CH2CHCH2NMe2H+ at 3.80-
3.69 (m, 1H), 3.68-3.55 (m, 2H), 3.20 (br d, 1H), 3.04 (s, 6H), 3.03-2.92 (m, 3H), 2.91-
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2.70 (m, 7H); 13C{1H} (100.6 MHz) 57.9 (s, CH2NMe2H+), 53.4 (s, CHNH2), 48.1 (s, 
CHCH2NH2), 45.8, 45.6, 45.4, 45.3 (4 × s, 2CH2CH2), 44.7 (s/double intensity, 
NMe2H+). 
The second band from the Sephadex column was concentrated to 100 mL. This 
was added to a Dowex column (3.0  12 cm), which was eluted with aqueous HCl 
(gradient, 1.0 M to 3.0 M). The orange band was collected (yellow eluent) and the 
solvent was removed by rotary evaporation and oil pump vacuum. This gave Λ-27a·H4+ 
4Cl–·4H2O as an orange solid (0.055 g, 0.125 mmol, 28% or 93% of theory from the 
30:70 mixture),26 which turned green around 220 °C and liquefied at 239 °C. Anal. 
Calcd. for C9H32Cl4CoN7·4H2O (511.2): C 21.15, H 7.89, N 19.18; found: C 21.51, H 
7.43, N 18.84.  
 NMR (D2O, δ in ppm): 1H (400 MHz) NH2 at 5.49-5.40 (br m, 2H), 5.37-5.14 
(br m, 4H), 5.07 (br s, 1H), 5.00-4.86 (br m, 4H), 4.73-4.65 (br m, 1H); 2CH2CH2, 
CH2CHCH2NMe2H+ at 3.73-3.64 (m, 2H), 3.62-3.54 (m, 1H), 3.15 (br d, 1H), 3.04 (s, 
6H), 3.01-2.73 (m, 10H); 13C{1H} (100.6 MHz) 58.1 (s, CH2NMe2H+), 52.4 (s, 
CHNH2), 47.1 (s, CHCH2NH2), 45.8, 45.7 (2 × s, NMe2H+), 45.3, 45.1, 45.0, 44.7 (4 × 
s, 2CH2CH2).  
Λ-27a3+ 3BArf–. A beaker was charged with Λ-27a·H4+ 4Cl–·4H2O (0.051 g, 
0.10 mmol), H2O (20 mL), and aqueous NaOH (0.10 M; 1.0 mL, 0.10 mmol). A solution 
of Na+ BArf
– (0.266 g, 0.300 mmol) in CH2Cl2 (20 mL) was added with stirring. After 
15 min, the biphasic mixture was allowed to stand. The lower orange CH2Cl2 phase was 
separated. This solution was allowed to evaporate to give Λ-27a3+ 3BArf–·10H2O as an 
orange solid (0.28 g, 0.092 mmol, 92%; from L1: 24% or 34% of theory),26 which 
continuously darkened with heating and liquefied at 157-162 °C. Anal. Calcd. for C105-
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H67B3CoF72N7·10H2O (3066.1): C 41.13, H 2.86, N 3.20; found: C 41.33, H 2.66, N 
2.13.27  
 1H NMR (500 MHz, CD3CN, δ in ppm): BArf– at 7.71 (s, 24H, o), 7.68 (s, 12H, 
p); NH2 at 4.35-3.64 (br overlapping m, 11H), 3.54 (br s, 1H); CH2NMe2, CHCH2NH2, 
2CH2CH2, and H2O at 3.05-2.59 (br m, 10H), 2.55-2.40 (m, 3H), 2.36-2.10 (m, 27H); 
13C{1H} (125 MHz, CD2Cl2, δ in ppm): BArf– at 162.1 (q, 1JBC = 50.0 Hz, i), 135.2 (s, 
o), 129.2 (qm, 2JCF =  31.3 Hz, m), 125.0 (q, 1JCF = 271.0 Hz, CF3), 117.9 (s, p); 59.4 
(s, CH2NMe2), 58.3 (s, CHNH2), 48.2 (s, CHCH2NH2), 46.9 (s/double intensity, 
NMe2), 46.1, 46.02, 45.98 (s, s, s/double intensity, 2CH2CH2). 
 -27a3+ 3BArf–. A beaker was charged with Δ-27a·H4+ 4Cl–·3H2O (0.050 g, 
0.101 mmol), H2O (10 mL), and aqueous NaOH (0.10 M; 1.0 mL, 0.10 mmol). A 
solution of Na+ BArf
– (0.269 g, 0.303 mmol) in CH2Cl2 (20 mL) was added with 
stirring. After 15 min, the biphasic mixture was allowed to stand. The lower orange 
CH2Cl2 phase was separated. This solution was allowed to evaporate to give Δ-27a3+ 
3BArf
–·12H2O as an orange solid (0.263 g, 0.0850 mmol, 84%; from L1: 22% or 31% 
of theory),26 which continuously darkened with heating and liquefied at 116-119 °C. 
Anal. Calcd. for C105H67B3CoF72N7·12H2O (3102.14): C 40.65, H 2.96, N 3.16; found: 
C 40.77, H 2.88, N 3.09. 
 NMR (CD3CN, δ in ppm): 1H (400 MHz) BArf– at 7.77 (m, 24H, o), 7.66 (s, 
12H, p); NH2 at 5.51-3.82 (7 br overlapping m, 9H), 3.71 (br s, 2H), 3.49 (br s, 1H); 
CH2NMe2, CHCH2NH2, 2CH2CH2, and H2O at 2.99-2.60 (br m, 10H), 2.57-2.33 (m, 
4H), 2.25 (br s, 28H); 13C{1H} (100.6 MHz) BArf– at 162.6 (q, 1JBC = 49.7 Hz, i), 
135.7 (s, o), 129.9 (q, 2JCF = 31.6 Hz, m), 126.0 (q, 1JCF = 271.7 Hz, CF3), 118.7 (s, p); 
60.5 (s, CH2NMe2), 57.5 (s, CHNH2), 48.5 (s, CHCH2NH2), 46.2 (s/double intensity, 
NMe2), 45.7, 45.6, 45.4, 45.3 (4 × s, 2CH2CH2). 
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Λ- and Δ-[Co(en)2((S)-H2NCH((CH2)2NMe2H)CH2NH2)]4+ 4Cl– (Λ- and Δ-
27b·H4+ 4Cl–). A. A round bottom flask was charged with [Co(en)2O2CO]+ Cl– (0.768, 
2.80 mmol),15 activated charcoal (0.450 g), and H2O (20 mL), and fitted with a 
condenser. The mixture was heated to 40 °C and a solution of the tris(hydrochloric acid) 
salt of (S)-H2NCH((CH2)2NMe2H)CH2NH2 ((S)-L2·(HCl)3, 0.561 g, 2.34 mmol; 0.83 
equiv)14a in H2O (5 mL) was added in one portion with stirring. The temperature was 
raised to 100 °C. After 0.75 h, the mixture was filtered. The solvent was removed from 
the red filtrate by rotary evaporation. The deep red solid was dissolved in HCl (0.50 M, 
100 mL). The solution was added to a Dowex column (50WX2 hydrogen form; 4.5 × 30 
cm; packed in water), which was eluted with HCl (1.0 M, 500 mL; 1.5 M, 500 mL; 2.0 
M, until the second orange band began to elute; then 3.0 M). The solvent was removed 
from the second orange band by rotary evaporation to give crude 27b·H4+ 4Cl– as an or-
ange solid (0.349 g. 0.770 mmol, 33%) and a 72:28 mixture of Λ/∆ isomers, as assayed 
by 13C{1H} NMR (δ, D2O, 55.9/54.7 ppm).25 NMR (D2O, δ in ppm): 1H (500 MHz) 
NH2 at 5.53-4.87 (br m, 9H), 4.50 (br s, 1H);28 3.45-3.37 (m, 1H, CHCHH'NH2), 3.35-
3.25 (m, 1H, CHCHH'NH2), 3.23-2.54 (m, 17H, CH2NHMe2+, CHNH2, and 
2CH2CH2), 2.29-2.19 (m, 2H, CHCH2CH2); 13C{1H} (125 MHz) 55.9/54.7 (s, 
CHNH2), 55.1 (s, CH2NHMe2+), 49.4/48.5 (s, CHCH2NH2), 45.8, 45.7, 45.6, 45.5, 
45.4, 45.3, 45.2, 45.1 (8 × s, 2CH2CH2), 43.6, 43.4 (2 × s, NHMe2+), 27.4 (s, 
CHCH2CH2).  
B. A solution of 27b·H4+ 4Cl– from A (0.274 g, 0.605 mmol) in H2O (40 mL) 
was added to a SP Sephadex column (C-25; 6.0 × 40 cm). Elution with 0.10 M (250 
mL), 0.15 M (250 mL), 0.20 M (500 mL) and 0.25 M aqueous 2Na+ d-tart2–·2H2O gave 
two bands. The first was concentrated to 100 mL. This was added to a Dowex column 
(3.3 × 25 cm), which was eluted with aqueous HCl (gradient, 1.0 M to 3.0 M). The 
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orange band was collected (yellow eluent) and the solvent was removed by rotary 
evaporation and oil pump vacuum. This gave Λ-27b·H4+ 4Cl–·0.6 NaCl·H2O as an 
orange solid (0.198 g, 0.391 mmol, 65% or 91% of theory from the 72:28 mixture),26 
dec pt 181-214 °C.29 Anal. Calcd. for C10H34Cl4CoN7·0.6NaCl·H2O (506.25):30,31 C 
23.72, H 7.17, N 19.37, Na 2.72; found: C 23.87, H 6.81, N 19.07, Na 2.33.  
NMR (D2O, δ in ppm): 1H (500 MHz) NH2 at 5.45 (br s, 1H), 5.30-4.83 (br m, 
11H); 3.46-3.35 (m, 1H, CHCHH'NH2), 3.34-3.25 (m, 1H, CHCHH'NH2), 3.19-2.54 
(m, 17H, CH2NHMe2+, CHNH2, 2CH2CH2), 2.29-2.18 (m, 2H, CHCH2CH2); 
13C{1H} (125 MHz) 56.1 (s, CHNH2), 55.0 (s, CH2NHMe2+), 49.6 (s, CHCH2NH2), 
45.6, 45.4, 45.34, 45.27 (4 × s, 2CH2CH2), 43.6, 43.4 (2 × s, NHMe2+), 27.3 (s, 
CHCH2CH2). 
The second band from the Sephadex column was concentrated to 100 mL. This 
was added to a Dowex column (3.0  12 cm), which was eluted with aqueous HCl 
(gradient, 1.0 M to 3.0 M). The orange band was collected (yellow eluent) and the 
solvent was removed by rotary evaporation and oil pump vacuum. This gave -27b·H4+ 
4Cl–·1.5NaCl·2H2O as an orange solid (0.078 g, 0.136 mmol, 22% or 80% of theory 
from the 72:28 mixture),26 dec pt 66-87 °C.29 Anal. Calcd. for 
C12H38Cl4CoN7·1.5NaCl·2.0H2O (576.86):30,31 C 20.82, H 6.64, N 17.00; found: C 
21.13, H 6.37, N 16.74.  
NMR (D2O, δ in ppm): 1H (500 MHz) NH2 at 5.38 (br s, 1H), 5.25-5.00 (br m, 
5H), 4.72-4.60 (br m, 2H), 4.48 (br s, 1H);28 3.43-3.34 (m, 1H, CHCHH'NH2), 3.33-
3.26 (m, 1H, CHCHH'NH2), 3.25-3.10 (m, 2H, CH2NHMe2+), 3.08-2.53 (m, 15H, 
CH2NHMe2+, CHNH2, 2CH2CH2), 2.28-2.16 (m, 2H, CHCHH'CH2); 13C{1H} (125 
MHz) 55.0 (s, CH2NHMe2+), 54.7 (s, CHNH2), 48.6 (s, CHCH2NH2), 45.71, 45.65, 
45.1, 45.0 (4 × s, 2CH2CH2), 43.5, 43.4 (2 × s, NHMe2+), 27.4 (s, CHCH2CH2). 
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Λ-27b3+ 3BArf–. A beaker was charged with Λ-27b·H4+ 4Cl–·0.6NaCl·H2O 
(0.0510 g, 0.101 mmol), H2O (15 mL), and aqueous NaOH (0.10 M; 1.05 mL, 0.105 
mmol). A solution of Na+ BArf
– (0.269 g, 0.303 mmol) in CH2Cl2 (15 mL) was added 
with stirring. After 15 min, the biphasic mixture was allowed to stand. The lower orange 
CH2Cl2 phase was separated. This solution was allowed to evaporate to give Λ-27b3+ 
3BArf
–·11H2O as an orange solid (0.282 g, 0.091 mmol, 91%; from L2: 19% or 27% of 
theory),26 which upon warming continually darkened and liquefied at 124 °C. Anal. 
Calcd. for C106H69B3CoF72N7.11H2O (3098.14): C 41.09, H 2.96, N 3.16; found: C 
41.05, H 2.91, N 3.12. 
 NMR (CD3CN, δ in ppm): 1H (500 MHz) BArf– at 7.70 (s, 24H, o), 7.66 (s, 12H, 
p); NH2 at 4.67-3.48 (br m, 12H); CH2NMe2, CHNH2, CHCH2NH2, 2CH2CH2, and 
H2O at 3.05-2.60 (br m, 10H), 2.58-2.47 (m, 2H), 2.38-2.16 (m, 33H); 1.94-1.87 (m, 1H, 
CHCHH'CH2), 1.76-1.68 (m, 1H, CHCHH'CH2); 13C{1H} (125 MHz) BArf– at 162.6 
(q, 1JBC = 50.0 Hz, i), 135.7 (s, o), 130.0 (qm, 2JCF =  31.3 Hz, m), 125.5 (q, 1JCF = 
270.0 Hz, CF3), 118.6 (m, p); 58.8 (s, CHNH2), 56.6 (s, CHCH2NH2), 49.4 (s, 
CH2NMe2), 45.7, 45.6, 45.30, 45.26 (s, s, s/triple intensity, s, 2CH2CH2, NMe2), 28.2 
(s, CHCH2CH2). 
Δ-27b3+ 3BArf–. A beaker was charged with Δ-27b·H4+ 4Cl–·1.5NaCl·2H2O 
(0.034 g, 0.0581 mmol), H2O (15 mL), and aqueous NaOH (0.10 M; 0.60 mL, 0.060 
mmol). A solution of Na+ BArf
– (0.154 g, 0.174 mmol) in CH2Cl2 (15 mL) was added 
with stirring. After 15 min, the biphasic mixture was allowed to stand. The lower orange 
CH2Cl2 phase was separated. This solution was allowed to evaporate to give Δ-27b3+ 
3BArf
–·11H2O as an orange solid (0.170 g, 0.055 mmol, 95%; from L2: 7% or 25% of 
theory),26 which upon warming continually darkened and liquefied at 127 °C. Anal. 
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Calcd. for C106H69B3CoF72N7.11H2O (3098.14): C 41.09, H 2.96, N 3.16; found: C 
41.03, H 3.00, N 3.07. 
NMR (CD3CN, δ in ppm): 1H (500 MHz) BArf– at 7.71 (s, 24H, o), 7.68 (s, 12H, 
p); NH2 at 4.88 (br s, 1H), 4.56-3.64 (m, 10H), 3.50 (br s, 1H); CH2NMe2, CHNH2, 
CHCH2NH2, 2CH2CH2, and H2O at 3.01 (br s, 1H), 2.89-2.46 (br m, 9H), 2.40-2.16 
(m, 33H); 1.93-1.87 (m, 1H, CHCHH'CH2), 1.78-1.66 (m, 1H, CHCHH'CH2); 13C{1H} 
(125 MHz) BArf– at 162.6 (q, 1JBC = 50.0 Hz, i), 135.7 (s, o), 129.9 (qm, 2JCF =  31.3 
Hz, m), 125.5 (q, 1JCF = 271.3 Hz, CF3), 118.7 (m, p); 57.3 (s, CHNH2), 56.3 (s, CH-
CH2NH2), 48.6 (s, CH2NMe2), 46.1, 46.0 (2 × s, NMe2), 45.34, 45.30, 45.25 (s/double 
intensity, s, s, 2CH2CH2), 27.8 (s, CHCH2CH2). 
Λ- and Δ-[Co(en)2((S)-H2NCH((CH2)3NMe2H)CH2NH2)]4+ 4Cl– (Λ- and Δ-
27c·H4+ 4Cl–). A. A round bottom flask was charged with [Co(en)2O2CO]+ Cl– (1.075 
g, 3.916 mmol),15 activated charcoal (0.450 g), and H2O (20 mL), and fitted with a 
condenser. The mixture was heated to 40 °C and a solution of the tris(hydrochloric acid) 
salt of (S)-H2NCH((CH2)3NMe2H)CH2NH2 ((S)-L3·(HCl)3, 0.921 g, 3.23 mmol; 0.83 
equiv)14a in H2O (5 mL) was added in one portion with stirring. The temperature was 
raised to 100 °C. After 0.75 h, the mixture was filtered. The solvent was removed from 
the red filtrate by rotary evaporation. The deep red solid was dissolved in HCl (0.50 M, 
100 mL). The solution was added to a Dowex column (50WX2 hydrogen form; 4.5 × 37 
cm; packed in water), which was eluted with HCl (1.0 M, 500 mL; 1.5 M, 500 mL; 2.0 
M, until the second orange band began to elute; then 3.0 M). The solvent was removed 
from the second orange band by rotary evaporation to give crude 27c·H4+ 4Cl– as an or-
ange solid (0.706 g. 1.512 mmol, 47%) and a 70:30 mixture of Λ/∆ isomers, as assayed 
by 13C{1H} NMR (δ, D2O, 58.5/57.1 ppm).25 NMR (D2O, δ in ppm): 1H (500 MHz) 
NH2 at 5.40-4.85 (br m, 10H), 4.64-4.37 (br m, 2H); CH2NHMe2+, CHNH2, 
 231 
CHCH2NH2, CHCH2CH2, and 2CH2CH2 at 3.27-3.13 (m, 2H), 3.12-2.69 (m, 16H), 
2.66-2.59 (br s, 1H), 2.01-1.72 (br m, 4H); 13C{1H} (125 MHz) 58.5/57.1 (s, CHNH2), 
57.7 (s, CH2NHMe2+), 49.7/48.8 (s, CHCH2NH2), 45.7, 45.6, 45.5, 45.4, 45.34, 45.27, 
45.1, 45.0 (8 × s, 2CH2CH2), 43.4, 43.3 (2 × s, NHMe2+), 29.2, 29.1, 22.1 (3 × s, 
CHCH2CH2). 
B. A solution of 27c·H4+ 4Cl– from A (0.648 g, 1.387 mmol) in H2O (40 mL) 
was added to a SP Sephadex column (C-25; 6.0 × 60 cm). Elution with 0.10 M (250 
mL), 0.15 M (250 mL), 0.20 M (500 mL) and 0.25 M aqueous 2Na+ d-tart2–·2H2O gave 
two bands. The first was collected and concentrated to 150 mL. This was added to a 
Dowex column (3.3 × 25 cm), which was eluted with aqueous HCl (gradient, 1.0 M to 
3.0 M). The orange band was collected (yellow eluent) and the solvent was removed by 
rotary evaporation and oil pump vacuum. This gave Λ-27c·H4+ 4Cl–·0.4NaCl·0.5H2O 
as an orange solid (0.442 g, 0.885 mmol, 64% or 91% of theory from the 70:30 
mixture),26 dec pt 177-213 °C.29 Anal. Calcd. for C11H36Cl4CoN7·0.4NaCl· 0.5H2O 
(499.58):30,31 C 26.45, H 7.46, N 19.63, Na 1.84; found: C 26.74, H 7.15, N 19.41, Na 
1.60.  
 NMR (D2O, δ in ppm): 1H (500 MHz) NH2 at 5.40 (br s, 1H), 5.23-4.86 (m, 
9H), 4.69-4.41 (m, 2H); CH2NHMe2+, CHNH2, CHCH2NH2, and 2CH2CH2 at 3.31-
3.12 (m, 2H), 3.11-2.44 (m, 18H); 2.01-1.71 (m, 4H, CHCH2CH2); 13C{1H} (125 MHz) 
58.4 (s, CHNH2), 57.6 (s, CH2NHMe2+), 49.7 (s, CHCH2NH2), 45.5, 45.4, 45.34, 45.27 
(4 × s, 2CH2CH2), 43.38, 43.33 (2 × s, NHMe2+), 29.1, 22.1 (2 × s, CHCH2CH2). 
The second band from the Sephadex column was concentrated to 100 mL. This 
was added to a Dowex column (3.0  12 cm), which was eluted with aqueous HCl 
(gradient, 1.0 M to 3.0 M). The orange band was collected (yellow eluent) and the 
solvent was removed by rotary evaporation and oil pump vacuum. This gave -27c·H4+ 
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4Cl–·0.5NaCl·H2O as an orange solid (0.172 g, 0.334 mmol, 24% or 80% of theory from 
the 70:30 mixture),26 dec pt 165-213 °C.29 Anal. Calcd. for 
C11H36Cl4CoN7·0.5NaCl·H2O (514.43):30,31 C 25.68, H 7.45, N 19.06; found: C 26.02, 
H 6.99, N 18.75.  
 NMR (D2O, δ in ppm): 1H (500 MHz) NH2 at 5.31 (br s, 1H), 5.13 (br s, 3H), 
5.03 (br s, 2H), 4.57 (br s, 1H), 4.43 (br s, 1H);28 3.27-3.09 (m, 3H, CH2NHMe2+, 
CHNH2), 3.07-2.57 (m, 16H, CH2NHMe2+, CHCH2NH2, 2CH2CH2), 1.98-1.73 (m, 
4H, CHCH2CH2); 13C{1H} (125 MHz) 57.7 (s, CH2NHMe2+), 57.1 (s, CHNH2), 48.7 
(s, CH2NH2), 45.7, 45.6, 45.1, 45.0 (4 × s, 2CH2CH2), 43.4 (s/double intensity, 
NHMe2+), 29.2, 22.1 (2 × s, CHCH2CH2). 
 Λ-27c3+ 3BArf–. A beaker was charged with Λ-27c·H4+ 4Cl–·0.4NaCl·0.5H2O 
(0.141 g, 0.282 mmol), H2O (30 mL), and aqueous NaOH (0.10 M; 2.82 mL, 0.282 
mmol). Then a solution of Na+ BArf
– (0.750 g, 0.846 mmol) in CH2Cl2 (30 mL) was 
added with stirring. After 15 min, the biphasic mixture was allowed to stand. The lower 
orange CH2Cl2 phase was separated. This solution was allowed to evaporate to give Λ-
27c3+ 3BArf
–·11H2O as an orange solid (0.764 g, 0.246 mmol, 87%; from L3: 26% or 
37% of theory),26 which upon warming continually darkened and liquefied at 133 °C. 
Anal. Calcd. for C107H71B3CoF72N7.11H2O (3112.17): C 41.29, H 3.01, N 3.15; found: 
C 41.23, H 2.98, N 3.17. 
 NMR (CD3CN, δ in ppm): 1H (500 MHz) BArf– at 7.70 (s, 24H, o), 7.66 (s, 12H, 
p); NH2 at 4.62 (br s, 1H), 4.37-3.61 (m, 10H), 3.48 (br s, 1H); CH2NMe2, CHNH2, 
CHCH2NH2, 2CH2CH2, and H2O at 2.98-2.57 (br m, 11H), 2.49-2.23 (br m, 24H), 2.20 
(br s, 6H); CHCH2CH2 at 1.78-1.48 (m, 4H); 13C{1H} (125 MHz) BArf– at 162.6 (q, 
1JBC = 50.0 Hz, i), 135.7 (s, o), 129.9 (qm, 2JCF =  31.3 Hz, m), 125.5 (q, 1JCF = 270.0 
Hz, CF3), 118.7 (m, p); 59.4, 59.3 (2 × s, CHNH2, CHCH2NH2), 50.1 (s, CH2NMe2), 
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45.8, 45.6, 45.5, 45.4, 45.3 (s, s, s/double intensity, s, s, 2CH2CH2, NMe2), 30.4, 24.8 (2 
× s, CHCH2CH2). 
 Δ-27c3+ 3BArf–. A beaker was charged with Δ-27c·H4+ 4Cl–·0.5NaCl·H2O 
(0.144 g, 0.280 mmol), H2O (30 mL), and aqueous NaOH (0.10 M; 2.80 mL, 0.28 
mmol). Then a solution of Na+ BArf
– (0.745 g, 0.840 mmol) in CH2Cl2 (30 mL) was 
added with stirring. After 15 min, the biphasic mixture was allowed to stand. The lower 
orange CH2Cl2 phase was separated. This solution was allowed to evaporate to give Δ-
27c3+ 3BArf
–·9H2O as an orange solid (0.767 g, 0.249 mmol, 89%; from L3: 10% or 
36% of theory),26 which upon warming continually darkened and liquefied at 131 °C. 
Anal. Calcd. for C107H71B3CoF72N7.9H2O (3076.14): C 41.78, H 2.92, N 3.19; found: 
C 41.74, H 3.10, N 3.19. 
NMR (CD3CN, δ in ppm): 1H (500 MHz) BArf– at 7.71 (s, 24H, o), 7.68 (s, 12H, 
p); NH2 at 4.43-3.60 (m, 11H), 3.48 (br s, 1H); CH2NMe2, CHNH2, CHCH2NH2, 
2CH2CH2, and H2O at 2.92-2.58 (br m, 10H), 2.39-2.11 (m, 33H); CHCH2CH2 at 1.79-
1.66 (m, 2H), 1.63-1.51 (m, 2H); 13C{1H} (125 MHz) BArf– at 162.6 (q, 1JBC = 50.0 
Hz, i), 135.7 (s, o), 129.9 (qm, 2JCF =  31.3 Hz, m), 125.5 (q, 1JCF = 270.0 Hz, CF3), 
118.7 (m, p); 59.5, 58.0 (2 × s, CHCH2NH2), 49.0 (s, CH2NMe2), 46.01, 45.96 (2 × s, 
NMe2), 45.5, 45.4, 45.34, 45.26 (4 × s, 2CH2CH2), 30.5, 24.6 (2 × s, CHCH2CH2). 
Λ- and Δ-[Co(en)2((S)-H2NCH((CH2)4NMe2H)CH2NH2)]4+ 4Cl– (Λ- and Δ-
27d·H4+ 4Cl–). A. A round bottom flask was charged with [Co(en)2O2CO]+ Cl– (0.754 
g, 2.752 mmol),15 activated charcoal (0.550 g), and H2O (30 mL), and fitted with a 
condenser. The mixture was heated to 40 °C. Then a solution of the tris(hydrochloric 
acid) salt of (S)-H2NCH((CH2)4NMe2H)CH2NH2 ((S)-L4·(HCl)3, 0.690 g, 2.29 mmol; 
0.83 equiv)14a in H2O (5 mL) was added in one portion with stirring. The temperature 
was raised to 100 °C. After 0.75 h, the mixture was filtered. The solvent was removed 
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from the red filtrate by rotary evaporation. The deep red solid was dissolved in HCl 
(0.50 M, 100 mL). The solution was added to a Dowex column (50WX2 hydrogen form; 
4.5 × 30 cm; packed in water), which was eluted with HCl (1.0 M, 500 mL; 1.5 M, 500 
mL; 2.0 M, until the second orange band began to elute; then 3.0 M). The solvent was 
removed from the second orange band by rotary evaporation to give crude 27d·H4+ 4Cl– 
as an orange solid (0.652 g. 1.36 mmol, 59%) and a 72:28 mixture of Λ/∆ isomers, as 
assayed by 13C {1H} NMR (δ, D2O, 58.8/57.5 ppm).25 NMR (D2O, δ in ppm): 1H (500 
MHz) NH2 at 5.32 (br s, 2H), 5.21-4.84 (br m, 8H), 4.50 (br m, 2H); 3.16 (t, 3JHH = 8.0 
Hz, 2H, CH2NHMe2+), 3.11-2.66 (m, 16H, CH2NHMe2+, CHNH2, CHCHH'NH2, 
2CH2CH2), 2.62-2.49 (m, 1H, CHCHH'NH2), 1.84-1.70 (m, 4H, CHCH2CH2CH2), 
1.61-1.40 (m, 2H, CHCH2CH2CH2); 13C{1H} (125 MHz) 58.8/57.5 (s, CHNH2), 58.0 
(s, CH2NHMe2+), 49.8/48.8 (2 × s, CHCH2NH2), 45.69, 45.65, 45.5, 45.38, 45.36, 45.3, 
45.1, 45.0 (8 × s, 2CH2CH2), 43.3 (s/double intensity, NHMe2+), 32.1/31.8, 24.5/24.4, 
23.6/23.5 (6 × s, CHCH2CH2CH2). 
B. A solution of 27d·H4+ 4Cl– from A (0.582 g, 1.212 mmol) in H2O (40 mL) 
was added to a SP Sephadex column (C-25; 6.0 × 60 cm). Elution with 0.10 M (250 
mL), 0.15 M (250 mL), 0.20 M (500 mL) and 0.25 M aqueous 2Na+ d-tart2–·2H2O gave 
two bands. The first was collected and concentrated to 150 mL. This was added to a 
Dowex column (3.3 × 25 cm), which was eluted with aqueous HCl (gradient, 1.0 M to 
3.0 M). The orange band was collected (yellow eluent) and the solvent was removed by 
rotary evaporation and oil pump vacuum. This gave Λ-27d·H4+ 4Cl–·NaCl·1.2H2O as 
an orange solid (0.461 g, 0.821 mmol, 68% or 94% of theory from the 72:28 mixture),26 
dec pt 160-209 °C.29 Anal. Calcd. for C12H38Cl4CoN7·NaCl·1.2H2O (561.28): C 25.68, 
H 7.25, N 17.47, Na 4.10; found: C 25.92, H 6.94, N 17.11, Na 2.63.30,31  
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NMR (D2O, δ in ppm): 1H (500 MHz) NH2 at 5.34 (br s, 1H), 5.22-4.86 (br m, 
9H), 4.49 (br s, 2H); 3.16 (br s, 2H, CH2NHMe2+), 3.10-2.64 (m, 16H, CH2NHMe2+, 
CHNH2, CHCHH'NH2, 2CH2CH2), 2.58 (br s, 1H, CHCHH'NH2), 1.78 (br s, 4H, 
CHCH2CH2CH2), 1.61-1.40 (m, 2H, CHCH2CH2CH2); 13C{1H} (125 MHz) 58.8 (s, 
CHNH2), 58.0 (s, CH2NHMe2+), 49.8 (s, CHCH2NH2), 45.5, 45.32, 45.25, 45.1 (4 × s, 
2CH2CH2), 43.3 (s/double intensity, NHMe2+), 31.9, 24.4, 23.5 (3 × s, 
CHCH2CH2CH2). 
The second band from the Sephadex column was collected and concentrated to 
100 mL. This was added to a Dowex column (3.0  12 cm), which was eluted with 
aqueous HCl (gradient, 1.0 M to 3.0 M). The orange band was collected (yellow eluent) 
and the solvent was removed by rotary evaporation and oil pump vacuum. This gave -
27d·H4+ 4Cl–·1.5NaCl·H2O as an orange solid (0.121 g, 0.206 mmol, 17% or 61% of 
theory from the 72:28 mixture),26 dec pt 180-209 °C.29 Anal. Calcd. for 
C12H38Cl4CoN7·1.5NaCl·H2O (586.90):30,31 C 24.56, H 6.87, N 16.71; found: C 24.92, 
H 6.56, N 16.19.  
NMR (D2O, δ in ppm): 1H (500 MHz) NH2 at 5.29 (br s, 2H), 5.22-4.87 (br m, 
6H), 4.58-4.34 (m, 3H);28 3.19-3.13 (m, 2H, CH2NHMe2+), 3.12-2.68 (m, 15H, 
CH2NHMe2+, CHNH2, 2CH2CH2), 2.64-2.51 (m, 2H, CHCH2NH2), 1.86-1.71 (m, 4H, 
CHCH2CH2CH2), 1.58-1.42 (m, 2H, CHCH2CH2CH2); 13C{1H} (125 MHz) 57.9 (s, 
CH2NHMe2+), 57.5 (s, CHNH2), 48.8 (s, CHCH2NH2), 45.64, 45.61, 45.04, 44.97 (4 × 
s, 2CH2CH2), 43.3 (s/double intensity, NHMe2+), 32.1, 24.5, 23.7 (3 × s, 
CHCH2CH2CH2).  
Λ-27d3+ 3BArf–. A beaker was charged with Λ-27d·H4+ 4Cl–·NaCl·1.2H2O 
(0.120 g, 0.215 mmol), H2O (30 mL), and aqueous NaOH (0.10 M; 2.25 mL, 0.225 
mmol). A solution of Na+ BArf
– (0.572 g, 0.645 mmol) in CH2Cl2 (30 mL) was added 
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with stirring. After 15 min, the biphasic mixture was allowed to stand. The lower orange 
CH2Cl2 phase was separated. This solution was allowed to evaporate to give Λ-27d3+ 
3BArf
–·9H2O as an orange solid (0.611 g, 0.198 mmol, 92%; from L4: 37% or 51% of 
theory),26 which upon warming continually darkened and liquefied at 110 °C. Anal. 
Calcd. for C108H73B3CoF72N7.9H2O (3090.17): C 41.98, H 2.97, N 3.17; found: C 
42.23, H 2.79, N 2.62.  
NMR (CD3CN, δ in ppm): 1H (500 MHz) BArf– at 7.71 (s, 24H, o), 7.67 (s, 12H, 
p); NH2 at 4.51-3.96 (br m, 8H), 3.92-3.70 (m, 3H), 3.53 (br s, 1H); CH2NMe2, 
CHNH2, CHCH2NH2, 2CH2CH2, and H2O at 2.90-2.64 (br m, 9H), 2.58-2.12 (m, 
32H); 1.74-1.35 (m, 6H, CHCH2CH2CH2); 13C{1H} (125 MHz) BArf– at 162.6 (q, 
1JBC = 50.0 Hz, i), 135.7 (s, o), 129.9 (qm, 2JCF =  31.3 Hz, m), 125.1 (q, 1JCF = 270.0 
Hz, CF3), 118.6 (m, p); 59.3, 59.2 (2 × s, CHNH2, CHCH2NH2), 50.1, 45.8, 45.6, 45.4, 
45.3, 45.0 (s, s, s, s, s, s/broad, 2CH2CH2, NMe2, CH2NMe2), 32.2, 26.7, 24.4 (3 × s, 
CHCH2CH2CH2). 
Δ-27d3+ 3BArf–. A beaker was charged with Δ-27d·H4+ 4Cl–·1.5NaCl·H2O 
(0.060 g, 0.102 mmol), H2O (15 mL), and aqueous NaOH (0.10 M; 1.05 mL, 0.105 
mmol). A solution of Na+ BArf
– (0.271 g, 0.306 mmol) in CH2Cl2 (15 mL) was added 
with stirring. After 15 min, the biphasic mixture was allowed to stand. The lower orange 
CH2Cl2 phase was separated. This solution was allowed to evaporate to give Δ-27d3+ 
3BArf
–·10H2O as an orange solid (0.285 g, 0.092 mmol, 90%; from L4: 9% or 32% of 
theory),26 which upon warming continually darkened and liquefied at 100 °C. Anal. 
Calcd. for C108H73B3CoF72N7.10H2O (3108.18): C 41.73, H 3.02, N 3.15; found: C 
41.60, H 3.13, N 3.13. 
NMR (CD3CN, δ in ppm): 1H (500 MHz) BArf– at 7.71 (s, 24H, o), 7.68 (s, 12H, 
p); NH2 at 4.66-3.48 (m, 12H); CH2NMe2, CHNH2, CHCH2NH2, 2CH2CH2, and H2O 
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at 3.03-2.19 (br m, 37H); 1.75-1.22 (m, 6H, CHCH2CH2CH2); 13C{1H} (125 MHz) 
BArf– at 162.6 (q, 1JBC = 50.0 Hz, i), 135.7 (s, o), 130.0 (qm, 2JCF =  31.3 Hz, m), 125.5 
(q, 1JCF = 270.0 Hz, CF3), 118.7 (m, p); 59.3, 58.1 (2 × s, CHNH2, CHCH2NH2), 49.0, 
46.04, 45.97, 45.4, 45.3, 45.1 (s, s, s, s, s, s/broad, 2CH2CH2, NMe2, CH2NMe2), 32.4, 
26.8, 24.7 (3 × s, CHCH2CH2CH2). 
Experiments in Scheme 7.3. A 5 mm NMR tube was charged with a solution of 
21a (0.0075 g, 0.050 mmol, 1.0 equiv), catalyst (0.0050 mmol, 0.10 equiv), and 
Ph2SiMe2 (0.0020 mL, internal standard) in a deuterated solvent (0.50 mL). A 1H NMR 
spectrum was recorded to measure the initial ratio of 21a to the standard. Then 22c 
(0.0068 mL, 0.060 mmol, 1.2 equiv) was added at the specified temperature. The 
conversions were monitored by 1H NMR and TLC. After the specified time, the mixture 
was loaded onto a plug of silica gel, which was eluted with hexanes/EtOAc (1:1 v/v, 50 
mL). The solvent was removed by rotary evaporation to give 23ac, and the enantiomeric 
purity was assayed by chiral HPLC.32  
Experiments in Scheme 7.4. A 1.5 mL vial was charged with a solution of 
nitroolefin (21-R, 0.10 mmol, 1.0 equiv) and Λ-27c3+ 3BArf–·11H2O (0.031 g, 0.010 
mmol, 0.10 equiv) in CH2Cl2 (0.70 mL). The sample was cooled to –35 °C, and dialkyl 
malonate (22-R″, 0.120 mmol, 1.20 equiv) was added. The conversion was monitored by 
TLC. After the specified time, the mixture was chromatographed on a silica gel column 
(1.9  14 cm, 9:1 v/v hexanes/EtOAc). The solvent was removed from the product 
containing fractions by rotary evaporation. The product was dried by oil pump vacuum 
at room temperature (yields: Scheme 7.4) and the enantiomeric purities were assayed by 
chiral HPLC.32  
Experiments in Figure 7.6 (Rate Profiles). A (monofunctional catalyst). A 5 
mm NMR tube was charged with a solution of 21a (0.0150 g, 0.101 mmol), dimethyl 
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malonate (22c, 0.0138 mL, 0.121 mmol, 1.20 equiv), Λ-[Co(en)3]3+ 3BArf–·14H2O 
(0.006 g, 0.0020 mmol, 0.020 equiv), and Ph2SiMe2 (0.0020 mL, internal standard) in 
CD2Cl2 (1.0 mL). A 1H NMR spectrum was recorded to measure the initial ratio of 21a 
to the standard. Then a solution of Et3N in CD2Cl2 (0.20 M, 0.010 mL, 0.0020 mmol, 
0.020 equiv) was added and the conversion to 23ac was periodically assayed by 1H 
NMR. After 3 h, the mixture was loaded directly onto a plug of silica gel, which was 
eluted with hexanes/EtOAc (1:1 v/v, 50 mL). The solvent was removed from the eluent 
by rotary evaporation. The enantiomeric purity of 23ac was assayed by chiral HPLC 
(9% ee, R dominant).32,33 B (bifunctional catalyst). A 5 mm NMR tube was charged 
with a solution of 21a (0.0150 g, 0.101 mmol), Λ- or Δ-27c3+ 3BArf– (0.0062, 0.0020 
mmol, 0.020 equiv), and Ph2SiMe2 (0.0020 mL, internal standard) in CD2Cl2 (1.0 mL). 
A 1H NMR spectrum was recorded to measure the initial ratio of 21a to the standard. 
Then 22c (0.0138 mL, 0.121 mmol, 1.20 equiv) was added and the reaction carried out 
and analyzed as in A. 
Dimethyl 2-(2-nitro-1-phenylethyl)malonate (23ac).3b,18c,d,19 This known 
compound was isolated as a white solid per the general procedure for Scheme 7.4. The 
1H and 13C{1H} NMR spectra were identical with those reported earlier. Chiral HPLC 
(see Figure A-4): Chiralpak AS-H column (90:10 v/v hexane/isopropanol, 1.0 mL/min, λ 
= 220 nm); tR = 17.3 min (minor), 19.6 min (major).32  
Diethyl 2-(2-nitro-1-phenylethyl)malonate (23ab).3b,18c,d,19 This known 
compound was isolated as a colorless oil per the general procedure for Scheme 7.4. The 
1H and 13C{1H} NMR spectra were identical with those reported earlier. Chiral HPLC 
(see Figure A-3): Chiralpak AS-H column (90:10 v/v hexane/isopropanol, 1.0 mL/min, λ 
= 220 nm); tR = 11.4 min (minor), 12.8 min (major).32  
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Dibenzyl 2-(2-nitro-1-phenylethyl)malonate (23ad).19b This known compound 
was isolated as a colorless oil per the general procedure for Scheme 7.4. NMR (CDCl3, δ 
in ppm):34 1H (500 MHz) 7.35-7.25 (m, 11H), 7.18-7.16 (m, 2H), 7.09-7.07 (m, 2H), 
5.18 (d, 2JHH = 12.0 Hz, 1H, CHH'Ph), 5.15 (d, 2JHH =  12.5 Hz, 1H, CHH'Ph), 4.96 (d, 
2JHH = 12.0 Hz, 1H, C'HH'Ph), 4.93 (d, 2JHH = 12.0 Hz, 1H, C'HH'Ph), 4.86-4.84 (m, 
2H, CH2NO2), 4.26 (td, 3JHH = 8.5 Hz, 3JHH = 5.5 Hz, 1H, CHCH2NO2), 3.94 (d, 3JHH 
= 9.0 Hz, 1H, CH(CO2Bn)2); 13C{1H} (125 MHz) 167.1 (s, CO2Bn), 166.5 (s, 
C'O2Bn), 135.9 (s, i-Ph), 134.7 (s, i-Bn), 134.6 (s, i-Bn'), 129.0, 128.62, 128.61, 128.5, 
128.44, 128.35, 128.3, 128.2, 127.9 (s/double intensity, s/double intensity, s, s/double 
intensity, s, s, s/double intensity, s/double intensity, s/double intensity, o/m/p Ph, Bn, 
Bn'), 77.4 (s, CH2NO2), 67.8 (s, CH2Ph), 67.6 (s, CH2Ph), 54.9 (s, CH(CO2Bn)2), 42.9 
(s, CHCH2NO2). Chiral HPLC (see Figure A-24): Chiralcel AS-H column (90:10 v/v 
hexane/isopropanol, 1.0 mL/min, λ = 220 nm); tR = 18.5 min (minor), 21.7 min (major).  
Dimethyl 2-(2-nitro-1-(4-methoxyphenyl)ethyl)malonate (23dc).3b,18d This 
known compound was isolated as a colorless oil per the general procedure for Scheme 
7.4. The 1H and 13C{1H} NMR spectra were identical with those reported earlier. Chiral 
HPLC (see Figure A-7): Chiralpak AD column (80:20 v/v hexane/isopropanol, 1.0 
mL/min, λ = 220 nm); tR = 11.7 min (major), 18.2 min (minor).32  
Dimethyl 2-(2-nitro-1-(3,4-dichlorophenyl)ethyl)malonate (23ec).3b,18d This 
known compound was isolated as a white solid per the general procedure for Scheme 
7.4. The 1H and 13C{1H} NMR spectra were identical with those reported earlier. Chiral 
HPLC (see Figure A-8): Chiralpak AS-H column (90:10 v/v hexane/isopropanol, 1.0 
mL/min, λ = 220 nm); tR = 20.8 min (minor), 22.9 min (major).32  
Dimethyl 2-(2-nitro-1-(3,4-dioxolophenyl)ethyl)malonate (23mc).19a This 
known compound was isolated as a colorless oil per the general procedure for Scheme 
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7.4. NMR (CDCl3, δ in ppm):34 1H (500 MHz) 6.74-6.67 (m, 3H, C6H3), 5.95 (s, 2H, 
OCH2O), 4.87 (dd, 2JHH = 13.0 Hz, 3JHH = 8.0 Hz, 1H, CHH'NO2), 4.80 (dd, 2JHH = 
13.0 Hz, 3JHH = 9.5 Hz, 1H, CHH'NO2), 4.16 (td, 3JHH = 9.0 Hz, 3JHH = 5.0 Hz, 1H, 
CHCH2NO2), 4.79 (dd, 3JHH = 9.0 Hz, 1H, CH(CO2Me)2), 3.76 (s, 3H, CH3), 3.61 (s, 
3H, C'H3); 13C{1H} (125 MHz) 167.9 (s, CO2Me), 167.3 (s, C'O2Me), 148.2, 147.7, 
129.7, 121.5, 108.8, 108.3, 101.5 (7  s, C6H3, OCH2O), 77.7 (s, CH2NO2), 55.0 (s, 
CH(CO2Me)2), 53.2 (s, CH3), 53.1 (s, C'H3), 42.8 (s, CHCH2NO2). Chiral HPLC (see 
Figure A-25): Chiralcel AS-H (90:10 v/v hexane/isopropanol, 1.0 mL/min, λ = 220 nm); 
tR = 49.8 min (major), 58.2 min (minor).32  
Dimethyl 2-(2-nitro-1-α-naphthylethyl)malonate (23bc).3b,18d This known 
compound was isolated as a colorless oil per the general procedure for Scheme 7.4. The 
1H and 13C{1H} NMR spectra were identical with those reported earlier. Chiral HPLC 
(see Figure A-5): Chiralpak AD column (90:10 v/v hexane/isopropanol, 1.0 mL/min, λ = 
254 nm); tR = 13.6 min (major), 19.1 min (minor).32  
Dimethyl 2-(2-nitro-1-furylethyl)malonate (23kc).3b,18d This known 
compound was isolated as a yellowish oil per the general procedure for Scheme 7.4. The 
1H and 13C{1H} NMR spectra were identical with those reported earlier. Chiral HPLC 
(see Figure A-14): Chiralcel OD column (90:10 v/v hexane/isopropanol, 1.0 mL/min, λ 
= 220 nm); tR = 12.6 min (minor), 28.4 min (major).32  
Dimethyl 2-(2-nitro-1-propylethyl)malonate (23lc).3b,18d This known 
compound was isolated as a colorless oil per the general procedure for Scheme 7.4. The 
1H and 13C{1H} NMR spectra were identical with those reported earlier. Chiral HPLC 
(see Figure A-15): Chiralcel OD column (97.5:2.5 v/v hexane/isopropanol, 1.0 mL/min, 
λ = 220 nm); tR = 9.2 min (minor), 16.4 min (major).32 
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Dimethyl 2-(2-nitro-1-cyclohexylethyl)malonate (23nc).18a,b This known 
compound was isolated as a colorless oil per the general procedure for Scheme 7.4. 
NMR (CDCl3, δ in ppm):34 1H (500 MHz) 4.72 (dd, 2JHH = 15.0 Hz, 3JHH = 5.0 Hz, 
1H, CHH'NO2), 4.61 (dd, 2JHH = 13.5 Hz, 3JHH = 6.5 Hz, 1H, CHH'NO2), 3.76 (s, 3H, 
OCH3), 3.75 (d, 3JHH = 5.0 Hz, 1H, CH(CO2Me)2), 3.74 (s, 3H, OC'H3), 2.90 (m, 1H, 
CHCH2NO2), 1.79-1.64 (m, 4H, ring CH2/CH), 1.49-1.39 (m, 1H, ring CH2/CH), 1.28-
1.06 (m, 4H, ring CH2/CH), 1.04-0.93 (m, 2H, ring CH2/CH); 13C{1H} (125 MHz) 
168.9 (s, CO2Me), 168.6 (s, C'O2Me), 75.4 (s, CH2NO2), 52.9 (s, OCH3), 52.7 (s, 
OC'H3), 51.0 (s, CH(CO2Me)2), 42.1 (s, CHCH2NO2), 39.6, 30.2, 29.8, 26.22, 26.17, 
26.0 (6  s, ring CH2/CH). Chiral HPLC (see Figure A-26): Chiralcel OD column 
(90:10 v/v hexane/ isopropanol, 0.5 mL/ min, λ = 220 nm); tR = 12.1 min (minor), 25.7 
min (major).32  
7.5. Crystallography.  
One drop of conc. HCl was added to a solution of Δ-27a·H4+ 4Cl–·3H2O (0.020 
g) in six drops of distilled water. After several days at room temperature, orange crystals 
had formed and were analyzed as outlined in Table 7.1. Cell parameters were obtained 
from 180 frames using a 0.5° scan.35 Integrated intensity information for each reflection 
was obtained by reduction of the data frames with the program APEX2.36 Data were 
corrected for Lorentz and polarization factors, as well as for crystal decay effects. 
SADABS37 was employed to correct the data for absorption effects. The space group 
was determined from systematic reflection conditions and statistical tests. The structure 
was solved by direct methods using SHELXTL (SHELXS),38 and revealed the same 
number of water molecules as in the starting material. The hydrogen atoms were fixed in 
idealized positions using a riding model. Non-hydrogen atoms were refined with 
anisotropic thermal parameters. The parameters were refined by weighted least squares 
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refinement on F2 to convergence.38,39 The absolute structure parameter was estimated as 
0.006(3) (Table 7.1).40  
 CCDC 1439942 contains the supplementary crystallographic data which can be 
obtained from www.ccdc.cam.ac.uk/data_request/cif. 
 
 
Table 7.1. Crystallographic data for Δ-27a·H4+ 4Cl–·3H2O 
Empirical formula  C9H38Cl4CoN7O3 
Formula weight  493.19 
Temperature  110(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions  
 a 7.4152(4) Å 
 b Å 
 c Å 
  
  
  
 V 2174.98(18) Å3 
Z  4 
Density (calculated) 1.506 Mg/m3 
Absorption coefficient 10.909 mm–1 
F(000) 1040 
Crystal size 0.08 × 0.07 × 0.02 mm3 
Theta range for data collection 4.34 to 60.00°. 
Index ranges –8 ≤ h ≤ 8, –16 ≤ k ≤ 16, –21 ≤ l ≤ 22 
Reflections collected 36509 
Independent reflections 3167 [R(int) = 0.0583] 
Completeness to theta = 60.00° 99.5%  
Absorption correction Semi-empirical from equivalents 
Max. / min. transmission 0.8113 / 0.4757 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3167 / 0 / 230 
Goodness-of-fit on F2 0.995 
Final R indices [I>2σ(I)] R1 = 0.0215, wR2 = 0.0411 
R indices (all data) R1 = 0.0234, wR2 = 0.0414 
Absolute structure parameter –0.006(3) 
Largest diff. peak and hole 0.161 and –0.195 e·Å–3 
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8. NEW MEDIA FOR CLASSICAL COORDINATION 
CHEMISTRY: PHASE TRANSFER OF WERNER AND 
RELATED POLYCATIONS INTO HIGHLY NONPOLAR 
FLUOROUS SOLVENTS† 
 
8.1. Introduction 
The chiral octahedral tris(ethylenediamine) cobalt trication [Co(en)3]3+, and 
related Werner systems, represent important milestones in the development of inorganic 
chemistry and stereochemistry.1-3 As Werner reported in 1912,2b the two enantiomers of 
[Co(en)3]3+ can be separated by crystallization of the diastereomeric tartrate salts. As 
depicted in Scheme 8.1, the configurations of the cobalt stereocenters are denoted  and 
. Separation is commonly followed by halide anion exchange. Despite the simplicity of 
this procedure, applications of Werner salts in enantioselective organic reactions have 
only been developed during the past 5 years.4   
 
 
 
  
Scheme 8.1. Enantiomers of the trication of [Co(en)3]3+ 3Cl–.  
 
 
 
One factor inhibiting progress has been the lack of solubility in organic solvents. The 
racemic tetraphenylborate salt [Co(en)3]3+ 3BPh4– has been reported, and is only 
 
†Reproduced with permission from Ghosh, S. K.; Sullivan, A. R.; Leas, J. G.; Bhuvanesh, N.; Gladysz, J. 
A. Inorg. Chem. 2013, 52, 9369-9378. Copyright 2013 American Chemical Society. 
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soluble in methanol and THF.5,6 We recently found that the more lipophilic B(3,5-
C6H3(CF3)2)4 or "barf" (BArf) salt could easily be prepared by adding a CH2Cl2 
solution of Na+ BArf– to an aqueous solution of enantiopure -[Co(en)3]3+ 3I–.4a,7 The 
trication rapidly transferred into the organic phase, and solvent removal afforded the 
hydrate [Co(en)3]3+ 3BArf–·14H2O. This substance was soluble in a wide range of 
organic solvents, and the water is believed to be associated with a "second" or "outer" 
coordination sphere involving hydrogen bonding with the NH protons.  
Ongoing work in our laboratory has demonstrated the extraordinary utility of 
such BArf salts in enantioselective catalysis.4 Accordingly, I became curious about the 
possibility of extending this chemistry to fluorous analogs and media.8 Fluorous 
catalysts, which often feature ponytails of the formula (CF2)n-1CF3 (Rfn), are easily 
separated from organic products and recycled by a number of protocols.9 Furthermore, 
the "fluorous BArf" salt Na+ B(3,5-C6H3(Rf6)2)4– (28, Na+ BArf6–) had previously been 
reported.10-12 Hence, I wondered whether it would be possible to render such 
polycations highly fluorophilic and readily soluble in perfluoroalkanes, which are some 
of the least polar solvents known. 
In this section, I describe the facile solubilization of tricationic Werner salts in fl-
uorous media. Since some difficulties were encountered in the synthesis of Na+ BArf6–, 
optimized procedures that have been repeated by several coworkers are provided. In 
order to confirm that this concept may be extended beyond cobalt hexaamine complexes, 
the synthesis of a fluorophilic salt of the extensively studied ruthenium dication 
[Ru(bipy)3]2+ is also detailed.13 During the course of these efforts, the crystal structure 
of a fluorous arene could be determined, and was found to exhibit several unusual 
features. 
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8.2. Results 
8.2.1. Synthesis of Na+ BArf6– (28) 
The van Koten/Deelman and Bühlmann research groups have reported syntheses 
of Na+ BArf6–,10,11 and each requires the fluorous bromoarene precursor Br(3,5-
C6H3(Rf6)2) (29). One route to the latter involves the selective disubstitution of 1,3,5-
tribromobenzene using perfluorohexyliodide (Rf6I) and copper.11,14,15 However, several 
coworkers have had difficulty stopping this reaction at the optimum stage, and with the 
separation of monosubstitution or trisubstitution byproducts. Thus, I have synthesized 28 
by modifying the sequence of van Koten and Deelman,10 which is summarized in 
Scheme 8.2. 
 
 
 
 
Scheme 8.2. Modified syntheses of Na+ BArf6– (28). 
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First, the copper mediated cross coupling of 1,3-diiodobenzene and a slight 
excess of Rf6I was carried out at 140 °C. Only DMSO was used as the solvent, as 
opposed to DMSO/C6F6 as employed earlier.10 The co-catalyst 2,2'-bipyridine was also 
omitted, necessitating a higher temperature. Workup after 3 d gave 1,3-di(perfluoro-
hexyl)benzene or 1,3-C6H4(Rf6)2 (30) in 86-70% yields.  
Next, 30 was brominated using a procedure developed by Dolbier for the 
analogous reaction of 1,3-di(trifluoromethyl)benzene.16 Thus, 30 was dissolved in 29:71 
(v/v) H2SO4/CF3CO2H and NBS was added in portions over the course of 6 h. Workup 
after 2 d gave the aryl bromide Br(3,5-C6H3(Rf6)2 (29) as a spectroscopically pure white 
solid in 88-75% yields. The literature procedure used a 41:59 (v/v) H2SO4/CF3CO2H 
mixture, with a charge of NBS added every two days over the course of seven days.10 I 
repeatedly verified that these seemingly minor differences afforded, as reported, a ca. 6:1 
29/30 mixture in only 54% yield. 
Fluorous molecules often resist crystallization, but colorless crystals of 29 were 
obtained from an acetone-d6 solution. X-ray data were collected and the structure was 
determined as summarized in Table 8.1 and the experimental section. Two views of the 
molecular structure, and key bond lengths and angles, are provided in Figure 8.1.17 
The perfluorohexyl groups adopt conformations that project "upwards" from the 
plane of the arene ring, as reflected by C2-C3-C7-C8, C4-C3-C7-C8, C4-C5-C13-C14, 
and C6-C5-C13-C1 torsion angles of 97.6° to 83.1° (Figure 8.1, bottom). Despite initial 
appearances, there is no mirror plane containing the carbon-bromine bond and the para 
carbon atom (Br1, C1, C4). Powder X-ray diffraction data obtained with samples of 29 
prior to crystallization agreed well with the single crystal data. There are several 
interesting aspects of this crystal structure, but further analyses are deferred to the 
discussion section. 
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Figure 8.1. Two views of the molecular structure of 29 with thermal ellipsoids at the 
50% probability level. Key bond lengths (Å) and angles (°): C1-Br 1.899(2), C1-C2 
1.385(3), C2-C3 1.391(3), C4-C5 1.394(3), C5-C6 1.391(3), C6-C1 1.383(3), C3-C7 
1.507(3), C5-C13 1.506(3), average of ten CF-CF 1.544(5), Br-C1-C2 119.14(17), C1-
C2-C3 118.7(2), C2-C3-C4 120.7(2), C3-C4-C5 119.3(2), C4-C5-C6 120.8(2), C5-C6-
C1 118.5(2), C6-C1-C2 121.9(2), C6-C1-Br 118.93(17), C2-C3-C7 120.3(2), C4-C3-C7 
119.0(2), C4-C5-C13 119.2(2), C6-C5-C13 120.0(2), average of eight CF-CF-CF 
115.0(8). 
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Table 8.1. Crystallographic data for 29. 
empirical formula  C18H3BrF26 
formula weight  793.11 
temperature of collection [K] 110(2) 
wavelength [Å] 1.54178 
crystal system  tetragonal 
space group I4 
unit cell dimensions  
 a [Å] 29.5335(13)  
 b [Å]  
 c [Å]  
 ° 
 °] 
 ° 
V [Å3]  4851.7(4)  
Z  8 
ρcalc [Mg/m3] 2.172 
μ [mm–1] 4.348 
F(000) 3040 
crystal dimension [mm3] 0.45 × 0.04 × 0.04 
Θ [°]  2.12 to 59.92 
range/indeces (h, k, l) –33,33; –33,33; –6,5 
reflections collected 56681 
independent reflections 3534 [R(int) = 0.0559] 
completeness to Θ = 59.92° 98.9% 
absorption correction semi-empirical from equivalents 
max. and min. transmission 0.8453 and 0.2451 
refinement method full-matrix least-squares on F2 
data/restraints/parameters 3534/1/407 
goodness-of-fit on F2 1.051 
final R indices [I>2σ(I)] R1 = 0.0190, wR2 = 0.0466 
R indices (all data) R1 = 0.0198, wR2 = 0.0470 
absolute structure parameter 0.00(9) 
largest diff. peak/hole [e Å–3] 0.187/–0.316 
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The "fluorous BArf" salt 28 was synthesized according to the literature recipe in 
Scheme 8.2,10 but with a chromatographic workup (silica gel, ether and then 
CH2Cl2/CH3OH) that avoided persistent acetone solvates encountered with the reported 
purification. White needles were obtained from perfluoro(2-butyltetrahydrofuran) (FC-
75) in 77-70% yields. As summarized in Table 8.2, 28 was soluble in all fluorous 
solvents investigated, as well as the hybrid solvent C6H5CF318 and a number of organic 
solvents. It was insoluble in benzene, toluene, and hexanes. The NMR properties of 28-
30 closely agreed with those previously reported. In the case of 28, a 13C{1H,19F}NMR 
spectrum was recorded, which showed a quartet for the ipso carbon at 161.8 ppm due to 
11B-13C coupling (J = 50.0 Hz), and singlets as opposed to multiplets for the CF2 
groups. 
 
 
 
Table 8.2. Solubility data (24 °C). 
Solvent 
Compound 
28 31a 32b 
FC-72c Soluble Soluble Soluble 
FC-75d Soluble Soluble Soluble 
PFMCe Soluble Soluble Soluble 
C6H5CF3 Soluble Soluble Soluble 
Acetone Soluble Soluble Soluble 
Et2O Soluble Soluble Soluble 
CH3OH Soluble Soluble Soluble 
CH2Cl2 Soluble Soluble Soluble 
CD3CN Soluble Sp. soluble Insoluble 
Ethyl acetate Soluble Soluble Sp. soluble 
Benzene Insoluble Insoluble Insoluble 
Toluene Insoluble Insoluble Insoluble 
Hexanes Insoluble Insoluble Insoluble 
FC-72c Soluble Soluble Soluble 
a·xH2O, x = 14-15; 
b xH2O, x = 4-8;
 c Perfluorohexanes. d Perfluoro- 
(2-butyltetrahydrofuran); e Perfluoro(methylcyclohexane) 
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8.2.2. Syntheses of BArf6 Salts of Werner Complexes 
As shown in Scheme 8.3 (top) and the photographs in Figure 8.2, a yellow 
aqueous solution of the racemic trichloride salt -[Co(en)3]3+ 3Cl–·2.5H2O19 and a 
colorless perfluoro(methylcyclohexane) (PFMC) solution of Na+ BArf6– (28) were 
combined (1:3 mol ratio) and stirred. The lower PFMC phase turned yellow, and the 
upper aqueous phase decolorized. This suggested the complete transfer of the trication 
[Co(en)3]3+ into the fluorous phase. The phases were separated and the PFMC was 
removed. This gave the new, anion exchanged salt [Co(en)3]3+ 3BArf6–·xH2O 
(31·xH2O) as an orange oil in 96% yield, which was characterized by NMR (1H, 13C) 
and elemental analysis (experimental section). In multiple runs, 31 was reproducibly 
isolated with 14-15 (x) water molecules of hydration, as assayed by 1H NMR integrals 
and supported by microanalyses. In other studies,4,20 such tris(diamine) trications have 
been shown to be superb hydrogen bond donors. 
 
 
 
 
Scheme 8.3. Syntheses of fluorous BArf6 salts of Werner trications. 
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Figure 8.2. (a) 2.1  10–3 M aqueous solution of [Co(en)3]3+ 3Cl– (10 mL). (b) 6.3  
10–3 M Na+ BArf6– solution in PFMC (10 mL). (c) Biphasic mixture after gentle 
addition of (b) to (a). (d) The sample from (c) was stirred (10 min). (e) The sample from 
(d) after stirring was halted. 
 
 
 
Figure 8.3. (a) 2.1  10–3 M aqueous solution of [Co(R,R-chxn)3]3+ 3Cl– (10 mL). (b) 
6.3  10–3 M Na+ BArf6– solution in PFMC (10 mL). (c) Biphasic mixture after gentle 
addition of (b) to (a). (d) The sample from (c) was stirred (10 min). (e) The sample from 
(d) after stirring was halted. 
 
 
 
 This protocol was extended to a related cobalt complex with somewhat more 
lipophilic and enantiopure trans-1,2-cyclohexanediamine or R,R-chxn ligands. As shown 
in Scheme 8.3 (bottom) and the photographs in Figure 8.3, an aqueous solution of the 
previously reported salt [Co(R,R-chxn)3]3+ 3Cl–·4H2O21 was treated with a PFMC 
solution of Na+ BArf6– The aqueous phase decolorized and the cobalt trication 
transferred to the fluorous phase. An identical workup gave [Co(R,R-chxn)3]3+ 3BArf6–
·xH2O (32·xH2O) in 92% yield, which in multiple runs was isolated as a tetrahydrate to 
octahydrate (x = 4-8). It was observed that both the starting material and product exhibit 
(a)            (b)               (c)                    (d)                    (e)
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three chxn 13C NMR signals, strongly suggestive of a single diastereomer (chirality at 
cobalt). In previous work (lacking 13C NMR data), the  or -lel3 isomer has been 
shown to be considerably more stable.21b  
 
 
 
 
Scheme 8.4. Synthesis of a fluorous BArf6 salt of the dication [Ru(bipy)3]2+. 
 
Figure 8.4. (a) 2.1  10–3 M aqueous solution of [Ru(bipy)3]2+ 2Cl–·6H2O (10 mL). (b) 
4.20  10–3 M Na+ BArf6– solution in PFMC (10 mL). (c) Biphasic mixture after gentle 
addition of (b) to (a). (d) The sample from (c) was stirred (10 min). (e) The sample from 
(d) after stirring was halted. 
 
 
 
Finally, to confirm the generality of these phase transfer phenomena, a 
comparable protocol was applied to the classic ruthenium dication, [Ru(bipy)3]2+.13 As 
shown in Scheme 8.4 and the photographs in Figure 8.4, an aqueous solution of racemic 
[Ru(bipy)3]2+ 2Cl–·6H2O22 was treated with a PFMC solution of Na+ BArf6– (1:2 mol 
ratio). The lower PFMC phase turned red, and the upper aqueous phase decolorized. An 
identical workup gave [Ru(bipy)3]2+ 2BArf6–·xH2O (33·xH2O) as a sticky red oil in 
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95% yield, which was characterized by NMR (1H, 13C) and elemental analysis 
(experimental section). The latter was best fit by a hemihydrate (x = 0.5), in agreement 
with the 1H NMR integral.  
8.2.3. Additional Physical Characterization of Werner Complexes 
The fluorophilicities of substances can be quantified by partition coefficients.23 
These are frequently determined using the biphasic system toluene/PFMC. For example, 
the lipophilic alkanes n-decane through n-hexadecane exhibit partition coefficients of 
94.6:5.4 to 98.9:1.1.23 For this study, data for water/PFMC mixtures were also sought, 
given the solvents employed in Schemes 8.3-8.4 and Figures 8.2-8.4. Partition 
coefficients were assayed by 19F NMR and UV-vis spectroscopy, as described in the 
experimental section. The 19F NMR data are summarized in Table 8.3, and the UV/vis 
data were in good agreement. 
 
 
 
Table 8.3. Partition coefficients measured by 19F NMR (24 °C). 
Compound Biphasic System Partition Coefficients 
Na+ BArf6– (28)a 
Water/PFMC 0.2:99.8 
Toluene/PFMC 1:99 
Na+ BArf6–b CH2Cl2/PFMC >99.9:<0.1 
31c Water/PFMC <1:>99 Toluene/PFMC <0.1:>99.9 
[Co(en)3]3+ 3BArf6–d CH2Cl2/PFMC >99.9:<0.1 
32e Water/PFMC <1:>99 Toluene/PFMC <0.1:>99.9 
33f Water/PFMC 1:99 Toluene/PFMC 1:99 
a2.5H2O; 
b2H2O;
 cxH2O, x = 14-15; 
d7H2O; 
exH2O, x = 4-8; 
 fxH2O, x = 0.5-2.0. 
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 The toluene/PFMC partition coefficients of the precursor salt Na+ BArf6– (28) 
and the tricationic cobalt salt [Co(en)3]3+ 3BArf6– (31) were 1:99 and <0.1:>99.9, 
respectively. The 1,2-cyclohexanediamine analog 32 exhibited a comparable 
fluorophilicity, at least within the limits of the assay method. The dicationic ruthenium 
salt 33 appeared to be slightly less fluorophilic than the cobalt complexes (1:99). In a 
control experiment, it was verified that the non-fluorous analog of 28, Na+ BArf–, 
exhibited a CH2Cl2/PFMC partition coefficient of >99.9:<0.1. The non-fluorous analog 
of 31, [Co(en)3]3+ 3BArf–, behaved similarly (neither of these salts are soluble in 
toluene). None of the salts exhibited an appreciable absolute solubility in water, although 
from a partitioning standpoint water seemed to be a slightly better solvent than toluene. 
 
 
 
 
Scheme 8.5. Partitioning of [Co(en)3]3+ between a CH2Cl2 solution of 3BArf– and a 
PFMC solution of xBArf6– in the presence of xNa+ (x = 3, 4) as determined by 1H NMR 
and UV-vis spectroscopy (unbracketed and bracketed values). 
 
H2N
H2N
NH2
NH2
N
H2
H2
N
Co
3+
H2N
H2N
NH2
NH2
N
H2
H2
N
Co
3+
xNa
xBArf6
3BArf
xNa
Co3+
Co3+
x = 3        x = 4
36
(34)
64
(66)
27
(26)
73
(74)
CH2Cl2
 PFMC
 261 
 
Figure 8.5. (a) Biphasic mixture after gentle addition of a 1.74  10–3 M CH2Cl2 
solution of [Co(en)3]3+ 3BArf– (10 mL, upper layer) to a 5.22  10–3 M PFMC solution 
of Na+ BArf6– (10 mL, bottom layer). (b) The sample from (a) after stirring was halted. 
(c) Biphasic mixture after gentle addition of a 1.74  10–3 M CH2Cl2 solution of 
[Co(en)3]3+ 3BArf– (10 mL, upper layer) to a 6.96  10–3 M PFMC solution of Na+ 
BArf6– (10 mL, bottom layer). (d) The sample from (c) after stirring was halted. 
 
 
 
A final question involves how the cobalt trication [Co(en)3]3+ would partition 
between organic and fluorous phases in the presence of both the non-fluorous and 
fluorous anions BArf– and BArf6–. In other words, would this species prefer fluorous or 
non-fluorous environs? Of course, a second cation is required to set up the equilibrium. 
Hence, the result will reflect the weighted partitioning preference of both species. As 
shown in Scheme 8.5 and Figure 8.5, equal volumes of CH2Cl2 and PFMC were charged 
with the non-fluorous salt [Co(en)3]3+ 3BArf– and 3.0 equiv of the fluorous sodium salt 
Na+ BArf6–, respectively. The trication [Co(en)3]3+ partitioned predominantly into the 
fluorous phase (64:36), as assayed by 1H NMR. By inference, the sodium monocation 
partitioned predominantly into the more polar organic phase. When an analogous 
experiment was carried out with 4.0 equiv of Na+ BArf6–, the [Co(en)3]3+ concentration 
ratio increased to 73:27. Similar data were obtained by UV-vis spectroscopy. 
Given the great interest in the photophysical properties of the ruthenium dication 
[Ru(bipy)3]2+,13 the UV-vis spectrum of 33 was measured in PFMC. A strong UV 
absorption tailed into the visible region, which exhibited a characteristic band at 446 nm 
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( 15310 M–1cm–1). This max is slightly lower than that that found for other salts of 
[Ru(bipy)3]2+ in aqueous and organic solutions (average ca. 450 nm),13a as well as 
another fluorous salt described in the discussion section.24 When the PFMC solution of 
33 was irradiated at 446 nm, the fluorescence spectrum exhibited a max at 594 nm. This 
Stokes shift (148 nm) is to my knowledge the largest observed for a [Ru(bipy)3]2+ salt to 
date,13a,24 and is consistent with the non-polar fluorous medium destabilizing the more 
polar excited state to a greater extent than the less polar ground state.  
8.3. Discussion 
The preceding results, together with other recently reported data,6 establish that it 
is possible to selectively solubilize tris(1,2-diamine) cobalt trications in aqueous, 
organic, and fluorous solvents depending upon the counteranion selected. Similar results 
can be expected with a variety of other tris(diamine) Werner complexes, which are 
generally di- to tetracations derived from middle to late transition metals.25 Thus, 
chemistry that has been largely limited to aqueous solutions for over a century can now 
be explored in less polar media that allow a much broader range of solutes.  
For example, Table 8.2 shows that the fluorous Werner salts 31 and 32 are 
soluble in the usual fluorous (FC-72, FC-75, PFMC) and hybrid (C6H5CF3) solvents, as 
well as a range of more polar organic solvents (acetone, Et2O, CH3OH, CH2Cl2, ethyl 
acetate). Thus, it is now possible to employ them as homogeneous catalysts in organic 
and fluorous media. Furthermore, Table 8.3 establishes that these salts markedly prefer 
to partition into fluorous over organic solvents (PFMC vs. toluene). Hence, it should 
prove possible to extract, recover, and recycle such salts using fluorous solvents or 
supports. 
In this context, it has been found that the non-fluorous Werner salt [Co(en)3]3+ 
3BArf– catalyzes the Michael additions of malonates to enones in the presence of tertiary 
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amines.4a,7 The trication is believed to function as a "second" coordination sphere chiral 
hydrogen bond donor towards the enone, activating it towards addition. Although 
enantioselectivities are modest (up to 33% ee), two classes of newer generation catalysts 
have recently been developed that afford Michael adducts with 80-95% ee.4b-e 
Obviously, fluorous analogs could have attractive features, and catalysis data will be 
reported in due course. 
Important related work of Vincent deserves emphasis.24 He first prepared a salt 
of the ruthenium dication [Ru(bipy)3]2+ with fluorous carboxylate anions, 
[Ru(bipy)3](O2CCF(CF3)(OCF2CF(CF3))3OCF2CF2CF3)2 (34). When taken up in 
CH2Cl2/perfluorodecalin mixtures, 34 partitioned exclusively into the organic phase. 
However, when two equivalents of the carboxylic acid HO2CCF(CF3)(OCF2CF-
(CF3))3OCF2CF2CF3)2 were added, the ruthenium was found exclusively in the fluorous 
phase. This was attributed to the generation of the salt 35 (Figure 8.6), which features  
 
 
 
 
Figure 8.6. A fluorophilic salt of [Ru(bipy)3]2+ prepared by Vincent. 
 
 
 
 264 
two much more fluorophilic monoanions derived from hydrogen bonded carboxylate 
ions and carboxylic acids. It should be noted in passing that it is also possible to 
solubilize polyanions – even dodecaanions – in fluorous media with suitable fluorous 
cations.26  
The UV-vis spectrum of 35 exhibited a band at 450 nm (perfluorodecalin;  
14100 M–1 cm–1), a very slightly longer wavelength than my fluorophilic analog 33 
(Scheme 8.4; 446 nm and  15300). In contrast, the max in the fluorescence spectrum of 
35 was at a somewhat shorter wavelength (585 vs. 594 nm), making for a slightly 
reduced Stokes shift (135 vs. 148 nm), suggestive of a marginally more polar 
environment. Salts of [Ru(bipy)3]2+ mediate a number of photochemically triggered 
processes with a range of substrates.13,27 There would seem to be possibilities for new 
selectivities or chemistries in fluorous media, for example due to the much higher 
solubilities of small gaseous molecules as compared to aqueous media.28 Vincent 
established that 35 is an efficient photosensitizer for singlet oxygen, and observed 
enhanced 1O2 lifetimes.  
Additional features of the crystal structure of bromoarene 29 (Figure 8.1) merit 
analysis. First, as noted in Table 8.1, 29 crystallizes in a chiral, polar space group (I4) as 
a tetragonal crystal system with , ß, and  equal to 90°. As represented in Figure 8.7 
(top), the unit cell dimensions are markedly skewed, with a and b equal to 29.5335(13) 
Å and c being >80% less at 5.5624(3) Å. The perfluorohexyl groups associated with the 
eight molecules in the unit cell lie roughly in a plane defined by the a/b axes. They 
exhibit C-C-C-C and F-C-C-F torsion angles characteristic of perfluoroalkyl groups, 
with the values for anti segments distinctly less than 180° (165.8(3.4)° and 164.3(1.8)°, 
respectiveely).29 They also segregate, as found for most fluorous molecules, into 
fluorous domains.29 
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Consider next the eight aryl rings. Figure 8.7 shows that (1) they are oriented 
distinctly out of the plane defined by the a/b axes, with plane/plane angles of 48.1°, and 
(2) all of the bromine atoms are found on the same "side" or a/b face of the unit cell.  
 
 
 
 
Figure 8.7. Packing of 29 in the unit cell (Z = 8). Top: ball and stick 
representation; bottom: space filling representation. 
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The bromine atoms from one unit cell nest approximately into the centroids of the arene 
rings of the adjacent unit cell (c direction), with bromine-centroid and centroid-centroid 
distances of 3.850 Å and 5.562 Å, respectively. The planes of the nesting rings are 
parallel, with separations of 3.71 Å. 
The features in the preceding paragraph are manifestations of the polar nature of 
the crystal. Such crystals are sometimes observed to give non-linear optical phenomena 
such as frequency doubling.30,31 However, when a powdered sample of 29 is irradiated 
with a Nd:YAG laser (1064 nm; "Kurtz test"32), no detectable visible light is scattered. 
Crystals of 29 are highly piezoelectric (qualitative plastic comb test), and the space 
group (I4) is one of ten that can exhibit spontaneous polarization without mechanical 
stress.31  
8.4. Summary 
In summary, this study has extended previous efforts in bringing the chemistry of 
Werner cations from aqueous solutions into the full spectrum of modern liquid phases. 
Towards this end, an improved, scalable synthesis of Na+ BArf6– (28), a sodium salt of a 
highly fluorophilic anion, has been developed. Based upon the successful demonstration 
with the salts 31-33, it can be anticipated that metal polycations can generally be 
solubilized in fluorous phases with the anion BArf6–. The toluene/PFMC partition 
coefficients establish very high fluorophilicities (<1:>99) and provide a valuable 
foundation for the design of future applications. Finally, an intermediate in the synthesis 
of 28, the fluorous bromoarene 29, crystallizes in an uncommon polar space group and 
exhibits a range of interesting properties.  
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8.5. Experimental section 
 General data: NMR spectra were recorded on a Varian 500 MHz spectrometer 
at ambient probe temperatures and referenced as follows: 1H: residual internal CHCl3 (δ, 
7.26 ppm), acetone-d5 (2.05 ppm), or CHD2CN (1.94 ppm); 13C: internal acetone-d6 
(29.8 ppm), CDCl3 (77.0 ppm), or CD3CN (1.3 ppm). UV-visible spectra were recorded 
on a Shimadzu UV-1800 spectrometer. Emission spectra were recorded on a PTI 
QuantaMaster spectrofluorimeter. Microanalyses were conducted by Atlantic Microlab. 
All reactions were carried out under air unless noted. All workups were carried 
out in air. Chemicals were treated as follows: Et2O (Fisher Scientific), dried and 
degassed using a Glass Contour solvent purification system; copper (100 mesh 99.5%, 
Alfa Aesar), perfluorohexyliodide (Rf6I; SynQuest Labs, 98%), C6F6 (TCI, 99%), 1,3-
diiodobenzene (Alfa Aesar, 98%), NBS (Alfa Aesar, 99%), H2SO4 (EDM, 95%), 
CF3CO2H (Alfa Aesar, 99.5%), t-BuLi (Alfa Aesar, 1.70 M in pentane), BCl3 (Acros, 
1.00 M in hexane), NaCl (EDM, 98%), NaOH (Mallinckrodt), FC-75 (perfluoro(2-
butyltetrahydrofuran); Alfa Aeser, 99%), FC-72 (perfluorohexanes; Apollo Scientific, 
98%), PFMC (perfluoro(methylcyclohexane); Alfa Aesar, 94%), CDCl3, CD3CN, and 
acetone-d6 (3  Cambridge Isotope Laboratories), CF3CH2OH (Sigma-Aldrich, ≥99%), 
C6H5CF3 (Acros, 99%), silica (Acros, 60 Å), CH2Cl2 (EMD Chemicals), hexanes 
(Macron Chemicals), cyclohexane (Fisher Scientific, 99.4%), CH3OH, benzene (2  
BDH, 99.8%), DMSO (Fisher Scientific, 99.9%), ethyl acetate (Macron Chemicals, 
99.5%), and toluene (Mallinckrodt, 98%), used as received. 
1,3-C6H4(Rf6)2 (30).10 An oven dried Schlenk tube was charged with copper 
(7.02 g, 110 mmol), 1,3-diiodobenzene (7.09 g, 21.5 mmol), and DMSO (60 mL) with 
stirring under N2. Then perfluorohexyliodide (Rf6I; 10.2 mL, 47.1 mmol) was added 
dropwise over 5 min. The tube was sealed and kept at 140 °C (with stirring). After 3 d, 
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the mixture was cooled to room temperature, and water (100 mL) was added. Some solid 
precipitated. The mixture was transferred to a separatory funnel and extracted with 
CH2Cl2 (3 × 150 mL; most of the solid was retained on the sides of the funnel). The 
combined extracts were filtered, washed with water (100 mL) and then brine (100 mL), 
and dried (Na2SO4). The solvent was removed by rotary evaporation. The yellow oil was 
dissolved in FC-72 (15 mL), which was washed with acetone (2 × 20 mL; separatory 
funnel). The solvent was removed from the fluorous phase by rotary evaporation to give 
30 as a light yellow oil (13.27 g, 18.58 mmol, 86%), the properties of which agreed with 
those previously reported.10 1H NMR (δ (ppm), 500 MHz, CDCl3 or C6F6/CDCl3 
mixture): 7.83 or 7.89 (s, 1H, doubly o to Rf6), 7.82 or 7.88 (s, 2H, singly o to Rf6), 7.69 
or 7.78 (m, 1H, doubly m to Rf6). 
Br(3,5-C6H3(Rf6)2) (29).10,14 A round-bottomed flask was charged with 30 
(11.4 g, 16.0 mmol). A mixture of H2SO4 (13.0 mL) and CF3CO2H (34.0 mL) was 
added with stirring. Then solid NBS (4.42 g, 24.8 mmol) was added over the course of 6 
h (one portion/h). After an additional 48 h (with stirring), the mixture was poured into a 
beaker of ice (300 g). Aqueous NaOH was added dropwise until a pH of 7-9 was 
reached. The mixture was extracted with CH2Cl2 (3 × 200 mL; separatory funnel). The 
combined extracts were dried (Na2SO4). The solvent was removed by rotary evaporation 
to give 29 as a white solid (11.23 g, 14.14 mmol, 88%), mp 44-42 °C, which was pure 
by GLC (Shimadzu SHRXI-5MS column) and which had previously been characterized 
as a mixture by a related route10 and a pure compound by a different route.14 1H NMR 
(δ (ppm), 500 MHz, CDCl3 or C6F6/CDCl3 mixture): 7.96 or 8.02 (s, 2H, o-BrC6H3), 
7.74 or 7.84 (s, 1H, p-BrC6H3). 13C{1H,19F} NMR (δ (ppm), 125 MHz, CDCl3): 133.6 
(s), 131.7 (s), 124.3 (s), 123.4 (s), 117.1 (s), 114.6 (s), 111.1 (s), 110.5 (s), 110.2 (s), 
108.4 (s). UV-vis (nm, 1.94 × 103 M in PFMC (, M–1cm–1)): 274 (995), 281 (969). 
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Na+ B(3,5-C6H3(Rf6)2)4– (28; Na+ BArf6–).10,11 A Schlenk flask was charged 
with 29 (3.70 g, 4.64 mmol) and Et2O (170 mL) under a positive N2 pressure and 
transferred to a –78 °C cold bath. After 20 min, t-BuLi (1.70 M in pentane; 6.00 mL, 
10.2 mmol) was added dropwise over 10 min with stirring. After an additional hour, 
BCl3 (1.00 M in hexane, 1.00 mL, 1.00 mmol) was added. After an additional 2 h, the 
cold bath was removed. After 2-3 h, the solution was poured into water (200 mL), which 
was saturated with NaCl with stirring. The mixture was extracted with Et2O (3 × 150 
mL). The combined extracts were dried (MgSO4). The solvent was removed by rotary 
evaporation. The brown oil was chromatographed on a silica gel column (3 × 16 cm) 
packed in hexanes. The column was eluted with Et2O, and a brown band was collected. 
The column was then eluted with CH2Cl2/CH3OH (98:2 to 80:20 v/v). The fractions 
were monitored by tlc. The product containing fractions were combined and the solvent 
was removed by rotary evaporation. The off white solid was recrystallized from FC-75 
and the white solid was dried by oil pump vacuum to give 28·2.5H2O as a white solid 
(2.26 g, 0.771 mmol, 76%), mp 89-86 °C, the properties of which agreed with those 
previously reported.10,11 1H NMR (δ (ppm), 500 MHz, acetone-d6): 7.71 (s, 8H, o-
BC6H3), 7.58 (s, 4H, p-BC6H3), 2.86-2.82 (m, 5H, H2O). 13C{1H,19F} NMR (δ (ppm), 
125 MHz, acetone-d6):33 161.8 (q, 1JBC = 50.0 Hz, i-BC6H3), 137.5 (s, o-BC6H3), 128.2 
(s, m-BC6H3), 121.4 (s, p-BC6H3), 118.1 (s, CF3), 116.8 (s, BCCCF2), 112.1 (s, CF2), 
111.8 (s, CF2), 111.2 (s, CF2), 109.3 (s, CF2). Anal. Calcd for C72H12BF104Na·2.5H2O: 
C, 29.50; H, 0.58; F, 67.40. Found: C, 29.23; H, 0.49; F, 67.50. 
[Co(en)3]3+ 3BArf6– (31). A beaker was charged with a solution of 28·2.5H2O 
in PFMC (0.0063 M; 10.0 mL, 0.0630 mmol). An aqueous solution of [Co(en)3]3+ 3Cl–
·2.5H2O (0.0021 M; 10.0 mL, 0.0210 mmol)19 was added. The biphasic mixture was 
vigorously stirred for 10 min. Stirring was halted, and the lower fluorous phase was 
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separated and dried (MgSO4). The solvent was removed by rotary evaporation and oil 
pump vacuum to give 31·xH2O (x = 14-15) as an orange oil (0.0183 g, 0.020 mmol, 
96%). 1H NMR (δ (ppm), 500 MHz, acetone-d6): 7.71 (s, 24H, o-BC6H3), 7.58 (s, 12H, 
p-BC6H3), 5.70 (br s, 6H,34 NHH'), 5.29 (br s, 6H,34 NHH'), 3.31 (br s, 12H, CH2), 2.83 
(s, 28-30H, H2O). 13C{1H,19F} NMR (δ (ppm), 125 MHz, acetone-d6):33 161.9 (q, 1JBC 
= 50.0 Hz, i-BC6H3), 137.5 (s, o-BC6H3), 128.3 (s, m-BC6H3), 121.4 (s, p-BC6H3), 
118.1 (s, CF3), 116.8 (s, BCCCF2), 112.1 (s, CF2), 111.8 (s, CF2), 111.2 (s, CF2), 109.3 
(s, CF2), 46.2 (s, CH2). Anal. Calcd for C222H60CoB3F312N6·14.5H2O: C, 29.33; H, 
0.99; N, 0.92; F, 65.20. Found: C, 29.43; H, 0.91; N, 0.88; F, 64.63.35  
[Co(R,R-chxn)3]3+ 3BArf6– (32). A beaker was charged with a solution of 28 in 
PFMC (0.0063 M; 10.0 mL, 0.0630 mmol). Then an aqueous solution of [Co(R,R-
chxn)3]3+ 3Cl–·4H2O (0.0021 M; 10.0 mL, 0.0210 mmol)6,21 was added. The biphasic 
mixture was vigorously stirred for 10 min. Stirring was halted, and the lower fluorous 
phase was separated and dried (MgSO4). The solvent was removed by rotary 
evaporation and oil pump vacuum to give 32·xH2O (x = 4-8) as an orange oil (0.175 g, 
0.019 mmol, 92%). 1H NMR (δ (ppm), 500 MHz, acetone-d6): 7.70 (s, 24H, o-BC6H3), 
7.57 (s, 12H, p-BC6H3), 5.53 (br s, 4H,34 NHH'), 5.16 (br s, 4H, NHH'), 3.00 (br s, 6H, 
CHN), 2.84 (s, 8-16H, H2O), 2.35 (m, 6H of (CH2)4), 1.74 (m, 6H of (CH2)4), 1.62 (m, 
6H of (CH2)4), 1.22 (m, 6H of (CH2)4). 13C{1H,19F} NMR (δ (ppm), 125 MHz, 
acetone-d6):33 161.8 (q, 1JBC = 50 Hz, i-BC6H3), 137.5 (s, o-BC6H3), 128.3 (s, m-
BC6H3), 121.4 (s, p-BC6H3), 118.1 (s, CF3), 116.8 (s, BCCCF2), 112.1 (s, CF2), 111.8 
(s, CF2), 111.2 (s, CF2), 109.3 (s, CF2), 61.5 (s, CHNH2), 33.6 (s, CH2), 24.6 (s, CH2). 
Anal. Calcd for C234H78CoB3F312N6· 4H2O: C, 31.01; H, 0.96; N, 0.93; F, 65.40. 
Found: C, 31.05; H, 0.86; N, 0.95; F, 63.97.35  
[Ru(bipy)3]2+ 2BArf6– (33). A beaker was charged with a solution of 28 in 
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PFMC (0.0130 M; 10.0 mL, 0.13 mmol). Then an aqueous solution of [Ru(bipy)3]2+ 
2Cl–·6H2O (0.00650 M, 10.0 mL, 0.065 mmol)21 was added. The biphasic mixture was 
vigorously stirred for 10 min. Stirring was halted, and the lower fluorous phase was 
separated and dried (MgSO4). The solvent was removed by rotary evaporation and oil 
pump vacuum to give 33·xH2O (x = 0.5-2.0) as a sticky red oil (0.391 g, 0.062 mmol, 
95%). 1H NMR (δ (ppm), 500 MHz, acetone-d6): 8.86 (d, J = 10.0 Hz, 6H of 3bipy), 
8.24 (t, J = 7.50 Hz, 6H of 3bipy), 8.10 (d, J = 5.00 Hz, 6H of 3bipy), 7.72 (s, 16H, o-
BC6H3), 7.61 (m, 6H of 3bipy), 7.58 (s, 8H, p-BC6H3), 2.81 (m, 1-4H, H2O). 
13C{1H,19F} NMR (δ (ppm), 125 MHz, acetone-d6): 161.5 (q, 1JBC = 50 Hz, i-BC6H3)), 
158.2 (s), 152.7 (s), 139.0 (s), 137.5 (s), 128.8 (s), 128.2 (s), 125.3 (s), 121.4 (s), 118.1 
(s, CF3), 116.8 (s), 112.0 (s), 111.8 (s), 111.2 (s), 109.3 (s). UV-vis (nm, 6.77 × 105 M 
in PFMC (, M–1cm–1)): 446 (15300). Fluorescence (nm, 3.05 × 106 M in PFMC, ex = 
446 nm): 594. Anal. Calcd for C174H48RuB2F208N6·0.5H2O: C, 33.14; H, 0.78; N, 1.33; 
F, 62.66. Found: C, 33.08; H, 0.68; N, 1.42; F, 59.80.35  
[Co(en)3]3+ 3BArf–.36 A beaker was charged with a solution of Na+ BArf–
·2H2O (0.510 g, 0.557 mmol)37 in CH2Cl2 (20 mL). Then a solution of racemic 
[Co(en)3]3+ 3Cl– ·2.5H2O (0.073 g, 0.186 mmol)19 in water (20 mL) was added. The 
heterogeneous mixture was vigorously stirred for 15 min. The orange CH2Cl2 phase was 
separated from the colorless aqueous phase. The CH2Cl2 was allowed to evaporate in a 
fume hood overnight to give [Co(en)3]3+ 3BArf–·7H2O as an orange powder (0.514 g, 
0.173 mmol, 93%).38 1H NMR (δ (ppm), 500 MHz, CD3CN): 7.70 (m,39 24H, o-
BC6H3), 7.67 (s, 12H, p-BC6H3), 4.20 (br s, 6H, NHH'), 3.76 (br s, 4H, NHH'), 2.75 (br 
s, 6H, CHH'), 2.70 (br s, 6H, CHH'), 2.27 (s, 14H, H2O). 13C{1H} NMR (δ (ppm), 125 
MHz, CD3CN):40 162.6 (q, 1JBC = 50.0 Hz, i-BC6H3), 135.7 (s, o-BC6H3), 130.1 (q, 
2JCF = 31.3 Hz, CCF3), 125.5 (q, 1JCF = 270 Hz, CF3), 118.7 (t, 3JCF = 3.8 Hz, p-
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BC6H3), 45.6 (s, CNH2). Anal. Calcd. for C102H60B3CoF72N6·7H2O: C, 41.46; H, 2.52; 
N, 2.84. Found: C, 41.45; H, 2.54; N, 2.76. 
 Partition Coefficients. The following are representative. A (UV-vis). A standard 
solution of 28·2.5H2O (0.0591 g, 0.0200 mmol) in PFMC (20.00 mL volumetric flask) 
was prepared (1.00  10–3 M). This was diluted in a series of volumetric flasks to give 
6.25  10–5 M, 1.25  10–4 M, and 2.50  10–4 M solutions. The three solutions gave 
UV-vis absorbances (A, 271 nm) of 0.33450, 0.60840, and 1.2424, indicating good 
agreement with Beer’s law and an extinction coefficient (ε) of 4968 M–1cm–1 (R = 
0.999). B. A standard solution of [Co(en)3]3+ 3BArf–·7H2O (0.0503 g, 0.0170 mmol) in 
CH2Cl2 (10.00 mL volumetric flask) was prepared (1.70  10–3 M). This was diluted in 
a series of volumetric flasks to give 8.0  10–4 M, 1.2  10–3 M, and 1.70  10–3 M 
solutions. The three solutions gave UV-vis absorbances (A, 468 nm) of 0.0643, 0.1026, 
and 0.1423, indicating good agreement with Beer’s law and an extinction coefficient (ε) 
of 82.99 M–1cm–1 (R = 0.998). C (partitioning, UV-vis). Water (4.0 mL) and a 1.00  
10–3 M PFMC solution of 28·2.5H2O (4.0 mL) were combined in a vial (20 mL) at room 
temperature (24 °C) and vigorously stirred (10 min). Stirring was halted. After 15 min, 
an aliquot (3.0 mL) was removed from the aqueous phase. An aliquot (0.50 mL) was 
removed from the PFMC phase and diluted to 2.0 mL. Aliquots were assayed by UV-vis, 
and the absorbances (0.02160 and 1.1735) indicated 4.30  10–6 M and 2.36  10–4 M 
concentrations, respectively (see data from A). This corresponds to a concentration ratio 
of 4.30  10–6/9.45  10–4 (1.72  10–5 mmol of 28 in the aqueous phase and 3.8  10–3 
mmol of 28 in the fluorous phase), or ca. 1:99 (Table 8.3). D (partitioning, NMR). A 20 
mL vial was charged with a PFMC solution of 28·2.5H2O (5.0  10–4 M, 4.0 mL) and 
toluene (4.0 mL), capped, and vigorously stirred. After 10 min at room temperature (24 
°C), aliquots were removed from the fluorous (2.0 mL) and organic (2.0 mL) phases. 
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The solvent was evaporated from each, and the residues were dried under vacuum. A 
solution of C6H5CF3 (internal standard; 0.020 mL) in acetone-d6 (5.0 mL) was prepared. 
Each residue was dissolved in this solution and 19F NMR spectra were recorded. The 
relative peak integrations gave the ratios in Table 8.3. For non-fluorous BArf, 
CF3CH2OH was used as the internal standard. E. A 30 mL beaker was charged with a 
PFMC solution of 28·2.5H2O (5.22  10–3 M, 10.0 mL, 0.0522 mmol) and a CH2Cl2 
solution of [Co(en)3]3+ 3BArf–·7H2O (1.74  10–3 M, 10.0 mL, 0.0174 mmol). The 
mixture was vigorously stirred. After 10 min at room temperature (24 °C), aliquots were 
removed from the fluorous (7.0 mL) and organic (7.0 mL) phases. The solvent was 
evaporated from each, and the residues were dried by oil pump vacuum. A solution of 
cyclohexane (internal standard; 0.020 mL) in acetone-d6/C6H5CF3 (5.0 mL, 4:1 v/v) was 
prepared. Each residue was dissolved in this solution and 1H NMR spectra were 
recorded. The relative peak integrations gave the ratios in Scheme 8.5. F (UV-vis). A 
beaker was charged with a solution of 28·2.5 H2O in PFMC (5.7  10–3 M; 6.0 mL, 
0.0342 mmol) and a solution of [Co(en)3]3+ 3BArf–·7H2O (1.9  10–3 M, 6.0 mL, 
0.0114 mmol) in CH2Cl2. The mixture was vigorously stirred. After 10 min at room 
temperature (24 °C), aliquots were removed from the organic (3.0 mL) and fluorous (3.0 
mL) phases. These were assayed by UV-vis, and the absorbances (0.0520 and 0.1314) 
indicated 6.3  10–4 M (see data from B) and 1.21  10–3 M (see data from A) 
concentrations, respectively. This corresponds to a concentration ratio of 6.3  10–4/1.21 
 10–3 (0.0038 mmol of [Co(en)3]+ in the CH2Cl2 phase and 0.0073 mmol of [Co(en)3]+ 
in the fluorous phase). 
8.6. Crystallography.  
A small vial was charged with 29 (0.025 g) and acetone-d6 (0.15 mL), and the 
solution was kept at room temperature. After few days, colorless crystals had formed and 
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were analyzed as outlined in Table 8.1. Cell parameters were obtained from 180 data 
frames using a 0.5° scan.41 No super-cell or erroneous reflections were observed. 
Integrated intensity information for each reflection was obtained by reduction of the data 
frames with the program APEX2.42 Data were corrected for Lorentz and polarization 
factors, as well as for crystal decay and (using SADABS)43 absorption effects. The 
space group was determined from systematic reflection conditions and statistical tests. 
The structure was solved by direct methods using SHELXTL (SHELXS).44 The absence 
of additional symmetry was verified using PLATON (ADDSYM).45 The hydrogen 
atoms were fixed in idealized positions using a riding model. Non-hydrogen atoms were 
refined with anisotropic thermal parameters. The parameters were refined by weighted 
least squares refinement on F2 to convergence.44,46 The absolute structure parameter 
was estimated as 0.00(9) (Table 8.1).47  
CCDC 968151 contains the supplementary crystallographic data for this section. 
These data can be obtained free of charge from the Cambridge Crystallographic Data 
Centre via www.ccdc.cam.ac.uk/data_request/cif. 
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9. SUMMARY AND CONCLUSION 
 
This thesis has described the development of highly effective, chiral-at-metal 
monofunctional and bifunctional hydrogen bond donor catalysts based on cobalt (III) 
Werner complexes (Figure 9.1) and their applications in enantioselective catalysis. Since 
cobalt (III) Werner cations are substitution inert, substrate activation and asymmetric 
induction must take place via second-coordination sphere mechanisms involving 
hydrogen bonding to the NH2 moieties of the diamine ligands. 
 
 
 
 
Figure 9.1. Chiral-at-metal hydrogen bond donor catalysts based on cobalt (III) 
Werner complexes. 
 
 
 
Thirteen bulky monofunctional complexes of the formula -or-[Co((S,S)-
NH2CHArCHArNH2)3]3+ 2Cl–B(aryl)4– (BArf–: aryl = 3,5-C6H3(CF3)2; BArf20–: aryl 
= C6F5; Ar = C6H5, 4-C6H4n-Bu, 4-C6H4Cl, 4-C6H4CF3, 4-C6H4OCH3, -naphthyl, ß-
naphthyl, 2-C6H4OBn) were synthesized in a highly stereoselective pathway and 
chromatographed on silica gel columns. Anion metatheses of -or-[Co((S,S)-
NH2CHArCHArNH2)3]3+ 2Cl–BArf– afforded the corresponding 2BF4–BArf– and 
2PF6–BArf– salts. The complexes -or-[Co((S,S)-dpen)3]3+ 3B(aryl)4– (dpen = 1,2-
 282 
diphenylethylenediamine), -[Co((S,S)-dpen)3]3+ 3BF4–, and -[Co((S,S)-dpen)3]3+ 
3PF6– were also synthesized. These complexes were used in the Michael additions of 
dialkyl malonates to nitroalkenes and α-aminations of 1,3-dicarbonyl compounds. In 
both cases, the reactions were highly enantioselective (up to 98% and 99% ee) and the 
chirality of the products were controlled by the cobalt configurations of the catalysts.  
To synthesize the bifunctional catalysts, first the tris(hydrochloric acid) salts of 
the chiral triamine ligands H2NCH((CH2)nNMe2)CH2NH2 (n = 1-4) were synthesized in 
enantiopure form (section 6). These salts were reacted with the racemic carbonate 
complex [Co(en)2O2CO]+ Cl– (en = ethylenediamine) and the reaction mixtures were 
chromatographed on Dowex cation exchange resin columns to give [Co(en)2((S)-
H2NCH((CH2)nNHMe2)CH2NH2)]4+ 4Cl– (Figure 7.2). The anddiastereomers of 
the complexes were separated using Sephadex columns (Figure 7.3). The cobalt 
configurations of Λ- and -[Co(en)2((S)-H2NCH((CH2)nNHMe2)CH2NH2)]4+ 4Cl– 
were assigned by comparison of their CD spectra with the known CD spectra of Λ- and 
-[Co(en)3]3+ 3I– (Figure 7.4). Anion metatheses with Na+ BArf– gave Λ- and -
[Co(en)2((S)-H2NCH((CH2)nNHMe2)CH2NH2)]3+ 3BArf
–. These salts were screened as 
catalysts for additions of dimethyl malonate to trans-ß-nitrostyrene (Scheme 7.3). The 
diastereomer Λ-[Co(en)2((S)-H2NCH((CH2)3NHMe2)CH2NH2)]3+ 3BArf– was found to 
be the best catalyst with excellent yields and enantioselectivities (up to 98% yield and 
99% ee).  
To extend this chemistry into the fluorous media, the highly "fluorous BArf" salt 
Na+ BArf6– (BArf6– = B(3,5-C6H3((CF2)5CF3)2)4–) was synthesized by an optimized 
procedure (77-70%, section 8). To show its effectiveness in the transportation of Werner 
cations and other polycations into fluorous media, the salts [Co(en)3]3+ 3BArf6–, 
[Co(R,R-chxn)3]3+ 3BArf6– (chxn = trans-1,2-cyclohexanediamine), and [Ru(bipy)3]2+ 
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2BArf6– (bipy = 2,2′-bipyridine) were synthesized in excellent yields. All of these salts 
exhibit toluene/PFMC (PFMC = perfluoromethylcyclohexane) partition coefficients of 
<1:>99 (Table 8.3), establishing that the anion BArf6– can efficiently transport polar 
polycations into highly nonpolar fluorous phases.  
These catalysts enable the syntheses of highly functionalized and synthetically 
useful building blocks that are very important for agricultural, pharmaceutical industries. 
In addition, the simple operational procedure and the use of air stable, inexpensive 
catalysts make this a highly attractive and effective approach. 
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APPENDIX A 
 
Table A-1. Crystal structures containing the [Co(en)3]3+ trication in the Cambridge Structural Database (CSD) minus 
duplicates.a 
entry/ 
reference 
CSD 
Refcode 
ob/lel 
orientation 
cobalt 
configuration
space 
group name as represented in CSD 
1 ABIXIT oblel2  P-31c bis(tris(Ethylenediamine)-cobalt) piperazinium bis(bis(μ5-hydrogen phosphato)-pentakis(μ2-oxo)-decaoxo-penta-molybdenum(vi)) hexahydrate 
2 ACUBAB ob3  P-31c catena-(tris(ethylenediamine)-cobalt(iii) hexakis(μ5-phosphato)-(μ2-chloro)-octa-zinc dihydrate) 
3 ARILES lel3  C2/c is(tris(Ethylenediamine)-cobalt(iii)) (μ3-borotriphosphato)-tris((μ2-oxo)-oxo-vanadium(v)) dihydrogen phosphate tetrahydrate 
4 BESFAG lel3  P-1 tris(Ethylenediamine)-cobalt(iii) dihydrogen tetrahydrofuran-tetracarboxylate trihydrogen tetrahydrofuran-tetracarboxylate hydrate 
5 BIRSUOb lel3  P-3 tris(Ethylenediamine)-cobalt(iii) arsenate trihydrate 
6 BIWLIC lel3  I-42d catena-[bis(λ,δ-tris(1,2-Diaminoethane)-cobalt) bis(bis(μ2-phosphato)-di-aluminium) dodecahydrate] 
7 CASTAS lel3  I212121 catena-(bis(d-tris(Ethylenediamine)-cobalt) tetrakis(μ2-phosphato)-di-aluminium tridecahydrate) 
8 COCRCL lel3  P321 tris(Ethylenediamine)-cobalt(iii) tris(ethylenediamine)-chromium(iii) chloride hydrate 
9 COCREN lel3  P1121 (+)-tris(Ethylenediamine) cobalt(iii)(-)-tris(ethylenediamine) chromium(iii) thiocyanate hydrate 
10 COENCF oblel2  P21/n tris(Ethylenediamine) cobalt(iii) hexacyanoferrate(iii) dihydrate 
11 COENCHb lel3  P43212 (+)D-tris(Ethylenediamine)-cobalt(iii) chloride monohydrate 
12 COENCL lel3  P321 (+)-tris(Ethylenediamine)-cobalt(iii) (-)-tris(ethylenediamine)-chromium(iii) chloride hydrate 
13 COENSI lel3  P21/n tris(Ethylenediamine)-cobalt(iii) hydrogen silicate hydrate 
14 COENTCb lel3  Pbca (+-)-tris(Ethylenediamine)-cobalt(iii) tris(thiocyanate) 
15 COENTDc lel3  c (+)-tris(Ethylenediamine)-cobalt(iii) (-)-tris(ethylenediamine)-chromium(iii) hexakis(thiocyanate) 
16 COTENCb lel3  P-3c1 (+-)-tris(Ethylenediamine)-cobalt(iii) trichloride hydrate 
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17 CUDGEN 
 
ob3  P6/mcc tris(Ethylenediamine)-cobalt(iii) hydroxonium hexakis(μ4-oxo)-dodecakis(μ2-oxo)-dodecaoxo-hexa-arsenic(iii)-cobalt(ii)-hexa-molybdenum(vi) dihydrate 
18 DUCYILb oblel2  P-1 tris(ethane-1,2-diamine)-cobalt(iii) hexahydroxyoctaborate tetrahydroxypentaborate pentahydrate 
19 EDANECb oblel2  P212121 Λ-(+)589-tris(Ethylenediamine)-cobalt(iii) tris(iodide) monohydrate 
20 EDCOBRb lel3  P43212 D-tris(Ethylenediamine)-cobalt(iii) tribromide monohydrate 
21 EGOXII oblel2  P21/c catena-(tris(1,2-ethanediamine)-cobalt(iii) tetrakis(μ3-hydrogen phosphito)-(μ2-hydrogen phosphito)-(μ2-dihydrogen phosphito)-tetra-zinc(ii)) 
22 ENCCUC10d lelob2  Pbca bis(tris(Ethylenediamine)-cobalt(iii)) bis(μ-chloro)-hexachloro-di-copper(ii) dichloride dihydrat 
23 ENCOCD lel3  P21/c bis(tris(Ethylenediamine)-cobalt(iii)) hexachloro-cadmium(ii) dichloride dihydrate 
24 ENCOCTb lel3  P1 tris(Ethylenediamine)-cobalt(iii) chloride (+)-tartrate pentahydrate 
25 ENCOFDc c c c (+-)-tris(Ethylenediamine)-cobalt(iii) trifluoride 
26 ENCOIH lelob2  Pbca (+-)-tris(Ethylenediamine)-cobalt(iii) iodide monohydrate 
27 ENCOPB lel3+ oblel2
e e P21 bis(tris(Ethylenediamine)-cobalt(iii)) catena(bis(μ2-chloro)-heptachloro-di-lead(ii)) chloride trihydrate 
28 ENCOPC lelob2  P21/c tris(Ethylenediamine) cobalt pentacyano-nitrosyl-chromate dihydrate 
29 ENCOPNb lel3  Pnma bis(tris(Ethylenediamine)-cobalt(iii)) tris(monohydrogen-phosphate) nonahydrate 
30 ENCOSN oblel2  Pbca tris(Ethylenediamine) cobalt(iii) trichlorotin(ii) dichloride 
31 ENCOTTc c c P21 (+)589-Hydrogen tris(ethylenediamine) cobalt(iii) D-tartrate trihydrate 
32 ENCTARc c c P1 tris(Ethylenediamine) cobalt(iii) D-tartrate bromide pentahydrate 
33 ENICON oblel2  P212121 tris(Ethylenediamine) cobalt(iii) tetrakis(isothiocyanato) cobalt(ii) nitrate 
34 EPAXOJ lel3  C2/c tris(1,2-Diaminoethane)cobalt(iii) bis(tetrabromo-gold(iii)) bromide 
35 EXOVAO lel3+ oblel2  P-1 bis(tris(Ethylenediamine-N,N')-cobalt(iii)) bis(μ2-(1-hydroxyethylidene)diphosphonato)-dichloro-di-ruthenium(ii,iii) chloride trihydrate 
36 FAHHIH lel3  P-1 bis[tris(ethylenediamine-N,N')-cobalt(iii)] tris(oxalate) hydrate 
37 FAHHON oblel2  C2/c bis[tris(ethylenediamine-N,N')-cobalt(iii)] tris(oxalate) heptahydrate 
38 FASHUE lel3  P21/c bis(tris(Ethylenediamine)-cobalt(iii)) hexabromo-cadmium(ii) dibromide dihydrate 
39 FASJAM lel3  P21/c bis(tris(Ethylenediamine)-cobalt(iii)) trans-tetrabromo-dichloro-cadmium(ii) dibromide dihydrate 
40 FAXMEXb lel3  P6322 tris(Ethylenediamine-N,N')-cobalt(iii) chloride di-iodide monohydrate clathrate 
41 FIRQIHb lel3  P6322 tris(Ethylendiamine-N,N')-cobalt(iii) hexafluoro-gallate 
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42 GAPHUA lel3  P212121 tris(Ethylenediamine-N,N')-cobalt(iii) iodide oxalate sesquihydrate 
43 GAXKIBb lelob2  C2/c tris(ethane-1,2-diamine)-cobalt(iii) sesquikis(3,4,5-trioxocyclopent-1-ene-1,2-diolate) trihydrate 
44 GEPGEOb oblel2  P42bc Tris(ethylenediamine)-cobalt(iii) tetrathioarsenate(v) 
45 GINLUKb lel3  P212121 Λ-bis(tris(Ethylenediamine-N,N)-cobalt) tris(d-tartrate) nonadecahydrate 
46 GINMARb lel3  P1 Delta-bis(tris(Ethylenediamine-N,N)-cobalt) tris(d-tartrate) hydrate 
47 GIXRIP lel3  P-3c1 tris(Ethylenediamine-N,N')-cobalt(iii) trichloride argon clathrate 
48 GIXROV lel3  P-3c1 tris(Ethylenediamine-N,N')-cobalt(iii) trichloride xenon clathrate 
49 GIXRUB lel3  P-3c1 tris(Ethylenediamine-N,N')-cobalt(iii) trichloride dioxygen clathrate 
50 GIXSAI lel3  P-3c1 tris(Ethylenediamine-N,N')-cobalt(iii) trichloride methane clathrate 
51 GIXSEM lel3  P-3c1 tris(Ethylenediamine-N,N')-cobalt(iii) trichloride carbon tetrachloride clathrate 
52 GIZLIL lel3  P-3c1 tris(Ethylenediamine-N,N')-cobalt(iii) trichloride tetrahydrate clathrate 
53 GIZLOR lel3  P-3c1 tris(Ethylenediamine-N,N')-cobalt(iii) trichloride ethanol clathrate 
54 GIZLUX lel3  P-3c1 tris(Ethylenediamine-N,N')-cobalt(iii) trichloride benzene clathrate 
55 GULNEH lelob2  C2/m bis(tris(Ethylenediamine)-cobalt(iii)) (μ2-oxalato-O,O',O'',O''')-tetrakis(oxalato-O,O')-di-manganese(ii) hexahydrate 
56 GUZNIYb lel3  P21/n rac-tris(Ethylenediamine-N,N')-cobalt(iii) cyclotriphosphate dihydrate 
57 GUZNOEb lel3  P21 Λ-tris(Ethylenediamine-N,N')-cobalt(iii) cyclotriphosphate dihydrate 
58 HAJCOM lel3  P-1 bis[tris(ethylenediamine)-cobalt(iii)] (μ2-oxalato)-tetrakis(oxalato)-di-cobalt(ii) tetrahydrate 
59 HEQWIL oblel2  C2/c tris(ethane-1,2-diamine)-cobalt(iii) chloride ethanedioate trihydrate 
60 HEYVAJ oblel2  Pn21a bis(tris(Ethylenediamine)-cobalt(iii)) (μ2-chloro)-aqua-pentachloro-di-mercurate(ii) tetrachloride 
61 HEYVEN lel3  C2/c tris(Ethylenediamine)-cobalt(iii) bis(tetrachloro-gold(iii)) chloride 
62 IGOZEK lel3  P21/c bis(tris(Ethylene-1,2-diamine)-cobalt) hexakis(μ2-fluoro)-diaqua-hexadecafluoro-tetra-zirconium 
63 IRIRACb lel3  P-3c1 (+-)-tris(Ethylenediamine)-cobalt(iii) trichloride 
64 IYIBIC lelob2  P212121 bis(tris(D-Penicillaminato-N,O,S,S)-tri-palladium(ii)) Δ-tris(ethylenediamine)-cobalt(iii) triperchlorate decahydrate 
65 IYIBOI lelob2  P212121 bis(tris(D-Penicillaminato-N,O,S,S)-tri-palladium(ii)) Λ-tris(ethylenediamine)-cobalt(iii) triperchlorate hydrate 
66 IZEQUZc c c C2/c tris(Ethylenediamine)-cobalt diaqua-bis(ethylenediamine)-cobalt (μ8-arsenato)-
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hexadecakis(μ3-oxo)-octakis(μ2-oxo)-hexadecaoxo-octa-molybdenum(v,vi)-octa-
vanadium(iv) 
67 JIMRUT lel3  Pnna catena-(tris(Ethylene-1,2-diamine)-cobalt tetrakis(μ3-phosphato)-tri-gallium pentahydrate) 
68 LALDUZ oblel2  P-1 catena-(tris(Ethylenediamine)-cobalt(iii) hemikis(pentakis(μ2-oxalato)-bis(oxalato)-tetra-zinc) pentahydrate) 
69 LITSOW oblel2  P212121 tris(Ethylenediamine)-cobalt(iii) (μ2-iodo)-hexachloro-di-mercury(ii) 
70 LIYMUB lel3  P21/n tris(Ethylenediamine-N,N')-cobalt(iii) oxalate perchlorate dihydrate 
71 MARGAP oblel2  P-1 bis(tris(ethane-1,2-diamine)-cobalt(iii)) tris(5,5'-azotetrazolate) trihydrate 
72 MOMWOB lel3  P-1 tris(ethylenediamine)-cobalt(iii) tetraiodo-tellurium(ii) iodide 
73 MOMWUH lelob2  P21/n tris(ethylenediamine)-cobalt(iii) hexaaiodo-tellurium(iv) iodide 
74 MOTXID oblel2  Cmc21 tetrakis(tris(1,2-diaminoethane)-cobalt(iii)) tris(hexacyano-iron(ii)) hydrate 
75 MOTXOJ lel3  P21/c bis(tris(1,2-diaminoethane)-cobalt(iii)) hexacyano-iron(ii) dichloride dihydrate 
76 MUTWUU oblel2  C2/c bis(tris(Ethylenediamine)-cobalt) tris(bis(pyridine-2,6-dicarboxylato)-cobalt) hexadecahydrate 
77 NAXTUC oblel2 
f P21/c 
tris(Ethylenediamine)-cobalt(iii) 4,4'-diazido-2,2'-stilbenedisulfonate perchlorate 
monohydrate 
78 NAZZEU lel3  C2/c bis(tris(Ethylenediamine-N,N')-cobalt) bis(μ2-fluoro)-decafluoro-di-zirconium hexafluoro-silicate tetrahydrate 
79 NEJDEMb oblel2  Pnma tris(ethylenediamine-N,N')-cobalt(iii) sesquikis(squarate) hydrate 
80 NEKHUG lelob2  Pmna tris(Ethylenediamine)-cobalt tris(μ2-chloro)-aqua-octabromo-tri-rhenium bromide 
81 NIHNEZ oblel2  Pna21 tris(ethylenediamine)-cobalt(iii) tetrathioantimonate(v) 
82 NONKAC lel3  C2221 catena(d-tris(1,2-Diaminoethane)-cobalt(iii) trialumino-tetraphosphate trihydrate) 
83 NOYQOH oblel2  Pca21 (+-)-tris(Ethylenediamine)-cobalt(iii) nitrate 
84 OBIWAZ oblel2  Pnma bis[tris(ethylenediamine)-cobalt(iii)] (μ12-silicato)-octakis(μ3-oxo)-hexadecakis(μ2-oxo)-tetradecaoxo-octa-molybdenum(vi)-hexa-vanadium hexahydrate 
85 OKOQOW oblel2  P21/n 
catena-[bis(tris(ethane-1,2-diamine)-cobalt) heptakis(μ-heptanedioato)-bis(μ-oxido)-
octakis(μ-hydroxy)-tetrakis(μ-oxido)-tetracosa(oxido)-dodeca-uranium acetonitrile 
solvate trihydrate] 
86 OLANOE oblel2  P21/n bis(tris(Ethylene-1,2-diamine)-cobalt) bis(iodide) hexacyanoferrate(ii) hydrate 
87 PEFPUM lel3+ lelob2  P-1 bis(tris(Ethylenediamine)-cobalt(iii)) bis(μ5-phosphato)-pentakis(μ2-oxo)-decaoxo-penta-molybdenum hydrate 
88 PEJGAO lel3  P21 Λ-tris(ethane-1,2-diamine)-cobalt sesquikis(fumaric acid) hydrate 
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89 PEJGESb lel3  P1 Λ-tris-1,2-(ethylenediamino)-cobalt(iii) sesquikis(terephthalate) decahydrate 
90 PEJGIW oblel2  P-1 tris(ethane-1,2-diamine)-cobalt(iii) sesquikis(acetylenedicarboxylate) tetrahydrate 
91 PEJGOCb oblel2  P21/c tris(ethane-1,2-diamine)cobalt benzene-1,3,5-tricarboxylate hydrate 
92 PEJGUI lel3  C2 Δ-tris-1,2-(ethylenediamino)-cobalt(iii) fumarate nitrate dihydrate 
93 PERHIE oblel2  P21/c tris(1,2-diaminoethane)-cobalt(iii) hexacyano-iron(iii) monohydrate 
94 PESVEP oblel2  P21/c tris(1,2-diaminoethane)-cobalt(iii) hexacyano-iron(iii) 
95 PEVXAP lel3+ oblel2  P1 bis(tris(Ethylenediamine-N,N')-cobalt) divanadate(v) hydrogen-vanadate(v) hexahydrate 
96 PIBFEL lel3  P21 tris(Ethylendiamine)-cobalt bis(oxalato)-ethylenediamine-cobalt di-iodide trihydrate 
97 PIBFIP lel3  P212121 tris(Ethylenediamine)-cobalt bis(oxalato)-ethylenediamine-cobalt di-iodide monohydrate 
98 PIBFOV lel3  P212121 tris(Ethylenediamine)-cobalt tris(oxalato)-(glycinato-O,N)-cobalt iodide monohydrate 
99 PIMXIS lelob2  R3 tris(1,2-Diaminoethane-N,N')-cobalt(iii) hexachloro-iron hexachloride monohydrate 
100 POVPEV lel3  P21/c bis(tris(1,2-bis(Diamino)ethane)-cobalt) tetraiodide oxalate deuteruim oxide solvate 
101 QATWIT lelob2  P212121 tris(ethylenediamine)-cobalt (benzoato)-tetrabromo-cadmium(ii) monohydrate 
102 QORFIM lel3  C2/c catena-(tris(1,2-Diaminoethane-N,N')-cobalt(iii) (dihydrogen diborate-triphosphate)) 
103 REGSIG lel3+ oblel2  P2/a hexakis(tris(Ethylenediamine)-cobalt(iii)) bis(nitrato-O)-tris(nitrato-O,O')-diaqua-lead(ii) pentadecakis(nitrate) dihydrate 
104 RUBDEY lel3  C2/c bis(tris(ethylenendiamine)-cobalt(iii)) (trihydrogen diphosphato)-bis(dihydrogen phosphato)-bis(hydrogen phosphato)-aluminium phosphoric acid 
105 SADQUL lelob2  Pbca catena-(tris(Ethylene-1,2-diamine)-cobalt (μ3-sulfido)-tetrakis(μ2-sulfido)-thio-di-antimony-germanium) 
106 SAETCO lel3  P3 Sodium D-tris(ethylenediamine)-cobalt(iii) heptachloride hexahydrate 
107 SAFFIQ oblel2  P-1 tris(ethane-1,2-diamine)-cobalt(iii) aqua-(tris(ethanedioato))-indium(iii) 
108 SATKEE lel3  Cmc21 tris(Ethylenediamine)-cobalt(iii) tris(μ2-iodo)-hexaiodo-di-bismuth 
109 SAYKUY lelob2  P21/a rac-tris(Ethylenediamine-N,N')-cobalt trichloro-iodo-mercury(ii) chloride 
110 SINQUB lel3  I2 catena-(d-tris(Ethylenediamine)-cobalt tris(μ2-hydrogen phosphato)-(μ2-phosphato)-di-gallium) 
111 SINRIQ lel3  I2 catena-(d-tris(Ethylenediamine)-cobalt tris(μ2-hydrogen phosphato)-(μ2-phosphato)-aluminium-gallium) 
112 SOZFIWb lel3  R3 Λ-tris(Ethylenediamine-N,N')-cobalt(iii) Λ-tris(oxalato-O,O')-rhodium(iii) 
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113 SOZFOCb lel3  P21 tris(Ethylenediamine-N,N')-cobalt(iii) Δ-tris(oxalato-O,O')-rhodium(iii) 
114 SUYFICb oblel2  Pna21 tris(Ethane-1,2-diamine)-cobalt(iii) carbonate iodide tetrahydrate 
115 TAKHOD lel3  P21/c tris(Ethylenediamine)-cobalt(iii) trichloro-fluoro-tin(ii) chloride 
116 TEDDOV lel3  Pb3 tris(Ethylenediamine)-cobalt(iii) hexanitro-rhodium(iii) trihydrate 
117 TENCONb lel3  P212121 (+-)-tris(Ethylenediamine)-cobalt(iii) nitrate 
118 TIFDOC oblel2  C2/c rac-tris(Ethylenediamine-N,N')-cobalt(iii) rac-tris(pyridine-2,6-dicarboxylato-N,O,O')-terbium(iii) hydrate 
119 TIFDUI oblel2+ lelob2  P21 Δ-tris(Ethylenediamine-N,N')-cobalt(iii) cdelta/Λ-tris(pyridine-2,6-dicarboxylato-N,O,O')-terbium(iii) hydrate 
120 TUZGEA lel3  P212121 catena-(α-(+)-tris(Ethylenediamine)-cobalt tris((μ2-oxo)-dioxo-vanadium) monohydrate) 
121 UNAVIP lel3  P212121 tris(ethylenediamine)-cobalt(iii) (μ12-phosphato)-tetracosakis(μ2-oxo)-dodecaoxo-dodeca-molybdenum N,N-diethylformamide solvate 
122 UNAVOV lel3+ oblel2  P-1 tris(ethylenediamine)-cobalt(iii) (μ12-phosphato)-tetracosakis(μ2-oxo)-dodecaoxo-dodeca-molybdenum N,N-dimethylformamide solvate 
123 UNAVUB ob3  P-1 
tris(ethylenediamine)-cobalt(iii) bis(hydroxonium) bis(μ5-oxo)-tetrakis(μ3-oxo)-
hexakis(μ2-oxo)-tetradecaoxo-octa-molybdenum chloride N,N-dimethylformamide 
solvate 
124 UNAWAI lel3  P212121 tris(ethylenediamine)-cobalt(iii) (μ12-phosphato)-tetracosakis(μ2-oxo)-dodecaoxo-dodeca-tungsten N,N-diethylformamide solvate 
125 UNAWEM lel3  P21/c tris(ethylenediamine)-cobalt(iii) (μ12-phosphato)-tetracosakis(μ2-oxo)-dodecaoxo-dodeca-tungsten N,N-dimethylformamide solvate 
126 UNAWIQ lel3  P21/n bis(tris(ethylenediamine)-cobalt(iii)) sesquikis((μ12-silicato)-tetracosakis(μ2-oxo)-dodecaoxo-dodeca-tungsten) N,N-diethylformamide methanol solvate hemihydrate 
127 UNAWOW lel3+ oblel2  P-1 
sesquikis(tris(ethylenediamine)-cobalt(iii)) (μ12-silicato)-tetracosakis(μ2-oxo)-
dodecaoxo-dodeca-tungsten hemichloride N,N-dimethylformamide solvate 
sesquihydrate 
128 UQUNIE oblel2  P-1 tris(ethylenediamine)-cobalt(iii) diformato-dioxalato-indium(iii) dihydrate 
129 VISHOW lel3  C2/c bis(tris(ethane-1,2-diamine)-cobalt(iii)) bis(μ4-oxo)-bis(μ3-oxo)-octakis(μ2-oxo)-dodecaoxo-hepta-tungsten hexahydrate 
130 WACMIX lel3  P21/c tris(ethylenediamine)-cobalt(iii) ethylenediammonium polyoxoborotrivanada(v)triphosphate hydrate 
131 WESRER ob3  P21212 tris(Ethylenediamine-N,N')-cobalt(iii) bis((ethylenediaminetetra-acetato-O,O',O'',O''',N,N')-cobalt(iii)) chloride decahydrate 
 290 
132 WILREP lel3  C2/c bis(rac-tris(Ethylenediamine)-cobalt(iii)) bis(μ2-hydrogen phosphato-O,O')-bis(μ2-dihydrogen phosphato-O,O')-octachloro-tetra-zinc(ii) 
133 WILRIT oblel2  P21/c catena-(rac-tris(Ethylenediamine)-cobalt(iii) bis(μ2-hydrogen phosphato-O,O')-(μ2-dihydrogen phosphato-O,O')-dichloro-di-zinc(ii)) 
134 WIMJEI lel3  P32 tris(Ethylenediamine-N,N')-cobalt(iii) (2(R)-((4,4-diphenylcyclohexyl)phosphono-oxymethyl)diethylenetriaminepenta-acetato)-aqua-gadolinium(iii) hydrate 
135 WIPBUT lel3  C2 bis(d-tris(Ethylenediamine)-cobalt(iii)) bis(μ2-hydrogen phosphato-O,O')-bis(μ2-dihydrogen phosphato-O,O')-octachloro-tetra-zinc(ii) 
136 WOQDUCb oblel2  C2/c hexakis(cyano)-cobalt tris(1,2-ethanediamine)-cobalt pentahydrate 
137 WOQFAK lel3  P21/c hexakis(cyano)-chromium tris(1,2-ethanediamine)-cobalt dihydrate 
138 WUQKEZ lel3  P1 tris(1,2-diaminoethane)-cobalt(iii) sesquikis(carbonate) α-cyclodextrin tridecahydrate 
139 WUQKID lel3  P1 tris(1,2-diaminoethane)-cobalt(iii) sesquikis(carbonate) α-cyclodextrin ethanol solvate tetradecahydrate 
140 WUQKOJ lel3+ oblel2  P1 tris(1,2-diaminoethane)-cobalt(iii) sesquikis(carbonate) α-cyclodextrin hydrate 
141 XAGWEIf f f P21/m 
catena-(tris(ethylenediamine)-cobalt bis(μ3-hydrogen phosphato)-(μ2-hydrogen 
phosphato)-tetrakis(μ2-dihydrogen phosphato)-bis(dihydrogen phosphato)-tri-indium 
monohydrate) 
142 XEMSEPb oblel2  P1 tris(Ethane-1,2-diamine)-cobalt(iii) tris(perrhenate) 
143 XONLIV lel3+ lelob2  P21/c tetrakis(tris(Ethylenediamine)-cobalt(iii)) tris(hexacyanoruthenate(ii)) decahydrate 
144 YEMFOM lelob2  P6522 catena-[tris(Ethylenediamine)-cobalt(iii) (μ6-hydrogen diphosphato)-bis(μ3-hydrogen phosphato)-tri-zinc] 
145 YIVHIU lel3  Pna21 catena(tris(Ethylenediamine-N,N')-cobalt(iii) tetrakis(phosphato)-tri-aluminium trihydrate) 
146 YURJOL lel3  Pna21 tris(ethane-1,2-diamine)-cobalt(iii) 1,3,5,7-tetrahydroxy-1,3,5,7-tetrabora-2,4,6,8,10-pentaoxabicyclo(3.3.1)decane chloride trihydrate 
147 YUXPOW lel3  P21/c tris(Ethylenediamine)-cobalt(iii) pentafluoro-di-tin(ii) dichlorofluoro-tin(ii) chloride 
148 ZZZAZY lel3  P21/n DL-tris(Ethylenediamine)-cobalt(iii) DL-tartrate decahydrate 
149 ZZZUZMc c c P4132 L-tris(Ethylenediamine)-cobalt (iii) tribromide monohydrate 
150 ZZZVXGc c  P-3c1 rac-tris(Ethylenediamine)-cobalt(iii) tribromide trihydrate 
a Dications (cobalt(II)) have been excluded. b This salt is analyzed in the main text. c The atomic coordinates for this salt are not available in the CSD, 
precluding certain assignments. d For duplicate structures in the CSD, an Arabic numeral is generally appended to the refcode. For this salt (refcode 
ENCCUC10), there is no corresponding structure that lacks the "10". Hence, it is included in the table of unique structures. In a private communication, 
a CSD representative confirmed this, but also indicated that there are plans to reinstate some structures with lower numerals that were deleted earlier. e 
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This crystal contains both orientations (oblel2 for the  enantiomer, lel3 for the  enantiomer). f The high degree of disorder in this structure precludes 
certain assignments. 
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Table A-2. Duplicate crystal structures containing the [Co(en)3]3+ trication in the Cambridge Structural Database (CSD). 
entry/ 
reference 
CSD 
Refcode 
ob/lel 
orientation 
cobalt 
configuration 
space 
group name as represented in CSD 
151 ACUBAB01a a a P-31c catena-[tris(Ethylenediamine)-cobalt(iii) hexakis(μ5-phosphato)-(μ2-chloro)-octa-zinc dihydrate] 
152 ACUBAB02a a a P-31c catena-(tris(Ethylenediamine)-cobalt(iii) hexakis(μ5-phosphato)-(μ2-chloro)-octa-zinc dihydrate) 
153 COCREN01 lel3  P1121 (+)-tris(Ethylenediamine) cobalt(iii)(-)-tris(ethylenediamine) chromium(iii) thiocyanate hydrate 
154 COENTC01a a  a (+-)-tris(Ethylenediamine)-cobalt(iii) thiocyanate 
155 COENTD01a a  a (+)-tris(Ethylenediamine)-cobalt(iii) (-)-tris(ethylenediamine)-chromium(iii) 
hexakis(thiocyanate) 
156 COENTD10 lel3  P212121 (+)-tris(Ethylenediamine)-cobalt(iii) (-)-tris(ethylenediamine)-chromium(iii) 
157 COTENC01 lel3  P-3c1 D,L-tris(Ethylenediamine)-cobalt(iii) trichloride trihydrate 
158 ENCOCT01 lel3  P1 tris(Ethylenediamine)-cobalt(iii) (+)589-(R,R)-tartrate chloride pentahydrate 
159 ENCOFD01a a a a (+-)tris-(Ethylenediamine)-cobalt(iii) trifluoride 
160 ENCOFD02a a a P21/n (+-)tris-(Ethylenediamine)-cobalt(iii) trifluoride 
161 ENCOPB01 lel3+ oblel2
b b P21 catena-(bis(tris(Ethylenediamine)-cobalt(iii)) bis(μ2-chloro)-heptachloro-di-lead(ii) chloride 
162 GIZLIL01 lel3  P-3c1 tris(Ethylenediamine-N,N')-cobalt(iii) trichloride tetrahydrate clathrate 
163 IRIRAC01 lel3  P-3c1 tris(Ethylenediamine-N,N')-cobalt(iii) trichloride 
164 NIHNEZ01 oblel2  P42bc tris(ethylenediamine)-cobalt(iii) tetrathioantimonate(v) 
165 PIMXIS01 lelob2  R32 tris(1,2-Diaminoethane-N,N')-cobalt(iii) hexachloro-iron hexachloride monohydrate 
166 SAETCO01 lel3  P3 bis[tris(Ethylenediammine)-cobalt(iii) trichloride] sodium chloride hexahydrate 
167 TUZGEA01 lel3  P212121 catena-(Δ-tris(Ethylenediamine)-cobalt(iii) tris((μ2-oxo)-dioxo-vanadium(v)) clathrate 
168 TUZGEA02 lel3  P212121 catena-(tris(1,2-Ethylenediamine)-cobalt tris(μ2-oxo)-hexaoxo-tri-vanadium monohydrate) 
169 ZZZAZY10 lel3  P21/n Delta,Lambda-bis(tris(Ethylenediamine-N,N)-cobalt) tris(d,l-tartrate) decahydrate 
a The atomic coordinates for this salt are not available in the CSD, precluding certain assignments. b This crystal contained both orientations (oblel2 for 
the  enantiomer, lel3 for the  enantiomer
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Table A-3. Dependence of the chemical shifts of the diastereotopic NHH' protons of Λ-
(S,S)-13+ 2X–BArf– on concentration.   
Λ-(S,S)-13+ 2Cl–BArf– Λ-(S,S)-13+ 2BF4–BArf– Λ-(S,S)-13+ 3BArf– 
con (M) -NH/C3 
(ppm) 
-NH'/C2 
(ppm) con (M) 
-NH/C3
(ppm) 
-NH'/C2
(ppm) con (M) 
-NH/C3
(ppm) 
-NH'/C2
(ppm) 
0.00429 8.34 3.77 0.008 6.02 4.20 0.00416 5.54 4.7 
0.00857 8.23 3.83 0.016 5.98 4.26 0.00833 5.57 4.73 
0.01710 8.07 3.92 0.024 5.93 4.31 0.01250 5.58 4.75 
0.02570 7.97 3.99 0.032 5.92 4.36 0.01670 5.60 4.77 
0.03430 7.86 4.06     0.048 5.87 4.37 0.02080 5.61 4.77 
0.04290 7.79 4.12    0.0250 5.61 4.78 
0.05140 7.72 4.15    0.0290 5.62 4.79 
 
Table A-4. Dependence of the chemical shifts of the 
diastereotopic NHH' protons of Λ-(S,S)-13+ 2Cl–BArf– on 
temperature. 
Temperature (° C) -NH/C3 (ppm) -NH'/C2(ppm) 
–75 7.37 4.60 
–60 7.43 4.58 
–45 7.58 4.48 
–30 7.75 4.27 
–15 7.92 4.10 
0 8.08 3.95 
23 8.27 3.75 
35 8.37 3.65 
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Table A-5. Summary of crystallographic data for solvates of stereoisomers of 13+ 3Cl–. 
Complex 
Λ-(S,S)-13+ 3Cl–·2H2O 
·2CH3OH 
-(R,R)-13+ 3Cl–·H2O 
·3CH3OHa 
-(S,S)-13+ 3Cl–
·12.5H2O 
empirical formula C44H60Cl3CoN6O4 C44.88H61.54Cl3CoN6O3.88a C84H146Cl6Co2N12O25b 
formula weight 902.26 912.60 2054.69b 
temperature of collection [K] 110(2) 110(2) 110(2) 
diffractometer Bruker APEX 2 Bruker GADDS Bruker GADDS 
wavelength [Å] 0.71073  1.54178  1.54178  
crystal system tetragonal tetragonal monoclinic 
space group P4(3) P4(1) P2(1) 
unit cell dimensions:    
               a [Å] 13.839(4)  13.8725(7) 12.0877(6) 
               b [Å] 13.839(4)  13.8725(7) 25.0985(14) 
               c [Å] 24.216(9)  24.3173(13) 16.8235(8) 
               α [deg] 90 90 90 
               β [deg] 90 90 90.887(3) 
               γ [deg] 90 90 90 
V [Å3] 4638(2)  4679.8(4) 5103.4(5)  
Z 4 4 2b 
ρcalc [Mg/m3] 1.292  1.295 1.337 
Absorption coefficient [mm–1] 0.590  4.822 4.607  
F(000) 1904 1928 2180 
crystal size [mm3] 0.60 × 0.10 × 0.10 0.12 × 0.08 × 0.04 0.16 × 0.15 × 0.07  
Θ [deg] 2.23 to 27.49 3.19 to 60.00 2.63 to 60.00 
range / indices (h, k, l) –17,17; –17,17; –31,31 –15,15; –15,15; –25,26 –13,13; –28,27; –18,18 
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reflections collected 70126 65183 112447 
independent reflections 10535 [R(int) = 0.0425] 6282 [R(int) = 0.0647] 14790 [R(int) = 0.0916] 
completeness to Θ = 27.49° 99.7% 98.5% 99.9% 
absorption correction semiempirical from equivalents semiempirical from equivalents 
semiempirical from 
equivalents 
max. and min. transmission 0.9434 and 0.7187 0.8305 and 0.5953 0.7386 and 0.5260 
refinement method full-matrix least-squares on F2 full-matrix least-squares on F2 
full-matrix least-squares 
on F2 
data / restraints / parameters 10535 / 7 / 525 6282 / 21 / 546 14790 / 265 / 1105 
goodness-of-fit on F2 1.059 1.071 1.149 
final R indices [I>2σ(I)] R1 = 0.0442, wR2 = 0.1171 R1 = 0.0407, wR2 = 0.0841 R1 = 0.0746, wR2 = 
0.1791 
R indices (all data) R1 = 0.0501, wR2 = 0.1220 R1 = 0.0510, wR2 = 0.0871 
R1 = 0.0807, wR2 = 
0.1830 
absolute structure parameter 0.000(12) 0.012(4) 0.069(5) 
largest diff. peak and hole [e Å–3] 0.945 / –0.255 0.362 / –0.622  0.972 / –0.698  
aThis salt is presented, for simplicity, as a tris(CH3OH) solvate; however, as detailed in the experimental section, one CH3OH molecule 
refined to an occupancy of 0.88. bFor the asymmetric unit; see experimental section. 
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Table A-6. Key interatomic distances (Å) and angles (°) in crystallographically 
characterrized complexes.a  
atoms 
Λ-(S,S)-13+ 3Cl–
·2H2O·2CH3OH
trication Ab tricationb -(R,R)-1
3+ 3Cl–
·H2O·3CH3OH
Co1-N1 1.910(2) 1.967(6) 1.976(5) 1.962(3) 
Co1-N2 1.975(3) 1.961(6) 1.959(6) 1.989(3) 
Co1-N3 1.985(2) 1.954(5) 1.955(6) 1.957(3) 
Co1-N4 1.963(2) 1.958(6) 1.950(6) 1.967(3) 
Co1-N5 1.963(3) 1.963(6) 1.973(7) 1.989(3) 
Co1-N6 1.949(3) 1.949(5) 1.963(6) 1.970(3) 
N1-C1 1.492(4) 1.488(9) 1.501(9) 1.484(5) 
N2-C8 1.511(4) 1.489(9) 1.505(9) 1.483(5) 
N3-C15 1.509(3) 1.475(9) 1.486(9) 1.506(5) 
N4-C22 1.502(4) 1.502(9) 1.495(9) 1.511(5) 
N5-C29 1.498(4) 1.494(9) 1.491(10) 1.504(5) 
N6-C36 1.506(4) 1.508(9) 1.489(10) 1.504(5) 
N1···Cl1 3.194(3) 3.3604(1) - 3.279(3) 
N3···Cl1 3.428(3) 3.2343(2) - 3.194(3) 
N5···Cl1 3.269(3) 3.2762(1) - 3.445(3) 
N2···Cl3 3.259(3) 3.2403(1) 3.3656(1) 3.208(3) 
N4···Cl3 3.198(3) 3.2363(1) 3.2062(2) 3.265(3) 
N6···Cl3 3.195(3) 3.3277(2) 3.2268(1) 3.220(3) 
N5···Cl2 3.231(3) 4.2407(2) - 3.327(4) 
N4···Cl2 3.266(3) 3.2458(2) - 3.202(3) 
N1H···Cl1 2.313 2.6254  2.437 
N3H···Cl1 2.606 2.5448  2.346 
N5H···Cl1 2.436 2.5689  2.634 
N2H···Cl3 2.379 2.5258 2.6708 2.324 
N4H···Cl3 2.376 2.4211 2.5065 2.379 
N6H···Cl3 2.364 2.6166 2.4632 2.398 
N5H···Cl2 2.386 3.8632 - 2.498 
N4H···Cl2 2.387 2.4074 - 2.356 
N3-Co1-N6 172.7(1) 175.2(2) 174.7(3) 172.66(14) 
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N1-Co1-N4 172.7(1) 175.5(2) 175.1(3) 171.66(13) 
N2-Co1-N5 171.9(1) 175.3(2) 175.4(3) 171.62(14) 
N3-Co1-N1 90.9(1) 92.3(2) 91.8(2) 90.95(14) 
N3-Co1-N2 96.3(1) 91.4(2) 90.8(3) 94.98(14) 
N3-Co1-N4 84.4(1) 84.4(2) 84.4(2) 84.56(13) 
N3-Co1-N5 90.5(1) 92.7(2) 92.2(2) 91.07(13) 
N6-Co1-N1 94.7(1) 92.1(2) 92.3(2) 94.39(14) 
N6-Co1-N2 89.0(1) 91.0(2) 92.8(2) 90.60(14) 
N6-Co1-N4 90.5(1) 91.3(2) 91.7(2) 90.74(13) 
N6-Co1-N5 84.6(1) 85.1(2) 84.5(3) 83.87(12) 
N1-Co1-N2 84.3(1) 84.7(2) 84.8(2) 83.76(14) 
N2-Co1-N4 90.7(1) 92.3(2) 92.2(2) 89.62(14) 
N4-Co1-N5 94.3(1) 90.5(2) 91.5(2) 96.72(14) 
N5-Co1-N1 91.3(1) 92.7(2) 91.6(2) 90.37(14) 
N1–H···Cl1 165.5 137.35  155.7 
N3–H···Cl1 152.4 132.09  156.9 
N5–H···Cl1 154.0 134.07  150.5 
N2–H···Cl3 165.8 134.78 132.9 161.2 
N4–H···Cl3 152.2 147.71 133.1 168.2 
N6–H···Cl3 153.6 134.60 140.5 151.9 
N5–H···Cl2 156.3 108.14 - 153.2 
N4–H···Cl2 165.5 151.51 - 156.6 
a The atoms are numbered such that for each salt, N1, N3, and N5 define one of the C3 
NH faces to which a chloride anion is hydrogen bonded, and N2, N4, and N6 the other. b 
These values are for one of the two independent trications of -(S,S)-13+ 3Cl– in the unit 
cell. These are distinguished by a different H2O hydrogen bonding pattern. 
 298 
 
Figure A-1. Dependence of the chemical shifts of the diastereotopic NHH' protons of Λ-(S,S)-13+ 2Cl–BArf– on temperature. 
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Figure A-2. HPLC traces of 23aa (Scheme 4.3, entry 1): (a) racemic sample; (b) 
catalyzed by Λ-(S,S)-13+ 2Cl–BArf–. 
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Figure A-3. HPLC traces of 23ab (Scheme 4.3, entry 3): (a) racemic sample; (b) 
catalyzed by Λ-(S,S)-13+ 2Cl–BArf–. For Scheme 7.4 (c) racemic sample; (d) catalyzed 
by Λ-27c3+ 3BArf–.  
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Figure A-4. HPLC traces of 23ac (Scheme 4.4, entry 1, Chiralcel OD column): (a) 
racemic sample; (b) catalyzed by Λ-(S,S)-13+ 2BF4–BArf–; (c) catalyzed by Λ-(S,S)-
13+3BF4–; (d) racemic sample (Chiralpak AS-H column); (e) catalyzed by Λ-27c3+ 
3BArf
– (Scheme 7.4, Chiralpak AS-H column). 
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Figure A-5. HPLC traces of 23bc (Scheme 4.4, entry 2): (a) racemic sample; (b) 
catalyzed by Λ-(S,S)-13+ 2BF4–BArf–; (c) catalyzed by Λ-(S,S)-13+3BF4–. For Scheme 
7.4 (d) racemic sample; (e) catalyzed by Λ-27c3+ 3BArf–.  
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Figure A-6. HPLC traces of 23cc (Scheme 4.4, entry 3): (a) racemic sample; (b) 
catalyzed by Λ-(S,S)-13+ 2BF4–BArf–; (c) catalyzed by Λ-(S,S)-13+ 3BF4– (older 
column). 
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Figure A-7. HPLC traces of 23dc (Scheme 4.4, entry 4): (a) racemic sample; (b) 
catalyzed by Λ-(S,S)-13+ 2BF4–BArf–; (c) catalyzed by Λ-(S,S)-13+ 3BF4–. For Scheme 
7.4 (d) racemic sample; (e) catalyzed by Λ-27c3+ 3BArf–. 
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Figure A-8. HPLC traces of 23ec (Scheme 4.4, entry 5): (a) racemic sample; (b) 
catalyzed by Λ-(S,S)-13+ 2BF4–BArf–; (c) catalyzed by Λ-(S,S)-13+ 3BF4–. For Scheme 
7.4 (d) racemic sample; (e) catalyzed by Λ-27c3+ 3BArf–. 
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Figure A-9. HPLC traces of 23fc (Scheme 4.4, entry 6): (a) racemic sample; (b) 
catalyzed by Λ-(S,S)-13+ 2BF4–BArf–. 
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Figure A-10. HPLC traces of 23gc (Scheme 4.4, entry 7): (a) racemic sample; (b) 
catalyzed by Λ-(S,S)-13+ 2BF4–BArf–; (c) catalyzed by Λ-(S,S)-13+ 3BF4–. 
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Figure A-11. HPLC traces of 23hc (Scheme 4.4, entry 8): (a) racemic sample; (b) 
catalyzed by Λ-(S,S)-13+ 2BF4–BArf–; (c) catalyzed by Λ-(S,S)-13+ 3BF4–. 
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Figure A-12. HPLC traces of 23ic (Scheme 4.4, entry 9): (a) racemic sample; (b) 
catalyzed by Λ-(S,S)-13+ 2BF4–BArf–; (c) catalyzed by Λ-(S,S)-13+ 3BF4–. 
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Figure A-13. HPLC traces of 23jc (Scheme 4.4, entry 10): (a) racemic sample; (b) 
catalyzed by Λ-(S,S)-13+ 2BF4–BArf–; (c) catalyzed by Λ-(S,S)-13+ 3BF4–. 
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Figure A-14. HPLC traces of 23kc (Scheme 4.4, entry 11): (a) racemic sample; (b) 
catalyzed by Λ-(S,S)-13+ 2BF4–BArf–; (c) catalyzed by Λ-(S,S)-13+ 3BF4–. For Scheme 
7.4 (d) racemic sample; (e) catalyzed by Λ-27c3+ 3BArf–.  
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Figure A-15. HPLC traces of 23lc (Scheme 4.4, entry 12): (a) racemic sample; (b) 
catalyzed by Λ-(S,S)-13+ 2BF4–BArf– and analyzed per a; (c) racemic sample six months 
later (older column); (d) catalyzed by Λ-(S,S)-13+ 3BF4– and analyzed per c. For 
Scheme 7.4 (e) racemic sample; (f) catalyzed by Λ-27c3+ 3BArf–.  
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Figure A-16. HPLC traces of 26a (Scheme 5.3): (a) racemic sample; (b) catalyzed by Δ-
(S,S)-23+ 2Cl–BArf20–. 
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Figure A-17. HPLC traces of 26b (Scheme 5.3): (a) racemic sample; (b) catalyzed by Δ-
(S,S)-13+ 2Cl–BArf20–. 
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Figure A-18. HPLC traces of 26c (Scheme 5.3): (a) racemic sample; (b) catalyzed by Δ-
(S,S)-13+ 2Cl–BArf20–. 
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Figure A-19. HPLC traces of 26d (Scheme 5.3): (a) racemic sample; (b) catalyzed by Δ-
(S,S)-13+ 2Cl–BArf20–. 
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Figure A-20. HPLC traces of 26e (Scheme 5.3): (a) racemic sample; (b) catalyzed by Δ-
(S,S)-13+ 2Cl–BArf20–; (c) catalyzed by Λ-(S,S)-13+ 2Cl–BArf20–; (d) catalyzed by Δ-
(S,S)-13+ 2Cl–BArf–. 
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Figure A-21. HPLC traces of 26f (Scheme 5.3): (a) racemic sample; (b) catalyzed by Δ-
(S,S)-13+ 2Cl–BArf20–. 
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Figure A-22. HPLC traces of 26g (Scheme 5.3): (a) racemic sample; (b) catalyzed by Δ-
(S,S)-13+ 2Cl–BArf20–; (c) catalyzed by Λ-(S,S)-13+ 2Cl–BArf20–; (d) catalyzed by Δ-
(S,S)-13+ 2Cl–BArf–. 
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Figure A-23. HPLC traces of 26h (Scheme 5.3): (a) racemic sample; (b) catalyzed by Δ-
(S,S)-13+ 2Cl–BArf20–. 
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Figure A-24. HPLC traces of 23ad (Scheme 7.4): (a) racemic sample; (b) catalyzed by 
Λ-27c3+ 3BArf–.  
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Figure A-25. HPLC traces of 23mc (Scheme 7.4): (a) racemic sample; (b) catalyzed by 
Λ-27c3+ 3BArf–.  
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Figure A-26. HPLC traces of 23nc (Scheme 7.4): (a) racemic sample; (b) catalyzed by 
Λ-27c3+ 3BArf–.  
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APPENDIX B 
 
Additional Syntheses and Data From Section 3. 
∆-(R,R)-13+ 2Cl–BArf–. This compound was prepared analogously to the 
enantiomer. The NMR spectra were similar. 
-(R,R)-13+ 2Cl–BArf–. This complex was prepared analogously to the 
enantiomer. Anal. Calcd. for C74H60BCl2CoF24N6 (1629.92): C 54.53, H 3.71, N 5.16; 
found C 54.44, H 4.08, N 5.15. The NMR spectra were similar. 
trans-[Co((S,S)-dpen)2(Cl)2]+ Cl–. A round bottom flask was charged with a 
solution of CoCl2.6H2O (3.02 g, 12.5 mmol) in ethanol (25 mL). Then a solution (S,S)-
dpen (5.04 g, 23.5 mmol) in ethanol (30 mL) was added with stirring. The solution was 
cooled to 15 °C, and aqueous HCl (2.5 mL, 4.0 M) and H2O2 (3.0 mL, 15%) were added 
with stirring. After 6 h, aqueous HCl (3.0 mL, 12.0 M) was added and the mixture was 
concentrated to ca. one third of the original volume by heating at 100 °C (oil bath). The 
sample was cooled to –8 °C (ice/salt bath) and filtered. The filter cake was washed with 
H2O (30 mL) and diethyl ether (2 × 15 mL) and dried by oil pump vacuum (6 h) to give 
trans-[Co((S,S)-dpen)2(Cl)2]+ Cl– as green powder (4.47 g, 7.57 mmol, 64% based upon 
(S,S)-dpen). 
NMR (CD3OD, δ in ppm): 1H (500 MHz) 7.43-7.22 (m, 20H, Ph), 6.61 (d, 3JHH 
= 10 Hz, 4H, NHH'), 5.16 (br, 4H, NHH'), 4.87 (br s, CD3OH/H2O, 5H), 4.67 (s, 4H, 
CHNH2); 13C{1H} (125 MHz) 138.8 (s, i), 130.2 (s, o), 129.9 (s, p), 128.7 (s, m), 66.8 
(s, CHNH2). 
Comproportionation, Λ-[Co((S,S)-13+ 3BArf– and Λ-[Co((S,S)-13+ 3Cl– 
(Scheme 3.7). An experiment analogous to that in the main text was conducted with Λ-
(S,S)-13+ 3BArf–·8H2O (0.035 g, 0.0102 mmol), CH2Cl2 (8 mL), and Λ-(S,S)-13+ 3Cl–
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·3H2O (0.0175 g, 0.0204 mmol, 2.0 equiv). The solvent was removed by rotary 
evaporation and oil pump vacuum (8 h) to give Λ-(S,S)-13+ 2Cl–BArf–·2H2O as an 
orange solid (0.048 g, 0.029 mmol, 95%). 1H NMR (CD2Cl2, δ in ppm, 500 MHz, key 
data): 8.07 (br s, 6H, NHH'), 4.46 (s, 6H, CHNH2), 3.95 (br s, 6H, NHH'); 13C{1H} 
(CD2Cl2, δ in ppm, 125 MHz, key data): 63.3 (s, CHNH2). 
Additional NMR Data (alternative solvents, concentrations, etc.)  
 ∆-(S,S)-13+ 2Cl–BArf–. 1H NMR (500 MHz, acetone-d6, δ in ppm): BArf– at 
7.79 (s, 8H, o), 7.67 (s, 4H, p); (S,S)-dpen ligand at 7.45-7.40 (m, 12H, Ph), 7.33-7.26 
(m, 18H, Ph), 7.13 (br s, 6H, NHH'), 6.16 (d, 6H, 3JHH = 10 Hz, NHH'), 5.11-5.05 (m, 
6H, CHNH2), 2.83 (br s, 8H, H2O).  
Λ-(S,S)-13+ 3PF6–. 1H NMR (500 MHz, 10:1 v/v DMSO-d6/CH3OH, δ in ppm): 
7.47 (d, 3JCH = 7.5 Hz, 12H, o-Ph), 7.39 (t, 3JCH = 7.5 Hz, 12H, m-Ph), 7.33 (d, 6H, p-
Ph), 5.55 (br s, 6H, NHH'), 5.37 (br s, 6H, NHH'), 4.83 (s, 6H, CHNH2), 3.36 (s, 8H, 
H2O). 
 Λ-(S,S)-153+ 3Cl– (intermediate in the synthesis of Λ-(S,S)-153+ 2Cl–BArf–). 
NMR (DMSO-d6, δ in ppm): 1H (500 MHz) 7.78 (br s, 24H, Ar), 7.04 (br s, 6H, NHH'), 
5.89 (br s, 6H, NHH'), 5.21 (s, 6H, CHNH2), 3.63 (br s, 8H, H2O); 13C{1H} (125 MHz) 
140.8 (s, i-Ar), 129.8 (s, Ar), 129.4 (s, Ar), 125.0 (s, Ar), 123.9 (q, 1JCF = 270.9 Hz, 
CF3), 61.0 (s, CHNH2).  
 
 
